10-K 1 hcp10-k12312017.htm 10-K Document

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K
(Mark One)
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the fiscal year ended December 31, 2017
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from             to             
Commission file number 001-08895
 
HCP, Inc.
(Exact name of registrant as specified in its charter)
Maryland
 
33-0091377
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
 
1920 Main Street, Suite 1200
Irvine, California
 
92614
(Zip Code)
(Address of principal executive offices)
 
 
Registrant’s telephone number, including area code (949) 407-0700
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Name of each exchange
on which registered
Common Stock
 
New York Stock Exchange
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes ☐ No ☒
Indicate by check mark whether the registrant; (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☒  No ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (check one):
Large accelerated filer ☒
Accelerated filer ☐
Non-accelerated filer ☐
(Do not check if a smaller
reporting company)
Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act.) Yes ☐ No ☒
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $12.8 billion.
As of January 31, 2018 there were 469,443,487 shares of common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive Proxy Statement for the registrant’s 2018 Annual Meeting of Stockholders have been incorporated by reference into Part III of this Report.
 


HCP, Inc.
Form 10-K
For the Fiscal Year Ended December 31, 2017
Table of Contents
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


All references in this report to “HCP,” the “Company,” “we,” “us” or “our” mean HCP, Inc., together with its consolidated subsidiaries. Unless the context suggests otherwise, references to “HCP, Inc.” mean the parent company without its subsidiaries.
Cautionary Language Regarding Forward-Looking Statements
Statements in this Annual Report on Form 10-K that are not historical factual statements are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “potential,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. Forward-looking statements reflect our current expectations and views about future events and are subject to risks and uncertainties that could significantly affect our future financial condition and results of operations. While forward-looking statements reflect our good faith belief and assumptions we believe to be reasonable based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this Annual Report, and such forward-looking statements are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under “Item 1A, Risk Factors” in this report, these risks and uncertainties include, but are not limited to:
•
our reliance on a concentration of a small number of tenants and operators for a significant percentage of our revenues;
•
the financial condition of our existing and future tenants, operators and borrowers, including potential bankruptcies and downturns in their businesses, and their legal and regulatory proceedings, which results in uncertainties regarding our ability to continue to realize the full benefit of such tenants’ and operators’ leases and borrowers’ loans;
•
the ability of our existing and future tenants, operators and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;
•
competition for the acquisition and financing of suitable healthcare properties as well as competition for tenants and operators, including with respect to new leases and mortgages and the renewal or rollover of existing leases;
•
our concentration in the healthcare property sector, particularly in senior housing, life sciences and medical office buildings, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries;
•
our ability to identify replacement tenants and operators and the potential renovation costs and regulatory approvals associated therewith;
•
the risks associated with property development and redevelopment, including costs above original estimates, project delays and lower occupancy rates and rents than expected;
•
the risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our partners’ financial condition and continued cooperation;
•
our ability to achieve the benefits of acquisitions or other investments within expected time frames or at all, or within expected cost projections;
•
the potential impact on us and our tenants, operators and borrowers from current and future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;
•
operational risks associated with third party management contracts, including the additional regulation and liabilities of our RIDEA lease structures;
•
the effect on us and our tenants and operators of legislation, executive orders and other legal requirements, including compliance with the Americans with Disabilities Act, fire, safety and health regulations, environmental laws, the Affordable Care Act, licensure, certification and inspection requirements, and laws addressing entitlement programs and related services, including Medicare and Medicaid, which may result in future reductions in reimbursements or fines for noncompliance;
•
changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations, of our tenants and operators;
•
our ability to foreclose on collateral securing our real estate-related loans;

1

•
volatility or uncertainty in the capital markets, the availability and cost of capital as impacted by interest rates, changes in our credit ratings, and the value of our common stock, and other conditions that may adversely impact our ability to fund our obligations or consummate transactions, or reduce the earnings from potential transactions;
•
changes in global, national and local economic and other conditions, including currency exchange rates;
•
our ability to manage our indebtedness level and changes in the terms of such indebtedness;
•
competition for skilled management and other key personnel;
•
the potential impact of uninsured or underinsured losses;
•
our reliance on information technology systems and the potential impact of system failures, disruptions or breaches; and
•
our ability to maintain our qualification as a real estate investment trust.
Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.

2

PART I
ITEM 1.
Business
General Overview
HCP, an S&P 500 company, invests primarily in real estate serving the healthcare industry in the United States (“U.S.”). We are a Maryland corporation organized in 1985 and qualify as a self-administered real estate investment trust (“REIT”). We are headquartered in Irvine, California, with offices in Nashville and San Francisco. Our diverse portfolio is comprised of investments in the following reportable healthcare segments: (i) senior housing triple-net, (ii) senior housing operating portfolio (“SHOP”), (iii) life science and (iv) medical office. At December 31, 2017, we had 190 full-time employees.
On October 31, 2016, we completed the spin-off (the “Spin-Off”) of Quality Care Properties, Inc. (“QCP”) (NYSE: QCP). The Spin-Off included 338 properties, primarily comprised of the HCR ManorCare, Inc. (“HCRMC”) direct financing lease (“DFL”) investments and an equity investment in HCRMC. QCP is an independent, publicly-traded, self-managed and self-administrated REIT. See Note 5 to the Consolidated Financial Statements for further information on the Spin-Off.
For a description of our significant activities during 2017, see Item 7 in this report.
Business Strategy
We invest and manage our real estate portfolio for the long-term to maximize the benefit to our stockholders and support the growth of our dividends. The core elements of our strategy are: (i) to acquire, develop, lease, own and manage a diversified portfolio of quality healthcare properties across multiple geographic locations and business segments including senior housing, medical office, and life science, among others; (ii) to align ourselves with leading healthcare companies, operators and service providers which, over the long-term, should result in higher relative rental rates, net operating cash flows and appreciation of property values; and (iii) to maintain an investment grade balance sheet with adequate liquidity and long-term fixed rate debt financing with staggered maturities, which supports the longer-term nature of our investments, while reducing our exposure to interest rate volatility and refinancing risk at any point in the interest rate or credit cycles.
Internal Growth Strategies
We believe our real estate portfolio holds the potential for increased future cash flows as it is well-maintained and in desirable locations. Our strategy for maximizing the benefits from these opportunities is to: (i) work with new or existing tenants and operators to address their space and capital needs; and (ii) provide high-quality property management services in order to motivate tenants to renew, expand or relocate into our properties.
We expect to continue our internal growth as a result of our ability to:  
•
Build and maintain long-term leasing and management relationships with quality tenants and operators. In choosing locations for our properties, we focus on their physical environment, adjacency to established businesses (e.g., hospital systems) and educational centers, proximity to sources of business growth and other local demographic factors.
•
Replace tenants and operators at the best available market terms and lowest possible transaction costs. We believe that we are well-positioned to attract new tenants and operators and achieve attractive rental rates and operating cash flow as a result of the location, design and maintenance of our properties, together with our reputation for high-quality building services and responsiveness to tenants, and our ability to offer space alternatives within our portfolio.
•
Extend and modify terms of existing leases prior to expiration. We structure lease extensions, early renewals or modifications, which reduce the cost associated with lease downtime or the re-investment risk resulting from the exercise of tenants’ purchase options, while securing the tenancy and relationship of our high quality tenants and operators on a long-term basis.
Investment Strategies
The delivery of healthcare services requires real estate and, as a result, tenants and operators depend on real estate, in part, to maintain and grow their businesses. We believe that the healthcare real estate market provides investment opportunities due to the: (i) compelling long-term demographics driving the demand for healthcare services; (ii) specialized nature of healthcare real estate investing; and (iii) ongoing consolidation of the fragmented healthcare real estate sector.

3

While we emphasize healthcare real estate ownership, we may also provide real estate secured financing to, or invest in equity or debt securities of, healthcare operators or other entities engaged in healthcare real estate ownership. We may also acquire all or substantially all of the securities or assets of other REITs, operating companies or similar entities where such investments would be consistent with our investment strategies. We may co-invest alongside institutional or development investors through partnerships or limited liability companies.
We monitor, but do not limit, our investments based on the percentage of our total assets that may be invested in any one property type, investment vehicle or geographic location, the number of properties that may be leased to a single tenant or operator, or loans that may be made to a single borrower. In allocating capital, we target opportunities with the most attractive risk/reward profile for our portfolio as a whole. We may take additional measures to mitigate risk, including diversifying our investments (by sector, geography, tenant or operator), structuring transactions as master leases, requiring tenant or operator insurance and indemnifications, and obtaining credit enhancements in the form of guarantees, letters of credit or security deposits.
We believe we are well-positioned to achieve external growth through acquisitions, financing and development. Other factors that contribute to our competitive position include:
•
our reputation gained through over 30 years of successful operations and the strength of our existing portfolio of properties;
•
our relationships with leading healthcare operators and systems, investment banks and other market intermediaries, corporations, private equity firms, non-profits and public institutions seeking to monetize existing assets or develop new facilities;
•
our relationships with institutional buyers and sellers of high-quality healthcare real estate;
•
our track record and reputation for executing acquisitions responsively and efficiently, which provides confidence to domestic and foreign institutions and private investors who seek to sell healthcare real estate in our market areas;
•
our relationships with nationally recognized financial institutions that provide capital to the healthcare and real estate industries; and
•
our control of sites (including assets under contract with radius restrictions).
Financing Strategies
Our REIT qualification requires us to distribute at least 90% of our REIT taxable income (excluding net capital gains); therefore, we don’t retain a significant amount of capital. As a result, we regularly access the public equity and debt markets to raise the funds necessary to finance acquisitions and debt investments, develop and redevelop properties, and refinance maturing debt. 
We may finance acquisitions and other investments through the following vehicles:
•
borrowings under our credit facility;
•
issuance or origination of debt, including unsecured notes, term loans and mortgage debt;
•
sale of ownership interests in properties or other investments; or
•
issuance of common or preferred stock or its equivalent.
We maintain a disciplined balance sheet by actively managing our debt to equity levels and maintaining multiple sources of liquidity. Our debt obligations are primarily long-term fixed rate with staggered maturities.
We finance our investments based on our evaluation of available sources of funding. For short-term purposes, we may utilize our revolving line of credit facility or arrange for other short-term borrowings from banks or other sources. We arrange for longer-term financing by offering debt and equity securities, placing mortgage debt and obtaining capital from institutional lenders and joint venture partners.

4

Segments
The following table summarizes our revenues by segment (dollars in thousands):
 
 
Year Ended December 31,
Segment
 
2017
 
%
 
2016
 
%
 
2015
 
%
Senior housing triple-net
 
$
313,547

 
17

 
$
423,118

 
20

 
$
428,269

 
22

SHOP
 
525,473

 
29

 
686,822

 
32

 
518,264

 
27

Life science
 
358,816

 
19

 
358,537

 
17

 
342,984

 
18

Medical office
 
477,459

 
26

 
446,280

 
21

 
415,351

 
21

Other non-reportable segments
 
173,083

 
9

 
214,537

 
10

 
235,621

 
12

Total revenues
 
$
1,848,378

 
100

 
$
2,129,294

 
100

 
$
1,940,489

 
100

Senior housing (triple-net and SHOP). Our senior housing facilities are managed utilizing triple-net leases and RIDEA structures, which are permitted by the Housing and Economic Recovery Act of 2008 (commonly referred to as “RIDEA”), and include independent living facilities (“ILFs”), assisted living facilities (“ALFs”), and memory care facilities (“MCFs”), and continuing care retirement communities ("CCRCs") which cater to different segments of the elderly population based upon their personal needs. Services provided by our tenants or operators in these facilities are primarily paid for by the residents directly or through private insurance and are less reliant on government reimbursement programs such as Medicare and Medicaid.
We have entered into long-term agreements with operators to manage properties under a RIDEA structure. Under the provisions of RIDEA, a REIT may lease a “qualified healthcare property” on an arm’s length basis to a taxable REIT subsidiary (“TRS”), if the property is managed on behalf of such subsidiary by a person who qualifies as an “eligible independent contractor.” RIDEA structures allow us to own the risks and rewards of the operations of healthcare facilities (as compared to leasing the property for contractual triple-net rents) in a tax efficient manner. We view RIDEA as a structure primarily to be used on properties that present attractive valuation entry points and/or growth profiles by: (i) transitioning the asset to a new operator that can bring scale, operating efficiencies, and/or ancillary services; or (ii) investing capital to reposition the asset. Our operators provide comprehensive facility management and accounting services for a majority of our senior housing RIDEA properties, for which we pay annual management fees pursuant to the aforementioned agreements. Most of the management agreements have terms ranging from 10 to 15 years, with three to four 5-year renewals. The base management fees are 4.5% to 5.0% of gross revenues (as defined) generated by the RIDEA facilities. In addition, there are incentive management fees payable to our operators if operating results of the RIDEA properties exceed pre-established EBITDAR (defined as earnings before interest, taxes, depreciation and amortization, and rent) thresholds.
Our senior housing property types under both triple-net leases and RIDEA structures are further described below:
•
Independent Living Facilities.  ILFs are designed to meet the needs of seniors who choose to live in an environment surrounded socially by their peers with services such as housekeeping, meals and activities. Additionally, the programs and services may include transportation, social activities, exercise and fitness programs, beauty or barber shop access, hobby and craft activities, community excursions, meals in a dining room setting and other activities sought by residents. These residents generally do not need assistance with activities of daily living (“ADL”). However, in some of our facilities, residents have the option to contract for these services.
•
Assisted Living Facilities.  ALFs are licensed care facilities that provide personal care services, support and housing for those who need help with ADL, such as bathing, eating, dressing and medication management, yet require limited medical care. These facilities are often in apartment-like buildings with private residences ranging from single rooms to large apartments. Certain ALFs may have a dedicated portion of a facility that offers higher levels of personal assistance for residents requiring memory care as a result of Alzheimer’s disease or other forms of dementia. Levels of personal assistance are based in part on local regulations.
•
Memory Care Facilities.  MCFs address the unique challenges of our residents with Alzheimer’s disease or other forms of dementia. Residents may live in semi-private apartments or private rooms and have structured activities delivered by staff members trained specifically on how to care for residents with memory impairment. These facilities offer programs that provide comfort and care in a secure environment.
•
Continuing Care Retirement Communities.  CCRCs offer several levels of service, including independent living, assisted living and nursing home care. CCRCs are different from other housing and care options for seniors because they usually provide written agreements or long-term contracts between residents and the communities (frequently lasting the term of the

5

resident’s lifetime), which offer a continuum of housing, services and healthcare on one campus or site. CCRCs are appealing as they allow residents to “age in place.” CCRCs typically require the individual to be in relatively good health and independent upon entry.
The following table provides information about our senior housing triple-net tenant concentration for the year ended December 31, 2017:
Tenant
 
Percentage of
Segment Revenues
 
Percentage of
Total Revenues
Brookdale Senior Living, Inc. (“Brookdale”)(1)
 
47
%
 
8
%
_______________________________________
(1)
Excludes facilities operated by Brookdale in our SHOP segment, as discussed below. Our concentration with respect to Brookdale as a tenant is expected to decrease with the completion of the transaction with Brookdale (see Note 3 in the Consolidated Financial Statements for additional information).
As of December 31, 2017, Brookdale operated, in our SHOP segment, approximately 13% of our real estate investments based on total assets. Our concentration with respect to Brookdale as an operator in our SHOP segment is expected to decrease with the completion of the transaction with Brookdale (see Note 3 in the Consolidated Financial Statements for additional information) and the sale of our remaining 40% ownership interest in RIDEA II (see Note 5 in the Consolidated Financial Statements for additional information). Because operators manage our facilities in exchange for the receipt of a management fee, we are not directly exposed to the credit risk of the operators in the same manner or to the same extent as our triple-net tenants. However, adverse developments in their business and affairs or financial condition could impair their ability to efficiently and effectively manage our facilities.
Life science.  These properties contain laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations involved in the life science industry. While these properties have characteristics similar to commercial office buildings, they generally contain more advanced electrical, mechanical, and heating, ventilating and air conditioning (“HVAC”) systems. The facilities generally have specialty equipment including emergency generators, fume hoods, lab bench tops and related amenities. In many instances, life science tenants make significant investments to improve their leased space, in addition to landlord improvements, to accommodate biology, chemistry or medical device research initiatives.
Life science properties are primarily configured in business park or campus settings and include multiple buildings. The business park and campus settings allow us the opportunity to provide flexible, contiguous/adjacent expansion to accommodate the growth of existing tenants. Our properties are located in well-established geographical markets known for scientific research and drug discovery, including San Francisco (63%) and San Diego (25%), California, Boston, Massachusetts, and Durham, North Carolina (based on square feet). At December 31, 2017, 93% of our life science properties were triple-net leased (based on leased square feet).
The following table provides information about our life science tenant concentration for the year ended December 31, 2017:
Tenants
 
Percentage of
Segment Revenues
 
Percentage of
Total Revenues
Amgen, Inc.
 
15
%
 
3
%
Google LLC
 
10
%
 
2
%
Medical office.   Medical office buildings (“MOBs”) typically contain physicians’ offices and examination rooms, and may also include pharmacies, hospital ancillary service space and outpatient services such as diagnostic centers, rehabilitation clinics and day-surgery operating rooms. While these facilities are similar to commercial office buildings, they require additional plumbing, electrical and mechanical systems to accommodate multiple exam rooms that may require sinks in every room, and special equipment such as x-ray machines. In addition, MOBs are often built to accommodate higher structural loads for certain equipment and may contain vaults or other specialized construction. Our MOBs are typically multi-tenant properties leased to healthcare providers (hospitals and physician practices), with approximately 81% of our MOBs, based on square feet, located on hospital campuses and 94% affiliated with hospital systems. Occasionally, we invest in MOBs located on hospital campuses, which may be subject to ground leases. At December 31, 2017, approximately 54% of our medical office buildings were net leased (based on leased square feet) with the remaining leased under gross or modified gross leases.

6

The following table provides information about our medical office tenant concentration for the year ended December 31, 2017:
Tenant
 
Percentage of
Segment Revenues
 
Percentage of
Total Revenues
Hospital Corporation of America ("HCA")(1)
 
17
%
 
6
%
_______________________________________
(1)
Percentage of total revenues from HCA includes revenues earned from both our medical office and other non-reportable segments.
Other non-reportable segments.  At December 31, 2017, we had interests in 14 hospitals, 61 care homes in the United Kingdom (“U.K.”), one post-acute/skilled nursing facilities (“SNF”) and debt investments. Additionally, we had interests in 72 senior housing facilities, four life science facilities, three MOBs and three SNFs owned and operated by our unconsolidated joint ventures. Services provided by our tenants and operators in hospitals are paid for by private sources, third-party payors (e.g., insurance and HMOs) or through Medicare and Medicaid programs. Our hospital property types include acute care, long-term acute care, and specialty and rehabilitation hospitals. Care homes offer personal care services, such as lodging, meal services, housekeeping and laundry services, medication management and assistance with ADL. Care homes are registered to provide different levels of services, ranging from personal care to nursing care. Some homes can be further registered for a specific care need, such as dementia or terminal illness. SNFs offer restorative, rehabilitative and custodial nursing care for people following a hospital stay or not requiring the more extensive and complex treatment available at hospitals. All of our care homes in the U.K., hospitals and SNFs are triple-net leased.
Competition
Investing in real estate serving the healthcare industry is highly competitive. We face competition from other REITs, investment companies, pension funds, private equity investors, sovereign funds, healthcare operators, lenders, developers and other institutional investors, some of whom may have greater flexibility (e.g., non-REIT competitors), resources and lower costs of capital than we do. Increased competition makes it more challenging for us to identify and successfully capitalize on opportunities that meet our objectives. Our ability to compete may also be impacted by global, national and local economic trends, availability of investment alternatives, availability and cost of capital, construction and renovation costs, existing laws and regulations, new legislation and population trends.
Income from our investments depends on our tenants’ and operators’ ability to compete with other companies on multiple levels, including: the quality of care provided, reputation, success of product or drug development, the physical appearance of a facility, price and range of services offered, alternatives for healthcare delivery, the supply of competing properties, physicians, staff, referral sources, location, the size and demographics of the population in surrounding areas, and the financial condition of our tenants and operators. For a discussion of the risks associated with competitive conditions affecting our business, see “Item 1A, Risk Factors” in this report.
Government Regulation, Licensing and Enforcement
Overview
Our healthcare facility operators (which include our TRSs when we use a RIDEA structure) and tenants are typically subject to extensive and complex federal, state and local healthcare laws and regulations relating to quality of care, licensure and certificate of need, government reimbursement, fraud and abuse practices, and similar laws governing the operation of healthcare facilities, and we expect that the healthcare industry, in general, will continue to face increased regulation and pressure in the areas of fraud, waste and abuse, cost control, healthcare management and provision of services, among others. These regulations are wide ranging and can subject our tenants and operators to civil, criminal and administrative sanctions. Affected tenants and operators may find it increasingly difficult to comply with this complex and evolving regulatory environment because of a relative lack of guidance in many areas as certain of our healthcare properties are subject to oversight from several government agencies, and the laws may vary from one jurisdiction to another. Changes in laws, regulations, reimbursement enforcement activity and regulatory non-compliance by our tenants and operators can all have a significant effect on their operations and financial condition, which in turn may adversely impact us, as detailed below and set forth under “Item 1A, Risk Factors” in this report.

7

The following is a discussion of certain laws and regulations generally applicable to our operators, and in certain cases, to us.
Fraud and Abuse Enforcement
There are various extremely complex U.S. federal and state laws and regulations (and in relation to our facilities located in the U.K., national laws and regulations of England, Scotland, Northern Ireland, and Wales) governing healthcare providers’ relationships and arrangements and prohibiting fraudulent and abusive practices by such providers. These laws include: (i) U.S. federal and state false claims acts and U.K. anti-fraud legislation and regulation, which, among other things, prohibit providers from filing false claims or making false statements to receive payment from Medicare, Medicaid or other U.S. federal or state or U.K. healthcare programs; (ii) U.S. federal and state anti-kickback and fee-splitting statutes, including the Medicare and Medicaid anti-kickback statute, which prohibit or restrict the payment or receipt of remuneration to induce referrals or recommendations of healthcare items or services, and U.K. legislation and regulations on financial inducements and vested interests; (iii) U.S. federal and state physician self-referral laws (commonly referred to as the “Stark Law”), which generally prohibit referrals by physicians to entities with which the physician or an immediate family member has a financial relationship; and (iv) the federal Civil Monetary Penalties Law, which prohibits, among other things, the knowing presentation of a false or fraudulent claim for certain healthcare services. Violations of U.S. and U.K. healthcare fraud and abuse laws carry civil, criminal and administrative sanctions, including punitive sanctions, monetary penalties, imprisonment, denial of Medicare and Medicaid reimbursement and potential exclusion from Medicare, Medicaid or other federal or state healthcare programs. These laws are enforced by a variety of federal, state and local agencies and in the U.S. can also be enforced by private litigants through, among other things, federal and state false claims acts, which allow private litigants to bring qui tam or “whistleblower” actions. Many of our tenants and operators are subject to these laws, and may become the subject of governmental enforcement actions or whistleblower actions if they fail to comply with applicable laws. Additionally, beginning in November 2019, the licensed operators of our U.S. long-term care facilities will be required to have compliance and ethics programs that meet the requirements of federal regulations. We have begun the process of developing and implementing such programs.
Laws and Regulations Governing Privacy and Security
There are various U.S. federal and state and U.K. privacy laws and regulations, including the privacy and security rules contained in the Health Insurance Portability and Accountability Act of 1996 (commonly referred to as “HIPAA”) and the U.K. Data Protection Act 1998, which provide for the privacy and security of personal health information. An increasing focus of the U. S. Federal Trade Commission’s (“FTC’s”) consumer protection regulation is the impact of technological change on protection of consumer privacy. The FTC has taken enforcement action against companies that do not abide by their representations to consumers regarding electronic security and privacy. To the extent we or our affiliated operating entities are a covered entity or business associate under HIPAA and the Health Information Technology for Economic and Clinical Health Act (the “HITECH Act”), compliance with those requirements would require us to, among other things, conduct a risk analysis, implement a risk management plan, implement policies and procedures, and conduct employee training. In most cases, we are dependent on our tenants and management companies to fulfill our compliance obligations. Because of the far reaching nature of these laws, there can be no assurance that we would not be required to alter one or more of our systems and data security procedures to be in compliance with these laws. Our failure to protect health information could subject us to civil or criminal liability and adverse publicity, and could harm our business and impair our ability to attract new customers and residents. We may be required to notify individuals, as well as government agencies and the media, if we experience a data breach.
Reimbursement
Sources of revenue for some of our tenants and operators include, among others, governmental healthcare programs, such as the federal Medicare programs and state Medicaid programs and, in the U.K., the National Health Service (“NHS”) and local authority funding, and non-governmental third-party payors, such as insurance carriers and HMOs. As federal and state governments focus on healthcare reform initiatives, and as the federal government and many states face significant current and future budget deficits, efforts to reduce costs by these payors will likely continue, which may result in reduced or slower growth in reimbursement for certain services provided by some of our tenants and operators. Similarly, in the U.K., the NHS and the local authorities are undertaking efforts to reduce costs, which may result in reduced or slower growth in reimbursement for certain services provided by our U.K. tenants and operators. Additionally, new and evolving payor and provider programs in the U.S., including but not limited to Medicare Advantage, Dual Eligible, Accountable Care Organizations (“ACO”), and Bundled Payments could adversely impact our tenants’ and operators’ liquidity, financial condition or results of operations.

8

Healthcare Licensure and Certificate of Need
Certain healthcare facilities in our portfolio (including our facilities located in the U.K.) are subject to extensive national, federal, state and local licensure, certification and inspection laws and regulations. A healthcare facility’s failure to comply with these laws and regulations could result in a revocation, suspension, or non-renewal of the facility’s license, which could adversely affect the facility’s operations and ability to bill for items and services provided at the facility. In addition, various licenses and permits are required to handle controlled substances (including narcotics), operate pharmacies, handle radioactive materials and operate equipment. Many states in the U.S. require certain healthcare providers to obtain a certificate of need, which requires prior approval for the construction, expansion or closure of certain healthcare facilities. The approval process related to state certificate of need laws may impact the ability of some of our tenants and operators to expand or change their businesses.
Life Science Facilities
While our life science tenants include some well-established companies, other tenants are less established and, in some cases, may not yet have a product approved by the Food and Drug Administration, or other regulatory authorities, for commercial sale. Creating a new pharmaceutical product or medical device requires substantial investments of time and capital, in part because of the extensive regulation of the healthcare industry; it also entails considerable risk of failure in demonstrating that the product is safe and effective and in gaining regulatory approval and market acceptance.
Senior Housing Entrance Fee Communities
Certain of our senior housing facilities, primarily the CCRCs in our unconsolidated joint ventures, are operated as entrance fee communities. Generally, an entrance fee is an upfront fee or consideration paid by a resident, a portion of which may be refundable, in exchange for some form of long-term benefit, typically consisting of a right to receive certain personal or health care services. Some of the entrance fee communities are subject to significant state regulatory oversight, including, for example, oversight of each facility’s financial condition, establishment and monitoring of reserve requirements and other financial restrictions, the right of residents to cancel their contracts within a specified period of time, the right of residents to receive a refund of their entrance fees, lien rights in favor of the residents, restrictions on change of ownership and similar matters.
Americans with Disabilities Act (the “ADA”)
Our properties must comply with the ADA and any similar state or local laws to the extent that such properties are “public accommodations” as defined in those statutes. The ADA may require removal of barriers to access by persons with disabilities in certain public areas of our properties where such removal is readily achievable. To date, we have not received any notices of noncompliance with the ADA that have caused us to incur substantial capital expenditures to address ADA concerns. Should barriers to access by persons with disabilities be discovered at any of our properties, we may be directly or indirectly responsible for additional costs that may be required to make facilities ADA-compliant. Noncompliance with the ADA could result in the imposition of fines or an award of damages to private litigants. The obligation to make readily achievable accommodations pursuant to the ADA is an ongoing one, and we continue to assess our properties and make modifications as appropriate in this respect.
Environmental Matters
A wide variety of federal, state and local environmental and occupational health and safety laws and regulations affect healthcare facility operations. These complex federal and state statutes, and their enforcement, involve a myriad of regulations, many of which involve strict liability on the part of the potential offender. Some of these federal and state statutes may directly impact us. Under various federal, state and local environmental laws, ordinances and regulations, an owner of real property or a secured lender, such as us, may be liable for the costs of removal or remediation of hazardous or toxic substances at, under or disposed of in connection with such property, as well as other potential costs relating to hazardous or toxic substances (including government fines and damages for injuries to persons and adjacent property). The cost of any required remediation, removal, fines or personal or property damages and any related liability therefore could exceed or impair the value of the property and/or the assets. In addition, the presence of such substances, or the failure to properly dispose of or remediate such substances, may adversely affect the value of such property and the owner’s ability to sell or rent such property or to borrow using such property as collateral which, in turn, could reduce our earnings. For a description of the risks associated with environmental matters, see “Item 1A, Risk Factors” in this report.
Insurance
We obtain various types of insurance to mitigate the impact of property, business interruption, liability, flood, windstorm, earthquake, environmental and terrorism related losses. We attempt to obtain appropriate policy terms, conditions, limits and deductibles considering the relative risk of loss, the cost of such coverage and current industry practice. There are, however, certain types of extraordinary losses, such as those due to acts of war or other events that may be either uninsurable or not economically

9

insurable. In addition, we have a large number of properties that are exposed to earthquake, flood and windstorm occurrences which carry higher deductibles.
We maintain property insurance for all of our properties, primary for our SHOP, life science and medical office segments. Tenants under triple-net leases, primarily in our senior housing triple-net segment, are required to provide primary property, business interruption and liability insurance. We maintain separate general and professional liability insurance for our SHOP facilities. Additionally, our corporate general liability insurance program also extends coverage for all of our properties beyond the aforementioned. We periodically review whether we or our RIDEA operators will bear responsibility for maintaining the required insurance coverage for the applicable SHOP properties, but the costs of such insurance are facility expenses paid from the revenues of those properties, regardless of who maintains the insurance. 
See Note 16 to the Consolidated Financial Statements for further information relating to casualty-related losses and recoveries incurred as a result of the hurricanes in the third quarter of 2017.
We also maintain directors and officers liability insurance which provides protection for claims against our directors and officers arising from their responsibilities as directors and officers. Such insurance also extends to us in certain situations.
Sustainability
We believe that sustainability initiatives are a vital part of corporate responsibility, which supports our primary goal of increasing stockholder value through profitable growth. We continue to advance our commitment to sustainability, with a focus on achieving goals in each of the Environmental, Social and Governance (“ESG”) dimensions of sustainability.
Our environmental management programs strive to capture cost efficiencies that ultimately benefit our investors, tenants, operators, employees and other stakeholders, while providing a positive impact on the communities in which we operate. Our social responsibility team leads our local philanthropic and volunteer activities, and our transparent corporate governance initiatives incorporate sustainability as a critical component to achieving our business objectives and properly managing risks.
Our 2017 sustainability achievements include being named an ENERGY STAR Partner of the Year and constituency in the FTSE4Good Index series for the sixth consecutive year. We also earned the Green Star designation from the Global Real Estate Sustainability Benchmark, or GRESB, and were named to the Leadership Band by CDP for outstanding ESG performance. We achieved constituency in the North America Dow Jones Sustainability Index (“DJSI”) for the fifth consecutive year, as well as the World DJSI for the third time. Additionally, we were included in The Sustainability Yearbook 2018, a listing of the world’s most sustainable companies. The list is compiled according to the results of RobecoSAM’s annual Corporate Sustainability Assessment, which also determines constituency for the Dow Jones Sustainability Index (“DJSI”) series. For additional information regarding our ESG sustainability initiatives and our approach to climate change, please visit our website at www.hcpi.com/sustainability.
Available Information
Our website address is www.hcpi.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) are available on our website, free of charge, as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the U.S. Securities and Exchange Commission (“SEC”).
ITEM 1A.
Risk Factors 
The section below discusses the most significant risk factors that may materially adversely affect our business, results of operations and financial condition.
As set forth below, we believe that the risks we face generally fall into the following categories:
•
risks related to our business and operations;
•
risks related to our capital structure and market conditions;
•
risks related to other events; and
•
risks related to tax, including REIT-related risks.

10

Risks Related to Our Business and Operations
We depend on one tenant and operator, Brookdale, for a significant percentage of our revenues and net operating income. Continuing adverse developments, including operational challenges, in Brookdale’s business and affairs or financial condition would likely have a materially adverse effect on us.
We manage our facilities utilizing RIDEA and triple-net lease structures. As of December 31, 2017, Brookdale leased or managed 78 senior housing facilities that we own and 62 SHOP facilities owned by our unconsolidated joint venture pursuant to long-term leases and management agreements. These properties represent a substantial portion of our portfolio, revenues and operating income.
Properties managed by Brookdale in our SHOP segment as of December 31, 2017, accounted for 13% of our total assets. Although we have various rights as the property owner under our management agreements, we rely on Brookdale’s personnel, expertise, technical resources and information systems, proprietary information, good faith and judgment to manage our related senior living operations efficiently and effectively. We also rely on Brookdale to set appropriate resident fees, manage occupancy, provide accurate and complete property-level financial results for these senior housing communities in a timely manner and otherwise operate them in compliance with the terms of our management agreements and all applicable laws and regulations.
Properties leased by Brookdale accounted for 8% of our revenues for the year ended December 31, 2017. In its capacity as a triple-net tenant, we depend on Brookdale to pay all insurance, tax, utilities, maintenance and repair expenses in connection with the leased properties. Brookdale may not have sufficient assets, income and access to financing to enable it to satisfy its obligations to us, and any failure, inability or unwillingness by Brookdale to do so would have a material adverse effect on us. In addition, we depend on Brookdale’s adequate maintenance and repair of the properties to remain competitive and attract and retain patients and residents. Adverse developments in Brookdale’s business and related declining rent coverage ratios have increased its credit risk. If these adverse developments result in prolonged inadequate property maintenance or improvements, or impair Brookdale’s access to capital necessary for maintenance or improvements, it would likely lead to a significant reduction in occupancy rates and market rents and have a materially adverse effect on us.
Brookdale has experienced significant challenges in recent years, including poor operational performance, ongoing class action litigation, stockholder activism and portfolio restructuring execution, among others. Brookdale has been adversely affected by increased competition that has negatively impacted occupancy rates and, in certain cases, Brookdale has offered additional discounts and incentives to residents. Brookdale, as well as our other operators, have also experienced labor expense pressure and increased labor turnover. Additionally, Brookdale has announced that it is considering corporate strategic alternatives. Brookdale’s operational, legal and financial challenges and its pursuit of strategic alternatives could significantly divert management’s attention, increase employee turnover, and impair its ability to manage our properties or its operations efficiently and effectively. These challenges and any adverse developments in Brookdale’s business, affairs and financial results could result in, among other adverse events, declining operational and financial performance of our properties, acceleration of Brookdale’s indebtedness, impairment of its continued access to capital, the enforcement of default remedies by its counterparties or the commencement of insolvency proceedings by or against it under the U.S. Bankruptcy Code.
In addition, Brookdale depends on private sources for its revenues and the ability of its patients and residents to pay its fees. For example, costs associated with independent and assisted living services are not generally reimbursable under governmental reimbursement programs such as Medicare and Medicaid. Accordingly, Brookdale depends on attracting seniors with appropriate levels of income and assets, which may be affected by many factors including prevailing economic and market trends, consumer confidence and demographics. Consequently, if Brookdale fails to effectively conduct its operations, or to maintain and improve our properties, it would adversely affect its business reputation and its ability to attract and retain patients and residents in our properties, which would have a materially adverse effect on its and our business, results of operations and financial condition.
Brookdale also relies on reimbursements from governmental programs for a portion of its revenues. Changes in reimbursement policies and other governmental regulation, such as potential changes to, or repeal of, the Patient Protection and Affordable Care Act, along with the Health Care and Education Reconciliation Act of 2010 (the “Affordable Care Act”), that may result from actions by Congress or executive orders, may result in reductions in Brookdale’s revenues, operations and cash flows and affect its ability to meet its obligations to us. For a further discussion of the legislation and regulation that are applicable to us and our tenants, operators and borrowers, see “The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid, may adversely affect our tenants’, operators’ and borrowers’ ability to meet their financial and other contractual obligations to us.” While Brookdale generally has also agreed to indemnify us for various claims, litigation and liabilities arising in connection with its business, it may have insufficient assets, income, access to financing and/or insurance coverage to enable them to satisfy its indemnification obligations.

11

We are currently in the process of reducing our exposure to Brookdale through asset sales and transitions to other operators (see “Management’s Discussion and Analysis of Financial Condition and Results of Operations--2017 Transaction Overview--Master Transactions and Cooperation Agreement with Brookdale” for more information). However, we may not be able to sell or transition assets managed or leased by Brookdale according to our plans or within our anticipated timeframe. In addition, the sale and transition process may divert Brookdale’s attention from the performance of the properties we are selling or transitioning, or from our properties Brookdale will continue to manage or lease from us following the contemplated transactions. This could result in further operational challenges and/or declining financial performance of our properties during or after the transition period. The inability, unwillingness or other failure of Brookdale to pursue the optimal performance of our properties or to meet its obligations to us under its leases and management agreements could materially reduce our cash flow, net operating income and results of operations and have other materially adverse effects on our business, results of operations and financial condition.
The bankruptcy, insolvency or financial deterioration of one or more of our major tenants, operators or borrowers may materially adversely affect our business, results of operations and financial condition.
We lease our properties directly to operators in most cases, and in certain other cases, we lease to third party tenants who enter into long-term management agreements with operators to manage the properties. We are also a direct or indirect lender to various tenants and operators and separately provide loans to certain third parties. We have very limited control over the success or failure of our tenants’, operators’ and borrowers’ businesses. Any of our tenants or operators may experience a downturn in their business that materially weakens their financial condition. As a result, they may fail to make payments when due. For example, one of our borrowers, Tandem Health Care (“Tandem”), has failed to make its required interest payments to us since November 10, 2017, which resulted in an event of default and adversely affected our revenues. Although we generally have arrangements and other agreements that give us the right under specified circumstances to terminate a lease, evict a tenant or operator, or demand immediate repayment of outstanding loan amounts or other obligations to us, we may determine not to do so if we believe that enforcement of our rights would be more detrimental to our business than seeking alternative approaches.
A downturn in any of our tenants’, operators’ or borrowers’ businesses could ultimately lead to bankruptcy if it is unable to timely resolve the underlying causes, which may be largely outside of its control. Bankruptcy and insolvency laws afford certain rights to a party that has filed for bankruptcy or reorganization that may render certain of these remedies unenforceable, or, at the least, delay our ability to pursue such remedies and realize any recoveries in connection therewith. For example, we cannot evict a tenant or operator solely because of its bankruptcy filing.
A debtor has the right to assume, or to assume and assign to a third party, or to reject its executory contracts and unexpired leases in a bankruptcy proceeding. If a debtor were to reject its leases with us, obligations under such rejected leases would cease. The claim against the rejecting debtor would be an unsecured claim, which would be limited by the statutory cap set forth in the U.S. Bankruptcy Code. This statutory cap may be substantially less than the remaining rent actually owed under the lease. In addition, a debtor may also assert in bankruptcy proceedings that leases should be re-characterized as financing agreements, which could result in our being deemed a lender instead of a landlord. A lender’s rights and remedies, as compared to a landlord’s, generally are materially less favorable, and our rights as a lender may be subordinated to other creditors’ rights.
Furthermore, the automatic stay provisions of the U.S. Bankruptcy Code would preclude us from enforcing our remedies unless we first obtain relief from the court having jurisdiction over the bankruptcy case. This would effectively limit or delay our ability to collect unpaid rent or interest payments, and we may ultimately not receive any payment at all. In addition, we would likely be required to fund certain expenses and obligations (e.g., real estate taxes, insurance, debt costs and maintenance expenses) to preserve the value of our properties, avoid the imposition of liens on our properties or transition our properties to a new tenant, operator or manager. Additionally, we lease many of our facilities to healthcare providers who provide long-term custodial care to the elderly. Evicting these operators for failure to pay rent while the facility is occupied may involve specific procedural or regulatory requirements and may not be successful. Even if eviction is possible, we may determine not to do so due to reputational or other risks. 
Bankruptcy or insolvency proceedings typically also result in increased costs to the operator, significant management distraction and performance declines. If we are unable to transition affected properties, they would likely experience prolonged operational disruption, leading to lower occupancy rates and further depressed revenues. Publicity about the operator’s financial condition and insolvency proceeds may also negatively impact their and our reputations, decreasing customer demand and revenues. Any or all of these risks could have a material adverse effect on our revenues, results of operations and cash flows. These risks would be magnified where we lease multiple properties to a single operator under a master lease, as an operator failure or default under a master lease would expose us to these risks across multiple properties.
Additionally, the financial weakness or other inability of our tenants, operators or borrowers to make payments or comply with certain other lease obligations may affect our compliance with certain covenants contained in our debt securities, credit facilities and the mortgages on the properties leased or managed by such borrowers, tenants and operators, or otherwise adversely affect

12

our results of operations. Under certain conditions, defaults under the underlying mortgages may result in cross default under our other indebtedness. Although we may be able to secure amendments under the applicable agreements in those circumstances, the bankruptcy of a borrower, tenant or operator may result in less favorable borrowing terms than currently available, delays in the availability of funding or other materially adverse consequences.
Increased competition and market and legislative changes have resulted and may further result in lower net revenues for some of our tenants, operators and borrowers and may affect their ability to meet their financial and other contractual obligations to us.
The healthcare industry is highly competitive. The occupancy levels at, and rental income from, our facilities are dependent on our ability and the ability of our tenants, operators and borrowers to compete with other tenants and operators on a number of different levels, including the quality of care provided, reputation, the physical appearance of a facility, price, the range of services offered, family preference, alternatives for healthcare delivery, the supply of competing properties, physicians, staff, referral sources, location, and the size and demographics of the population in the surrounding area. In addition, our tenants, operators and borrowers face an increasingly competitive labor market for skilled management personnel and nurses. An inability to attract and retain skilled management personnel and nurses and other trained personnel could negatively impact the ability of our tenants, operators and borrowers to meet their obligations to us. A shortage of nurses or other trained personnel or general inflationary pressures on wages may force tenants, operators and borrowers to enhance pay and benefits packages to compete effectively for skilled personnel, or to use more expensive contract personnel, but they be unable to offset these added costs by increasing the rates charged to residents. Any increase in labor costs and other property operating expenses or any failure by our tenants, operators or borrowers to attract and retain qualified personnel could adversely affect our cash flow and have a materially adverse effect on our business, results of operations and financial condition.
Our tenants, operators and borrowers also compete with numerous other companies providing similar healthcare services or alternatives such as home health agencies, life care at home, community-based service programs, retirement communities and convalescent centers. This competition, which is due, in part, to over-development in some segments in which we invest, has caused the occupancy rate of newly constructed buildings to slow and the monthly rate that many newly built and previously existing facilities were able to obtain for their services to decrease. Our tenants, operators and borrowers may be unable to achieve occupancy and rate levels, and to manage their expenses, in a way that will enable them to meet all of their obligations to us. Further, many competing companies may have resources and attributes that are superior to those of our tenants, operators and borrowers. Our tenants, operators and borrowers may encounter increased competition that could limit their ability to maintain or attract residents or expand their businesses or to manage their expenses, either of which could materially adversely affect their ability to meet their financial and other contractual obligations to us, potentially decreasing our revenues and impairing our assets and/or increasing collection and dispute costs.
In addition, our operators’ revenues are determined by a number of factors, including licensed bed capacity, occupancy, the healthcare needs of residents, the rate of reimbursement, and the income and assets of seniors in the regions in which we operate. For example, due to generally increased vulnerability to illness, a severe flu season, an epidemic or any other widespread illness could result in early move-outs or delayed move-ins during quarantine periods, which would reduce our operators’ revenues. Additionally, new and evolving payor and provider programs in the United States, including but not limited to Medicare Advantage, Dual Eligible, Accountable Care Organizations, and Bundled Payments, have resulted in reduced reimbursement rates, average length of stay and average daily census, particularly for higher acuity patients.
Furthermore, potential executive orders and legislation have introduced uncertainty in the direction of the healthcare regulatory landscape and we cannot predict the impact of any regulatory or legislative changes on the industry or our ability to compete effectively therein. See the risks described under “Legislation and Regulation-The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid, may adversely affect our tenants’, operators’ and borrowers’ ability to meet their financial and other contractual obligations to us.” 
Competition may make it difficult to identify and purchase, or develop, suitable healthcare facilities to grow our investment portfolio, to finance acquisitions on favorable terms, or to retain or attract tenants and operators.
We face significant competition from other REITs, investment companies, private equity and hedge fund investors, sovereign funds, healthcare operators, lenders, developers and other institutional investors, some of whom may have greater resources and lower costs of capital than we do. Increased competition makes it more challenging for us to identify and successfully capitalize on opportunities that meet our business goals and could improve the bargaining power of property owners seeking to sell, thereby impeding our investment, acquisition and development activities. Similarly, our properties face competition for tenants and operators from other properties in the same market, which may affect our ability to attract and retain tenants and operators, or may reduce the rents we are able to charge. If we cannot capitalize on our development pipeline, identify and purchase a sufficient

13

quantity of healthcare facilities at favorable prices, finance acquisitions on commercially favorable terms, or attract and retain profitable tenants and operators, our business, results of operations and financial condition may be materially adversely affected.
We depend on investments in the healthcare property sector, making our profitability more vulnerable to a downturn or slowdown in that specific sector than if we were investing in multiple industries.
We concentrate our investments in the healthcare property sector. As a result, we are subject to risks inherent to investments in a single industry. A downturn or slowdown in the healthcare property sector would have a greater adverse impact on our business than if we had investments in multiple industries. Specifically, a downturn in the healthcare property sector could negatively impact the ability of our tenants, operators and borrowers to meet their obligations to us, as well as the ability to maintain rental and occupancy rates. This could adversely affect our business, financial condition and results of operations. In addition, a downturn in the healthcare property sector could adversely affect the value of our properties and our ability to sell properties at prices or on terms acceptable to us.
In addition, we are exposed to the risks inherent in concentrating our investments in real estate, which investments are relatively illiquid. Our ability to quickly sell or transition any of our properties in response to changes in the performance of our properties or economic and other conditions is limited. We may be unable to recognize full value for any property that we seek to sell for liquidity reasons. Our inability to respond rapidly to changes in the performance of our investments could adversely affect our financial condition and results of operations.
Changes within the life science industry may adversely impact our revenues and results of operations.
Our life science investments could be adversely affected if the life science industry is impacted by an economic, financial, or banking crisis or if the life science industry migrates from the U.S. to other countries or to areas outside of primary life science markets in South San Francisco, San Diego and greater Boston. Also, some of our properties may be better suited for a particular life science industry client tenant and could require modification before we are able to re-lease vacant space to another life science industry client tenant. Generally, our properties may not be suitable for lease to traditional office client tenants without significant expenditures on renovations.
Our ability to negotiate contractual rent escalations on future leases and to achieve increases in rental rates will depend upon market conditions and the demand for life science properties at the time the leases are negotiated and the increases are proposed.
Many life science entities have completed mergers or consolidations. Future mergers or consolidations of life science entities could reduce the amount of rentable square footage requirements of our client tenants and prospective client tenants, which may adversely impact our revenues from lease payments and results of operations.
Our tenants in the life science industry face high levels of regulation, expense and uncertainty.
Life science tenants, particularly those involved in developing and marketing pharmaceutical products, are subject to certain unique risks, including the following:
•
some of our tenants require significant outlays of funds for the research, development, clinical testing and manufacture of their products and technologies. If private investors, the government or other sources of funding are unavailable to support such activities, a tenant’s business may be adversely affected or fail;
•
the research, development, clinical testing, manufacture and marketing of some of our tenants’ products require federal, state and foreign regulatory approvals which may be costly or difficult to obtain, may take several years and be subject to delay, may not be obtained at all, require valuation through clinical trials and the use of substantial resources, and may often be unpredictable;
•
even after a life science tenant gains regulatory approval and market acceptance, the product may still present significant regulatory and liability risks, including, among others, the possible later discovery of safety concerns and other defects and potential loss of approvals, competition from new products and the expiration of patent protection for the product;
•
our tenants with marketable products may be adversely affected by healthcare reform and the reimbursement policies of government or private healthcare payors;
•
dependence on the commercial success of certain products, which may be reliant on the efficacy of the products, acceptance of the products among doctors and patients, negative publicity and the negative results or safety signals from the clinical trials of competitors which may reduce demand or prompt regulatory actions; and

14

•
our tenants may be unable to adapt to the rapid technological advances in the industry and to adequately protect their intellectual property under patent, copyright or trade secret laws and defend against third party claims of intellectual property violations.
If our tenants’ businesses are adversely affected, they may have difficulty making payments to us, which could materially adversely affect our business, results of operations and financial condition.
The hospitals on whose campuses our MOBs are located and their affiliated healthcare systems could fail to remain competitive or financially viable, which could adversely impact their ability to attract physicians and physician groups to our MOBs and our other facilities that serve the healthcare industry.
Our MOBs and other facilities that serve the healthcare industry depend on the viability of the hospitals on whose campuses our MOBs are located and their affiliated healthcare systems in order to attract physicians and other healthcare-related users. The viability of these hospitals, in turn, depends on factors such as the quality and mix of healthcare services provided, competition, demographic trends in the surrounding community, market position and growth potential, as well as the ability of the affiliated healthcare systems to provide economies of scale and access to capital. If a hospital whose campus is located on or near one of our MOBs is unable to meet its financial obligations, and if an affiliated healthcare system is unable to support that hospital, the hospital may not be able to compete successfully or could be forced to close or relocate, which could adversely impact its ability to attract physicians and other healthcare-related users. Because we rely on our proximity to and affiliations with these hospitals to create tenant demand for space in our MOBs, their inability to remain competitive or financially viable, or to attract physicians and physician groups, could adversely affect our MOB operations and have a materially adverse effect on us.
In addition, the potential repeal of the Affordable Care Act and related regulations and uncertainty regarding potential replacement legislation, could result in significant changes to the scope of insurance coverage and reimbursement policies, which could put negative pressure on the operations and revenues of our MOBs.
We may be unable to maintain or expand our relationships with our existing and future hospital and health system clients.
The success of our medical office portfolio depends, to a large extent, on past, current and future relationships with hospitals and their affiliated health systems. We invest significant amounts of time in developing relationships with both new and existing clients. If we fail to maintain these relationships, including through a lack of responsiveness, failure to adapt to the current market and employment of individuals with adequate experience, our reputation and relationships will be harmed and we may lose business to competitors. If our relationships with hospitals and their affiliated health systems deteriorate, it could have a materially adverse effect on us.
Economic and other conditions that negatively affect geographic areas from which a greater percentage of our revenue is recognized could materially adversely affect our business, results of operations and financial condition.
For the year ended December 31, 2017, 26% of our revenue was derived from properties located in California, which is also where substantially all of our life science portfolio is located. As a result, we are subject to increased exposure to adverse conditions affecting the state, including downturns in the local economies or changes in local real estate conditions, increased competition or decreased demand, changes in state-specific legislation and local climate events and natural disasters (such as earthquakes, wildfires and hurricanes), which could cause significant disruption in our businesses in the region, harm our ability to compete effectively, result in increased costs and divert more management attention, any or all of which could adversely affect our business and results of operations.
If we must replace any of our tenants or operators, we may have difficulty identifying replacements and we may be required to incur substantial renovation costs to make certain of our healthcare properties suitable for other tenants and operators.
We cannot predict whether our tenants will renew existing leases beyond their current term. If we or our tenants terminate or do not renew the leases for our properties, we would attempt to reposition those properties with another tenant or operator. We may also voluntarily change operators for a variety of reasons. For example, in November 2017, we announced a plan to transition a significant number of properties managed by Brookdale to other operators as part of our strategic plan to reduce our concentration of assets managed or leased by Brookdale. Healthcare facilities are typically highly customized. The improvements generally required to conform a property to healthcare use, such as upgrading electrical, gas and plumbing infrastructure, are costly and at times tenant-specific and are typically subject to regulatory requirements. A new or replacement tenant or operator may require different features in a property, depending on that tenant’s or operator’s particular business. In addition, infrastructure improvements for life science facilities typically are significantly more costly than improvements to other property types, and we may be unable to recover part or all of these higher costs. Therefore, if a current tenant or operator is unable to pay rent and/or vacates a property, we may incur substantial expenditures to modify a property and experience delays before we are able to secure another tenant or operator or to accommodate multiple tenants or operators. These expenditures or renovations and delays may materially adversely affect our business, results of operations and financial condition.

15

Additionally, we may fail to identify suitable replacements or enter into leases or other arrangements with new tenants or operators on a timely basis or on terms as favorable to us as our current leases, if at all. Furthermore, during transition periods to new tenants or operators, we anticipate that the attention of existing tenants or operators will be diverted from the performance of the properties, which would cause the financial and operational performance at these properties to further decline. We also may be required to fund certain expenses and obligations such as real estate taxes, debt costs and maintenance expenses, to preserve the value of, and avoid the imposition of liens on, our properties while they are being repositioned. In addition, we may incur certain obligations and liabilities, including obligations to indemnify the replacement tenant or operator, which could have a materially adverse effect on our business, results of operations and financial condition.
We face additional risks associated with property development and redevelopment that can render a project less profitable or not profitable at all and, under certain circumstances, prevent completion of development activities once undertaken.
Property development is a component of our growth strategy. At December 31, 2017, our actual investment and estimated commitments under our development and redevelopment platforms, including land held for development, represented approximately $682 million, or 5% of our total assets. Large-scale, ground-up development of healthcare properties presents additional risks for us, including risks that:
•
a development opportunity may be abandoned after expending significant resources resulting in the loss of deposits or failure to recover expenses already incurred;
•
the development and construction costs of a project may exceed original estimates due to increased interest rates and higher materials, transportation, labor, leasing or other costs, which could make the completion of the development project less profitable;
•
the project may not be completed on schedule as a result of a variety of factors that are beyond our control, including natural disasters, labor conditions, material shortages, regulatory hurdles, civil unrest and acts of war, which result in increases in construction costs and debt service expenses or provide tenants or operators with the right to terminate pre-construction leases; and
•
occupancy rates and rents at a newly completed property may not meet expected levels and could be insufficient to make the property profitable.
Any of the foregoing risks could materially adversely affect our business, results of operations and financial condition.
Our use of joint ventures may limit our flexibility with jointly owned investments.
We have and may continue to develop and/or acquire properties in joint ventures with other persons or entities when circumstances warrant the use of these structures. Our participation in joint ventures is subject to risks that may not be present with other methods of ownership, including:
•
we could experience an impasse on certain decisions because we do not have sole decision-making authority, which could require us to expend additional resources on resolving such impasses or potential disputes, including litigation or arbitration;
•
our joint venture partners could have investment and financing goals that are not consistent with our objectives, including the timing, terms and strategies for any investments, and what levels of debt to incur or carry;
•
our ability to transfer our interest in a joint venture to a third party may be restricted and the market for our interest may be limited;
•
our joint venture partners may be structured differently than us for tax purposes, and this could create conflicts of interest and risks to our REIT status;
•
our joint venture partners might become insolvent, fail to fund their share of required capital contributions or fail to fulfill their obligations as a joint venture partner, which may require us to infuse our own capital into the venture on behalf of the partner despite other competing uses for such capital; and
•
our joint venture partners may have competing interests in our markets that could create conflict of interest issues.
Any of the foregoing risks could materially adversely affect our business, results of operations and financial condition. In addition, in some instances, we and/or our joint venture partner will have the right to cause us to sell our interest, or acquire our partner’s interest, at a time when we otherwise would not have initiated such a transaction. Our ability to acquire our partner’s interest will

16

be limited if we do not have sufficient cash, available borrowing capacity or other capital resources. This would require us to sell our interest in the joint venture when we would otherwise prefer to retain it.
From time to time we have made, and we may seek to make, one or more material acquisitions, which may involve the expenditure of significant funds.
We regularly review potential transactions in order to maximize stockholder value. Our review process may require significant management attention and a potential transaction could be abandoned or rejected by us or the other parties involved after we expend significant resources and time. In addition, future acquisitions may require the issuance of securities, the incurrence of debt, assumption of contingent liabilities or incurrence of significant expenditures, each of which could materially adversely impact our business, financial condition or results of operations. In addition, the financing required for acquisitions may not be available on commercially favorable terms or at all.
From time to time, we acquire other companies, and if we are unable to successfully integrate these operations, our business, results of operations and financial condition may be materially adversely affected.
Acquisitions require the integration of companies that have previously operated independently. Successful integration of the operations of these companies depends primarily on our ability to consolidate operations, systems, procedures, properties and personnel, and to eliminate redundancies and costs. We may encounter difficulties in these integrations. Potential difficulties associated with acquisitions include our ability to effectively monitor and manage our expanded portfolio of properties, the loss of key employees, the disruption of our ongoing business or that of the acquired entity, possible inconsistencies in standards, controls, procedures and policies, and the assumption of unexpected liabilities, including:
•
liabilities relating to the cleanup or remediation of undisclosed environmental conditions;
•
unasserted claims of vendors, residents, patients or other persons dealing with the seller;
•
liabilities, claims and litigation, whether or not incurred in the ordinary course of business, relating to periods prior to our acquisition;
•
claims for indemnification by general partners, directors, officers and others indemnified by the seller;
•
claims for return of government reimbursement payments; and
•
liabilities for taxes relating to periods prior to our acquisition.
In addition, the acquired companies and their properties may fail to perform as expected, including in respect of estimated cost savings. Inaccurate assumptions regarding future rental or occupancy rates could result in overly optimistic estimates of future revenues. Similarly, we may underestimate future operating expenses or the costs necessary to bring properties up to standards established for their intended use or for property improvements.
If we have difficulties with any of these areas, or if we later discover additional liabilities or experience unforeseen costs relating to our acquired companies, we might not achieve the economic benefits we expect from our acquisitions, and this may materially adversely affect our business, results of operations and financial condition.
Our tenants, operators and borrowers face litigation and may experience rising liability and insurance costs.
In some states, advocacy groups have been created to monitor the quality of care at healthcare facilities, and these groups have brought litigation against the tenants and operators of such facilities. Also, in several instances, private litigation by patients, residents or “whistleblowers” has sought, and sometimes resulted in, large damage awards. See “The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid, may adversely affect our tenants’, operators’ and borrowers’ ability to meet their financial and other contractual obligations to us.” The effect of this litigation and other potential litigation may materially increase the costs incurred by our tenants, operators and borrowers for monitoring and reporting quality of care compliance. In addition, their cost of liability and medical malpractice insurance can be significant and may increase or not be available at a reasonable cost so long as the present healthcare litigation environment continues. Cost increases could cause our tenants and operators to be unable to make their lease or mortgage payments or fail to purchase the appropriate liability and malpractice insurance, or cause our borrowers to be unable to meet their obligations to us, potentially decreasing our revenues and increasing our collection and litigation costs.
In addition, as a result of our ownership of healthcare facilities, we may be named as a defendant in lawsuits arising from the alleged actions of our tenants or operators. While our operators generally have agreed to indemnify us for various claims, litigation

17

and liabilities arising in connection with their operation of our properties, they may have insufficient assets, income, access to financing and/or insurance coverage to enable them to satisfy their indemnification obligations, in which case we would incur unanticipated expenditures. Furthermore, although our leases and agreements provide us with certain information rights with respect to our tenants and operators, one or more of our tenants may be or become party to pending litigation or investigation to which we are unaware or do not have a right to participate or evaluate. In such cases, we would be unable to determine the potential impact of such litigation or investigation on our tenants or our business or results. Moreover, negative publicity of any of our operators’ or tenants’ litigation, other legal proceedings or investigations may also negatively impact their and our reputation, resulting in lower customer demand and revenues, which could have a material adverse effect on our financial condition, results of operations and cash flow.
We, through our subsidiaries, enter into management contracts with third party eligible independent contractors to manage some of our facilities whereby we assume additional operational risks and are subject to additional regulation and liability.
RIDEA structures at the year ended December 31, 2017, accounted for 12% of our total assets. RIDEA permits REITs, such as us, to lease healthcare facilities that we own or partially own to a TRS, provided that our TRS hires an independent qualifying management company to operate the facility. Under the RIDEA lease structure, the independent qualifying management company receives a management fee from our TRS for operating the facility as an independent contractor. As the owner of the facility contracting out operational responsibility, we assume most of the operational risk relative to other structures because we lease our facility to our own partially- or wholly-owned subsidiary rather than a third party operator. Our resulting revenues therefore depend most on occupancy rates, the rates charged to residents and the ability to control operating expenses. Our TRS, and hence we, are responsible for any operating deficits incurred by the facility.
The operator, which would be our TRS when we use a RIDEA lease structure, of a healthcare facility is generally required to be the holder of the applicable healthcare license. This licensing requirement subjects our TRS and us (through our ownership interest in our TRS) to various regulatory laws, including those described above. Most states regulate and inspect healthcare facility operations, patient care, construction and the safety of the physical environment. If one or more of our healthcare real estate facilities fails to comply with applicable laws, our TRS, if it holds the healthcare license and is the entity enrolled in government health care programs, would be subject to penalties including loss or suspension of license, certification or accreditation, exclusion from government healthcare programs (i.e., Medicare, Medicaid), administrative sanctions, civil monetary penalties, and in certain instances, criminal penalties. Additionally, when we receive individually identifiable health information relating to residents of our TRS-operated healthcare facilities, we are subject to federal and state data privacy and confidentiality laws and rules, and could be subject to liability in the event of an audit, complaint, or data breach. Furthermore, if our TRS holds the healthcare license, it could have exposure to professional liability claims arising out of an alleged breach of the applicable standard of care rules.
In addition, rents from this TRS structure are treated as qualifying rents from real property if (i) they are paid pursuant to an arms-length lease of a “qualified healthcare property” with the TRS and (ii) the manager qualifies as an “eligible independent contractor,” as defined in the Internal Revenue Code of 1986, as amended (the “Code”). If either of these conditions is not satisfied, then the rents will not be qualifying rents.
The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid, may adversely affect our tenants’, operators’ and borrowers’ ability to meet their financial and other contractual obligations to us.
Certain of our tenants, operators and borrowers are affected, directly or indirectly, by an extremely complex set of federal, state and local laws and regulations pertaining to governmental reimbursement programs. These laws and regulations are subject to frequent and substantial changes that are sometimes applied retroactively. See “Item 1—Business—Government Regulation, Licensing and Enforcement.” For example, to the extent that our tenants, operators or borrowers receive a significant portion of their revenues from governmental payors, primarily Medicare and Medicaid, they are generally subject to, among other things:
•
statutory and regulatory changes;
•
retroactive rate adjustments;
•
recovery of program overpayments or set-offs;
•
federal, state and local litigation and enforcement actions;
•
administrative proceedings;
•
policy interpretations;
•
payment or other delays by fiscal intermediaries or carriers;

18

•
government funding restrictions (at a program level or with respect to specific facilities); and
•
interruption or delays in payments due to any ongoing governmental investigations and audits at such properties.
The failure to comply with the extensive laws, regulations and other requirements applicable to their business and the operation of our properties could result in, among other challenges: (i) becoming ineligible to receive reimbursement from governmental reimbursement programs; (ii) bans on admissions of new patients or residents; (iii) civil or criminal penalties; and (iv) significant operational changes. These laws and regulations are enforced by a variety of federal, state and local agencies and can also be enforced by private litigants through, among other things, federal and state false claims acts, which allow private litigants to bring qui tam or “whistleblower” actions.
For example, we have provided a loan to Tandem Health Care (“Tandem”), a property company that owns and operates 32 post-acute/skilled nursing facilities, in addition to operating nine leasehold interests, totaling 4,766 beds (the “Tandem Portfolio”) (see Note 7 to the Consolidated Financial Statements for additional information). Affiliates of the sole tenant and operator of Tandem’s facilities, Consulate, were named in a qui tam or “whistleblower” action that alleged that Consulate overbilled the federal government and the State of Florida (United States of America v. CMC II, LLC, et al, U.S. District Court, M.D. Florida). In February, 2017, a jury returned an adverse verdict against five Consulate entities as defendants, resulting in a $348 million judgment against all defendants. As a result of these legal and financial challenges, Consulate has failed to fully pay its contractual rent to Tandem since April 1, 2017, which has impacted Tandem’s ability to service its debt obligations to us. Since November 10, 2017, Tandem has failed to make its required interest payment to us, resulting in an event of default and adversely impacting our results of operations. On January 11, 2018, the Court overturned the jury verdict against Consulate and vacated the judgment. The plaintiff has provided notice that it will appeal the ruling, and we cannot predict the outcome. It is also possible that the parties could reach an out-of-court settlement. An unfavorable ruling against Consulate on appeal would have a materially adverse effect on its financial condition, cash flows and results of operations. This would cause additional declines in the Tandem Portfolio’s operating performance and would likely negatively affect Consulate’s and Tandem’s ability to raise capital, which would further adversely affect Tandem’s ability to meet its debt service obligations to us. We are currently evaluating our options in respect of the Tandem mezzanine loan. Regardless of the ultimate outcome, our tenants, operators and borrowers could be adversely affected by the resources required to respond to an investigation or other enforcement action. In such event, the results of operations and financial condition of our tenants and the results of operations of our properties operated by those entities could be materially adversely affected, which, in turn, could have a materially adverse effect on us.
We are unable to predict future federal, state and local regulations and legislation, including the Medicare and Medicaid statutes and regulations, or the intensity of enforcement efforts with respect to such regulations and legislation, and any changes in the regulatory framework could have a materially adverse effect on our tenants and operators, which, in turn, could have a materially adverse effect on us.
Sometimes, governmental payors freeze or reduce payments to healthcare providers, or provide annual reimbursement rate increases that are smaller than expected, due to budgetary and other pressures. Healthcare reimbursement will likely continue to be of significant importance to federal and state authorities. We cannot make any assessment as to the ultimate timing or the effect that any future legislative reforms may have on our tenants’, operators’ and borrowers’ costs of doing business and on the amount of reimbursement by government and other third-party payors. The failure of any of our tenants, operators or borrowers to comply with these laws and regulations, and significant limits on the scope of services reimbursed and on reimbursement rates and fees, could materially adversely affect their ability to meet their financial and contractual obligations to us.
Furthermore, executive orders and legislation may amend or repeal the Affordable Care Act and related regulations in whole or in part. We also anticipate that Congress, state legislatures, and third-party payors may continue to review and assess alternative healthcare delivery and payment systems and may propose and adopt legislation or policy changes or implementations effecting additional fundamental changes in the healthcare system. We cannot quantify or predict the likely impact of these possible changes on our business model, prospects, financial condition or results of operations.
Legislation to address federal government operations and administration decisions affecting the Centers for Medicare and Medicaid Services could have a materially adverse effect on our tenants’, operators’ and borrowers’ liquidity, financial condition or results of operations.
Congressional consideration of legislation pertaining to the federal debt ceiling, the Affordable Care Act, tax reform and entitlement programs, including reimbursement rates for physicians, could have a materially adverse effect on our tenants’, operators’ and borrowers’ liquidity, financial condition or results of operations. In particular, reduced funding for entitlement programs such as Medicare and Medicaid would result in increased costs and fees for programs such as Medicare Advantage Plans and additional reductions in reimbursements to providers. Amendments to or repeal of the Affordable Care Act and decisions by the Centers for Medicare and Medicaid Services could impact the delivery of services and benefits under Medicare, Medicaid or Medicare

19

Advantage Plans and could affect our tenants and operators and the manner in which they are reimbursed by such programs. Such changes could have a materially adverse effect on our tenants’, operators’ and borrowers’ liquidity, financial condition or results of operations, which could adversely affect their ability to satisfy their obligations to us and could have a materially adverse effect on us.
Compliance with the Americans with Disabilities Act and fire, safety and other regulations may require us to make expenditures that adversely affect our cash flows.
Our properties must comply with applicable ADA and any similar state and local laws. This may require removal of barriers to access by persons with disabilities in public areas of our properties. Noncompliance could result in imposition of fines or an award of damages to private litigants and the incurrence of additional costs associated with bringing the properties into compliance. While the tenants to whom we lease our properties are obligated to comply with the ADA and similar state and local provisions, and typically under tenant leases are obligated to cover costs associated with compliance, if required changes involve greater expenditures than anticipated, or if the changes must be made on a more accelerated basis than anticipated, the ability of these tenants to cover costs could be adversely affected. As a result, we could be required to expend funds to comply with the provisions of the ADA and similar state and local laws on behalf of tenants, which could adversely affect our results of operations and financial condition.
In addition, we are required to operate our properties in compliance with fire and safety regulations, building codes and other land use regulations. New and revised regulations and codes may be adopted by governmental agencies and bodies and become applicable to our properties. Compliance could require substantial capital expenditures, and may restrict our ability to renovate our properties. These expenditures and restrictions could have a material adverse effect on our ability to meet our financial obligations.
Tenants and operators that fail to comply with federal, state, local and international laws and regulations, including licensure, certification and inspection requirements, may cease to operate or be unable to meet their financial and other contractual obligations to us.
Our tenants, operators and borrowers are subject to or impacted by extensive, frequently changing federal, state, local and international laws and regulations. These laws and regulations include, among others: laws protecting consumers against deceptive practices; laws relating to the operation of our properties and how our tenants and operators conduct their business, such as fire, health and safety, data security and privacy laws; federal and state laws affecting hospitals, clinics and other healthcare communities that participate in both Medicare and Medicaid that mandate allowable costs, pricing, reimbursement procedures and limitations, quality of services and care, food service and physical plants, and similar foreign laws regulating the healthcare industry; resident rights laws (including abuse and neglect laws) and fraud laws; anti-kickback and physician referral laws; the ADA and similar state and local laws; and safety and health standards set by the Occupational Safety and Health Administration or similar foreign agencies. Certain of our properties may also require a license, registration and/or certificate of need to operate. 
Our tenants’, operators’ or borrowers’ failure to comply with any of these laws, regulations or requirements could result in loss of accreditation, denial of reimbursement, imposition of fines, suspension or decertification from government healthcare programs, civil liability, loss of license or closure of the facility and/or the incurrence of considerable costs arising from an investigation or regulatory action, which may have an adverse effect on facilities owned by or mortgaged to us, and therefore may materially adversely impact us. See “Item 1—Business—Government Regulation, Licensing and Enforcement—Healthcare Licensure and Certificate of Need” above.
We may be unable to successfully foreclose on the collateral securing our real estate-related loans, and even if we are successful in our foreclosure efforts, we may be unable to successfully operate, occupy or reposition the underlying real estate, which may adversely affect our ability to recover our investments.
If a tenant or operator defaults under one of our mortgages or mezzanine loans, we may have to foreclose on the loan or protect our interest by acquiring title to the collateral and thereafter making substantial improvements or repairs in order to maximize the property’s investment potential. In some cases, the collateral consists of the equity interests in an entity that directly or indirectly owns the applicable real property or interests in operating facilities and, accordingly, we may not have full recourse to assets of that entity, or that entity may have incurred unexpected liabilities. Tenants, operators or borrowers may contest enforcement of foreclosure or other remedies, seek bankruptcy protection against our exercise of enforcement or other remedies and/or bring claims for lender liability in response to actions to enforce mortgage obligations. Foreclosure-related costs, high loan-to-value ratios or declines in the value of the facility may prevent us from realizing an amount equal to our mortgage or mezzanine loan upon foreclosure, and we may be required to record a valuation allowance for such losses. Even if we are able to successfully foreclose on the collateral securing our real estate-related loans, we may inherit properties for which we may be unable to expeditiously secure tenants or operators, if at all, or we may acquire equity interests that we are unable to immediately resell due to limitations under the securities laws, either of which would adversely affect our ability to fully recover our investment.

20

Required regulatory approvals can delay or prohibit transfers of our healthcare facilities.
Transfers of healthcare facilities to successor tenants or operators are typically subject to regulatory approvals or ratifications, including, but not limited to, change of ownership approvals and Medicare and Medicaid provider arrangements that are not required for transfers of other types of commercial operations and other types of real estate. The replacement of any tenant or operator could be delayed by the regulatory approval process of any federal, state or local government agency necessary for the transfer of the facility or the replacement of the operator licensed to manage the facility. If we are unable to find a suitable replacement tenant or operator upon favorable terms, or at all, we may take possession of a facility, which could expose us to successor liability, require us to indemnify subsequent operators to whom we transfer the operating rights and licenses, or require us to spend substantial time and funds to preserve the value of the property and adapt the facility to other uses, all of which may materially adversely affect our business, results of operations and financial condition.
Risks Related to Our Capital Structure and Market Conditions
Interest rate increases could result in a decrease in our stock price and increased interest costs on new debt and existing variable rate debt, which could materially adversely impact our ability to refinance existing debt, sell assets and conduct acquisition, investment and development activities.
An increase in interest rates could reduce the amount investors are willing to pay for our common stock. Because REIT stocks are often perceived as high-yield investments, investors may perceive less relative benefit to owning REIT stocks as interest rates and the yield on government treasuries and other bonds increase.
Additionally, we have existing debt obligations that are variable rate obligations with interest and related payments that vary with the movement of certain indices. If interest rates increase, so would our interest costs for any variable rate debt and for new debt. This increased cost would make the financing of any acquisition and development activity more costly. Rising interest rates could limit our ability to refinance existing debt when it matures, or cause us to pay higher interest rates upon refinancing and increase interest expense on refinanced indebtedness. In addition, an increase in interest rates could decrease the amount third parties are willing to pay for our assets, thereby limiting our ability to reposition our portfolio promptly in response to changes in economic or other conditions.
We manage a portion of our exposure to interest rate risk by accessing debt with staggered maturities and through the use of derivative instruments, primarily interest rate swap agreements. However, no amount of hedging activity can fully insulate us from the risks associated with changes in interest rates. Swap agreements involve risk, including that counterparties may fail to honor their obligations under these arrangements, that these arrangements may not be effective in reducing our exposure to interest rate changes, that the amount of income we earn from hedging transactions may be limited by federal tax provisions governing REITs and that these arrangements may cause us to pay higher interest rates on our debt obligations than would otherwise be the case. Failure to hedge effectively against interest rate risk could adversely affect our results of operations and financial condition.
We rely on external sources of capital to fund future capital needs, and if access to such capital is unavailable on acceptable terms or at all, it could have a materially adverse effect on our ability to meet commitments as they become due or make future investments necessary to grow our business.
We may not be able to fund all future capital needs, including capital expenditures, debt maturities and other commitments, from cash retained from operations and dispositions. If we are unable to obtain enough internal capital, we may need to rely on external sources of capital (including debt and equity financing) to fulfill our capital requirements. Our access to capital depends upon a number of factors, some of which we have little or no control over, including but not limited to:
•
general availability of capital, including less favorable terms, rising interest rates and increased borrowing costs;
•
the market price of the shares of our equity securities and the credit ratings of our debt and any preferred securities we may issue;
•
the market’s perception of our growth potential and our current and potential future earnings and cash distributions;
•
our degree of financial leverage and operational flexibility;
•
the financial integrity of our lenders, which might impair their ability to meet their commitments to us or their willingness to make additional loans to us, and our inability to replace the financing commitment of any such lender on favorable terms, or at all;

21

•
the stability of the market value of our properties;
•
the financial performance and general market perception of our tenants and operators;
•
changes in the credit ratings on U.S. government debt securities or default or delay in payment by the United States of its obligations;
•
issues facing the healthcare industry, including, but not limited to, healthcare reform and changes in government reimbursement policies; and
•
the performance of the national and global economies generally.
In 2017, we announced our plans to sell a significant number of assets managed or leased by Brookdale, our remaining interest in RIDEA II, our mezzanine loan facility to Tandem, and our U.K. portfolio. If these transactions are successful, our financial leverage is projected to decrease, which could improve our access to capital on favorable terms. However, these transactions may not be completed on a timely basis or at all, which would delay or impede our deleveraging plan. If access to capital is unavailable on acceptable terms or at all, it could have a materially adverse impact on our ability to fund operations, repay or refinance our debt obligations, fund dividend payments, acquire properties and make the investments needed to grow our business.
Adverse changes in our credit ratings could impair our ability to obtain additional debt and equity financing on favorable terms, if at all, and negatively impact the market price of our securities, including our common stock.
Our credit ratings can affect the amount and type of capital we can access, as well as the terms of any financing we may obtain. We may be unable to maintain our current credit ratings, and in the event that our current credit ratings deteriorate, we would likely incur higher borrowing costs, which would make it more difficult or expensive to obtain additional financing or refinance existing obligations and commitments. Also, a downgrade in our credit ratings would trigger additional costs or other potentially negative consequences under our current and future credit facilities and debt instruments. The credit ratings of our senior unsecured debt are based on, among other things, our operating performance, liquidity and leverage ratios, overall financial position, level of indebtedness and pending or future changes in the regulatory framework applicable to our operators and our industry.
Our level of indebtedness may increase and materially adversely affect our future operations.
Our outstanding indebtedness as of December 31, 2017, was approximately $7.9 billion. We may incur additional indebtedness, including in connection with the development or acquisition of assets, which may be substantial. Any significant additional indebtedness would likely negatively affect the credit ratings of our debt and require us to dedicate a substantial portion of our cash flow to interest and principal payments due on our indebtedness. Greater demands on our cash resources may reduce funds available to us to pay dividends, conduct development activities, make capital expenditures and acquisitions or carry out other aspects of our business strategy. Increased indebtedness can also make us more vulnerable to general adverse economic and industry conditions and create competitive disadvantages for us compared to other companies with relatively lower debt levels. Increased future debt service obligations may limit our operational flexibility, including our ability to finance or refinance our properties, contribute properties to joint ventures or sell properties as needed.
Covenants in our debt instruments limit our operational flexibility, and breaches of these covenants could materially adversely affect our business, results of operations and financial condition.
The terms of our current secured and unsecured debt instruments and other indebtedness that we may incur, require or will require us to comply with a number of customary financial and other covenants, such as maintaining leverage ratios, minimum tangible net worth requirements, REIT status and certain levels of debt service coverage. Our continued ability to incur additional debt and to conduct business in general is subject to compliance with these financial and other covenants, which limit our operational flexibility. For example, mortgages on our properties contain customary covenants such as those that limit or restrict our ability, without the consent of the lender, to further encumber or sell the applicable properties, or to replace the applicable tenant or operator. Breaches of certain covenants may result in defaults under the mortgages on our properties and cross-defaults under certain of our other indebtedness, even if we satisfy our payment obligations to the respective obligee. Covenants that limit our operational flexibility as well as defaults resulting from the breach of any of these covenants could materially adversely affect our business, results of operations and financial condition.

22

Cash available for distribution to stockholders may be insufficient to make dividend distributions at expected levels and are made at the discretion of our Board of Directors.
If cash available for distribution generated by our assets decreases as a result of our announced dispositions or otherwise, we may be unable to make dividend distributions at expected levels. Our inability to make expected distributions would likely result in a decrease in the market price of our common stock. All distributions are made at the discretion of our Board of Directors in accordance with Maryland law and depend on our earnings, our financial condition, debt and equity capital available to us, our expectations of our future capital requirements and operating performance, restrictive covenants in our financial or other contractual arrangements (including those in our credit facility agreement), maintenance of our REIT qualification, restrictions under Maryland law and other factors as our Board of Directors may deem relevant from time to time. Additionally, our ability to make distributions will be adversely affected if any of the risks described herein, or other significant adverse events, occur.
Volatility, disruption or uncertainty in the financial markets may impair our ability to raise capital, obtain new financing or refinance existing obligations and fund real estate and development activities.
We may be affected by general market and economic conditions. Increased or prolonged market disruption, volatility or uncertainty could materially adversely impact our ability to raise capital, obtain new financing or refinance our existing obligations as they mature and fund real estate and development activities. Market volatility could also lead to significant uncertainty in the valuation of our investments and those of our joint ventures, which may result in a substantial decrease in the value of our properties and those of our joint ventures. As a result, we may be unable to recover the carrying amount of such investments and the associated goodwill, if any, which may require us to recognize impairment charges in earnings.
We may be adversely affected by fluctuations in currency exchange rates.
We have certain investments in international markets where the U.S. dollar is not the denominated currency. The ownership of investments located outside of the United States subjects us to risk from fluctuations in exchange rates between foreign currencies and the U.S. dollar. A significant change in the value of the British pound sterling (“GBP”) may have a materially adverse effect on our financial position, debt covenant ratios, results of operations and cash flow.
We may attempt to manage the impact of foreign currency exchange rate changes through the use of derivative contracts or other methods. For example, we currently utilize GBP denominated liabilities as a natural hedge against our GBP denominated assets. Additionally, we executed currency swap contracts to hedge the risk related to a portion of the forecasted interest receipts on these investments. However, no amount of hedging activity can fully insulate us from the risks associated with changes in foreign currency exchange rates, and the failure to hedge effectively against foreign currency exchange rate risk, if we choose to engage in such activities, could materially adversely affect our results of operations and financial condition. In addition, any international currency gain recognized with respect to changes in exchange rates may not qualify under the 75% gross income test or the 95% gross income test that we must satisfy annually in order to qualify and maintain our status as a REIT.
Risks Related to Other Events
We are subject to certain provisions of Maryland law and our charter relating to business combinations which may prevent a transaction that may otherwise be in the interest of our stockholders.
The Maryland Business Combination Act provides that unless exempted, a Maryland corporation may not engage in business combinations, including a merger, consolidation, share exchange or, in circumstances specified in the statute, an asset transfer or issuance or reclassification of equity securities with an “interested stockholder” or an affiliate of an interested stockholder for five years after the most recent date on which the interested stockholder became an interested stockholder, and thereafter unless specified criteria are met. An interested stockholder is generally a person owning or controlling, directly or indirectly, 10% or more of the voting power of the outstanding voting stock of a Maryland corporation. Unless our Board of Directors takes action to exempt us, generally or with respect to certain transactions, from this statute, the Maryland Business Combination Act will be applicable to business combinations between us and other persons.
In addition to the restrictions on business combinations contained in the Maryland Business Combination Act, our charter also contains restrictions on business combinations. Our charter requires that, except in certain circumstances, “business combinations,” including a merger or consolidation, and certain asset transfers and issuances of securities, with a “related person,” including a beneficial owner of 10% or more of our outstanding voting stock, be approved by the affirmative vote of the holders of at least 90% of our outstanding voting stock.

23

The restrictions on business combinations provided under Maryland law and contained in our charter may delay, defer or prevent a change of control or other transaction even if such transaction involves a premium price for our common stock or our stockholders believe that such transaction is otherwise in their best interests.
Unfavorable resolution of litigation matters and disputes could have a material adverse effect on our financial condition.
From time to time, we are involved in legal proceedings, lawsuits and other claims. We may also be named as defendants in lawsuits arising out of our alleged actions or the alleged actions of our tenants and operators for which such tenants and operators have agreed to indemnify, defend and hold us harmless. An unfavorable resolution of any such litigation may have a materially adverse effect on our business, results of operations and financial condition. Regardless of the outcome, litigation or other legal proceedings may result in substantial costs, disruption of our normal business operations and the diversion of management attention. We may be unable to prevail in, or achieve a favorable settlement of, any pending or future legal action against us. See Item 3—Legal Proceedings of this Annual Report on Form 10-K.
Loss of our key personnel could temporarily disrupt our operations and adversely affect us.
We depend on the efforts of our executive officers, and competition for these individuals is intense. Although they are covered by our Executive Severance Plan and Change in Control Plan, which provide many of the benefits typically found in executive employment agreements, none of our executive officers have employment agreements with us. The loss or limited availability of the services of any of our executive officers, or our inability to recruit and retain qualified personnel, could, at least temporarily, have a materially adverse effect on our business, results of operations and financial condition and the value of our common stock.
We may experience uninsured or underinsured losses, which could result in a significant loss of the capital invested in a property, lower than expected future revenues or unanticipated expense.
We maintain and regularly review the comprehensive insurance coverage on our properties with terms, conditions, limits and deductibles that we believe are adequate and appropriate given the relative risk and costs of such coverage. However, a large number of our properties are located in areas exposed to earthquake, windstorm, flood and other natural disasters. In particular, our life science portfolio is concentrated in areas known to be subject to earthquake activity. While we purchase insurance coverage for earthquake, windstorm, flood and other natural disasters that we believe is adequate in light of current industry practice and analyses prepared by outside consultants, such insurance may not fully cover such losses. For example, we incurred uninsured losses of approximately $11 million during 2017 as a result of hurricane-related property damage. These losses can result in decreased anticipated revenues from a property and the loss of all or a portion of the capital we have invested in a property. Following these events, we may remain liable for any mortgage debt or other financial obligations related to the property. The insurance market for such exposures can be very volatile, and we may be unable to purchase the limits and terms we desire on a commercially reasonable basis. In addition, there are certain exposures for which we do not purchase insurance because we do not believe it is economically feasible to do so or where there is no viable insurance market.
If one of our properties experiences a loss that is uninsured or that exceeds policy coverage limits, we could lose our investment in the damaged property as well as the anticipated future cash flows from such property. If the damaged property is subject to recourse indebtedness, we could continue to be liable for the indebtedness even if the property is irreparably damaged.
In addition, even if damage to our properties is covered by insurance, a disruption of business caused by a casualty event may result in loss of revenues for us. Any business interruption insurance may not fully compensate the lender or us for such loss of revenue.
Environmental compliance costs and liabilities associated with our real estate-related investments may be substantial and may materially impair the value of those investments.
Federal, state and local laws, ordinances and regulations may require us, as a current or previous owner of real estate, to investigate and clean up certain hazardous or toxic substances or petroleum released at a property. We may be held liable to a governmental entity or to third parties for property damage and for investigation and cleanup costs incurred by the third parties in connection with the contamination. The costs of cleanup and remediation could be substantial. In addition, some environmental laws create a lien on the contaminated site in favor of the government for damages and the costs it incurs in connection with the contamination.
Although we currently carry environmental insurance on our properties in an amount that we believe is commercially reasonable and generally require our tenants and operators to indemnify us for environmental liabilities they cause, such liabilities could exceed the amount of our insurance, the financial ability of the tenant or operator to indemnify us or the value of the contaminated property. As the owner of a site, we may also be held liable to third parties for damages and injuries resulting from environmental contamination emanating from the site. We may also experience environmental liabilities arising from conditions not known to

24

us. The cost of defending against these claims, complying with environmental regulatory requirements, conducting remediation of any contaminated property, or paying personal injury or other claims or fines could be substantial and could have a materially adverse effect on our business, results of operations and financial condition.
In addition, the presence of contamination or the failure to remediate contamination may materially adversely affect our ability to use, sell or lease the property or to borrow using the property as collateral.
We rely on information technology in our operations, and any material failure, inadequacy, interruption or security failure of that technology could harm our business.
We rely on information technology networks and systems, including the Internet, to process, transmit and store electronic information, and to manage or support a variety of business processes, including financial transactions and records, and maintaining personal identifying information and tenant and lease data. We purchase some of our information technology from vendors, on whom our systems depend. We rely on commercially available systems, software, tools and monitoring to provide security for the processing, transmission and storage of confidential tenant and customer data, including individually identifiable information relating to financial accounts. Although we have taken steps to protect the security of our information systems and the data maintained in those systems, it is possible that our safety and security measures will not prevent the systems’ improper functioning or damage, or the improper access or disclosure of personally identifiable information such as in the event of cyber-attacks. In addition, the pace and unpredictability of cyber threats generally quickly renders long-term implementation plans designed to address cybersecurity risks obsolete. Security breaches, including those caused by physical or electronic break-ins, computer viruses, malware, worms, attacks by hackers or foreign governments, disruptions from unauthorized access and tampering, including through social engineering such as phishing attacks, coordinated denial-of-service attacks and similar breaches, can create system disruptions, shutdowns or unauthorized disclosure of confidential information. The risk of security breaches has generally increased as the number, intensity and sophistication of attacks and intrusions have increased. In some cases, it may be difficult to anticipate or immediately detect such incidents and the damage they cause. In addition, our technology infrastructure and information systems are vulnerable to damage or interruption from natural disasters, power loss and telecommunications failures. Any failure to maintain proper function, security and availability of our information systems and the data maintained in those systems could interrupt our operations, damage our reputation, subject us to liability claims or regulatory penalties and could have a materially adverse effect on our business, financial condition and results of operations.
Risk Related to Tax, including REIT-Related Risks
Loss of our tax status as a REIT would substantially reduce our available funds and would have materially adverse consequences for us and the value of our common stock.
Qualification as a REIT involves the application of numerous highly technical and complex provisions of the Code, for which there are only limited judicial and administrative interpretations, as well as the determination of various factual matters and circumstances not entirely within our control. We intend to continue to operate in a manner that enables us to qualify as a REIT. However, our qualification and taxation as a REIT depend upon our ability to meet, through actual annual operating results, asset diversification, distribution levels and diversity of stock ownership, the various qualification tests imposed under the Code. For example, to qualify as a REIT, at least 95% of our gross income in any year must be derived from qualifying sources, and we must make distributions to our stockholders aggregating annually at least 90% of our REIT taxable income, excluding net capital gains. In addition, new legislation, regulations, administrative interpretations or court decisions could change the tax laws or interpretations of the tax laws regarding qualification as a REIT, or the federal income tax consequences of that qualification, in a manner that is materially adverse to our stockholders. Accordingly, there is no assurance that we have operated or will continue to operate in a manner so as to qualify or remain qualified as a REIT.
If we lose our REIT status, we will face serious tax consequences that will substantially reduce the funds available to make payments of principal and interest on the debt securities we issue and to make distributions to stockholders. If we fail to qualify as a REIT:
•
we will not be allowed a deduction for distributions to stockholders in computing our taxable income;
•
we will be subject to corporate-level income tax, including any applicable alternative minimum tax, on our taxable income at regular corporate rates;
•
we could be subject to increased state and local income taxes; and
•
unless we are entitled to relief under relevant statutory provisions, we will be disqualified from taxation as a REIT for the four taxable years following the year during which we fail to qualify as a REIT.

25

As a result of all these factors, our failure to qualify as a REIT could also impair our ability to expand our business and raise capital and could materially adversely affect the value of our common stock.
The present federal income tax treatment of REITs may be modified, possibly with retroactive effect, by legislative, judicial or administrative action at any time, which could affect the federal income tax treatment of an investment in us. The federal income tax rules dealing with REITs constantly are under review by persons involved in the legislative process, the U.S. Internal Revenue Service (the “IRS”) and the U.S. Treasury Department, which results in statutory changes as well as frequent revisions to regulations and interpretations. Revisions in federal tax laws and interpretations thereof could affect or cause us to change our investments and commitments and affect the tax considerations of an investment in us.
We could have potential deferred and contingent tax liabilities from corporate acquisitions that could limit, delay or impede future sales of our properties.
If, during the five-year period beginning on the date we acquire certain companies, we recognize a gain on the disposition of any property acquired, then, to the extent of the excess of (i) the fair market value of such property as of the acquisition date over (ii) our adjusted income tax basis in such property as of that date, we will be required to pay a corporate-level federal income tax on this gain at the highest regular corporate rate. There can be no assurance that these triggering dispositions will not occur, and these requirements could limit, delay or impede future sales of our properties.
In addition, the IRS may assert liabilities against us for corporate income taxes for taxable years prior to the time that we acquire certain companies, in which case we will owe these taxes plus interest and penalties, if any.
There are uncertainties relating to the calculation of non-REIT tax earnings and profits (“E&P”) in certain acquisitions, which may require us to distribute E&P.
In order to remain qualified as a REIT, we are required to distribute to our stockholders all of the accumulated non-REIT E&P of certain companies that we acquire, prior to the close of the first taxable year in which the acquisition occurs. Failure to make such E&P distributions would result in our disqualification as a REIT. The determination of the amount to be distributed in such E&P distributions is a complex factual and legal determination. We may have less than complete information at the time we undertake our analysis, or we may interpret the applicable law differently from the IRS. We currently believe that we have satisfied the requirements relating to such E&P distributions. There are, however, substantial uncertainties relating to the determination of E&P, including the possibility that the IRS could successfully assert that the taxable income of the companies acquired should be increased, which would increase our non-REIT E&P. Moreover, an audit of the acquired company following our acquisition could result in an increase in accumulated non-REIT E&P, which could require us to pay an additional taxable distribution to our then-existing stockholders, if we qualify under rules for curing this type of default, or could result in our disqualification as a REIT.
Thus, we might fail to satisfy the requirement that we distribute all of our non-REIT E&P by the close of the first taxable year in which the acquisition occurs. Moreover, although there are procedures available to cure a failure to distribute all of our E&P, we cannot now determine whether we will be able to take advantage of these procedures or the economic impact on us of doing so.
Changes to U.S. federal income tax laws could materially and adversely affect us and our stockholders.
The recently enacted Tax Cuts and Jobs Act (the ‘‘Act’’) makes substantial changes to the Code. Among those changes are a significant permanent reduction in the generally applicable corporate tax rate, changes in the taxation of individuals and other non-corporate taxpayers that generally but not universally reduce their taxes on a temporary basis subject to ‘‘sunset’’ provisions, the elimination or modification of various currently allowed deductions (including substantial limitations on the deductibility of interest and, in the case of individuals, the deduction for personal state and local taxes), certain additional limitations on the deduction of net operating losses, and preferential rates of taxation on most ordinary REIT dividends and certain business income derived by non-corporate taxpayers in comparison to other ordinary income recognized by such taxpayers. The effect of these, and the many other, changes made in the Act is highly uncertain, both in terms of their direct effect on the taxation of an investment in our common stock and their indirect effect on the value of our assets or market conditions generally. Furthermore, many of the provisions of the Act will require guidance through the issuance of Treasury regulations in order to assess their effect. There may be a substantial delay before such regulations are promulgated, increasing the uncertainty as to the ultimate effect of the statutory amendments on us. It is also likely that there will be technical corrections legislation proposed with respect to the Act next year, the effect of which cannot be predicted and may be adverse to us or our stockholders.

26

Our international investments and operations may result in additional tax-related risks.
We have investments and operations in the U.K., and may further expand internationally. International expansion presents tax-related risks that are different from those we face with respect to our domestic properties and operations. These risks include, but are not limited to:  
•
international currency gain recognized with respect to changes in exchange rates may not always qualify under the 75% gross income test or the 95% gross income test that we must satisfy annually in order to qualify and maintain our status as a REIT;
•
challenges with respect to the repatriation of foreign earnings and cash; and
•
challenges of complying with foreign tax rules (including the possible revisions in tax treaties or other laws and regulations, including those governing the taxation of our international income).
Our charter contains ownership limits with respect to our common stock and other classes of capital stock.
Our charter contains restrictions on the ownership and transfer of our common stock and preferred stock that are intended to assist us in preserving our qualification as a REIT. Under our charter, subject to certain exceptions, no person or entity may own, actually or constructively, more than 9.8% (by value or by number of shares, whichever is more restrictive) of the outstanding shares of our common stock or any class or series of our preferred stock.
Additionally, our charter has a 9.9% ownership limitation on the direct or indirect ownership of our voting shares, which may include common stock or other classes of capital stock. Our Board of Directors, in its sole discretion, may exempt a proposed transferee from either ownership limit. The ownership limits may delay, defer or prevent a transaction or a change of control that might involve a premium price for our common stock or might otherwise be in the best interests of our stockholders.
ITEM 1B.
Unresolved Staff Comments
None.
ITEM 2.
Properties
We are organized to invest in income-producing healthcare-related facilities. In evaluating potential investments, we consider a multitude of factors, including:
•
location, construction quality, age, condition and design of the property;
•
geographic area, proximity to other healthcare facilities, type of property and demographic profile, including new competitive supply;
•
whether the expected risk-adjusted return exceeds the incremental cost of capital;
•
whether the rent or operating income provides a competitive market return to our investors;
•
duration, rental rates, tenant and operator quality and other attributes of in-place leases, including master lease structures and coverage;
•
current and anticipated cash flow and its adequacy to meet our operational needs;
•
availability of security such as letters of credit, security deposits and guarantees;
•
potential for capital appreciation;
•
expertise and reputation of the tenant or operator;
•
occupancy and demand for similar healthcare facilities in the same or nearby communities;
•
the mix of revenues generated at healthcare facilities between privately paid and government reimbursed;
•
availability of qualified operators or property managers and whether we can manage the property;

27

•
potential alternative uses of the facilities;
•
the regulatory and reimbursement environment in which the properties operate;
•
tax laws related to REITs;
•
prospects for liquidity through financing or refinancing; and
•
our access to and cost of capital.
Property and Direct Financing Lease Investments
The following table summarizes our consolidated property and direct financing leases ("DFL") investments as of and for the year ended December 31, 2017 (square feet and dollars in thousands):
Facility Location
 
Number of
Facilities
 
Capacity
 
Gross Asset
Value(1)
 
Rental
Revenues(2)
 
Operating
Expenses
Senior housing triple-net—real estate:
 
 
 
(Units)
 
 
 
 
 
 
California
 
17

 
1,727

 
$
416,949

 
$
53,589

 
$
(3,139
)
Virginia
 
10

 
1,227

 
273,045

 
20,409

 
—

Florida
 
13

 
1,683

 
258,538

 
25,691

 
—

Texas
 
16

 
1,762

 
218,137

 
5,058

 
—

Washington
 
14

 
953

 
190,674

 
16,361

 
—

Oregon
 
13

 
1,118

 
162,628

 
17,082

 
(243
)
New Jersey
 
7

 
680

 
144,574

 
100

 
3

Other (25 States)
 
64

 
6,063

 
1,082,775

 
138,144

 
(392
)
 
 
154

 
15,213

 
2,747,320

 
276,434

 
(3,771
)
Senior housing—DFLs(3):
 
 
 
 
 
 
 
 
 
 
Other (12 States)
 
27

 
3,118

 
629,748

 
37,113

 
(48
)
Total Senior Housing Triple-Net
 
181

 
18,331

 
$
3,377,068

 
$
313,547

 
$
(3,819
)
SHOP:
 
 
 
(Units)
 
 
 
 
 
 
Texas
 
21

 
3,640

 
$
518,021

 
$
135,763

 
$
(98,929
)
Florida
 
23

 
3,234

 
436,429

 
135,751

 
(108,063
)
Colorado
 
6

 
952

 
203,717

 
46,755

 
(27,042
)
Illinois
 
5

 
1,063

 
203,644

 
42,126

 
(32,189
)
Maryland
 
6

 
590

 
176,702

 
33,292

 
(24,341
)
Other (16 States)
 
41

 
4,265

 
680,298

 
131,786

 
(105,927
)
Total SHOP
 
102

 
13,744

 
$
2,218,811

 
$
525,473

 
$
(396,491
)

28

Facility Location
 
Number of
Facilities
 
Capacity
 
Gross Asset
Value(1)
 
Rental
Revenues(2)
 
Operating
Expenses
Life science:
 
 
 
(Sq. Ft.)
 
 
 
 
 
 
California
 
121

 
6,818

 
$
3,618,619

 
$
338,668

 
$
(74,066
)
Other (3 States)
 
10

 
909

 
359,157

 
20,148

 
(3,935
)
Total life science
 
131

 
7,727

 
$
3,977,776

 
$
358,816

 
$
(78,001
)
Medical office:
 
 
 
(Sq. Ft.)
 
 
 
 
 
 
Texas
 
67

 
5,867

 
$
1,078,259

 
$
135,349

 
$
(55,733
)
California
 
18

 
1,031

 
324,021

 
35,418

 
(18,532
)
Pennsylvania
 
4

 
1,059

 
309,085

 
31,326

 
(12,523
)
Florida
 
23

 
1,329

 
235,550

 
31,227

 
(12,317
)
Other (29 States)
 
142

 
9,169

 
1,783,694

 
244,139

 
(84,092
)
Total medical office
 
254

 
18,455

 
$
3,730,609

 
$
477,459

 
$
(183,197
)
Other(4):
 
 
 
(Beds)
 
 
 
 
 
 
Texas
 
4

 
1,035

 
$
231,645

 
$
35,650

 
$
(4,489
)
California
 
2

 
111

 
143,500

 
19,350

 
(172
)
Other (7 States)
 
8

 
988

 
154,558

 
28,813

 
(82
)
 
 
14

 
2,134

 
$
529,703

 
$
83,813

 
$
(4,743
)
Other—U.K.:
 
 
 
(Units)
 
 
 
 
 
 
Other (U.K.)
 
61

 
3,183

 
337,179

 
31,798

 
—

Other—Post-acute/skilled nursing.:
 
 
 
(Beds)
 
 
 
 
 
 
Virginia
 
1

 
120

 
16,596

 
1,235

 
—

Total other non-reportable segments
 
76

 
 
 
$
883,478

 
$
116,846

 
$
(4,743
)
Total properties
 
744

 
 
 
$
14,187,742

 
$
1,792,141

 
$
(666,251
)
_______________________________________
(1)
Represents gross real estate and the carrying value of DFLs. Gross real estate represents the carrying amount of real estate after adding back accumulated depreciation and amortization. Includes real estate held for sale with an aggregate gross asset value of $485 million.
(2)
Represent the combined amount of rental and related revenues, tenant recoveries, resident fees and services and income from DFLs.
(3)
Represents leased properties that are classified as DFLs.
(4)
Includes leased properties that are classified as DFLs.

29

Occupancy and Annual Rent Trends
The following table summarizes occupancy and average annual rent trends for our consolidated property and DFL investments for the years ended December 31, (average occupied square feet in thousands). Average annual rent is presented as a ratio of revenues comprised of rental and related revenues, tenant recoveries and income from DFLs divided by the average capacity or average occupied square feet of the facilities and annualized for mergers and acquisitions for the year in which they occurred. Average annual rent for leased properties (including DFLs) excludes termination fees and non-cash revenue adjustments (i.e., straight-line rents, amortization of market lease intangibles and DFL non-cash interest).
 
2017
    
2016
    
2015
    
2014
    
2013
Senior Housing Triple-Net:
 
 
 
 
 
 
 
 
 
Average annual rent per unit
$
15,352

 
$
14,604

 
$
14,544

 
$
13,907

 
$
13,361

Average capacity (available units)
21,536

 
28,455

 
28,777

 
33,917

 
35,932

SHOP:
 
 
 
 
 
 
 
 
 
Average annual rent per unit
$
41,133

 
$
42,851

 
$
41,435

 
$
38,017

 
$
32,070

Average capacity (available units)
12,758

 
16,028

 
12,704

 
6,408

 
4,620

Life science:
 
 
 
 
 
 
 
 
 
Average occupancy percentage
96
%
 
98
%
 
97
%
 
93
%
 
92
%
Average annual rent per square foot
$
52

 
$
48

 
$
46

 
$
46

 
$
44

Average occupied square feet
6,841

 
7,332

 
7,179

 
6,637

 
6,480

Medical office:
 
 
 
 
 
 
 
 
 
Average occupancy percentage
92
%
 
91
%
 
91
%
 
91
%
 
91
%
Average annual rent per square foot
$
28

 
$
28

 
$
28

 
$
28

 
$
27

Average occupied square feet
16,674

 
15,697

 
14,677

 
13,136

 
12,767

Other non-reportable segments:
 
 
 
 
 
 
 
 
 
Average annual rent per bed - Hospital
$
38,017

 
$
39,076

 
$
39,834

 
$
38,756

 
$
38,089

Average capacity (available beds) - Hospital
2,161

 
2,271

 
2,187

 
2,184

 
2,138

Average annual rent per unit - U.K.
9,097

 
9,200

 
10,048

 
11,240

 
—

Average capacity (available units) - U.K.
3,188

 
3,190

 
2,515

 
501

 
—

Average annual rent per bed - SNF
10,298

 
10,803

 
8,292

 
8,062

 
7,537

Average capacity (available beds) - SNF
120

 
426

 
1,047

 
1,022

 
974




30

Tenant Lease Expirations
The following table shows tenant lease expirations, including those related to DFLs, for the next 10 years and thereafter at our consolidated properties, assuming that none of the tenants exercise any of their renewal or purchase options, unless otherwise noted below (dollars and square feet in thousands), and excludes properties in our SHOP segment and assets held for sale. See “Tenant Purchase Options” section of Note 11 to the Consolidated Financial Statements for additional information on leases subject to purchase options.
 
 
Expiration Year
Segment
 
Total
 
2018(1)
 
2019
 
2020
 
2021
 
2022
 
2023
 
2024
 
2025
 
2026
 
2027
 
Thereafter
Senior housing triple-net:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties
 
179

 
5

 
2

 
22

 
6

 
1

 
24

 
11

 
5

 
7

 
4

 
92

Base rent(2)
 
$
304,452

 
$
6,191

 
$
2,238

 
$
39,646

 
$
10,191

 
$
1,513

 
$
44,926

 
$
18,052

 
$
9,618

 
$
5,746

 
$
12,090

 
$
154,241

% of segment base rent
 
100

 
2

 
1

 
13

 
3

 
—

 
15

 
6

 
3

 
2

 
4

 
51

Life science:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Square feet
 
6,900

 
457

 
832

 
556

 
948

 
631

 
1,035

 
83

 
845

 
203

 
373

 
937

Base rent(2)
 
$
291,683

 
$
15,081

 
$
31,693

 
$
19,598

 
$
50,307

 
$
22,656

 
$
60,929

 
$
4,618

 
$
34,653

 
$
8,991

 
$
15,328

 
$
27,829

% of segment base rent
 
100

 
5

 
11

 
7

 
17

 
8

 
21

 
2

 
12

 
3

 
5

 
9

Medical office:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Square feet
 
16,945

 
2,939

 
2,172

 
2,280

 
1,548

 
1,670

 
719

 
809

 
1,926

 
758

 
722

 
1,402

Base rent(2)
 
$
389,497

 
$
70,049

 
$
53,422

 
$
58,461

 
$
39,115

 
$
41,392

 
$
17,213

 
$
21,240

 
$
31,625

 
$
18,541

 
$
14,387

 
$
24,052

% of segment base rent
 
100

 
18

 
14

 
15

 
10

 
11

 
4

 
5

 
8

 
5

 
4

 
6

Other non-reportable segments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties
 
76

 
—

 
5

 
1

 
1

 
4

 
—

 
2

 
1

 
—

 
—

 
62

Base rent(2)
 
$
105,051

 
$
—

 
$
7,594

 
$
7,977

 
$
1,572

 
$
13,179

 
$
—

 
$
15,375

 
$
20,619

 
$
—

 
$
—

 
$
38,735

% of segment base rent
 
100

 
—

 
7

 
8

 
1

 
13

 
—

 
15

 
20

 
—

 
—

 
36

Total:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Base rent(2)
 
$
1,090,683

 
$
91,321

 
$
94,947

 
$
125,682

 
$
101,185

 
$
78,740

 
$
123,068

 
$
59,285

 
$
96,515

 
$
33,278

 
$
41,805

 
$
244,857

% of total base rent
 
100

 
8

 
9

 
12

 
9

 
7

 
11

 
5

 
9

 
3

 
4

 
23

_______________________________________
(1)
Includes month-to-month leases.
(2)
The most recent month’s (or subsequent month’s if acquired in the most recent month) base rent including additional rent floors and cash income from DFLs annualized for 12 months. Base rent does not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e., straight-line rents, amortization of market lease intangibles, DFL non-cash interest and deferred revenues).
See Schedule III: Real Estate and Accumulated Depreciation, included in this report, which information is incorporated by reference in this Item 2.
ITEM 3.
Legal Proceedings
Except as described below, we are not aware of any legal proceedings or claims that we believe could have, individually or taken together, a material adverse effect on our financial condition, results of operations or cash flows.
See “Legal Proceedings” section of Note 11 to the Consolidated Financial Statements for information regarding legal proceedings, which information is incorporated by reference in this Item 3.
ITEM 4.
Mine Safety Disclosures
None.

31

PART II
ITEM 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock is listed on the New York Stock Exchange ("NYSE"). It has been our policy to declare quarterly dividends to common stockholders so as to comply with applicable provisions of the Code governing REITs. For the fiscal quarters indicated below are the reported high and low sales prices per share of our common stock on the NYSE and the cash dividends paid per common share:
 
High
 
Low
 
Per Share
Distribution
2017
 
 
 
 
 
Fourth Quarter
$
27.62

 
$
25.09

 
$
0.370

Third Quarter
32.65

 
27.47

 
0.370

Second Quarter
33.67

 
29.55

 
0.370

First Quarter
32.97

 
29.36

 
0.370

2016(1)
 
 
 
 
 
Fourth Quarter
$
38.09

 
$
27.61

 
$
0.370

Third Quarter
40.43

 
34.56

 
0.575

Second Quarter
36.90

 
31.91

 
0.575

First Quarter
39.25

 
25.11

 
0.575

_______________________________________
(1)
Price as originally traded. Does not give effect to the stock dividend of $6.17 per common share related to the Spin-Off (discussed below).
At January 31, 2018, we had 9,384 stockholders of record, and there were 192,786 beneficial holders of our common stock.
Dividends (Distributions)
Distributions with respect to our common stock can be characterized for federal income tax purposes as taxable ordinary dividends, capital gain dividends, nondividend distributions or a combination thereof. Following is the characterization of our annual common stock distributions per share:
 
Year Ended December 31,
 
2017
 
2016
 
2015
Ordinary dividends
$
1.4800

 
$
1.5561

 
$
2.1184

Capital gain dividends
—

 
—

 
0.0316

Nondividend distributions
—

 
6.7089

 
0.1100

 
$
1.4800

 
$
8.2650

(1) 
$
2.2600

_______________________________________
(1)
Consists of $2.095 per common share of quarterly cash dividends and $6.17 per common share of stock dividends related to the Spin-Off (discussed below).
HCP common stockholders on October 24, 2016, the record date for the Spin-Off (the “Record Date”), received upon the Spin-Off on October 31, 2016 one share of QCP common stock for every five shares of HCP common stock they held (the “Distributed Shares”) and cash in lieu of fractional shares of QCP. For U.S. federal income tax purposes, HCP reported the fair market value of the QCP common stock distributed per each share of HCP common stock outstanding on the Record Date was $6.17, or $30.85 for each share of QCP common stock. Accordingly, every HCP common stockholder who received a Distributed Share has a tax cost basis of $30.85 per Distributed Share.
On February 1, 2018, we announced that our Board of Directors declared a quarterly common stock cash dividend of $0.37 per share. The common stock dividend will be paid on March 2, 2018 to stockholders of record as of the close of business on February 15, 2018.

32

Recent Sales of Unregistered Securities
On January 6, 2017, we issued 12,143 shares of our common stock upon the redemption of 5,283 non-managing member units of our subsidiary, HCPI/Utah, LLC. The shares of our common stock were issued in a private placement to an accredited investor pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. We did not receive any cash proceeds from the issuance of shares of our common stock upon redemption of the non-managing member units of HCPI/Utah, LLC, although we did acquire non-managing member units of the subsidiary in exchange for the shares of common stock we issued upon redemption of the units.
Issuer Purchases of Equity Securities
The table below sets forth the information with respect to purchases of our common stock made by or on our behalf during the quarter ended December 31, 2017.
Period Covered
 
Total Number
of Shares
Purchased(1)
 
Average Price
Paid per Share
 
Total Number of Shares
Purchased as
Part of Publicly
Announced Plans
or Programs
 
Maximum Number (or
Approximate Dollar Value)
of Shares that May Yet
be Purchased Under
the Plans or Programs
October 1-31, 2017
 
12,220

 
$
25.37

 
—

 
—

November 1-30, 2017
 
—

 
—

 
—

 
—

December 1-31, 2017
 
590

 
26.10

 
—

 
—

Total
 
12,810

 
$
25.41

 
—

 
—

_______________________________________
(1)
Represents restricted shares withheld under our equity incentive plans to offset tax withholding obligations that occur upon vesting of restricted shares. The value of the shares withheld is based on the closing price of our common stock on the last trading day prior to the date the relevant transaction occurred.

33

Performance Graph
The graph and table below compare the cumulative total return of HCP, the S&P 500 Index and the Equity REIT Index of NAREIT, from January 1, 2013 to December 31, 2017. Total cumulative return is based on a $100 investment in HCP common stock and in each of the indices at the close of trading on December 31, 2012 and assumes quarterly reinvestment of dividends before consideration of income taxes. Stockholder returns over the indicated periods should not be considered indicative of future stock prices or stockholder returns.
COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN
AMONG S&P 500, EQUITY REITS AND HCP, INC.
RATE OF RETURN TREND COMPARISON
JANUARY 1, 2013–DECEMBER 31, 2017
(JANUARY 1, 2013 = $100)
Performance Graph Total Stockholder Return

chart-cb15351815970ce7fcf.jpg
 
December 31,
 
2013
 
2014
 
2015
    
2016
 
2017
FTSE NAREIT Equity REIT Index
$
102.88

 
$
131.68

 
$
135.42

 
$
147.35

 
$
160.11

S&P 500
132.36

 
150.43

 
152.51

 
170.70

 
207.92

HCP, Inc.
84.35

 
107.66

 
99.15

 
90.20

 
83.15


34

ITEM 6.
Selected Financial Data
Set forth below is our selected financial data as of and for each of the years in the five-year period ended December 31, (dollars in thousands, except per share data):
 
Year Ended December 31,
 
2017
 
2016
 
2015
 
2014
 
2013
Statement of operations data:
 
 
 
 
 
 
 
 
 
Total revenues
$
1,848,378

 
$
2,129,294

 
$
1,940,489

 
$
1,636,833

 
$
1,488,786

Income (loss) from continuing operations
422,634

 
374,171

 
152,668

 
271,315

 
253,526

Net income (loss) applicable to common shares
413,013

 
626,549

 
(560,552
)
 
919,796

 
969,103

Basic earnings per common share
 
 
 
 
 
 
 
 
 
Continuing operations
0.88

 
0.77

 
0.30

 
0.56

 
0.52

Discontinued operations
—

 
0.57

 
(1.51
)
 
1.45

 
1.61

Net income (loss) attributable to common stockholders
0.88

 
1.34

 
(1.21
)
 
2.01

 
2.13

Diluted earnings per common share
 
 
 
 
 
 
 
 
 
Continuing operations
0.88

 
0.77

 
0.30

 
0.56

 
0.52

Discontinued operations
—

 
0.57

 
(1.51
)
 
1.44

 
1.61

Net income (loss) attributable to common stockholders
0.88

 
1.34

 
(1.21
)
 
2.00

 
2.13

Balance sheet data:
 
 
 
 
 
 
 
 
 
Total assets
14,088,461

 
15,759,265

 
21,449,849

 
21,331,436

 
20,040,310

Debt obligations(1)
7,880,466

 
9,189,495

 
11,069,003

 
9,721,269

 
8,626,067

Total equity
5,594,938

 
5,941,308

 
9,746,317

 
10,997,099

 
10,931,134

Other data:
 
 
 
 
 
 
 
 
 
Dividends paid
694,955

 
979,542

 
1,046,638

 
1,001,559

 
956,685

Dividends paid per common share(2)
1.480

 
2.095

 
2.260

 
2.180

 
2.100

Funds from operations (“FFO”)(3)
661,113

 
1,119,153

 
(10,841
)
 
1,381,634

 
1,349,264

Diluted FFO per common share(3)
1.41

 
2.39

 
(0.02
)
 
3.00

 
2.95

FFO as adjusted(3)
918,402

 
1,282,390

 
1,470,167

 
1,398,691

 
1,382,699

Diluted FFO as adjusted per common share(3)
1.95

 
2.74

 
3.16

 
3.04

 
3.02

Funds available for distribution (“FAD”)(3)
803,720

 
1,215,696

 
1,261,849

 
1,178,822

 
1,158,082

_______________________________________
(1)
Includes bank line of credit, term loans, senior unsecured notes, mortgage and other secured debt, and other debt.
(2)
Represents cash dividends. Additionally, in October 2016 we issued $6.17 of stock dividends related to the Spin-Off.
(3)
For a more detailed discussion and reconciliation of FFO, FFO as adjusted and FAD, see "Results of Operations" and “Non-GAAP Financial Measure Reconciliations” in Item 7.

35

ITEM 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The information set forth in this Item 7 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:
•
2017 Transaction Overview
•
Dividends
•
Results of Operations
•
Liquidity and Capital Resources
•
Contractual Obligations
•
Off-Balance Sheet Arrangements
•
Inflation
•
Non-GAAP Financial Measure Reconciliations
•
Critical Accounting Policies
•
Recent Accounting Pronouncements
2017 Transaction Overview
Master Transactions and Cooperation Agreement with Brookdale
On November 1, 2017, HCP and Brookdale entered into a Master Transactions and Cooperation Agreement (the “MTCA”) to provide us with the ability to significantly reduce our concentration of assets leased to and/or managed by Brookdale (the "Brookdale Transaction"). Through a series of dispositions and transitions of assets currently leased to and/or managed by Brookdale, as contemplated by the MTCA, our exposure to Brookdale is expected to be significantly reduced.
In connection with the overall transaction pursuant to the MTCA, HCP (through certain of its subsidiaries), and Brookdale (through certain of its subsidiaries) (the “Lessee”) entered into an Amended and Restated Master Lease and Security Agreement (the “Amended Master Lease”), which amended and restated the then-existing triple-net leases between the parties for 78 assets (before giving effect to the contemplated sale or transition of 34 assets discussed below), which account for primarily all of the assets subject to triple-net leases between HCP and the Lessee. Under the Amended Master Lease, we have the benefit of a guaranty from Brookdale of the Lessee’s obligations and, upon a change in control, will have various additional protections under the MTCA and the Amended Master Lease.
The Amended Master Lease preserves the renewal terms and, with certain exceptions, the rents under the previously existing triple-net leases. In addition, HCP and Brookdale agreed to the following:
•
We have the right to sell, or transition to other operators, 32 triple-net assets. If such sale or transition does not occur within one year, the triple-net lease with respect to such assets will convert to a cash flow lease (under which we will bear the risks and rewards of operating the assets) with a term of two years, provided that we have the right to terminate the cash flow lease at any time during the term without penalty;
•
We have provided an aggregate $5 million annual reduction in rent on three assets, effective January 1, 2018; and
•
We will sell two triple-net assets to Brookdale or its affiliates for $35 million, which we anticipate completing during the first half of 2018.

36

Also pursuant to the MTCA, HCP and Brookdale agreed to the following:
•
HCP, which owned 90% of the interests in its RIDEA I and RIDEA III joint ventures with Brookdale at the time the MTCA was executed, agreed to purchase Brookdale’s 10% noncontrolling interest in each joint venture for an aggregate purchase price of $95 million. These joint ventures collectively own and operate 58 independent living, assisted living, memory care and/or skilled nursing facilities (the “RIDEA Facilities”). We completed our acquisition of the RIDEA III noncontrolling interest in December 2017 and anticipate completing our acquisition of the RIDEA I noncontrolling interest during the first half of 2018;
•
We have the right to sell, or transition to other managers, 36 of the RIDEA Facilities and terminate related management agreements with an affiliate of Brookdale without penalty. If the related management agreements are not terminated within one year, the base management fee (5% of gross revenues) increases by 1% of gross revenues per year over the following two years to a maximum of 7% of gross revenues;
•
We will sell four of the RIDEA Facilities to Brookdale or its affiliates for $239 million, one of which was sold in January 2018 for $27 million. We anticipate completing the sale of the remaining three RIDEA Facilities during the first half of 2018;
•
A Brookdale affiliate continues to manage the remaining 18 RIDEA Facilities pursuant to amended and restated management agreements, which provide for extended terms on select assets, modified performance hurdles for extensions and incentive fees, and modified termination rights (including stricter performance-based termination rights, a staggered right to terminate seven agreements over a 10 year period beginning in 2021, and a right to terminate at will upon payment of a termination fee, in lieu of sale-related termination rights), and two other existing facilities managed in separate RIDEA structures; and
•
We have the right to sell, to certain permitted transferees, our 49% ownership interest in joint ventures that own and operate a portfolio of continuing care retirement communities and in which Brookdale owns the other 51% interest (the “CCRC JV”), subject to certain conditions and a right of first offer in favor of Brookdale. Brookdale will have a corresponding right to sell its 51% interest in the CCRC JV to certain permitted transferees, subject to certain conditions, a right of first offer and a right to terminate management agreements following such sale of Brookdale’s interest, each in favor of HCP. Following a change in control of Brookdale, we will have the right to initiate a sale of the CCRC portfolio, subject to certain rights of first offer and first refusal in favor of Brookdale.
See Note 3 to the Consolidated Financial Statements for additional information.
RIDEA II Sale Transaction
In January 2017, we completed the contribution of our ownership interest in RIDEA II to an unconsolidated JV owned by HCP and an investor group led by Columbia Pacific Advisors, LLC (“CPA”) (“HCP/CPA PropCo” and “HCP/CPA OpCo,” together, the “HCP/CPA JV”). In addition, RIDEA II was recapitalized with $602 million of debt, of which $360 million was provided by a third-party and $242 million was provided by HCP. In return for both transaction elements, we received combined proceeds of $480 million from the HCP/CPA JV and $242 million in loan receivables and retained an approximately 40% ownership interest in RIDEA II (the note receivable and 40% ownership interest are herein referred to as the “RIDEA II Investments”). This transaction resulted in us deconsolidating the net assets of RIDEA II and recognizing a net gain on sale of $99 million. The RIDEA II Investments are currently recognized and accounted for as equity method investments.
On November 1, 2017, we entered into a definitive agreement with an investor group led by CPA to sell our remaining 40% ownership interest in RIDEA II. We expect the transaction to close in 2018. CPA has also agreed to refinance our $242 million loan receivables from RIDEA II within one year following the closing of the transaction.
Investment Transactions
During the second quarter of 2017, we acquired a 124,000 square foot campus in the Sorrento Mesa submarket of San Diego, California for $26 million. Upon acquisition, we commenced repositioning one of the buildings into class-A lab space following an office-to-lab conversion strategy.
During the third quarter of 2017, we acquired a portfolio of three medical office buildings in Texas for $49 million and a life science facility in South San Francisco, California for $64 million.

37

During the fourth quarter of 2017, we completed the following investments:
•
In November 2017, we acquired a 90-unit SHOP facility in a suburb of Boston, Massachusetts for $45 million. HCP owns a majority interest in this facility through a joint venture with LCB Senior Living.
•
In December 2017, we acquired a $228 million life science campus known as the Hayden Research Campus located in the Boston suburb of Lexington, Massachusetts. HCP owns a majority interest in this campus through a joint venture with King Street Properties (“King Street”). The campus includes two existing buildings totaling 400,000 square feet and was 66% leased at closing, anchored by major life science tenants including Shire US, Inc., a subsidiary of Shire plc, and Merck, Sharp and Dohme, a subsidiary of Merck and Co., Inc. Additionally, King Street is currently seeking entitlement approvals from local authorities for the joint venture to develop an additional 209,000 square feet of life science space on the campus.
•
In December 2017, we acquired a portfolio of 11 MOBs located throughout the United States, totaling approximately 378,000 square feet, for $151 million.
•
In December 2017, we entered into a participating debt financing arrangement with Columbia Pacific Advisors, LLC to fund the construction of 620 Terry, a $147 million, 243-unit senior living development located in Seattle. Upon expected completion in 2019, 620 Terry will be operated by Leisure Care, LLC, a leading senior housing operator, and offer a mix of independent-living, assisted-living and memory care units. We will provide up to $115 million of financing and earn 6.5% interest on the outstanding loan balance. Upon sale or refinancing, we will receive 20% of fair market value in excess of the total development cost.
Disposition and Loan Repayment Transactions
During the first quarter of 2017, we completed the following disposition and loan repayment transactions:
•
In January 2017, we sold four life science facilities in Salt Lake City, Utah for $76 million.
•
In March 2017, we sold 64 senior housing triple-net assets, previously under triple-net leases with Brookdale, for $1.125 billion to affiliates of Blackstone Real Estate Partners VIII, L.P.
•
In March 2017, we sold our aggregate £138.5 million par value Four Seasons senior notes (“Four Seasons Notes”) for £83 million ($101 million). The disposition of the Four Seasons Notes generated a £42 million ($51 million) gain on sale as the sales price was above the previously-impaired (2015) carrying value of £41 million ($50 million). In addition, we sold our Four Seasons senior secured term loan at par plus accrued interest for £29 million ($35 million).
During the second quarter of 2017, we completed the following disposition and loan repayment transactions:
•
In April 2017, we sold a land parcel in San Diego, California for $27 million and one life science building in San Diego, California for $5 million.
•
In June 2017, we received £283 million ($367 million) from the repayment of our HC-One Facility.
During the third quarter of 2017, we sold two senior housing triple-net facilities for $15 million.
During the fourth quarter 2017, we completed the following disposition transactions:
•
In October 2017, we sold two senior housing triple-net facilities for $12 million.
•
In November 2017, we sold a MOB for $11 million and a SHOP facility for $24 million.
•
In December 2017, we sold three SHOP assets for $17 million and two MOBs for $3 million.
Financing Activities
•
During the year ended December 31, 2017, we had net debt repayments of $1.4 billion primarily using proceeds from the dispositions of real estate (primarily the sale of 64 senior housing triple-net assets), the partial sale of RIDEA II, the sale of our Four Seasons Notes and the repayment of our HC-One Facility. Debt repayments during the year ended December 31, 2017 consisted of the following:
◦
During the first quarter of 2017, we repaid our £137 million unsecured term loan (the “2012 Term Loan”) and $472 million of mortgage debt.
◦
During the second quarter of 2017, we repaid $250 million of maturing senior unsecured notes and paid down £51 million of our £220 million unsecured term loan (the “2015 Term Loan”).

38

◦
During the third quarter of 2017, we repurchased $500 million of our 5.375% senior notes due 2021 and recorded a $54 million loss on debt extinguishment.
•
During the fourth quarter of 2017, we terminated our then existing bank line of credit facility (the "Facility") and entered into a new $2.0 billion unsecured revolving line of credit facility (the “New Facility”) maturing on October 19, 2021. Borrowings under the New Facility accrue interest at LIBOR plus a margin that depends on our credit ratings (1.00% initially). We pay a facility fee on the entire revolving commitment that depends on our credit ratings (0.20% initially and as of December 31, 2017). The New Facility contains two, six-month extension options and includes a feature that allows us to increase the borrowing capacity by an aggregate amount of up to $750 million, subject to securing additional commitments.
Developments and Redevelopments
The Cove Phase I and Phase II have reached 100% leased during the year ended December 31, 2017.
During the year ended December 31, 2017, we added $384 million of new projects to our development and redevelopment pipelines including:
•
Commenced the $219 million Phase I development at Sierra Point, consisting of two buildings totaling 215,000 square feet of Class A life science and office space in South San Francisco, California, with an estimated completion in late 2019.
•
Commenced a $40 million redevelopment of a MOB located in the University City submarket of Philadelphia, near the University of Pennsylvania, with an estimated completion in the second quarter of 2018.
•
Entered into a joint venture agreement and commenced development on a 111-unit senior housing facility in Otay Ranch, California (San Diego MSA) for $31 million. Our share of the estimated total construction cost is approximately $28 million, with an estimated completion in the second half of 2018.
•
Commenced development on a 79-unit senior housing facility in Waldwick, New Jersey (New York MSA) for $31 million in a joint venture. Our share of the estimated total construction costs is approximately $26 million, with an estimated completion in late 2018.
•
Commenced $22 million of redevelopment projects at two recently-acquired life science assets in the Sorrento Mesa submarket of San Diego, California, with an estimated completion in late 2018.
•
Commenced a $16 million life science development expansion project in the Sorrento Mesa submarket of San Diego, California, with an estimated completion in the second half of 2019.

Dividends
Quarterly cash dividends paid during 2017 aggregated to $1.48 per share. On February 1, 2018, our Board of Directors declared a quarterly cash dividend of $0.37 per common share. The dividend will be paid on March 2, 2018 to stockholders of record as of the close of business on February 15, 2018.
Results of Operations
We evaluate our business and allocate resources among our reportable business segments: (i) senior housing triple-net, (ii) senior housing operating portfolio (SHOP), (iii) life science and (iv) medical office. Under the medical office and life science segments, we invest through the acquisition and development of MOBs and life science facilities, which generally require a greater level of property management. Our senior housing facilities are managed utilizing triple-net leases and RIDEA structures. We have other non-reportable segments that are comprised primarily of our U.K. care homes, debt investments, unconsolidated joint ventures and hospitals. We evaluate performance based upon: (i) property net operating income from continuing operations (“NOI”) and (ii) adjusted NOI (cash NOI) in each segment. The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the Consolidated Financial Statements).
Non-GAAP Financial Measures
Net Operating Income
NOI and Adjusted NOI are non-U.S. generally accepted accounting principles (“GAAP”) supplemental financial measures used to evaluate the operating performance of real estate. NOI is defined as rental and related revenues, including tenant recoveries,

39

resident fees and services, and income from DFLs, less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss) as presented in Note 13 to the Consolidated Financial Statements. Management believes NOI provides relevant and useful information because it reflects only income and operating expense items that are incurred at the property level and presents them on an unleveraged basis. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees and the impact of deferred community fee income and expense. The adjustments to NOI and resulting Adjusted NOI for SHOP have been recast for prior periods presented to conform to the current period presentation which excludes the impact of deferred community fee income and expense, resulting in recognition as cash is received and expenses are paid. Adjusted NOI is oftentimes referred to as “cash NOI.” During the fourth quarter of 2017, as a result of a change in how operating results are reported to our chief operating decision makers for the purpose of evaluating performance and allocating resources, we began excluding unconsolidated joint ventures from the evaluation of our segments' operating results. Unconsolidated joint ventures are now reflected in other non-reportable segments, and as a result, excluded from NOI and Adjusted NOI. Prior period NOI and Adjusted NOI have also been recast to conform to current period presentation which excludes unconsolidated joint ventures. We use NOI and Adjusted NOI to make decisions about resource allocations, to assess and compare property level performance, and to evaluate our same property portfolio (“SPP”), as described below. We believe that net income (loss) is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, our definition of NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating NOI. For a reconciliation of NOI and Adjusted NOI to net income (loss) by segment, refer to Note 13 to the Consolidated Financial Statements.
Operating expenses generally relate to leased medical office and life science properties and SHOP facilities. We generally recover all or a portion of our leased medical office and life science property expenses through tenant recoveries. We present expenses as operating or general and administrative based on the underlying nature of the expense.
Same Property Portfolio
SPP NOI and Adjusted NOI information allows us to evaluate the performance of our property portfolio under a consistent population by eliminating changes in the composition of our consolidated portfolio of properties. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis. SPP NOI for properties that undergo a change in ownership is reported based on the current ownership percentage.
Properties are included in SPP once they are stabilized for the full period in both comparison periods. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) control(s) the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly completed developments and redevelopments are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. Properties that experience a change in reporting structure, such as a transition from a triple-net lease to a RIDEA reporting structure, are considered stabilized after 12 months in operations under a consistent reporting structure. A property is removed from SPP when it is classified as held for sale, sold, placed into redevelopment, experiences a casualty event that significantly impacts operations or changes its reporting structure (such as triple-net to SHOP).
For a reconciliation of SPP to total portfolio Adjusted NOI and other relevant disclosures by segment, refer to our Segment Analysis below.
Funds From Operations
We believe FFO applicable to common shares, diluted FFO applicable to common shares, and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.
FFO, as defined by the National Association of Real Estate Investment Trusts (“NAREIT”), is net income (loss) applicable to common shares (computed in accordance with GAAP), excluding gains or losses from sales of depreciable property, including any current and deferred taxes directly associated with sales of depreciable property, impairments of, or related to, depreciable real estate, plus real estate and other depreciation and amortization, and adjustments to compute our share of FFO and FFO as adjusted (see below) from joint ventures. Adjustments for joint ventures are calculated to reflect our pro-rata share of both our consolidated and unconsolidated joint ventures. We reflect our share of FFO for unconsolidated joint ventures by applying our actual ownership percentage for the period to the applicable reconciling items on an entity by entity basis. For consolidated joint ventures in which we do not own 100%, we reflect our share of the equity by adjusting our FFO to remove the third party ownership share of the applicable reconciling items based on actual ownership percentage for the applicable periods. Our pro-rata share information is prepared on a basis consistent with the comparable consolidated amounts, is intended to reflect our proportionate

40

economic interest in the operating results of properties in our portfolio and is calculated by applying our actual ownership percentage for the period. We do not control the unconsolidated joint ventures, and the pro-rata presentations of reconciling items included in FFO do not represent our legal claim to such items. The joint venture members or partners are entitled to profit or loss allocations and distributions of cash flows according to the joint venture agreements, which provide for such allocations generally according to their invested capital.
The presentation of pro-rata information has limitations, which include, but are not limited to, the following: (i) the amounts shown on the individual line items were derived by applying our overall economic ownership interest percentage determined when applying the equity method of accounting and do not necessarily represent our legal claim to the assets and liabilities, or the revenues and expenses and (ii) other companies in our industry may calculate their pro-rata interest differently, limiting the usefulness as a comparative measure. Because of these limitations, the pro-rata financial information should not be considered independently or as a substitute for our financial statements as reported under GAAP. We compensate for these limitations by relying primarily on our GAAP financial statements, using the pro-rata financial information as a supplement.
FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income (loss). We compute FFO in accordance with the current NAREIT definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from ours.
In addition, we present FFO before the impact of non-comparable items including, but not limited to, transaction-related items, impairments (recoveries) of non-depreciable assets, severance and related charges, prepayment costs (benefits) associated with early retirement or payment of debt, litigation costs, casualty-related charges (recoveries), foreign currency remeasurement losses (gains) and changes in tax legislation (“FFO as adjusted”). Transaction-related items include transaction expenses and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities. Prepayment costs (benefits) associated with early retirement of debt include the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of debt. Management believes that FFO as adjusted provides a meaningful supplemental measurement of our FFO run-rate and is frequently used by analysts, investors and other interested parties in the evaluation of our performance as a REIT. At the same time that NAREIT created and defined its FFO measure for the REIT industry, it also recognized that “management of each of its member companies has the responsibility and authority to publish financial information that it regards as useful to the financial community.” We believe stockholders, potential investors and financial analysts who review our operating performance are best served by an FFO run-rate earnings measure that includes certain other adjustments to net income (loss), in addition to adjustments made to arrive at the NAREIT defined measure of FFO. FFO as adjusted is used by management in analyzing our business and the performance of our properties, and we believe it is important that stockholders, potential investors and financial analysts understand this measure used by management. We use FFO as adjusted to: (i) evaluate our performance in comparison with expected results and results of previous periods, relative to resource allocation decisions, (ii) evaluate the performance of our management, (iii) budget and forecast future results to assist in the allocation of resources, (iv) assess our performance as compared with similar real estate companies and the industry in general and (v) evaluate how a specific potential investment will impact our future results. Other REITs or real estate companies may use different methodologies for calculating an adjusted FFO measure, and accordingly, our FFO as adjusted may not be comparable to those reported by other REITs. For a reconciliation of net income (loss) to FFO and FFO as adjusted and other relevant disclosure, refer to “Non-GAAP Financial Measures Reconciliations” below.
Funds Available for Distribution
FAD is defined as FFO as adjusted after excluding the impact of the following: (i) amortization of deferred compensation expense, (ii) amortization of deferred financing costs, net, (iii) straight-line rents, (iv) amortization of acquired market lease intangibles, net, (v) non-cash interest and depreciation related to DFLs and lease incentive amortization (reduction of straight-line rents) and (vi) deferred revenues, excluding amounts amortized into rental income that are associated with tenant funded improvements owned/recognized by us and up-front cash payments made by tenants to reduce their contractual rents. Also, FAD: (i) is computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements, and (ii) includes lease restructure payments and adjustments to compute our share of FAD from our unconsolidated joint ventures and those related to CCRC non-refundable entrance fees. Certain prior period amounts in the “Non-GAAP Financial Measures Reconciliation” below for FAD have been reclassified to conform to the current period presentation. More specifically, we have combined wholly-owned and our share from unconsolidated joint ventures recurring capital expenditures, including leasing costs and second generation tenant and capital improvements ("FAD capital expenditures") into a single line item. In addition, we have combined cash CCRC JV entrance fees with CCRC JV entrance fee amortization into a single line item, separately disclosed deferred income taxes (previously reported in “other”) and collapsed immaterial line items into ‘other’. Adjustments for joint ventures are calculated to reflect our pro-rata share of both our consolidated and unconsolidated joint ventures. We reflect our share of FAD for unconsolidated joint ventures by applying our actual ownership percentage for the period to the applicable reconciling items on an entity by entity basis. We reflect our share for consolidated joint ventures in which we do not own 100% of the equity by adjusting our FAD to remove the third party ownership share of the applicable reconciling items based on actual

41

ownership percentage for the applicable periods (see FFO above for further disclosure regarding our use of pro-rata share information and its limitations). Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, our FAD may not be comparable to those reported by other REITs. Although our FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of our performance and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. We believe FAD is an alternative run-rate earnings measure that improves the understanding of our operating results among investors and makes comparisons with: (i) expected results, (ii) results of previous periods and (iii) results among REITS more meaningful. FAD does not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs as it excludes the following items which generally flow through our cash flows from operating activities: (i) adjustments for changes in working capital or the actual timing of the payment of income or expense items that are accrued in the period, (ii) transaction-related costs, (iii) litigation settlement expenses, (iv) severance-related expenses and (v) actual cash receipts from interest income recognized on loans receivable (in contrast to our FAD adjustment to exclude non-cash interest and depreciation related to our investments in direct financing leases). Furthermore, FAD is adjusted for recurring capital expenditures, which are generally not considered when determining cash flows from operations or liquidity. FAD is a non-GAAP supplemental financial measure and should not be considered as an alternative to net income (loss) determined in accordance with GAAP. For a reconciliation of net income (loss) to FAD and other relevant disclosure, refer to “Non-GAAP Financial Measures Reconciliations” below.
Comparison of the Year Ended December 31, 2017 to the Year Ended December 31, 2016 and the Year Ended December 31, 2016 to the Year Ended December 31, 2015
Overview(1) 
2017 and 2016
The following table summarizes results for the years ended December 31, 2017 and 2016 (dollars in thousands except per share data):
 
 
Year Ended
 
Year Ended
 
 
 
 
December 31, 2017
 
December 31, 2016
 
 
 
 
Amount
 
Per Diluted Share
 
Amount
 
Per Diluted Share
 
Per Share Change
Net income (loss) applicable to common shares
 
$
413,013

 
$
0.88

 
$
626,549

 
$
1.34

 
$
(0.46
)
FFO
 
661,113

 
1.41

 
1,119,153

 
2.39

 
(0.98
)
FFO as adjusted
 
918,402

 
1.95

 
1,282,390

 
2.74

 
(0.79
)
FAD
 
803,720

 
 
 
1,215,696

 
 
 
 
_______________________________________
(1)
For the reconciliation of non-GAAP financial measures, see “Non-GAAP Financial Measure Reconciliations” section below.
Net income (loss) applicable to common shares (“EPS”) decreased primarily as a result of the following:
•
a reduction in net income from discontinued operations due to the Spin-Off of QCP on October 31, 2016;
•
a loss on debt extinguishment in July 2017, representing a premium for early payment on the repurchase of our senior notes;
•
a reduction in rental and related revenues primarily as a result of assets sold during 2017, including the sale of 64 senior housing triple-net assets in the first quarter of 2017;
•
a reduction in NOI primarily related to the net impact of the Brookdale Transaction during the fourth quarter of 2017;
•
a reduction in earnings due to the partial sale and deconsolidation of RIDEA II during the first quarter of 2017;
•
impairments related to: (i) our mezzanine loan facility to Tandem Health Care (the “Tandem Mezzanine Loan”) and (ii) 11 underperforming senior housing triple-net facilities in the third quarter of 2017;
•
increased litigation-related costs, including costs from securities class action litigation, and a legal settlement in 2017;
•
casualty-related charges due to hurricanes in the third quarter of 2017; and

42

•
a reduction in interest income due to (i) the payoffs of our HC-One Facility in June 2017 and a participating development loan during the third quarter of 2016 and (ii) decreased interest received from our Tandem Mezzanine Loan during the fourth quarter of 2017, partially offset by additional interest income in 2017 from our $131 million loan to Maria Mallaband in November 2016.
The decrease in EPS was partially offset by:
•
a reduction in interest expense as a result of debt repayments in the fourth quarter of 2016 and throughout 2017;
•
a reduction in severance and related charges primarily related to the departure of our former President and Chief Executive Officer ("CEO") in 2016 compared to severance and related charges primarily related to the departure of our former Executive Vice President and Chief Accounting Officer ("CAO") in 2017;
•
a larger net gain on sales of real estate during 2017 compared to 2016, primarily related to the sale of 64 senior housing triple-net assets and the partial sale of RIDEA II during 2017;
•
an increase in income tax benefit primarily from real estate dispositions during 2017, partially offset by an income tax expense related to the impact of tax rate legislation during the fourth quarter of 2017; and
•
an increase in other income, net primarily related to the gain on sale of our Four Seasons investments during 2017.
FFO decreased primarily as a result of the aforementioned events impacting EPS, except for gain on sales of real estate and impairments of real estate, which are excluded from FFO.
FFO as adjusted decreased primarily as a result of the following:
•
a reduction in net income from discontinued operations due to the Spin-Off of QCP on October 31, 2016;
•
a reduction in rental and related revenues primarily as a result of assets sold during 2017, including the sale of 64 senior housing triple-net assets;
•
a reduction in earnings due to the partial sale and deconsolidation of RIDEA II during the first quarter of 2017; and
•
a reduction in interest income due to (i) the payoffs of our HC-One Facility in June 2017 and a participating development loan during the third quarter of 2016 and (ii) decreased interest received from our Tandem Mezzanine Loan during the fourth quarter of 2017, partially offset by additional interest income in 2017 from our $131 million loan to Maria Mallaband in November 2016.
The decrease in FFO as adjusted was partially offset by a reduction in interest expense as a result of debt repayments in the fourth quarter of 2016 and throughout 2017.
FAD decreased primarily as a result of the aforementioned events impacting FFO as adjusted, (i) increased leasing costs and tenant capital improvements and (ii) decreased installment payments received from Brookdale for 2014 lease terminations that were paid over a period of three years and concluded in 2017.
2016 and 2015
The following table summarizes results for the years ended December 31, 2016 and 2015 (dollars in thousands except per share data):
 
 
Year Ended
 
Year Ended
 
 
 
 
December 31, 2016
 
December 31, 2015
 
 
 
 
Amount
 
Per Diluted Share
 
Amount
 
Per Diluted Share
 
Per Share Change
Net income (loss) applicable to common shares
 
$
626,549

 
$
1.34

 
$
(560,552
)
 
$
(1.21
)
 
$
2.55

FFO
 
1,119,153

 
2.39

 
(10,841
)
 
(0.02
)
 
2.41

FFO as adjusted
 
1,282,390

 
2.74

 
1,470,167

 
3.16

 
(0.42
)
FAD
 
1,215,696

 
 
 
1,261,849

 
 
 
 
EPS increased primarily as a result of the following:
•
impairment charges during 2015, not repeated in 2016;

43

•
increased NOI from: (i) our 2015 and 2016 acquisitions, (ii) annual rent escalations and (iii) developments placed in service;
•
increased gain on sales of real estate due to a higher volume of disposition activity during 2016;
•
a reduction in interest expense as a result of debt repayments during 2015 and 2016; and
•
a net termination fee expense recognized in 2015, not repeated in 2016.
The increase in EPS was partially offset by following:
•
a reduction in income from our HCR Manor Care, Inc. ("HCRMC") investments as a result of: (i) the HCRMC lease amendment effective April 1, 2015, (ii) the sale of non-strategic assets during the second half of 2015 and 2016, and (iii) a change in income recognition to a cash basis method beginning in January 2016;
•
the impact from the Spin-Off of QCP resulting in: (i) increased transaction costs and (ii) loss on debt extinguishment, representing penalties on the prepayment of debt using proceeds from the Spin-Off;
•
increased income tax expense related to our estimated exposure to state built-in gain tax;
•
a reduction in interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and loan repayments during 2015 and 2016;
•
increased severance-related charges during 2016 primarily related to the departure of our former CEO in July 2016;
•
increased depreciation and amortization from our 2015 and 2016 acquisitions; and
•
a reduction of foreign currency remeasurement gains recognized as a result of effective hedges designated in September 2015.
FFO increased primarily as a result of the aforementioned events impacting EPS, except for depreciation and amortization and gain on sales of real estate, which are excluded from FFO.
FFO as adjusted decreased primarily as a result of the following:
•
a reduction in income from our HCRMC investments as a result of: (i) the HCRMC lease amendment effective April 1, 2015, (ii) the sale of non-strategic assets during the second half of 2015 and 2016 and (iii) a change in income recognition to a cash basis method beginning in January 2016;
•
decreased income from the QCP assets included in the Spin-Off; and
•
a reduction in interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and loan repayments during 2015 and 2016.
The decrease in FFO as adjusted was partially offset by the following:
•
increased NOI from: (i) our 2015 and 2016 consolidated acquisitions, (ii) annual rent escalations and (iii) developments placed in service; and
•
a reduction in interest expense as a result of debt repayments during 2015 and 2016.
FAD decreased primarily as a result of the following:
•
decreased income from our HCRMC investments as a result of the HCRMC lease amendment effective April 1, 2015 and the sale of non-strategic assets during the second half of 2015 and the first half of 2016;
•
decreased income from the QCP assets included in the Spin-Off;
•
decreased interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and loan repayments during 2015 and 2016; and
•
increased leasing costs and second generation capital expenditures.
The decrease in FAD was partially offset by the following:
•
increased NOI from: (i) our 2015 and 2016 consolidated acquisitions, (ii) annual rent escalations and (iii) developments placed in service; and
•
increased incremental interest income from the payoff of participating development loans.


44

Segment Analysis
The tables below provide selected operating information for our SPP and total property portfolio for each of our reportable segments. For the year ended December 31, 2017, our SPP consists of 617 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2016 and that remained in operations under a consistent reporting structure through December 31, 2017. For the year ended December 31, 2016, our SPP consisted of 621 properties acquired or placed in service and stabilized on or prior to January 1, 2015 and that remained in operations under a consistent reporting structure through December 31, 2017. Our total consolidated property portfolio consists of 744, 851 and 869 properties at December 31, 2017, 2016 and 2015, respectively, excluding properties in the Spin-Off.
Senior Housing Triple-Net
2017 and 2016
The following table summarizes results at and for the years ended December 31, 2017 and 2016 (dollars in thousands except per unit data):
 
SPP
 
Total Portfolio
 
2017
 
2016
 
Change
 
2017
 
2016
 
Change
Rental revenues(1)
$
249,347

 
$
273,984

 
$
(24,637
)
 
$
313,547

 
$
423,118

 
$
(109,571
)
Operating expenses
(495
)
 
(197
)
 
(298
)
 
(3,819
)
 
(6,710
)
 
2,891

NOI
248,852

 
273,787

 
(24,935
)
 
309,728

 
416,408

 
(106,680
)
Adjustments to NOI
38,760

 
(1,374
)
 
40,134

 
17,098

 
(7,566
)
 
24,664

Adjusted NOI
$
287,612

 
$
272,413

 
$
15,199

 
326,826

 
408,842

 
(82,016
)
Non-SPP adjusted NOI
 
 
 
 
 
 
(39,214
)
 
(136,429
)
 
97,215

SPP adjusted NOI
 
 
 
 
 
 
$
287,612

 
$
272,413

 
$
15,199

SPP Adjusted NOI % change
 
 
 
 
5.6
%
 
 
 
 
 
 
Property count(2)
174

 
174

 
 
 
181

 
274

 
 
Average capacity (units)(3)
17,724

 
17,741

 
 
 
21,536

 
28,455

 
 
Average annual rent per unit
$
16,255

 
$
15,366

 
 
 
$
15,352

 
$
14,604

 
 
_______________________________________
(1)
Represents rental and related revenues and income from DFLs.
(2)
From our 2016 presentation of SPP, we removed four senior housing triple-net properties that were sold, 25 senior housing triple-net properties that were transitioned to our SHOP segment and two senior housing triple-net properties that were classified as held for sale. Our 2016 Total Portfolio property count has been adjusted to include 64 properties classified as held for sale as of December 31, 2016.
(3)
Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.
SPP NOI decreased primarily as a result of the net impact of triple-net lease terminations from the Brookdale Transaction during the fourth quarter of 2017.
SPP Adjusted NOI increased primarily as a result of the following:
•
annual rent escalations; and
•
higher cash rent received from our portfolio of assets leased to Sunrise Senior Living.
Additionally, Total Portfolio NOI and Adjusted NOI decreased primarily as a result of the following Non-SPP impacts:
•
senior housing triple-net facilities sold during 2016 and 2017; and
•
the transfer of 42 senior housing triple-net facilities to our SHOP segment.
The decrease to Total Portfolio NOI and Adjusted NOI is partially offset by (i) increased non-SPP income from five senior housing triple-net facilities acquired in the first quarter of 2016 and (ii) the aforementioned increases to SPP Adjusted NOI.

45

2016 and 2015
The following table summarizes results at and for the years ended December 31, 2016 and 2015 (dollars in thousands except per unit data):
 
SPP
 
Total Portfolio
 
2016
 
2015
 
Change
 
2016
 
2015
 
Change
Rental revenues(1)
$
302,976

 
$
304,442

 
$
(1,466
)
 
$
423,118

 
$
428,269

 
$
(5,151
)
Operating expenses
(237
)
 
(637
)
 
400

 
(6,710
)
 
(3,427
)
 
(3,283
)
NOI
302,739

 
303,805

 
(1,066
)
 
416,408

 
424,842

 
(8,434
)
Non-cash adjustments to NOI
(5,282
)
 
(7,550
)
 
2,268

 
(7,566
)
 
(9,716
)
 
2,150

Adjusted NOI
$
297,457

 
$
296,255

 
$
1,202

 
408,842

 
415,126

 
(6,284
)
Non-SPP adjusted NOI
 
 
 
 
 
 
(111,385
)
 
(118,871
)
 
7,486

SPP adjusted NOI
 
 
 
 
 
 
$
297,457

 
$
296,255

 
$
1,202

Adjusted NOI % change
 
 
 
 
0.4
%
 
 
 
 
 
 
Property count(2)
205

 
205

 
 
 
274

 
295

 
 
Average capacity (units)(3)
20,269

 
20,268

 
 
 
28,455

 
28,777

 
 
Average annual rent per unit
$
14,684

 
$
14,645

 
 
 
$
14,604

 
$
14,544

 
 
_______________________________________
(1)
Represents rental and related revenues and income from DFLs.
(2)
From our 2015 presentation of SPP, we removed nine senior housing triple-net properties that were sold, 17 senior housing triple-net properties that were transitioned to a RIDEA structure in our SHOP segment and 64 senior housing triple-net properties that were classified as held for sale. Our 2016 Total Portfolio property count has been adjusted to include 64 properties classified as held for sale as of December 31, 2016.
(3)
Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.
SPP NOI decreased primarily as a result of lower rents in our portfolio of assets leased to Sunrise Senior Living (the “Sunrise Portfolio”). SPP adjusted NOI increased primarily as a result of annual rent escalations, partially offset by lower cash rent received from our Sunrise portfolio.
Additionally, Total Portfolio NOI and adjusted NOI decreased primarily as a result of the following Non-SPP impacts:
•
nine senior housing triple-net facilities sold in 2016; and
•
the transition of 17 senior housing triple-net facilities to a RIDEA structure (reported in our SHOP segment); partially offset by
•
five senior housing triple-net facilities acquired in the first quarter of 2016.

46

Senior Housing Operating Portfolio
2017 and 2016
The following table summarizes results at and for the years ended December 31, 2017 and 2016 (dollars in thousands, except per unit data):
 
SPP
 
Total Portfolio
 
2017
 
2016
 
Change
 
2017
 
2016
 
Change
Resident fees and services
$
321,209

 
$
317,361

 
$
3,848

 
$
525,473

 
$
686,822

 
$
(161,349
)
Operating expenses
(239,702
)
 
(202,624
)
 
(37,078
)
 
(396,491
)
 
(480,870
)
 
84,379

NOI
81,507

 
114,737

 
(33,230
)
 
128,982

 
205,952

 
(76,970
)
Adjustments to NOI
32,863

 
(1,297
)
 
34,160

 
33,227

 
(2,686
)
 
35,913

Adjusted NOI
$
114,370

 
$
113,440

 
$
930

 
162,209

 
203,266

 
(41,057
)
Non-SPP adjusted NOI
 
 
 
 
 
 
(47,839
)
 
(89,826
)
 
41,987

SPP adjusted NOI
 
 
 
 
 
 
$
114,370

 
$
113,440

 
$
930

SPP Adjusted NOI % change
 
 
 
 
0.8
%
 
 
 
 
 
 
Property count(1)
48

 
48

 
 
 
102

 
130

 
 
Average capacity (units)(2)
8,128

 
8,136

 
 
 
12,758

 
16,028

 
 
Average annual rent per unit
$
44,378

 
$
43,842

 
 
 
$
41,133

 
$
42,851

 
 
_______________________________________
(1)
From our 2016 presentation of SPP, we removed a SHOP property that was placed into redevelopment, two SHOP properties that were classified as held for sale and 49 SHOP properties that were deconsolidated. Our 2016 Total Portfolio property count has been adjusted to include a property classified as held for sale as of December 31, 2016.
(2)
Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.
SPP NOI decreased primarily as a result of increased operating expenses related to the management fee terminations from the Brookdale Transaction during the fourth quarter of 2017.
SPP Adjusted NOI increased primarily as a result of the following:
•
increased rates for resident fees and services; partially offset by
•
higher expense growth and a decline in occupancy.
Additionally, Total Portfolio NOI and Adjusted NOI decreased primarily as a result of the following Non-SPP impacts:
•
decreased non-SPP income from our partial sale of RIDEA II; partially offset by
•
non-SPP income for 42 senior housing triple-net assets transferred to SHOP during the fourth quarter of 2016 and year-to-date 2017.

47

2016 and 2015
The following table summarizes results at and for the years ended December 31, 2016 and 2015 (dollars in thousands, except per unit data):
 
SPP
 
Total Portfolio
 
2016
 
2015
 
Change
 
2016
 
2015
 
Change
Resident fees and services
$
439,607

 
$
419,217

 
$
20,390

 
$
686,822

 
$
518,264

 
$
168,558

Operating expenses
(311,278
)
 
(298,648
)
 
(12,630
)
 
(480,870
)
 
(371,016
)
 
(109,854
)
NOI
128,329

 
120,569

 
7,760

 
205,952

 
147,248

 
58,704

Adjustments to NOI
—

 
—

 
—

 
(2,686
)
 
8,145

 
(10,831
)
Adjusted NOI
$
128,329

 
$
120,569

 
$
7,760

 
203,266

 
155,393

 
47,873

Non-SPP adjusted NOI
 
 
 
 
 
 
(74,937
)
 
(34,824
)
 
(40,113
)
SPP adjusted NOI
 
 
 
 
 
 
$
128,329

 
$
120,569

 
$
7,760

SPP Adjusted NOI % change
 
 
 
 
6.4
%
 
 
 
 
 
 
Property count(1)
69

 
69

 
 
 
130

 
130

 
 
Average capacity (units)(2)
9,944

 
9,962

 
 
 
16,028

 
12,704

 
 
Average annual rent per unit
$
44,209

 
$
42,081

 
 
 
$
42,851

 
$
41,435

 
 
_______________________________________
(1)
From our 2015 presentation of SPP, we removed two SHOP properties that were sold and a SHOP property that was classified as held for sale. Our 2016 and 2015 Total Portfolio property count has been adjusted to include a property classified as held for sale as of December 31, 2016 and 2015.
(2)
Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.
SPP NOI and adjusted NOI increased primarily as a result of increased occupancy and rates for resident fees and services.
Total Portfolio NOI and adjusted NOI increased primarily as a result of the aforementioned increases to SPP along with 2015 acquisitions, primarily our RIDEA III acquisition. The increase in Total Portfolio NOI was partially offset by a termination fee related to our RIDEA III acquisition, which was not repeated in 2016.  

48

Life Science
2017 and 2016
The following table summarizes results at and for the years ended December 31, 2017 and 2016 (dollars and sq. ft. in thousands, except per sq. ft. data):
 
SPP
 
Total Portfolio
 
2017
 
2016
 
Change
 
2017
 
2016
 
Change
Rental revenues(1)
$
304,858

 
$
292,147

 
$
12,711

 
$
358,816

 
$
358,537

 
$
279

Operating expenses
(63,612
)
 
(58,363
)
 
(5,249
)
 
(78,001
)
 
(72,478
)
 
(5,523
)
NOI
241,246

 
233,784

 
7,462

 
280,815

 
286,059

 
(5,244
)
Adjustments to NOI
2,427

 
339

 
2,088

 
(4,517
)
 
(2,954
)
 
(1,563
)
Adjusted NOI
$
243,673

 
$
234,123

 
$
9,550

 
276,298

 
283,105

 
(6,807
)
Non-SPP adjusted NOI
 
 
 
 
 
 
(32,625
)
 
(48,982
)
 
16,357

SPP adjusted NOI
 
 
 
 
 
 
$
243,673

 
$
234,123

 
$
9,550

SPP Adjusted NOI % change
 
 
 
 
4.1
%
 
 
 
 
 
 
Property count(2)
108

 
108

 
 
 
131

 
128

 
 
Average occupancy
96.3
%
 
97.7
%
 
 
 
96.2
%
 
97.5
%
 
 
Average occupied square feet
6,105

 
6,193

 
 
 
6,841

 
7,332

 
 
Average annual total revenues per occupied square foot
$
50

 
$
47

 
 
 
$
52

 
$
48

 
 
Average annual base rent per occupied square foot
$
41

 
$
39

 
 
 
$
42

 
$
40

 
 
_______________________________________
(1)
Represents rental and related revenues and tenant recoveries.
(2)
From our 2016 presentation of SPP, we removed one life science facility that was sold and four life science facilities that were classified as held for sale. Our 2016 Total Portfolio property count has been adjusted to include eight properties in development and four properties classified as held for sale as of December 31, 2016.
SPP NOI and Adjusted NOI increased primarily as a result of the following:
•
mark-to-market lease renewals;
•
new leasing activity; and
•
specific to adjusted NOI, annual rent escalations.
Total Portfolio NOI and Adjusted NOI decreased primarily as a result of the following impacts to Non-SPP:
•
decreased income from the sale of life science facilities in 2016 and 2017; partially offset by
•
increased income from (i) increased occupancy in portions of developments placed in operations in 2016 and 2017 and (ii) life science acquisitions in 2016 and 2017.
The decrease in Total Portfolio NOI and Adjusted NOI was also partially offset by the aforementioned increases to SPP.



49

2016 and 2015
The following table summarizes results at and for the years ended December 31, 2016 and 2015 (dollars and sq. ft. in thousands, except per sq. ft. data):
 
SPP
 
Total Portfolio
 
2016
 
2015
 
Change
 
2016
 
2015
 
Change
Rental revenues(1)
$
306,317

 
$
295,515

 
$
10,802

 
$
358,537

 
$
342,984

 
$
15,553

Operating expenses
(58,812
)
 
(58,779
)
 
(33
)
 
(72,478
)
 
(70,217
)
 
(2,261
)
NOI
247,505

 
236,736

 
10,769

 
286,059

 
272,767

 
13,292

Adjustments to NOI
554

 
(6,366
)
 
6,920

 
(2,954
)
 
(10,128
)
 
7,174

Adjusted NOI
$
248,059

 
$
230,370

 
$
17,689

 
283,105

 
262,639

 
20,466

Non-SPP adjusted NOI
 
 
 
 
 
 
(35,046
)
 
(32,269
)
 
(2,777
)
SPP adjusted NOI
 
 
 
 
 
 
$
248,059

 
$
230,370

 
$
17,689

SPP Adjusted NOI % change
 
 
 
 
7.7
%
 
 
 
 
 
 
Property count(2)
107

 
107

 
 
 
128

 
120

 
 
Average occupancy
97.8
%
 
96.8
%
 
 
 
97.5
%
 
97.1
%
 
 
Average occupied square feet
6,378

 
6,314

 
 
 
7,332

 
7,179

 
 
Average annual total revenues per occupied square foot
$
48

 
$
46

 
 
 
$
48

 
$
46

 
 
Average annual base rent per occupied square foot
$
40

 
$
37

 
 
 
$
40

 
$
38

 
 
_______________________________________
(1)
Represents rental and related revenues and tenant recoveries.
(2)
From our 2015 presentation of SPP, we removed four life science facilities that were sold and four life science facilities that were classified as held for sale. Our 2016 Total Portfolio property count has been adjusted to include eight properties in development and four properties classified as held for sale as of December 31, 2016. Our 2015 Total Portfolio property count has been adjusted to include two properties in development as of December 31, 2015.
SPP NOI and Adjusted NOI increased primarily as a result of the following:
•
mark-to-market lease renewals;
•
new leasing activity; and
•
increased occupancy.
Additionally, SPP adjusted NOI increased as a result of annual rent escalations and a decline in rent abatements.
Total Portfolio NOI and adjusted NOI increased primarily as a result of the aforementioned increases to SPP and the following impacts to Non-SPP:
•
life science acquisitions in 2015 and 2016; and
•
increased occupancy in a development placed in operation in 2016; partially offset by
•
five life science facilities sold in 2016.

50


Medical Office
2017 and 2016
The following table summarizes results at and for the years ended December 31, 2017 and 2016 (dollars and sq. ft. in thousands, except per sq. ft. data):
 
SPP
 
Total Portfolio
 
2017
 
2016
 
Change
 
2017
 
2016
 
Change
Rental revenues(1)
$
400,747

 
$
392,166

 
$
8,581

 
$
477,459

 
$
446,280

 
$
31,179

Operating expenses
(150,329
)
 
(146,300
)
 
(4,029
)
 
(183,197
)
 
(173,687
)
 
(9,510
)
NOI
250,418

 
245,866

 
4,552

 
294,262

 
272,593

 
21,669

Adjustments to NOI
2,183

 
(523
)
 
2,706

 
(2,952
)
 
(3,536
)
 
584

Adjusted NOI
$
252,601

 
$
245,343

 
$
7,258

 
291,310

 
269,057

 
22,253

Non-SPP adjusted NOI
 
 
 
 
 
 
(38,709
)
 
(23,714
)
 
(14,995
)
SPP adjusted NOI
 
 
 
 
 
 
$
252,601

 
$
245,343

 
$
7,258

SPP Adjusted NOI % change
 
 
 
 
3.0
%
 
 
 
 
 
 
Property count(2)
212

 
212

 
 
 
254

 
242

 
 
Average occupancy
91.9
%
 
92.2
%
 
 
 
91.8
%
 
91.5
%
 
 
Average occupied square feet
14,224

 
14,303

 
 
 
16,674

 
15,697

 
 
Average annual total revenues per occupied square foot
$
28

 
$
27

 
 
 
$
28

 
$
28

 
 
Average annual base rent per occupied square foot
$
24

 
$
23

 
 
 
$
24

 
$
24

 
 
_______________________________________
(1)
Represents rental and related revenues and tenant recoveries.
(2)
From our 2016 presentation of SPP, we removed four MOBs that were sold and two MOBs that were placed into redevelopment. Our 2016 Total Portfolio property count has been adjusted to include four properties in development as of December 31, 2016.
SPP NOI and Adjusted NOI increased primarily as a result of mark-to-market lease renewals and new leasing activity. Additionally, SPP Adjusted NOI increased as a result of annual rent escalations.
Total Portfolio NOI and Adjusted NOI increased primarily as a result of the aforementioned increases to SPP and the following impacts to Non-SPP:
•
increased income from our 2016 and 2017 acquisitions; and
•
increased occupancy in former redevelopment and development properties that have been placed into operations; partially offset by
•
decreased income from the sale of seven MOBs during 2016 and 2017 and the placement of a MOB into redevelopment.



51

2016 and 2015
The following table summarizes results at and for the years ended December 31, 2016 and 2015 (dollars and sq. ft. in thousands, except per sq. ft. data):
 
SPP
 
Total Portfolio
 
2016
 
2015
 
Change
 
2016
 
2015
 
Change
Rental revenues(1)
$
376,346

 
$
367,804

 
$
8,542

 
$
446,280

 
$
415,351

 
$
30,929

Operating expenses
(141,897
)
 
(138,130
)
 
(3,767
)
 
(173,687
)
 
(162,054
)
 
(11,633
)
NOI
234,449

 
229,674

 
4,775

 
272,593

 
253,297

 
19,296

Adjustments to NOI
(443
)
 
(2,379
)
 
1,936

 
(3,536
)
 
(4,933
)
 
1,397

Adjusted NOI
$
234,006

 
$
227,295

 
$
6,711

 
269,057

 
248,364

 
20,693

Non-SPP adjusted NOI
 
 
 
 
 
 
(35,051
)
 
(21,069
)
 
(13,982
)
SPP adjusted NOI
 
 
 
 
 
 
$
234,006

 
$
227,295

 
$
6,711

SPP Adjusted NOI % change
 
 
 
 
3.0
%
 
 
 
 
 
 
Property count(2)
202

 
202

 
 
 
242

 
231

 
 
Average occupancy
91.8
%
 
91.5
%
 
 
 
91.5
%
 
90.7
%
 
 
Average occupied square feet
12,976

 
12,905

 
 
 
15,697

 
14,677

 
 
Average annual total revenues per occupied square foot
$
29

 
$
28

 
 
 
$
28

 
$
28

 
 
Average annual base rent per occupied square foot
$
24

 
$
24

 
 
 
$
24

 
$
23

 
 
_______________________________________
(1)
Represents rental and related revenues and tenant recoveries.
(2)
From our 2015 presentation of SPP, we removed three MOBs that were sold and six MOBs that were placed into redevelopment. Our 2016 Total Portfolio property count has been adjusted to include four and five properties in development as of December 31, 2016 and December 31, 2015, respectively.
SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.
Total Portfolio NOI and Adjusted NOI increased primarily as a result of the aforementioned increases to SPP and the following impacts to Non-SPP:
•
increased occupancy in former redevelopment and development properties that have been placed into operations;
•
additional NOI from our MOB acquisitions in 2015 and 2016; partially offset by
•
the sale of three MOBs.


52

Other Income and Expense Items
The following table summarizes results for the years ended December 31, 2017, 2016 and 2015 (in thousands):
 
Year Ended December 31,
 
2017 vs.
 
2016 vs.
 
2017
 
2016
 
2015
 
2016
 
2015
Interest income
$
56,237

 
$
88,808

 
$
112,184

 
$
(32,571
)
 
$
(23,376
)
Interest expense
307,716

 
464,403

 
479,596

 
(156,687
)
 
(15,193
)
Depreciation and amortization
534,726

 
568,108

 
504,905

 
(33,382
)
 
63,203

General and administrative
88,772

 
103,611

 
95,965

 
(14,839
)
 
7,646

Transaction costs
7,963

 
9,821

 
27,309

 
(1,858
)
 
(17,488
)
Impairments (recoveries), net
166,384

 
—

 
108,349

 
166,384

 
(108,349
)
Gain (loss) on sales of real estate, net
356,641

 
164,698

 
6,377

 
191,943

 
158,321

Loss on debt extinguishments
(54,227
)
 
(46,020
)
 
—

 
(8,207
)
 
(46,020
)
Other income (expense), net
31,420

 
3,654

 
16,208

 
27,766

 
(12,554
)
Income tax benefit (expense)
1,333

 
(4,473
)
 
9,807

 
5,806

 
(14,280
)
Equity income (loss) from unconsolidated joint ventures
10,901

 
11,360

 
6,590

 
(459
)
 
4,770

Total discontinued operations
—

 
265,755

 
(699,086
)
 
(265,755
)
 
964,841

Noncontrolling interests’ share in earnings
(8,465
)
 
(12,179
)
 
(12,817
)
 
3,714

 
638

Interest income.  The decrease in interest income for the year ended December 31, 2017 was primarily the result of: (i) the payoff of our HC-One Facility in June 2017, (ii) incremental interest income received during the second quarter of 2016 due to the payoff of three participating development loans, and (iii) decreased interest received from our Tandem Mezzanine Loan during the fourth quarter of 2017, partially offset by additional interest income in 2017 from our $131 million loan to Maria Mallaband in November 2016.
The decrease in interest income for the year ended December 31, 2016 was primarily the result of: (i) placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and (ii) paydowns in our loan portfolio. The decrease in interest income was partially offset by additional interest income from: (i) the Four Seasons senior secured term loan purchased in the fourth quarter of 2015 and (ii) additional fundings in our loan portfolio, including our £105 million ($131 million) loan to Maria Mallaband in November 2016.
Interest expense.  The decrease in interest expense for the year ended December 31, 2017 was primarily the result of senior unsecured notes and mortgage debt repayments, which occurred primarily in the second half of 2016 and throughout 2017.
The decrease in interest expense for the year ended December 31, 2016 was primarily the result of: (i) mortgage debt repayments during 2015 and 2016, primarily from mortgage debt secured by properties in our senior housing triple-net, life science and medical office segments, (ii) senior unsecured notes payoffs during 2015 and 2016 and higher capitalized interest. The decrease in interest expense was partially offset by: (i) senior unsecured notes issued during 2015 and (ii) increased borrowings under our Facility.
Approximately 84%, 83% and 96% of our total debt, inclusive of $44 million, $46 million and $71 million of variable rate debt swapped to fixed through interest rate swaps, was fixed rate debt as of December 31, 2017, 2016 and 2015, respectively. At December 31, 2017, our fixed rate debt and variable rate debt had weighted average interest rates of 4.19% and 2.56%, respectively. At December 31, 2016, our fixed rate debt and variable rate debt had weighted average interest rates of 4.26% and 2.23%, respectively. At December 31, 2015, our fixed rate debt and variable rate debt had weighted average interest rates of 4.68% and 1.72%, respectively. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3 below.
Depreciation and amortization.  The decrease in depreciation and amortization expense for the year ended December 31, 2017 was primarily as a result of the sale of 64 senior housing triple-net assets and the deconsolidation of RIDEA II during the first quarter of 2017, partially offset by depreciation and amortization of assets acquired and placed in service during 2016 and 2017.
The increase in depreciation and amortization expense for the year ended December 31, 2016 was primarily the result of the impact of acquisitions primarily in our SHOP and medical office segments.

53

General and administrative expenses.  The decrease in general and administrative expenses for the year ended December 31, 2017 was primarily as a result of severance and related charges primarily resulting from the departure of our former President and CEO in the third quarter of 2016 which exceeded severance and related charges primarily related to the departure of our former CAO in the third quarter of 2017.
The increase in general and administrative expenses for the year ended December 31, 2016 was primarily the result of: (i) higher severance-related charges primarily resulting from the departure of our former President and CEO in the third quarter of 2016 and (ii) higher professional fees in 2016, partially offset by lower compensation related expenses.
We expect to record severance and related charges of approximately $9 million in the first quarter of 2018 related to the previously announced departure of our Executive Chairman, effective March 1, 2018.
Transaction costs.  The decrease in transaction costs for the year ended December 31, 2016 was primarily a result of lower levels of transactional activity in 2016 compared to the same period in 2015. 
Impairments (recoveries), net.  During the year ended December 31, 2017, we recognized (i) $144 million of impairments on our Tandem Mezzanine Loan due to a variety of factors including recent operating results of the underlying collateral and events of default under the loan agreement (see Note 7 to the Consolidated Financial Statements for further information) and (ii) $23 million of impairments on 11 underperforming senior housing triple-net facilities.
For the year ended December 31, 2016, there were no impairments recognized.
During the year ended December 31, 2015, we recognized the following impairment charges: (i) $112 million related to our investment in Four Seasons Notes and (ii) $3 million related to a MOB. The impairment charges were partially offset by a $6 million impairment recovery related to the repayment of a loan.
Gain (loss) on sales of real estate, net.  During the year ended December 31, 2017, we sold 68 senior housing triple-net assets for $1.152 billion, five life science facilities for $81 million, five SHOP facilities for $43 million, four MOBs for $15 million and a 40% interest in RIDEA II and recognized total net gain on sales of real estate of $357 million.
During the year ended December 31, 2016, we sold a portfolio of five facilities in one of our non-reportable segments and two senior housing triple-net facilities for $130 million, five life science facilities for $386 million, seven senior housing triple-net facilities for $88 million, three MOBs for $20 million and three SHOP facilities for $41 million, recognizing total gain on sales of $165 million.
During the year ended December 31, 2015, we sold the following assets: (i) nine senior housing triple-net facilities for $60 million, resulting from Brookdale’s exercise of its purchase option, and (ii) a MOB for $0.4 million, recognizing total gain on sales of $6 million.
Loss on debt extinguishments.  During the year ended December 31, 2017, we repurchased $500 million of our 5.375% senior notes due 2021 and recognized a $54 million loss on debt extinguishment, primarily related to a premium for early payment.
During the fourth quarter of 2016, using proceeds from the Spin-Off, we repaid $1.1 billion of senior unsecured notes that were due to mature in January 2017 and January 2018 and repaid $108 million of mortgage debt, incurring aggregate loss on debt extinguishments of $46 million, primarily related to prepayment penalties.  
Other income (expense), net.  The increase in other income, net for the year ended December 31, 2017 was primarily as a result of the £42 million ($51 million) gain on sale of our Four Seasons Notes, partially offset by $12 million of casualty-related charges due to hurricanes in the third quarter of 2017 and $13 million of increased litigation-related expenses, including costs from securities class action litigation, and a legal settlement in 2017.
The decrease in other income, net for the year ended December 31, 2016 was primarily the result of a reduction of foreign currency remeasurement gains from remeasuring assets and liabilities denominated in GBP to U.S. dollars (“USD”) as a result of effective hedges designated in September 2015.
Income tax benefit (expense).  The increase in income tax benefit for the year ended December 31, 2017 was primarily the result of: (i) a $6 million income tax benefit from the partial sale of RIDEA II in 2017, (ii) a $5 million income tax benefit related to our share of operating losses from our RIDEA joint ventures, (iii) a $1 million deferred tax benefit from casualty-related charges recognized in the second half of 2017 and (iv) a $11 million income tax expense recognized in 2016 associated with federal income tax and state built-in gain tax for the disposition of certain real estate assets. The total tax benefit was partially offset by a $17 million income tax expense related to the impact of tax rate legislation during the fourth quarter of 2017.

54

The increase in income tax expense for the year ended December 31, 2016 was primarily the result of recognizing tax liabilities representing state built-in gain tax for the disposition of certain real estate assets.
Equity income (loss) from unconsolidated joint ventures.  The decrease in equity income from unconsolidated joint ventures for the year ended December 31, 2017 was primarily the result of income from our share of gains on sales of real estate in 2016, partially offset by income from our investment in RIDEA II, which was deconsolidated in the first quarter of 2017.
The increase in equity income from unconsolidated joint ventures for the year ended December 31, 2016 was primarily the result of increased income from our share of gains on sales of real estate.
Total discontinued operations.  Discontinued operations for the years ended December 31, 2016 and 2015 resulted in income of $266 million and loss of $699 million, respectively. Income and loss from discontinued operations primarily relates to the operations of QCP. Income from discontinued operations increased during the year ended December 31, 2016 as a result of impairment charges during 2015 not repeated in 2016. The increase in discontinued operations was partially offset by the following: (i) a reduction in income from our HCRMC investments as a result of the HCRMC lease amendment effective April 1, 2015, the sale of non-strategic assets during the second half of 2015 and the first half of 2016, and a change in income recognition to a cash basis method beginning in January 2016, (ii) transaction costs of $87 million related to the Spin-Off and (iii) increased income tax expense related to our estimated exposure to state built-in gain tax. During the year ended December 31, 2015, we recognized impairments of $1.3 billion related to our HCRMC portfolio. There were no discontinued operations for the year ended December 31, 2017.
Liquidity and Capital Resources
We anticipate that our cash flow from operations, available cash balances and cash from our various financing activities will be adequate for at least the next 12 months for purposes of: (i) funding recurring operating expenses; (ii) meeting debt service requirements, including principal payments and maturities; and (iii) satisfying our distributions to our stockholders and non-controlling interest members.  
Our principal investing liquidity needs for the next 12 months are to:
•
fund capital expenditures, including tenant improvements and leasing costs; and
•
fund future acquisition, transactional and development activities.
We anticipate satisfying these future investing needs using one or more of the following:
•
issuance of common or preferred stock;
•
issuance of additional debt, including unsecured notes and mortgage debt;
•
draws on our credit facilities; and/or
•
sale or exchange of ownership interests in properties.
Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, our revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our credit ratings. We also pay a facility fee on the entire revolving commitment that depends upon our credit ratings. As of January 31, 2018, we had a credit rating of BBB from Fitch, Baa2 from Moody’s and BBB from S&P Global on our senior unsecured debt securities.
Cash Flow Summary
During the fourth quarter of 2017, we adopted Accounting Standards Update ("ASU") No. 2016-18, Restricted Cash and ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments using the full retrospective approach. See Note 2 to the Consolidated Financial Statements for additional information. The following summary discussion of our cash flows is based on the Consolidated Statements of Cash Flows and is not meant to be an all-inclusive discussion of the changes in our cash flows for the periods presented below.

55

Cash, cash equivalents and restricted cash were $82 million, $137 million and $407 million at December 31, 2017, 2016 and 2015, respectively. The following table sets forth changes in cash flows (in thousands):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Net cash provided by (used in) operating activities
$
847,041

 
$
1,214,131

 
$
1,222,145

Net cash provided by (used in) investing activities
1,246,257

 
(428,973
)
 
(1,660,365
)
Net cash provided by (used in) financing activities
(2,148,461
)
 
(1,054,265
)
 
614,087

Operating cash flow decreased $367 million between the years ended December 31, 2017 and 2016 primarily as the result of: (i) decreased Adjusted NOI related to the QCP Spin-Off and dispositions in 2016 and 2017 and (ii) decreased interest received as a result of loan repayments during 2016 and 2017; partially offset by (i) 2016 and 2017 acquisitions, (ii) annual rent increases, (iii) and decreased interest paid as a result of lower balances on our senior unsecured notes and term loans. Our cash flow from operations is dependent upon the occupancy levels of our buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.
Operating cash flow decreased $8 million between the years ended December 31, 2016 and 2015 primarily as the result of: (i) decreased Adjusted NOI related to the QCP Spin-Off and dispositions in 2015 and 2016 and (ii) decreased interest received as a result of loan repayments during 2016; partially offset by (i) 2015 and 2016 acquisitions, (ii) annual rent increases, (iii) and decreased interest paid as a result of lower balances on our senior unsecured notes and term loans.
The following are significant investing and financing activities for the year ended December 31, 2017:
•
received net proceeds of $1.8 billion from the sale of real estate, including the sale and recapitalization of RIDEA II;
•
received net proceeds of $559 million primarily from the sale of our Four Seasons investments, the repayment of our HC-One Facility, and a DFL repayment;
•
made investments of $1.1 billion primarily for the acquisition and development of real estate;
•
repaid $1.4 billion of debt under our 2012 Term Loan, 2015 Term Loan, senior unsecured notes and mortgage debt, partially offset by net borrowings under our bank line of credit; and
•
paid cash dividends on common stock of $695 million.
The following are significant investing and financing activities for the year ended December 31, 2016:
•
made investments of $1.3 billion (development, leasing and acquisition of real estate, investments in unconsolidated joint ventures and loans, and purchases of securities) and received proceeds of $908 million primarily from real estate and DFL sales;
•
paid cash dividends on common stock of $980 million, which were generally funded by cash provided by our operating activities and cash on hand; and
•
received net proceeds of $1.7 billion from the Spin-Off of QCP, raised proceeds of $1.1 billion primarily from our net borrowings under our bank line of credit, and repaid $2.9 billion under our bank line of credit, senior unsecured notes and mortgage debt.
The following are significant investing and financing activities for the year ended December 31, 2015:
•
made investments of $2.4 billion (development, leasing and acquisition of real estate, and investments in unconsolidated joint ventures and loans);
•
paid dividends on common stock of $1 billion, which were generally funded by cash provided by our operating activities and cash on hand; and
•
raised proceeds of $2.7 billion primarily from issuing senior unsecured notes, the term loan originated in January 2015, net borrowings under our bank line of credit, issuances of common stock and noncontrolling interest, and an additional $684 million from sales of real estate, and loan and DFL repayments; and repaid $969 million of senior unsecured notes, bank line of credit and mortgage debt.

56

Debt
See Note 10 in the Consolidated Financial Statements for information about our outstanding debt.
See “2017 Transaction Overview” for further information regarding our significant financing activities during the year ended December 31, 2017.
Equity
At December 31, 2017, we had 469 million shares of common stock outstanding, equity totaled $5.6 billion, and our equity securities had a market value of $12.4 billion.
At December 31, 2017, non-managing members held an aggregate of 4 million units in five limited liability companies (“DownREITs”) for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).
At-The-Market Program.  In June 2015, we established an at-the-market program, in connection with the renewal of our Shelf Registration Statement. Under this program, we may sell shares of our common stock from time to time having an aggregate gross sales price of up to $750 million through a consortium of banks acting as sales agents or directly to the banks acting as principals. There was no activity during the year ended December 31, 2017 and, as of December 31, 2017, shares of our common stock having an aggregate gross sales price of $676 million were available for sale under the at-the-market program. Actual future sales will depend upon a variety of factors, including but not limited to market conditions, the trading price of our common stock and our capital needs. We have no obligation to sell the remaining shares available for sale under our program.
Shelf Registration
We filed a prospectus with the SEC as part of a registration statement on Form S-3ASR, using a shelf registration process. Our current shelf registration statement expires in June 2018. We expect to file a new shelf registration statement on or before such time. Under the “shelf” process, we may sell any combination of the securities described in the prospectus through one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities and warrants.

57

Contractual Obligations
The following table summarizes our material contractual payment obligations and commitments at December 31, 2017 (in thousands):
 
Total(1)
 
2018
 
2019-2020
 
2021-2022
 
More than
Five Years
Bank line of credit(2)
$
1,017,076

 
$
—

 
$
—

 
$
1,017,076

 
$
—

Term loan(3)
228,674

 
—

 
228,674

 
—

 
—

Senior unsecured notes
6,450,000

 
—

 
1,250,000

 
1,600,000

 
3,600,000

Mortgage debt
138,567

 
3,512

 
7,458

 
13,978

 
113,619

U.K. loan commitments(4)
3,236

 
3,236

 
—

 
—

 
—

Construction loan commitments(5)
114,691

 
45,863

 
68,828

 
—

 
—

Development commitments(6)
133,371

 
128,101

 
2,228

 
3,042

 
—

Ground and other operating leases
395,796

 
6,619

 
13,434

 
13,524

 
362,219

Interest(7)
1,938,466

 
297,694

 
551,684

 
419,699

 
669,389

Total
$
10,419,877

 
$
485,025

 
$
2,122,306

 
$
3,067,319

 
$
4,745,227

_______________________________________
(1)
Excludes $94 million of other debt that represents life care bonds and demand notes that have no scheduled maturities. 
(2)
Includes £105 million ($142 million) translated into USD.
(3)
Represents £169 million translated into USD.
(4)
Represents £2 million translated into USD for commitments to fund our U.K. loan facilities.
(5)
Represents commitments to finance development projects.
(6)
Represents construction and other commitments for developments in progress.
(7)
Interest on variable-rate debt is calculated using rates in effect at December 31, 2017.
Off-Balance Sheet Arrangements
We own interests in certain unconsolidated joint ventures as described in Note 8 to the Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable. In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities, as described under Note 11 to the Consolidated Financial Statements. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described above under “Contractual Obligations”.
Inflation
Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Most of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, and remaining other leases require the tenant or operator to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the tenant or operator expense reimbursements and contractual rent increases described above.

58

Non-GAAP Financial Measure Reconciliations
Funds From Operations and Funds Available for Distribution
The following is a reconciliation from net income (loss) applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO, FFO as adjusted and FAD (in thousands, except per share data):
 
Year Ended December 31,
 
2017
 
2016
 
2015
 
2014
 
2013
Net income (loss) applicable to common shares
$
413,013

 
$
626,549

 
$
(560,552
)
 
$
919,796

 
$
969,103

Real estate related depreciation and amortization
534,726

 
572,998

 
510,785

 
459,995

 
429,174

Real estate related depreciation and amortization on unconsolidated joint ventures
60,058

 
49,043

 
48,188

 
21,303

 
9,891

Real estate related depreciation and amortization on noncontrolling interests and other
(15,069
)
 
(21,001
)
 
(14,506
)
 
(8,027
)
 
(6,217
)
Other depreciation and amortization
9,364

 
11,919

 
22,223

 
18,864

 
14,326

Loss (gain) on sales of real estate, net
(356,641
)
 
(164,698
)
 
(6,377
)
 
(31,298
)
 
(69,866
)
Loss (gain) on sales of real estate, net on unconsolidated joint ventures
(1,430
)
 
(16,332
)
 
(15,003
)
 
—

 
—

Loss (gain) on sales of real estate, net on noncontrolling interests
—

 
224

 
1,453

 
1,001

 
1,481

Taxes associated with real estate dispositions(1)
(5,498
)
 
60,451

 
—

 
—

 
—

Impairments (recoveries) of real estate, net
22,590

 
—

 
2,948

 
—

 
1,372

FFO applicable to common shares
661,113

 
1,119,153

 
(10,841
)
 
1,381,634

 
1,349,264

Distributions on dilutive convertible units
—

 
8,732

 
—

 
13,799

 
13,276

Diluted FFO applicable to common shares
$
661,113

 
$
1,127,885

 
$
(10,841
)
 
$
1,395,433

 
$
1,362,540

Weighted average shares used to calculate diluted FFO per common share
468,935

 
471,566

 
462,795

 
464,845

 
461,710

 
 
 
 
 
 
 
 
 
 
Impact of adjustments to FFO:
 
 
 
 
 
 
 
 
 
Transaction-related items(2)
$
62,576

 
$
96,586

 
$
32,932

 
$
(18,856
)
 
$
6,191

Other impairments (recoveries), net(3)
92,900

 
—

 
1,446,800

 
35,913

 
—

Severance and related charges(4)
5,000

 
16,965

 
6,713

 
—

 
27,244

Loss on debt extinguishments(5)
54,227

 
46,020

 
—

 
—

 
—

Litigation costs(6)
15,637

 
3,081

 
—

 
—

 
—

Casualty-related charges (recoveries), net
10,964

 
—

 
—

 
—

 
—

Foreign currency remeasurement losses (gains)
(1,043
)
 
585

 
(5,437
)
 
—

 
—

Tax rate legislation impact(7)
17,028

 
—

 
—

 
—

 
—

 
$
257,289

 
$
163,237

 
$
1,481,008

 
$
17,057

 
$
33,435

 
 
 
 
 
 
 
 
 
 
FFO as adjusted applicable to common shares
$
918,402

 
$
1,282,390

 
$
1,470,167

 
$
1,398,691

 
$
1,382,699

Distributions on dilutive convertible units and other
6,657

 
12,849

 
13,597

 
13,766

 
13,220

Diluted FFO as adjusted applicable to common shares
$
925,059

 
$
1,295,239

 
$
1,483,764

 
$
1,412,457

 
$
1,395,919

Weighted average shares used to calculate diluted FFO as adjusted per common share
473,620

 
473,340

 
469,064

 
464,845

 
461,710

 
 
 
 
 
 
 
 
 
 
FFO as adjusted applicable to common shares
$
918,402

 
$
1,282,390

 
$
1,470,167

 
$
1,398,691

 
$
1,382,699

Amortization of deferred compensation(8)
13,510

 
15,581

 
23,233

 
21,885

 
23,327

Amortization of deferred financing costs
14,569

 
20,014

 
20,222

 
19,260

 
18,541

Straight-line rents
(23,933
)
 
(27,560
)
 
(38,415
)
 
(43,857
)
 
(39,587
)
FAD capital expenditures(9)
(124,176
)
 
(93,407
)
 
(91,320
)
 
(85,183
)
 
(75,163
)
Lease restructure payments
1,470

 
16,604

 
22,657

 
9,425

 
—

CCRC entrance fees(10)
21,385

 
21,287

 
27,895

 
11,121

 
—

Deferred income taxes(11)
(15,490
)
 
(13,692
)
 
(15,281
)
 
(4,580
)
 
3,500

Other FAD adjustments(12)
(2,017
)
 
(5,521
)
 
(157,309
)
 
(147,940
)
 
(155,235
)
FAD applicable to common shares
803,720

 
1,215,696

 
1,261,849

 
1,178,822

 
1,158,082

Distributions on dilutive convertible units
—

 
13,088

 
14,230

 
13,799

 
13,276

Diluted FAD applicable to common shares
$
803,720

 
$
1,228,784

 
$
1,276,079

 
$
1,192,621

 
$
1,171,358


59

 
Year Ended December 31,
 
2017
 
2016
 
2015
 
2014
 
2013
Diluted earnings per common share
$
0.88

 
$
1.34

 
$
(1.21
)
 
$
2.00

 
$
2.13

Depreciation and amortization
1.25

 
1.30

 
1.22

 
1.07

 
0.97

Loss (gain) on sales of real estate, net
(0.76
)
 
(0.38
)
 
(0.04
)
 
(0.07
)
 
(0.15
)
Taxes associated with real estate dispositions
(0.01
)
 
0.13

 
—

 
—

 
—

Impairments (recoveries) of real estate, net
0.05

 
—

 
0.01

 
—

 
—

Diluted FFO per common shares
$
1.41

 
$
2.39

 
$
(0.02
)
 
$
3.00

 
$
2.95

Transaction-related items(2)
0.13

 
0.20

 
0.07

 
(0.04
)
 
0.01

Other impairments (recoveries), net(3)
0.20

 
—

 
3.11

 
0.08

 
—

Severance and related charges(4)
0.01

 
0.04

 
0.01

 
—

 
0.06

Loss on debt extinguishments(5)
0.11

 
0.10

 
—

 
—

 
—

Litigation costs(6)
0.03

 
0.01

 
—

 
—

 
—

Casualty-related charges (recoveries), net
0.02

 
—

 
—

 
—

 
—

Foreign currency remeasurement losses (gains)
—

 
—

 
(0.01
)
 
—

 
—

Tax rate legislation impact(7)
0.04

 
—

 
—

 
—

 
—

Diluted FFO as adjusted per common shares
$
1.95

 
$
2.74

 
$
3.16

 
$
3.04

 
$
3.02

_______________________________________
(1)
For the year ended December 31, 2017, represents income tax benefit associated with the disposition of real estate assets in our RIDEA II transaction. For the year ended December 31, 2016, represents income tax expense associated with the state built-in gain tax payable upon the disposition of specific real estate assets, of which $49 million relates to the HCRMC real estate portfolio.
(2)
For the year ended December 31, 2017, includes $55 million of net non-cash charges related to the right to terminate certain triple-net leases and management agreements in conjunction with the November 2017 Brookdale transaction. For the year ended December 31, 2016, primarily relates to the Spin-Off. For the year ended December 31, 2015, primarily related to acquisition and pursuit costs. For the year ended December 31, 2014, includes a net benefit from the 2014 Brookdale transaction, partially offset by acquisition and pursuit costs. For the year ended December 31, 2013, primarily relates to acquisition and pursuit costs.
(3)
For the year ended December 31, 2017, relates to $144 million of impairments on our Tandem Mezzanine Loan throughout 2017, net of a $51 million impairment recovery upon the sale of our Four Seasons Notes in the first quarter of 2017. For the year ended December 31, 2015, include impairment charges of: (i) $1.3 billion related to our HCRMC DFL investments, (ii) $112 million related to our Four Seasons Notes and (iii) $46 million related to our equity investment in HCRMC, partially offset by an impairment recovery of $6 million related to a loan payoff. For the year ended December 31, 2014, relates to our equity investment in HCRMC. 
(4)
For the year ended December 31, 2017, primarily relates to the departure of our former Executive Vice President and Chief Accounting Officer. For the year ended December 31, 2016, primarily relates to the departure of our former President and Chief Executive Officer. For the year ended December 31, 2015, relates to the departure of our former Executive Vice President and Chief Investment Officer. For the year ended December 31, 2013, relates to the departure of our former Chairman, CEO and President.
(5)
For the year ended December 31, 2017, represents the premium associated with the prepayment of $500 million of senior unsecured notes. For the year ended December 31, 2016, represents penalties of $46 million from the prepayment of $1.1 billion of senior unsecured notes and $108 million of mortgage debt using proceeds from the Spin-Off.
(6)
For the year ended December 31, 2017, relates to costs from securities class action litigation and a legal settlement. For the year ended December 31, 2016, primarily relates to costs from securities class action litigation. See Note 3 in the Consolidated Financial Statements for additional information.
(7)
Represents the remeasurement of deferred tax assets and liabilities as a result of the Tax Cuts and Jobs Act that was signed into legislation on December 22, 2017.
(8)
Excludes $0.7 million related to the acceleration of deferred compensation for restricted stock units that vested upon the departure of our former Executive Vice President and Chief Accounting Officer, which is included in the severance and related charges for the year ended December 31, 2017. Excludes $7 million related to the acceleration of deferred compensation for restricted stock units that vested upon the departure of our former President and Chief Executive Officer, which is included in severance and related charges for the year ended December 31, 2016. Excludes $3 million related to the acceleration of deferred compensation for restricted stock units and stock options that vested upon the departure of our former Executive Vice President and Chief Investment Officer, which is included in the severance-related charge for year ended December 31, 2015. Excludes $17 million related to the acceleration of deferred compensation for restricted stock units and options that vested upon the departure of our former CEO, which is included in severance-related charges for the year ended December 31, 2013.
(9)
Includes our share of recurring capital expenditures, leasing costs, and tenant and capital improvements from unconsolidated joint ventures.
(10)
Represents our 49% share of non-refundable entrance fees as the fees are collected by our CCRC JV, net of reserves and CCRC JV entrance fee amortization.
(11)
Excludes $17 million of deferred tax expenses, which is included in tax rate legislation impact for the year ended December 31, 2017. Additionally, the year ended December 31, 2017, excludes $1 million of deferred tax benefit from the casualty-related charges, which is included in casualty-related charges (recoveries), net.
(12)
Our equity investment in HCRMC was accounted for using the equity method, which required an elimination of DFL income that is proportional to our ownership in HCRMC. Further, our share of earnings from HCRMC (equity income) increased for the corresponding elimination of related lease expense recognized at the HCRMC entity level, which we presented as a non-cash joint venture FAD adjustment. Beginning in January 2016, as a result of placing our equity investment in HCRMC on a cash basis method of accounting, we no longer eliminated our proportional ownership share of income from DFLs to equity income (loss) from unconsolidated joint ventures. See Note 5 to the Consolidated Financial Statements for additional discussion.

60

Critical Accounting Policies
The preparation of financial statements in conformity with U.S. GAAP requires our management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. For a more detailed discussion of our significant accounting policies, see Note 2 to the Consolidated Financial Statements. Below is a discussion of accounting policies that we consider critical in that they may require complex judgment in their application or require estimates about matters that are inherently uncertain.
Principles of Consolidation
The consolidated financial statements include the accounts of HCP, Inc., our wholly-owned subsidiaries and joint ventures that we control, through voting rights or other means. We consolidate investments in variable interest entities (“VIEs”) when we are the primary beneficiary of the VIE. A variable interest holder is considered to be the primary beneficiary of a VIE if it has the power to direct the activities that most significantly impact the entity’s economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to the VIE.
We make judgments about which entities are VIEs based on an assessment of whether: (i) the equity investors as a group, do not have a controlling financial interest, (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support, or (iii) substantially all of the entity’s activities involve or are performed on behalf of an equity investor that holds disproportionately few voting rights. We make judgments with respect to our level of influence or control over an entity and whether we are (or are not) the primary beneficiary of a VIE. Consideration of various factors includes, but is not limited to, our ability to direct the activities that most significantly impact the entity’s economic performance, our form of ownership interest, our representation on the entity’s governing body, the size and seniority of our investment, and our ability and the rights of other investors to participate in policy making decisions, replace the manager and/or liquidate the entity, if applicable. Our ability to correctly assess our influence or control over an entity when determining the primary beneficiary of a VIE affects the presentation of these entities in our consolidated financial statements. When we perform a re-analysis of the primary beneficiary at a date other than at inception of the VIE, our assumptions may be different and may result in the identification of a different primary beneficiary.
If we determine that we are the primary beneficiary of a VIE, our consolidated financial statements include the operating results of the VIE rather than the results of our variable interest in the VIE. We require VIEs to provide us timely financial information and review the internal controls of VIEs to determine if we can rely on the financial information it provides. If a VIE has deficiencies in its internal controls over financial reporting, or does not provide us with timely financial information, it may adversely impact the quality and/or timing of our financial reporting and our internal controls over financial reporting.
Revenue Recognition
At the inception of a new lease arrangement, including new leases that arise from amendments, we assess the terms and conditions to determine the proper lease classification. A lease arrangement is classified as an operating lease if none of the following criteria are met: (i) transfer of ownership to the lessee prior to or shortly after the end of the lease term, (ii) the lessee has a bargain purchase option during or at the end of the lease term, (iii) the lease term is equal to 75% or more of the underlying property’s economic life, or (iv) the present value of future minimum lease payments (excluding executory costs) is equal to 90% or more of the estimated fair value of the leased asset. If one of the four criteria is met and the minimum lease payments are determined to be reasonably predictable and collectible, the lease arrangement is generally accounted for as a DFL. If the assumptions utilized in the above classifications assessments were different, our lease classification for accounting purposes may have been different; thus the timing and amount of our revenue recognized would have been impacted, which may be material to our consolidated financial statements.
We recognize rental revenue for operating leases on a straight-line basis over the lease term when collectibility of all minimum lease payments is reasonably assured and the tenant has taken possession or controls the physical use of a leased asset. If the lease provides for tenant improvements, we determine whether the tenant improvements are owned by the tenant or us. When we are the owner of the tenant improvements, the tenant is not considered to have taken physical possession or have control of the leased

61

asset until the tenant improvements are substantially complete. When the tenant is the owner of the tenant improvements, any tenant improvement allowance funded is treated as a lease incentive and amortized as a reduction of revenue over the lease term. The determination of ownership of a tenant improvement is subject to significant judgment. If our assessment of the owner of the tenant improvements was different, the timing and amount of our revenue recognized would be impacted.
Certain leases provide for additional rents that are contingent upon a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the base amount or other thresholds. The recognition of additional rents requires us to make estimates of amounts owed and, to a certain extent, is dependent on the accuracy of the facility results reported to us. Our estimates may differ from actual results, which could be material to our consolidated financial statements.
We maintain an allowance for doubtful accounts, including an allowance for operating lease straight-line rent receivables, for estimated losses resulting from tenant defaults or the inability of tenants to make contractual rent and tenant recovery payments. We monitor the liquidity and creditworthiness of our tenants and operators on a continuous basis. This evaluation considers industry and economic conditions, property performance, credit enhancements and other factors. For straight-line rent receivable amounts, our assessment is based on income recoverable over the term of the lease. We exercise judgment in establishing allowances and consider payment history and current credit status in developing these estimates. These estimates may differ from actual results, which could be material to our consolidated financial statements.
We use the direct finance method of accounting to record income from DFLs. For leases accounted for as DFLs, the net investment in the DFL represents receivables for the sum of future minimum lease payments receivable and the estimated residual values of the leased properties, less the unamortized unearned income. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield when collectibility of the lease payments is reasonably assured. The determination of estimated useful lives and residual values are subject to significant judgment. If these assessments were to change, the timing and amount of our revenue recognized would be impacted.
Loans receivable are classified as held-for-investment based on management’s intent and ability to hold the loans for the foreseeable future or to maturity. We recognize interest income on loans, including the amortization of discounts and premiums, using the interest method applied on a loan-by-loan basis when collectibility of the future payments is reasonably assured. Premiums, discounts and related costs are recognized as yield adjustments over the term of the related loans. If management determined that certain loans should no longer be classified as held-for-investment, the timing and amount of our interest income recognized would be impacted.
Loans receivable and DFLs (collectively, “Finance Receivables”), are reviewed and assigned an internal rating of Performing, Watch List or Workout. Finance Receivables that are deemed Performing meet all present contractual obligations, and collection and timing, of all amounts owed is reasonably assured. Watch List Finance Receivables are defined as Finance Receivables that do not meet the definition of Performing or Workout. Workout Finance Receivables are defined as Finance Receivables in which we have determined, based on current information and events, that: (i) it is probable we will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the tenant, operator, or borrower is delinquent on making payments under the contractual terms of the agreement and (iii) we have commenced action or anticipate pursuing action in the near term to seek recovery of our investment.
Finance Receivables are placed on nonaccrual status when management determines that the collectibility of contractual amounts is not reasonably assured (the asset will have an internal rating of either Watch List or Workout). Further, we perform a credit analysis to support the tenant’s, operator’s, borrower’s and/or guarantor’s repayment capacity and the underlying collateral values. We use the cash basis method of accounting for Finance Receivables placed on nonaccrual status unless one of the following conditions exist whereby we utilize the cost recovery method of accounting: (i) if we determine that it is probable that we will only recover the recorded investment in the Finance Receivable, net of associated allowances or charge-offs (if any), or (ii) we cannot reasonably estimate the amount of an impaired Finance Receivable. For cash basis method of accounting we apply payments received, excluding principal paydowns, to interest income so long as that amount does not exceed the amount that would have been earned under the original contractual terms. For cost recovery method of accounting any payment received is applied to reduce the recorded investment. Generally, we return a Finance Receivable to accrual status when all delinquent payments become current under the terms of the loan or lease agreements and collectibility of the remaining contractual loan or lease payments is reasonably assured.
Allowances are established for Finance Receivables on an individual basis utilizing an estimate of probable losses, if they are determined to be impaired. Finance Receivables are impaired when it is deemed probable that we will be unable to collect all amounts due in accordance with the contractual terms of the loan or lease. An allowance is based upon our assessment of the lessee’s or borrower’s overall financial condition, economic resources, payment record, the prospects for support from any financially responsible guarantors and, if appropriate, the net realizable value of any collateral. These estimates consider all

62

available evidence, including the expected future cash flows discounted at the Finance Receivable’s effective interest rate, fair value of collateral, general economic conditions and trends, historical and industry loss experience, and other relevant factors, as appropriate. Should a Finance Receivable be deemed partially or wholly uncollectible, the uncollectible balance is charged off against the allowance in the period in which the uncollectible determination has been made.
Real Estate
We make estimates as part of our process for allocating a purchase price to the various identifiable assets of an acquisition based upon the relative fair value of each asset. The most significant components of our allocations are typically buildings as-if-vacant, land and in-place leases. In the case of allocating fair value to buildings and intangibles, our fair value estimates will affect the amount of depreciation and amortization we record over the estimated useful life of each asset acquired. In the case of allocating fair value to in-place leases, we make our best estimates based on our evaluation of the specific characteristics of each tenant’s lease. Factors considered include estimates of carrying costs during hypothetical expected lease-up periods, market conditions and costs to execute similar leases. Our assumptions affect the amount of future revenue and/or depreciation and amortization expense that we will recognize over the remaining lease term for the acquired in-place leases.
A variety of costs are incurred in the development and leasing of properties. After determination is made to capitalize a cost, it is allocated to the specific component of a project that is benefited. Determination of when a development project is substantially complete and capitalization must cease involves a degree of judgment. The costs of land and buildings under development include specifically identifiable costs. The capitalized costs include pre-construction costs essential to the development of the property, development costs, construction costs, interest costs, real estate taxes and other costs incurred during the period of development. We consider a construction project to be considered substantially complete and available for occupancy and cease capitalization of costs upon the completion of the related tenant improvements.
Impairment of Long-Lived Assets
We assess the carrying value of our real estate assets and related intangibles (“real estate assets”) when events or changes in circumstances indicate that the carrying amount of the real estate assets may not be recoverable, but at least annually. Recoverability of real estate assets is measured by comparing the carrying amount of the real estate assets to the respective estimated future undiscounted cash flows. The estimated future undiscounted cash flows are calculated utilizing the lowest level of identifiable cash flows that are largely independent of the cash flows of other assets and liabilities. In order to review our real estate assets for recoverability, we consider market conditions, as well as our intent with respect to holding or disposing of the asset. If our analysis indicates that the carrying value of the real estate assets is not recoverable on an undiscounted cash flow basis, we recognize an impairment charge for the amount by which the carrying value exceeds the fair value of the real estate asset.
The determination of the fair value of real estate assets involves significant judgment. This judgment is based on our analysis and estimates of fair value of real estate assets, future operating results and resulting cash flows of each real estate asset whose carrying amount may not be recoverable. Our ability to accurately predict future operating results and resulting cash flows, and estimate and allocate fair values, impacts the timing and recognition of impairments. While we believe our assumptions are reasonable, changes in these assumptions may have a material impact on our financial results.
Investments in Unconsolidated Joint Ventures
The initial carrying value of investments in unconsolidated joint ventures is based on the amount paid to purchase the joint venture interest or the carrying value of the assets prior to the sale or contribution of the interests to the joint venture. We evaluate our equity method investments for impairment by first reviewing for indicators of impairment based upon the performance of the underlying real estate assets held by the joint venture. If an equity method investment shows indicators of impairment, we compare the fair value of the equity method investment to our carrying value. If we determine there is a decline in the fair value of our investment in an unconsolidated joint venture below its carrying value and it is other-than-temporary, an impairment is recorded. The determination of the fair value of investments in unconsolidated joint ventures and as to whether a deficiency in fair value is other-than-temporary involves significant judgment. Our estimates consider all available evidence including, as appropriate, the present value of the expected future cash flows discounted at market rates, general economic conditions and trends, severity and duration of a fair value deficiency, and other relevant factors. Capitalization rates, discount rates and credit spreads utilized in our valuation models are based upon rates that we believe to be within a reasonable range of current market rates for the respective investments. While we believe our assumptions are reasonable, changes in these assumptions may have a material impact on our financial results.

63

Income Taxes
As part of the process of preparing our consolidated financial statements, significant management judgment is required to evaluate our compliance with REIT requirements. Our determinations are based on interpretation of tax laws, and our conclusions may have an impact on the income tax expense recognized. Adjustments to income tax expense may be required as a result of: (i) audits conducted by federal, state and local tax authorities, (ii) our ability to qualify as a REIT, (iii) the potential for built-in gain recognition, and (iv) changes in tax laws. Adjustments required in any given period are included within the income tax provision.
Recent Accounting Pronouncements
See Note 2 to the Consolidated Financial Statements for the impact of new accounting standards.
ITEM 7A.
Quantitative and Qualitative Disclosures About Market Risk
We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates, specifically the GBP. We use derivative financial instruments in the normal course of business to mitigate interest rate and foreign currency risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the consolidated balance sheets at fair value (see Note 23 to the Consolidated Financial Statements).
To illustrate the effect of movements in the interest rate and foreign currency markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the change in fair value. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $2 million.
Interest Rate Risk
At December 31, 2017, we are exposed to market risks related to fluctuations in interest rates primarily on variable rate debt. As of December 31, 2017, $44 million of our variable-rate debt was hedged by interest rate swap transactions. The interest rate swaps are designated as cash flow hedges, with the objective of managing the exposure to interest rate risk by converting the interest rates on our variable-rate debt to fixed interest rates.
Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets until their maturity or earlier prepayment and refinancing. If interest rates have risen at the time we seek to refinance our fixed rate debt, whether at maturity or otherwise, our future earnings and cash flows could adversely be affected by additional borrowing costs. Conversely, lower interest rates at the time of refinancing may reduce our overall borrowing costs. However, interest rate changes will affect the fair value of our fixed rate instruments. A one percentage point increase or decrease in interest rates would change the fair value of our fixed rate debt by approximately $332 million and $358 million, respectively, and would not materially impact earnings or cash flows. A one percentage point increase or decrease in interest rates would change the fair value of our fixed rate debt investments by approximately $8 million and $9 million, respectively, and would not materially impact earnings or cash flows. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not materially impact the fair value of those instruments. Assuming a one percentage point change in the interest rate related to our variable-rate debt and variable-rate investments, and assuming no other changes in the outstanding balance as of December 31, 2017, our annual interest expense and interest income would change by approximately $12 million and $1 million, respectively.
Foreign Currency Exchange Rate Risk
At December 31, 2017, our exposure to foreign currencies primarily relates to U.K. investments in leased real estate and related GBP denominated cash flows. Our foreign currency exposure is partially mitigated through the use of GBP denominated borrowings and foreign currency swap contracts. Based solely on our operating results for the year ended December 31, 2017, including the impact of existing hedging arrangements, if the value of the GBP relative to the U.S. dollar were to increase or decrease by 10% compared to the average exchange rate during the year ended December 31, 2017, the increase or decrease to our cash flows would not be material.

64

Market Risk
We have investments in marketable debt securities classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At December 31, 2017, both the fair value and carrying value of marketable debt securities were $19 million.

65

ITEM 8.
Financial Statements and Supplementary Data
HCP, Inc.
Index to Consolidated Financial Statements


66

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of HCP, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of HCP, Inc. and subsidiaries (the "Company") as of December 31, 2017 and 2016, the related consolidated statements of operations, comprehensive income (loss), equity, and cash flows, for each of the three years in the period ended December 31, 2017, and the related notes and the schedules listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2017, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 13, 2018, expressed an unqualified opinion on the Company's internal control over financial reporting.
As discussed in Note 2 to the financial statements, the Company has changed its method of accounting for real estate acquisitions effective January 1, 2017 due to the adoption of Accounting Standards Update 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
 
/s/ Deloitte & Touche LLP
Los Angeles, California
February 13, 2018

We have served as the Company's auditor since 2010.


67

HCP, Inc.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
 
December 31,
 
2017
 
2016
ASSETS
 
 
 
Real estate:
 
 
 
Buildings and improvements
$
11,239,732

 
$
11,692,654

Development costs and construction in progress
447,976

 
400,619

Land
1,785,865

 
1,881,487

Accumulated depreciation and amortization
(2,741,695
)
 
(2,648,930
)
Net real estate
10,731,878

 
11,325,830

Net investment in direct financing leases
714,352

 
752,589

Loans receivable, net
313,326

 
807,954

Investments in and advances to unconsolidated joint ventures
800,840

 
571,491

Accounts receivable, net of allowance of $4,425 and $4,459, respectively
40,733

 
45,116

Cash and cash equivalents
55,306

 
94,730

Restricted cash
26,897

 
42,260

Intangible assets, net
410,082

 
479,805

Assets held for sale, net
417,014

 
927,866

Other assets, net
578,033

 
711,624

Total assets
$
14,088,461

 
$
15,759,265

LIABILITIES AND EQUITY
 
 
 
Bank line of credit
$
1,017,076

 
$
899,718

Term loans
228,288

 
440,062

Senior unsecured notes
6,396,451

 
7,133,538

Mortgage debt
144,486

 
623,792

Other debt
94,165

 
92,385

Intangible liabilities, net
52,579

 
58,145

Liabilities of assets held for sale, net
14,031

 
3,776

Accounts payable and accrued liabilities
401,738

 
417,360

Deferred revenue
144,709

 
149,181

Total liabilities
8,493,523

 
9,817,957

Commitments and contingencies


 


Common stock, $1.00 par value: 750,000,000 shares authorized; 469,435,678 and 468,081,489 shares issued and outstanding, respectively
469,436

 
468,081

Additional paid-in capital
8,226,113

 
8,198,890

Cumulative dividends in excess of earnings
(3,370,520
)
 
(3,089,734
)
Accumulated other comprehensive income (loss)
(24,024
)
 
(29,642
)
Total stockholders' equity
5,301,005

 
5,547,595

Joint venture partners
117,045

 
214,377

Non-managing member unitholders
176,888

 
179,336

Total noncontrolling interests
293,933

 
393,713

Total equity
5,594,938

 
5,941,308

Total liabilities and equity
$
14,088,461

 
$
15,759,265


See accompanying Notes to Consolidated Financial Statements.

68

HCP, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
 
Year Ended December 31,
 
2017
 
2016
 
2015
Revenues:
 
 
 
 
 
Rental and related revenues
$
1,071,153

 
$
1,159,791

 
$
1,116,830

Tenant recoveries
142,496

 
134,280

 
125,022

Resident fees and services
524,275

 
686,835

 
525,453

Income from direct financing leases
54,217

 
59,580

 
61,000

Interest income
56,237

 
88,808

 
112,184

Total revenues
1,848,378

 
2,129,294

 
1,940,489

Costs and expenses:
 
 
 
 
 
Interest expense
307,716

 
464,403

 
479,596

Depreciation and amortization
534,726

 
568,108

 
504,905

Operating
666,251

 
738,399

 
610,679

General and administrative
88,772

 
103,611

 
95,965

Transaction costs
7,963

 
9,821

 
27,309

Impairments (recoveries), net
166,384

 
—

 
108,349

Total costs and expenses
1,771,812

 
1,884,342

 
1,826,803

Other income (expense):
 

 
 

 
 

Gain (loss) on sales of real estate, net
356,641

 
164,698

 
6,377

Loss on debt extinguishments
(54,227
)
 
(46,020
)
 
—

Other income (expense), net
31,420

 
3,654

 
16,208

Total other income (expense), net
333,834

 
122,332

 
22,585

Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures
410,400

 
367,284

 
136,271

Income tax benefit (expense)
1,333

 
(4,473
)
 
9,807

Equity income (loss) from unconsolidated joint ventures
10,901

 
11,360

 
6,590

Income (loss) from continuing operations
422,634

 
374,171

 
152,668

Discontinued operations:
 
 
 
 
 
Income before impairments, transaction costs and income taxes
—

 
400,701

 
643,109

Impairments, net
—

 
—

 
(1,341,399
)
Transaction costs
—

 
(86,765
)
 
—

Income tax benefit (expense)
—

 
(48,181
)
 
(796
)
Total discontinued operations
—

 
265,755

 
(699,086
)
Net income (loss)
422,634

 
639,926

 
(546,418
)
Noncontrolling interests' share in earnings
(8,465
)
 
(12,179
)
 
(12,817
)
Net income (loss) attributable to HCP, Inc.
414,169

 
627,747

 
(559,235
)
Participating securities' share in earnings
(1,156
)
 
(1,198
)
 
(1,317
)
Net income (loss) applicable to common shares
$
413,013

 
$
626,549

 
$
(560,552
)
Basic earnings per common share:
 
 
 
 
 
Continuing operations
$
0.88

 
$
0.77

 
$
0.30

Discontinued operations
—

 
0.57

 
(1.51
)
Net income (loss) applicable to common shares
$
0.88

 
$
1.34

 
$
(1.21
)
Diluted earnings per common share:
 
 
 
 
 
Continuing operations
$
0.88

 
$
0.77

 
$
0.30

Discontinued operations
—

 
0.57

 
(1.51
)
Net income (loss) applicable to common shares
$
0.88

 
$
1.34

 
$
(1.21
)
Weighted average shares used to calculate earnings per common share:
 
 
 
 
 
Basic
468,759

 
467,195

 
462,795

Diluted
468,935

 
467,403

 
462,795

 
See accompanying Notes to Consolidated Financial Statements.

69

HCP, Inc.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
 
Year Ended December 31,
 
2017
 
2016
 
2015
Net income (loss)
$
422,634

 
$
639,926

 
$
(546,418
)
Other comprehensive income (loss):
 
 
 
 
 
Change in net unrealized gains (losses) on cash flow hedges:
 
 
 
 
 
Unrealized gains (losses)
(11,107
)
 
3,233

 
1,894

Reclassification adjustment realized in net income (loss)
799

 
707

 
148

Change in Supplemental Executive Retirement Plan obligation and other
64

 
220

 
121

Foreign currency translation adjustment
15,862

 
(3,332
)
 
(8,738
)
Total other comprehensive income (loss)
5,618

 
828

 
(6,575
)
Total comprehensive income (loss)
428,252

 
640,754

 
(552,993
)
Total comprehensive income (loss) attributable to noncontrolling interests
(8,465
)
 
(12,179
)
 
(12,817
)
Total comprehensive income (loss) attributable to HCP, Inc.
$
419,787

 
$
628,575

 
$
(565,810
)
See accompanying Notes to Consolidated Financial Statements.

70

HCP, Inc.
CONSOLIDATED STATEMENTS OF EQUITY
(In thousands, except per share data)
 
Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares
 
Amount
 
Additional
Paid-In
Capital
 
Cumulative
Dividends
In Excess
Of Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
Stockholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
January 1, 2015
459,746

 
$
459,746

 
$
11,431,987

 
$
(1,132,541
)
 
$
(23,895
)
 
$
10,735,297

 
$
261,802

 
$
10,997,099

Net income (loss)
—

 
—

 
—

 
(559,235
)
 
—

 
(559,235
)
 
12,817

 
(546,418
)
Other comprehensive income (loss)
—

 
—

 
—

 
—

 
(6,575
)
 
(6,575
)
 
—

 
(6,575
)
Issuance of common stock, net
5,117

 
5,117

 
176,950

 
—

 
—

 
182,067

 
(3,183
)
 
178,884

Repurchase of common stock
(198
)
 
(198
)
 
(8,540
)
 
—

 
—

 
(8,738
)
 
—

 
(8,738
)
Exercise of stock options
823

 
823

 
26,764

 
—

 
—

 
27,587

 
—

 
27,587

Amortization of deferred compensation
—

 
—

 
26,127

 
—

 
—

 
26,127

 
—

 
26,127

Common Dividends ($2.260 per share)
—

 
—

 
—

 
(1,046,638
)
 
—

 
(1,046,638
)
 
—

 
(1,046,638
)
Distributions to noncontrolling interest
—

 
—

 
(263
)
 
—

 
—

 
(263
)
 
(18,884
)
 
(19,147
)
Issuances of noncontrolling interest
—

 
—

 
—

 
—

 
—

 
—

 
151,185

 
151,185

Purchase of noncontrolling interest
—

 
—

 
(5,986
)
 
—

 
—

 
(5,986
)
 
(1,063
)
 
(7,049
)
December 31, 2015
465,488

 
$
465,488

 
$
11,647,039

 
$
(2,738,414
)
 
$
(30,470
)
 
$
9,343,643

 
$
402,674

 
$
9,746,317

Net income (loss)
—

 
—

 
—

 
627,747

 
—

 
627,747

 
12,179

 
639,926

Other comprehensive income (loss)
—

 
—

 
—

 
—

 
828

 
828

 
—

 
828

Issuance of common stock, net
2,552

 
2,552

 
61,625

 
—

 
—

 
64,177

 
—

 
64,177

Conversion of DownREIT units to common stock
145

 
145

 
5,948

 
—

 
—

 
6,093

 
(6,093
)
 
—

Repurchase of common stock
(237
)
 
(237
)
 
(8,448
)
 
—

 
—

 
(8,685
)
 
—

 
(8,685
)
Exercise of stock options
133

 
133

 
3,340

 
—

 
—

 
3,473

 
—

 
3,473

Amortization of deferred compensation
—

 
—

 
22,884

 
—

 
—

 
22,884

 
—

 
22,884

Common dividends ($2.095 per share)
—

 
—

 
—

 
(979,542
)
 
—

 
(979,542
)
 
—

 
(979,542
)
Distribution of QCP, Inc.
—

 
—

 
(3,532,763
)
 
—

 
—

 
(3,532,763
)
 
—

 
(3,532,763
)
Distributions to noncontrolling interests
—

 
—

 
(36
)
 
—

 
—

 
(36
)
 
(26,311
)
 
(26,347
)
Issuances of noncontrolling interests
—

 
—

 
—

 
—

 
—

 
—

 
11,834

 
11,834

Deconsolidation of noncontrolling interests
—

 
—

 
(36
)
 
475

 
—

 
439

 
67

 
506

Purchase of noncontrolling interests
—

 
—

 
(663
)
 
—

 
—

 
(663
)
 
(637
)
 
(1,300
)
December 31, 2016
468,081

 
$
468,081

 
$
8,198,890

 
$
(3,089,734
)
 
$
(29,642
)
 
$
5,547,595

 
$
393,713

 
$
5,941,308

Net income (loss)
—

 
—

 
—

 
414,169

 
—

 
414,169

 
8,465

 
422,634

Other comprehensive income (loss)
—

 
—

 
—

 
—

 
5,618

 
5,618

 
—

 
5,618

Issuance of common stock, net
1,402

 
1,402

 
25,951

 
—

 
—

 
27,353

 
—

 
27,353

Conversion of DownREIT units to common stock
78

 
78

 
2,411

 
—

 
—

 
2,489

 
(2,489
)
 
—

Repurchase of common stock
(157
)
 
(157
)
 
(4,628
)
 
—

 
—

 
(4,785
)
 
—

 
(4,785
)
Exercise of stock options
32

 
32

 
736

 
—

 
—

 
768

 
—

 
768

Amortization of deferred compensation
—

 
—

 
14,258

 
—

 
—

 
14,258

 
—

 
14,258

Common Dividends ($1.480 per share)
—

 
—

 
—

 
(694,955
)
 
—

 
(694,955
)
 
—

 
(694,955
)
Distributions to noncontrolling interests
—

 
—

 
—

 
—

 
—

 
—

 
(26,129
)
 
(26,129
)
Issuances of noncontrolling interests
—

 
—

 
—

 
—

 
—

 
—

 
1,615

 
1,615

Deconsolidation of noncontrolling interests
—

 
—

 
—

 
—

 
—

 
—

 
(58,062
)
 
(58,062
)
Purchase of noncontrolling interests
—

 
—

 
(11,505
)
 
—

 
—

 
(11,505
)
 
(23,180
)
 
(34,685
)
December 31, 2017
469,436

 
$
469,436

 
$
8,226,113

 
$
(3,370,520
)
 
$
(24,024
)
 
$
5,301,005

 
$
293,933

 
$
5,594,938

See accompanying Notes to Consolidated Financial Statements.

71

HCP, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
 
Year Ended December 31,
 
2017
 
2016
 
2015
Cash flows from operating activities:
 
 
 
 
 
Net income (loss)
$
422,634

 
$
639,926

 
$
(546,418
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
 
 
 
Depreciation and amortization of real estate, in-place lease and other intangibles:
 
 
 
 
 
Continuing operations
534,726

 
568,108

 
504,905

Discontinued operations
—

 
4,890

 
5,880

Amortization of deferred compensation
14,258

 
22,884

 
26,127

Amortization of deferred financing costs
14,569

 
20,014

 
20,222

Straight-line rents
(23,933
)
 
(18,003
)
 
(28,859
)
Loan and direct financing lease non-cash interest, net:
 
 
 
 
 
Continuing operations
(613
)
 
599

 
(5,648
)
Discontinued operations
—

 
—

 
(90,065
)
Equity loss (income) from unconsolidated joint ventures
(10,901
)
 
(11,360
)
 
(57,313
)
Distributions of earnings from unconsolidated joint ventures
44,142

 
26,492

 
15,111

Loss (gain) on sales of real estate, net
(356,641
)
 
(164,698
)
 
(6,377
)
Lease and management fee termination loss (income), net
54,641

 
—

 
(1,103
)
Deferred income tax expense (benefit)
(5,523
)
 
47,195

 
—

Impairments (recoveries), net
166,384

 
—

 
1,449,748

Loss on extinguishment of debt
54,227

 
46,020

 
—

Casualty-related loss (recoveries), net
12,053

 
—

 
—

Loss (gain) on sale of marketable securities
(50,895
)
 
—

 
—

Other non-cash items
(2,122
)
 
(2,968
)
 
(11,286
)
Decrease (increase) in accounts receivable and other assets, net
(24,782
)
 
(6,992
)
 
(29,022
)
Increase (decrease) accounts payable and accrued liabilities
4,817

 
42,024

 
(23,757
)
Net cash provided by (used in) operating activities
847,041

 
1,214,131

 
1,222,145

Cash flows from investing activities:
 
 
 
 
 
Acquisition of RIDEA III, net
—

 
—

 
(768,413
)
Acquisitions of other real estate
(560,753
)
 
(467,162
)
 
(613,252
)
Development and redevelopment of real estate
(373,479
)
 
(421,322
)
 
(281,017
)
Leasing costs, tenant improvements, and recurring capital expenditures
(115,260
)
 
(91,442
)
 
(84,282
)
Proceeds from sales of real estate, net
1,314,325

 
647,754

 
73,149

Contributions to unconsolidated joint ventures
(46,334
)
 
(10,186
)
 
(69,936
)
Distributions in excess of earnings from unconsolidated joint ventures
37,023

 
28,366

 
30,989

Proceeds from the RIDEA II transaction, net
462,242

 
—

 
—

Proceeds from sales/principal repayments on debt investments and direct financing leases
558,769

 
231,990

 
628,049

Investments in loans receivable, direct financing leases and other
(30,276
)
 
(273,693
)
 
(575,652
)
Purchase of securities for debt defeasance
—

 
(73,278
)
 
—

Net cash provided by (used in) investing activities
1,246,257

 
(428,973
)
 
(1,660,365
)
Cash flows from financing activities:
 
 
 
 
 
Borrowings under bank line of credit, net
1,244,189

 
1,108,417

 
98,743

Repayments under bank line of credit
(1,150,596
)
 
(540,000
)
 
(511,521
)
Proceeds related to QCP Spin-Off, net
—

 
1,685,172

 
—

Issuance and borrowings of debt, excluding bank line of credit
5,395

 
—

 
2,269,031

Repayments and repurchase of debt, excluding bank line of credit
(1,468,446
)
 
(2,316,774
)
 
(457,845
)
Payments for debt extinguishment and deferred financing costs
(51,415
)
 
(54,856
)
 
(19,995
)
Issuance of common stock and exercise of options
28,121

 
67,650

 
206,471

Repurchase of common stock
(4,785
)
 
(8,685
)
 
(8,738
)
Dividends paid on common stock
(694,955
)
 
(979,542
)
 
(1,046,638
)
Issuance of noncontrolling interests
1,615

 
11,834

 
110,775

Distributions to and purchase of noncontrolling interests
(57,584
)
 
(27,481
)
 
(26,196
)
Net cash provided by (used in) financing activities
(2,148,461
)
 
(1,054,265
)
 
614,087

Effect of foreign exchanges on cash, cash equivalents and restricted cash
376

 
(1,019
)
 
(1,537
)
Net increase (decrease) in cash, cash equivalents and restricted cash
(54,787
)
 
(270,126
)
 
174,330

Cash, cash equivalents and restricted cash, beginning of year
136,990

 
407,116

 
232,786

Cash, cash equivalents and restricted cash, end of year
$
82,203

 
$
136,990

 
$
407,116

Less: cash, cash equivalents and restricted cash of discontinued operations
—

 
—

 
(6,058
)
Cash, cash equivalents and restricted cash of continuing operations, end of year
$
82,203

 
$
136,990

 
$
401,058

See accompanying Notes to Consolidated Financial Statements.

72

HCP, Inc.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1.
Business
Overview
HCP, Inc., an S&P 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (“REIT”) which, together with its consolidated entities (collectively, “HCP” or the “Company”), invests primarily in real estate serving the healthcare industry in the United States (“U.S.”). The Company acquires, develops, leases, and manages and disposes of healthcare real estate. The Company’s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i) senior housing triple-net, (ii) senior housing operating portfolio (“SHOP”), (iii) life science and (iv) medical office.

NOTE 2.
Summary of Significant Accounting Policies
Use of Estimates
Management is required to make estimates and assumptions in the preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”). These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management’s estimates.
Principles of Consolidation
The consolidated financial statements include the accounts of HCP, Inc., its wholly-owned subsidiaries, joint ventures and variable interest entities that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation.
The Company is required to continually evaluate its variable interest entity (“VIE”) relationships and consolidate these entities when it is determined to be the primary beneficiary of their operations. A VIE is broadly defined as an entity where either: (i) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support, (ii) substantially all of an entity’s activities either involve or are conducted on behalf of an investor that has disproportionately few voting rights, or (iii) the equity investors as a group lack any of the following: (a) the power through voting or similar rights to direct the activities of an entity that most significantly impact the entity’s economic performance, (b) the obligation to absorb the expected losses of an entity, or (c) the right to receive the expected residual returns of an entity.
A variable interest holder is considered to be the primary beneficiary of a VIE if it has the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to the VIE. The Company qualitatively assesses whether it is (or is not) the primary beneficiary of a VIE. Consideration of various factors include, but is not limited to, its form of ownership interest, its representation on the VIE’s governing body, the size and seniority of its investment, its ability and the rights of other investors to participate in policy making decisions and its ability to replace the VIE manager and/or liquidate the entity.
For its investments in joint ventures that are not considered to be VIEs, the Company evaluates the type of ownership rights held by the limited partner(s) that may preclude consolidation by the sole general partner or majority interest holder. The assessment of limited partners’ rights and their impact on the control of a joint venture should be made at inception of the joint venture and should be reassessed if: (i) there is a change to the terms or in the ability to exercise the limited partner rights, (ii) the sole general partner increases or decreases its ownership interest in the limited partnership, or (iii) there is an increase or decrease in the number of outstanding limited partnership interests. The Company similarly evaluates the rights of managing members of limited liability companies.

73

Revenue Recognition
At the inception of a new lease arrangement, including new leases that arise from amendments, the Company assesses its terms and conditions to determine the proper lease classification. A lease arrangement is classified as an operating lease if none of the following criteria are met: (i) transfer of ownership to the lessee prior to or shortly after the end of the lease term, (ii) lessee has a bargain purchase option during or at the end of the lease term, (iii) the lease term is equal to 75% or more of the underlying property’s economic life, or (iv) the present value of future minimum lease payments (excluding executory costs) is equal to 90% or more of the excess fair value (over retained tax credits) of the leased property. If one of the four criteria is met and the minimum lease payments are determined to be reasonably predictable and collectible, the lease arrangement is generally accounted for as a direct financing lease (“DFL”).
The Company utilizes the direct finance method of accounting to record DFL income. For a lease accounted for as a DFL, the net investment in the DFL represents receivables for the sum of future minimum lease payments and the estimated residual value of the leased property, less the unamortized unearned income. Unearned income is deferred and amortized to income over the lease term to provide a constant yield when collectibility of the lease payments is reasonably assured.
The Company commences recognition of rental revenue for operating lease arrangements when the tenant has taken possession or controls the physical use of a leased asset; the tenant is not considered to have taken physical possession or have control of the leased asset until the Company-owned tenant improvements are substantially completed. If a lease arrangement provides for tenant improvements, the Company determines whether the tenant improvements are owned by the tenant or the Company. When the Company is the owner of the tenant improvements, any tenant improvements funded by the tenant are treated as lease payments which are deferred and amortized into income over the lease term. When the tenant is the owner of the tenant improvements, any tenant improvement allowance that is funded by the Company is treated as a lease incentive and amortized as a reduction of revenue over the lease term. Ownership of tenant improvements is determined based on various factors including, but not limited to, the following criteria:
•
lease stipulations of how and on what a tenant improvement allowance may be spent;
•
which party to the arrangement retains legal title to the tenant improvements upon lease expiration;
•
whether the tenant improvements are unique to the tenant or general purpose in nature;
•
if the tenant improvements are expected to have significant residual value at the end of the lease term;
•
the responsible party for construction cost overruns; and
•
which party constructs or directs the construction of the improvements.
Certain leases provide for additional rents that are contingent upon a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the base amount or other thresholds, and only after any contingency has been removed (when the related thresholds are achieved). This may result in the recognition of rental revenue in periods subsequent to when such payments are received.
Tenant recoveries subject to operating leases generally relate to the reimbursement of real estate taxes, insurance and repairs and maintenance expense. These expenses are recognized as revenue in the period they are incurred. The reimbursements of these expenses are recognized and presented gross, as the Company is generally the primary obligor and, with respect to purchasing goods and services from third party suppliers, has discretion in selecting the supplier and bears the associated credit risk.
For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight line basis over the lease term when collectibility is reasonably assured. Recognizing rental income on a straight line basis results in a difference in the timing of revenue amounts from what is contractually due from tenants. If the Company determines that collectibility of straight line rents is not reasonably assured, future revenue recognition is limited to amounts contractually owed and paid, and, when appropriate, an allowance for estimated losses is established.
Resident fee revenue is recorded when services are rendered and includes resident room and care charges, community fees and other resident charges. Residency agreements are generally for a term of 30 days to one year, with resident fees billed monthly. Revenue for certain care related services is recognized as services are provided and is billed monthly in arrears.
Loans receivable are classified as held-for-investment based on management’s intent and ability to hold the loans for the foreseeable future or to maturity. Loans held-for-investment are carried at amortized cost and reduced by a valuation allowance for estimated credit losses, as necessary. The Company recognizes interest income on loans, including the amortization of discounts and premiums, loan fees paid and received, using the interest method. The interest method is applied on a loan-by-loan basis when collectibility of the future payments is reasonably assured. Premiums and discounts are recognized as yield adjustments over the term of the related loans.

74

The Company recognizes a gain on sales of real estate upon the closing of a transaction with the purchaser. Gains on real estate sold are recognized using the full accrual method when collectibility of the sales price is reasonably assured, the Company is not obligated to perform additional activities that may be considered significant, the initial investment from the buyer is sufficient and other profit recognition criteria have been satisfied. Gain on sales of real estate may be deferred in whole or in part until the requirements for gain recognition have been met.
Allowance for Doubtful Accounts
The Company evaluates the liquidity and creditworthiness of its tenants, operators and borrowers on a monthly and quarterly basis. The Company’s evaluation considers industry and economic conditions, individual and portfolio property performance, credit enhancements, liquidity and other factors. The Company’s tenants, borrowers and operators furnish property, portfolio and guarantor/operator-level financial statements, among other information, on a monthly or quarterly basis; the Company utilizes this financial information to calculate the lease or debt service coverages that it uses as a primary credit quality indicator. Lease and debt service coverage information is evaluated together with other property, portfolio and operator performance information, including revenue, expense, net operating income, occupancy, rental rate, reimbursement trends, capital expenditures and EBITDA (defined as earnings before interest, tax, and depreciation and amortization), along with other liquidity measures. The Company evaluates, on a monthly basis or immediately upon a significant change in circumstance, its tenants’, operators’ and borrowers’ ability to service their obligations with the Company.
The Company maintains an allowance for doubtful accounts for straight-line rent receivables resulting from tenants’ inability to make contractual rent and tenant recovery payments or lease defaults. For straight-line rent receivables, the Company’s assessment is based on amounts estimated to be recoverable over the lease term.
In connection with the Company’s quarterly review process or upon the occurrence of a significant event, loans receivable and DFLs (collectively, “Finance Receivables”), are reviewed and assigned an internal rating of Performing, Watch List or Workout. Finance Receivables that are deemed Performing meet all present contractual obligations, and collection and timing, of all amounts owed is reasonably assured. Watch List Finance Receivables are defined as Finance Receivables that do not meet the definition of Performing or Workout. Workout Finance Receivables are defined as Finance Receivables in which the Company has determined, based on current information and events, that: (i) it is probable it will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the tenant, operator, or borrower is delinquent on making payments under the contractual terms of the agreement and (iii) the Company has commenced action or anticipates pursuing action in the near term to seek recovery of its investment.
Finance Receivables are placed on nonaccrual status when management determines that the collectibility of contractual amounts is not reasonably assured (the asset will have an internal rating of either Watch List or Workout). Further, the Company performs a credit analysis to support the tenant’s, operator’s, borrower’s and/or guarantor’s repayment capacity and the underlying collateral values. The Company uses the cash basis method of accounting for Finance Receivables placed on nonaccrual status unless one of the following conditions exist whereby it utilizes the cost recovery method of accounting: (i) if the Company determines that it is probable that it will only recover the recorded investment in the Finance Receivable, net of associated allowances or charge-offs (if any), or (ii) the Company cannot reasonably estimate the amount of an impaired Finance Receivable. For cash basis method of accounting the Company applies payments received, excluding principal paydowns, to interest income so long as that amount does not exceed the amount that would have been earned under the original contractual terms. For cost recovery method of accounting any payment received is applied to reduce the recorded investment. Generally, the Company returns a Finance Receivable to accrual status when all delinquent payments become current under the terms of the loan or lease agreements and collectibility of the remaining contractual loan or lease payments is reasonably assured.
Allowances are established for Finance Receivables on an individual basis utilizing an estimate of probable losses, if they are determined to be impaired. Finance Receivables are impaired when it is deemed probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the loan or lease. An allowance is based upon the Company’s assessment of the lessee’s or borrower’s overall financial condition, economic resources, payment record, the prospects for support from any financially responsible guarantors and, if appropriate, the net realizable value of any collateral. These estimates consider all available evidence, including the expected future cash flows discounted at the Finance Receivable’s effective interest rate, fair value of collateral, general economic conditions and trends, historical and industry loss experience, and other relevant factors, as appropriate. Should a Finance Receivable be deemed partially or wholly uncollectible, the uncollectible balance is charged off against the allowance in the period in which the uncollectible determination has been made.
Real Estate
On January 1, 2017 the Company adopted Accounting Standards Update (“ASU”) No. 2017-01, Clarifying the Definition of a Business (“ASU 2017-01”) which narrows the Financial Accounting Standards Board’s (“FASB”) definition of a business and provides a framework that gives entities a basis for making reasonable judgments about whether a transaction involves an asset, or a group of assets, or a business (see “Accounting Pronouncements” section for complete details of the adoption of ASU 2017-01).

75

As a result of adopting ASU 2017-01, the majority of the Company’s real estate acquisitions subsequent to January 1, 2017 are classified as asset acquisitions for which the Company records identifiable assets acquired, liabilities assumed and any associated noncontrolling interests at cost on a relative fair value basis. In addition, for such asset acquisitions, no goodwill is recognized, third party transaction costs are capitalized and any associated contingent consideration is recorded when the contingency is resolved.
Prior to the adoption of ASU 2017-01, the majority of the Company’s real estate acquisitions were classified as business combinations and identifiable assets acquired, liabilities assumed and any associated noncontrolling interests were recorded at fair value, with any excess consideration recorded as goodwill. Transaction costs related to business combinations were expensed as incurred.
The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate appropriate discount and/or capitalization rates or other available market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant.
The Company records acquired “above and below market” leases at fair value using discount rates which reflect the risks associated with the leases acquired. The amount recorded is based on the present value of the difference between (i) the contractual amounts paid pursuant to each in-place lease and (ii) management’s estimate of fair market lease rates for each in-place lease, measured over a period equal to the remaining term of the lease for above market leases and the initial term plus the extended term for any leases with bargain renewal options. Other intangible assets acquired include amounts for in-place lease values that are based on an evaluation of the specific characteristics of each property and the acquired tenant lease(s). Factors considered include estimates of carrying costs during hypothetical expected lease-up periods, market conditions and costs to execute similar leases. In estimating carrying costs, the Company includes estimates of lost rents at market rates during the hypothetical expected lease-up periods, which are dependent on local market conditions and expected trends. In estimating costs to execute similar leases, the Company considers leasing commissions, legal and other related costs.
The Company capitalizes direct construction and development costs, including predevelopment costs, interest, property taxes, insurance and other costs directly related and essential to the development or construction of a real estate asset. The Company capitalizes construction and development costs while substantive activities are ongoing to prepare an asset for its intended use. The Company considers a construction project as substantially complete and held available for occupancy upon the completion of Company-owned tenant improvements, but no later than one year from cessation of significant construction activity. Costs incurred after a project is substantially complete and ready for its intended use, or after development activities have ceased, are expensed as incurred. For redevelopment of existing operating properties, the Company capitalizes the cost for the construction and improvement incurred in connection with the redevelopment.
Costs previously capitalized related to abandoned developments/redevelopments are charged to earnings. Expenditures for repairs and maintenance are expensed as incurred. The Company considers costs incurred in conjunction with re-leasing properties, including tenant improvements and lease commissions, to represent the acquisition of productive assets and, accordingly, such costs are reflected as investing activities in the Company’s consolidated statement of cash flows.
The Company computes depreciation on properties using the straight-line method over the assets’ estimated useful lives. Depreciation is discontinued when a property is identified as held for sale. Buildings and improvements are depreciated over useful lives ranging up to 60 years. Market lease intangibles are amortized primarily to revenue over the remaining noncancellable lease terms and bargain renewal periods, if any. In-place lease intangibles are amortized to expense over the remaining noncancellable lease term and bargain renewal periods, if any.
Impairment of Long-Lived Assets and Goodwill
The Company assesses the carrying value of real estate assets and related intangibles (“real estate assets”) when events or changes in circumstances indicate that the carrying value may not be recoverable. The Company tests its real estate assets for impairment by comparing the sum of the expected future undiscounted cash flows to the carrying value of the real estate assets. The expected future undiscounted cash flows are calculated utilizing the lowest level of identifiable cash flows that are largely independent of the cash flows of other assets and liabilities. If the carrying value exceeds the expected future undiscounted cash flows, an impairment loss will be recognized to the extent that the carrying value of the real estate assets is greater than their fair value. If an asset is classified as held for sale, it is reported at the lower of its carrying value or fair value less costs to sell and no longer depreciated.
During the fourth quarter of 2017, the Company adopted ASU 2017-04, Simplifying the Test for Goodwill Impairment (“ASU 2017-04”) which eliminates step two from the goodwill impairment test, as described below (see “Accounting Pronouncements” section for complete details of the adoption of ASU 2017-04). Effective October 1, 2017, if the Company concludes that it is more

76

likely than not that the fair value of a reporting unit is less than its carrying value, the Company recognizes an impairment loss for the amount by which the carrying value, including goodwill, exceeds the reporting unit’s fair value.
Prior to its adoption of ASU 2017-04, if the Company determined that it was more likely than not that the fair value of a reporting unit was less than its carrying value, the Company applied the required two-step quantitative approach. The quantitative procedures of the two-step approach: (i) compared the fair value of a reporting unit with its carrying value, including goodwill, and, if necessary, (ii) compared the implied fair value of reporting unit goodwill with the carrying value as if it had been acquired in a business combination at the date of the impairment test. The excess fair value of the reporting unit over the fair value of assets and liabilities, excluding goodwill, is the implied value of goodwill and was used to determine the impairment loss amount, if any.
Assets Held for Sale and Discontinued Operations
The Company classifies a real estate property as held for sale when: (i) management has approved the disposal, (ii) the property is available for sale in its present condition, (iii) an active program to locate a buyer has been initiated, (iv) it is probable that the property will be disposed of within one year, (v) the property is being marketed at a reasonable price relative to its fair value, and (vi) it is unlikely that the disposal plan will significantly change or be withdrawn. A discontinued operation represents: (i) a component of an entity or group of components that has been disposed of or is classified as held for sale in a single transaction and represents a strategic shift that has or will have a major effect on the Company’s operations and financial results or (ii) an acquired business that is classified as held for sale on the date of acquisition. Examples of a strategic shift include disposing of: (i) a separate major line of business, (ii) a separate major geographic area of operations, or (iii) other major parts of the Company.
Investments in Unconsolidated Joint Ventures
Investments in entities which the Company does not consolidate, but has the ability to exercise significant influence over the operating and financial policies of, are reported under the equity method of accounting. Under the equity method of accounting, the Company’s share of the investee’s earnings or losses is included in the Company’s consolidated results of operations.
The initial carrying value of investments in unconsolidated joint ventures is based on the amount paid to purchase the joint venture interest or the fair value of the assets prior to the sale of interests in the joint venture. To the extent that the Company’s cost basis is different from the basis reflected at the joint venture level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of equity in earnings of the joint venture. The Company evaluates its equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value. When the Company determines a decline in the fair value of an investment in an unconsolidated joint venture below its carrying value is other-than-temporary, an impairment is recorded. The Company recognizes gains on the sale of interests in joint ventures to the extent the economic substance of the transaction is a sale.
The Company’s fair values of its equity method investments are determined based on discounted cash flow models that include all estimated cash inflows and outflows over a specified holding period and, where applicable, any estimated debt premiums or discounts. Capitalization rates, discount rates and credit spreads utilized in these valuation models are based upon assumptions that the Company believes to be within a reasonable range of current market rates for the respective investments.
Share-Based Compensation
Compensation expense for share-based awards granted to employees, including grants of employee stock options, are recognized in the consolidated statements of operations based on their grant date fair market value. Compensation expense for awards with graded vesting schedules is generally recognized on a straight-line basis over the vesting period. Forfeitures of share-based awards are recognized as they occur.
Cash and Cash Equivalents and Restricted Cash
Cash and cash equivalents consist of cash on hand and short-term investments with original maturities of three months or less when purchased. Restricted cash primarily consists of amounts held by mortgage lenders to provide for (i) real estate tax expenditures, tenant improvements and capital expenditures, (ii) security deposits, and (iii) net proceeds from property sales that were executed as tax-deferred dispositions.
Derivatives and Hedging
During its normal course of business, the Company uses certain types of derivative instruments for the purpose of managing interest rate and foreign currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company’s related assertions.

77

The Company recognizes all derivative instruments, including embedded derivatives that are required to be bifurcated, as assets or liabilities in the consolidated balance sheets at fair value. Changes in fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in earnings. For derivative instruments designated in qualifying cash flow hedging relationships, changes in fair value related to the effective portion of the derivative instruments are recognized in accumulated other comprehensive income (loss), whereas changes in fair value of the ineffective portion are recognized in earnings.
Using certain of its British pound sterling (“GBP”) denominated debt, the Company applies net investment hedge accounting to hedge the foreign currency exposure from its net investment in GBP-functional subsidiaries. The variability of the GBP-denominated debt due to changes in the GBP to U.S. dollar (“USD”) exchange rate (“remeasurement value”) is recognized as part of the cumulative translation adjustment component of accumulated other comprehensive income (loss).
If it is determined that a derivative instrument ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, the Company discontinues its cash flow hedge accounting prospectively and records the appropriate adjustment to earnings based on the current fair value of the derivative instrument. For net investment hedge accounting, upon sale or liquidation of the hedged investment, the cumulative balance of the remeasurement value is reclassified to earnings.
Income Taxes
HCP, Inc. elected REIT status and believes it has always operated so as to continue to qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986, as amended (the “Code”). Accordingly, HCP, Inc. will not be subject to U.S. federal income tax, provided that it continues to qualify as a REIT and makes distributions to stockholders equal to or in excess of its taxable income. In addition, the Company has formed several consolidated subsidiaries, which have elected REIT status. HCP, Inc. and its consolidated REIT subsidiaries are each subject to the REIT qualification requirements under the Code. If any REIT fails to qualify as a REIT in any taxable year, it will be subject to federal income taxes at regular corporate rates and may be ineligible to qualify as a REIT for four subsequent tax years.
HCP, Inc. and its consolidated REIT subsidiaries are subject to state, local and foreign income taxes in some jurisdictions, and in certain circumstances each REIT may also be subject to federal excise taxes on undistributed income. In addition, certain activities that the Company undertakes may be conducted by entities which have elected to be treated as taxable REIT subsidiaries (“TRSs”). TRSs are subject to both federal and state income taxes. The Company recognizes tax penalties relating to unrecognized tax benefits as additional income tax expense. Interest relating to unrecognized tax benefits is recognized as interest expense.
Capital Raising Issuance Costs
Costs incurred in connection with the issuance of common shares are recorded as a reduction of additional paid-in capital. Debt issuance costs related to debt instruments excluding line of credit arrangements are deferred, recorded as a reduction of the related debt liability, and amortized to interest expense over the remaining term of the related debt liability utilizing the interest method. Debt issuance costs related to line of credit arrangements are deferred, included in other assets, and amortized to interest expense over the remaining term of the related line of credit arrangement utilizing the interest method.
Penalties incurred to extinguish debt and any remaining unamortized debt issuance costs, discounts and premiums are recognized as income or expense in the consolidated statements of operations at the time of extinguishment.
Segment Reporting
The Company’s reportable segments, based on how it evaluates its business and allocates resources, are as follows: (i) senior housing triple-net, (ii) SHOP, (iii) life science and (iv) medical office. During the fourth quarter of 2017, as a result of a change in how operating results are reported to the Company's chief operating decision makers, for the purpose of evaluating performance and allocating resources, unconsolidated joint ventures are now included in other non-reportable segments. Accordingly, all prior period segment information has been recast to conform to the current period presentation.
Noncontrolling Interests
Arrangements with noncontrolling interest holders are reported as a component of equity separate from the Company’s equity. Net income attributable to a noncontrolling interest is included in net income on the consolidated statements of operations and, upon a gain or loss of control, the interest purchased or sold, and any interest retained, is recorded at fair value with any gain or loss recognized in earnings. The Company accounts for purchases or sales of equity interests that do not result in a change in control as equity transactions.
The Company consolidates non-managing member limited liability companies (“DownREITs”) because it exercises control, and the noncontrolling interests in these entities are carried at cost. The non-managing member limited liability company (“LLC”) units (“DownREIT units”) are exchangeable for an amount of cash approximating the then-current market value of shares of the

78

Company’s common stock or, at the Company’s option, shares of the Company’s common stock (subject to certain adjustments, such as stock splits and reclassifications). Upon exchange of DownREIT units for the Company’s common stock, the carrying amount of the DownREIT units is reclassified to stockholders’ equity.
Foreign Currency Translation and Transactions
Assets and liabilities denominated in foreign currencies that are translated into U.S. dollars use exchange rates in effect at the end of the period, and revenues and expenses denominated in foreign currencies that are translated into U.S. dollars use average rates of exchange in effect during the related period. Gains or losses resulting from translation are included in accumulated other comprehensive income (loss), a component of stockholders’ equity on the consolidated balance sheets. Gains or losses resulting from foreign currency transactions are translated into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of transaction gains or losses are included in other income, net in the consolidated statements of operations.
Fair Value Measurement
The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:
•
Level 1—quoted prices for identical instruments in active markets;
•
Level 2—quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
•
Level 3—fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The Company measures fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at fair value. When available, the Company utilizes quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1. In instances where a market price is available, but the instrument is in an inactive or over-the-counter market, the Company consistently applies the dealer (market maker) pricing estimate and classifies the asset or liability in Level 2.
If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads and/or market capitalization rates. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or Level 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by the Company include discounted cash flow models. The Company also considers its counterparty’s and own credit risk for derivative instruments and other liabilities measured at fair value. The Company has elected the mid-market pricing expedient when determining fair value.
Earnings per Share
Basic earnings per common share is computed by dividing net income applicable to common shares by the weighted average number of shares of common stock outstanding during the period. The Company accounts for unvested share-based payment awards that contain non-forfeitable dividend rights or dividend equivalents (whether paid or unpaid) as participating securities, which are included in the computation of earnings per share pursuant to the two-class method. Diluted earnings per common share is calculated by including the effect of dilutive securities.
Recent Accounting Pronouncements
During the year ended December 31, 2017, the Company adopted the following ASUs, each of which did not have a material impact to its consolidated financial position, results of operations, cash flows, or disclosures upon adoption:
•
On January 1, 2017 the Company adopted ASU 2017-01 which narrows the FASB’s definition of a business and provides a framework that gives entities a basis for making reasonable judgments about whether a transaction involves an asset, or a group of assets, or a business. ASU 2017-01 states that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or group of similar identifiable assets, the set is not a business. If this initial test is not met, a set cannot be considered a business unless it includes an acquired input and a substantive process that together significantly contribute to the ability to create outputs. In addition, ASU 2017-01 clarifies the requirements for

79

a set of activities to be considered a business and narrows the definition of an output. This ASU is to be applied prospectively and the Company expects that a majority of its real estate acquisitions and dispositions will be deemed asset transactions rather than business combinations. As a result of adopting ASU 2017-01, the majority of the Company’s real estate acquisitions subsequent to January 1, 2017 are classified as asset acquisitions for which the Company records identifiable assets acquired, liabilities assumed and any associated noncontrolling interests at cost on a relative fair value basis. In addition, for such asset acquisitions, no goodwill is recognized, third party transaction costs are capitalized and any associated contingent consideration is recorded when the contingency is resolved.
•
During the fourth quarter of 2017, the Company adopted ASU 2017-04 which eliminates the two-step approach to testing goodwill for impairment by requiring that an entity, upon concluding that it is more likely than not that the fair value of a reporting unit is less than its carrying value, recognize an impairment loss for the amount by which the carrying value, including goodwill, exceeds the reporting unit’s fair value.
•
During the fourth quarter of 2017, the Company adopted ASU No. 2016-18, Restricted Cash (“ASU 2016-18”) and ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”) (collectively, the “Cash Flow ASUs”). ASU 2016-18 requires an entity to reconcile and explain the period-over-period change in total cash, cash equivalents and restricted cash within its statements of cash flows and ASU 2016-15 provides guidance clarifying how certain cash receipts and cash payments should be classified. The full retrospective approach of adoption is required for the Cash Flow ASUs and, accordingly, certain line items in the Company’s consolidated statements of cash flows have been reclassified to conform to the current period presentation.
The following table illustrates changes in the Company’s cash flows as reported and as previously reported prior to the adopted the Cash Flow ASUs during the fourth quarter of 2017 (in thousands):
 
 
Year Ended
 
 
December 31, 2016
 
December 31, 2015
Net cash provided by (used in):
 
As Reported
 
As Previously Reported
 
As Reported
 
As Previously Reported
Net cash provided by (used in) investing activities
    
$
(428,973
)
    
$
(410,617
)
 
$
(1,660,365
)
    
$
(1,672,005
)
Net increase (decrease) in balance(1)
 
(270,126
)
 
(251,770
)
 
174,330

 
162,690

Balance - beginning of year(1)
 
407,116

 
346,500

 
232,786

 
183,810

Balance - end of year(1)
 
136,990

 
94,730

 
407,116

 
346,500

Balance - continuing operations, end of year(1)
 
136,990

 
94,730

 
401,058

 
340,442

_______________________________________
(1)
Amounts in the As Reported column include cash and cash equivalents and restricted cash as required upon the adoption of the Cash Flow ASUs. Amounts in the As Previously Reported column reflects only cash and cash equivalents.
In addition to the changes in the consolidated statements of cash flows as a result of the adoption the Cash Flow ASUs, certain amounts within the consolidated statements of cash flows have been reclassified for prior periods to conform to the current period presentation. Such reclassifications primarily combined line items of similar classes of transactions and had no impact on the cash flows from operating, investing, and financing activities.
Revenue Recognition. Between May 2014 and February 2017, the FASB issued four ASUs changing the requirements for recognizing and reporting revenue (together, herein referred to as the “Revenue ASUs”): (i) ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), (ii) ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”), (iii) ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients (“ASU 2016-12”), and (iv) ASU No. 2017-05, Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets (“ASU 2017-05”). ASU 2014-09 provides guidance for revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2016-08 is intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. ASU 2016-12 provides practical expedients and improvements on the previously narrow scope of ASU 2014-09. ASU 2017-05 clarifies the scope of the FASB’s recently established guidance on nonfinancial asset derecognition and aligns the accounting for partial sales of nonfinancial assets and in-substance nonfinancial assets with the guidance in ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date (“ASU 2015-14”). ASU 2015-14 defers the effective date of ASU 2014-09 by one year to fiscal years, and interim periods within, beginning after December 15, 2017. All subsequent ASUs related to ASU 2014-09, including ASU 2016-08, ASU 2016-12, and ASU 2017-05, assumed the deferred effective date enforced by ASU 2015-14. A reporting entity may apply the amendments in the Revenue ASUs using either a modified retrospective approach, by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or full retrospective approach. The

80

Company has elected to use the modified retrospective approach for its adoption of the Revenue ASUs and will adopt with an effective date of January 1, 2018.
As the primary source of revenue for the Company is generated through leasing arrangements, which are excluded from the Revenue ASUs (as it relates to the timing and recognition of revenue), the Company has narrowed the impacts, upon and subsequent to adoption, that the Revenue ASUs will have on its consolidated financial statements to the following:
•
A requirement to disclose, on an ongoing basis, ancillary resident fee revenue generated from its RIDEA structures. The Company will disclose that these represent fees received for additional services provided to the resident on an as-needed or desired basis, which are not included in the fees charged pursuant to the resident lease agreement, and that they are billed individually and collected one month in arrears. The Company anticipates its ancillary resident fee revenue to be immaterial.
•
A requirement, upon adoption, to reassess its partial sale of RIDEA II in the first quarter of 2017 (which was not a completed sale as of the Company's adoption date due to an immaterial obligation related to the interest sold), and record its retained 40% equity investment at fair value as of the sale date. The Company estimates the fair value of its retained equity investment as of the sale date to be $107 million which, upon adoption, will increase the Company’s investment to a carrying value of $121 million. However, such carrying value exceeds fair value at the date of adoption due to an other-than-temporary impairment of $30 million determined using the terms of the agreement to sell the Company’s remaining investment in RIDEA II (see Note 5) which are considered to be Level 2 measurements within the fair value hierarchy. As such, effective January 1, 2018, the Company reduced this carrying value to the agreed upon sales price of $91 million. Both the impact of the increase in value and the related $30 million impairment charge are recorded as a net adjustment to beginning retained earnings as of January 1, 2018 pursuant to the Company’s elected transition approach.
•
Under ASU 2014-09, revenue recognition for real estate sales is largely based on the transfer of control versus continuing involvement under historic guidance. As a result, the Company generally expects that the new guidance will result in more transactions qualifying as sales of real estate and revenue being recognized at an earlier date than under historical accounting guidance.
Leases. In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02”). ASU 2016-02 amends the current accounting for leases to: (i) require lessees to put most leases on their balance sheets, but continue recognizing expenses on their income statements in a manner similar to requirements under current accounting guidance, (ii) eliminate current real estate specific lease provisions and (iii) modify the classification criteria and accounting for sales-type leases for lessors. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. The transition method required by ASU 2016-02 varies based on the specific amendment being adopted. As a result of adopting ASU 2016-02, the Company: (i) will recognize all of its significant operating leases for which it is the lessee, including corporate office leases and ground leases, on its consolidated balance sheets, (ii) will capitalize fewer legal costs related to the drafting and execution of its lease agreements, and (iii) may be required to increase its revenue and expense for the amount of real estate taxes and insurance paid by its tenants under triple-net leases.
Although not yet finalized, the FASB has proposed an option for lessors to elect a practical expedient allowing them to not separate lease and nonlease components in a contract for the purpose of revenue recognition and disclosure. This practical expedient is limited to circumstances in which (i) the timing and pattern of revenue recognition are the same for the nonlease component and the related lease component and (ii) the combined single lease component would be classified as an operating lease. If finalized, the Company plans to elect this practical expedient. In addition, ASU 2016-02 provides a practical expedient that allows an entity to not reassess the following upon adoption (must be elected as a group): (i) whether an expired or existing contract contains a lease arrangement, (ii) lease classification related to expired or existing lease arrangements, or (iii) whether costs incurred on expired or existing leases qualify as initial direct costs. The Company plans to elect this practical expedient. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures.
Credit Losses. In June 2016, the FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 is intended to improve financial reporting by requiring timelier recognition of credit losses on loans and other financial instruments held by financial institutions and other organizations. The amendments in ASU 2016-13 eliminate the “probable” initial threshold for recognition of credit losses in current accounting guidance and, instead, reflect an entity’s current estimate of all expected credit losses over the life of the financial instrument. Previously, when credit losses were measured under current accounting guidance, an entity generally only considered past events and current conditions in measuring the incurred loss. The amendments in ASU 2016-13 broaden the information that an entity must consider in developing its expected credit loss estimate for assets measured either collectively or individually. The use of forecasted information incorporates more timely information in the estimate of expected credit loss. ASU 2016-13 is effective for fiscal years, and interim periods within, beginning after December 15, 2019. Early adoption is permitted for fiscal years, and interim periods within, beginning after December 15, 2018. A reporting entity is required to apply the amendments in ASU 2016-13 using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. A prospective transition approach is

81

required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. Upon adoption of ASU 2016-13, the Company is required to reassess its financing receivables, including direct finance leases and loans receivable, and expects that application of ASU 2016-13 may result in the Company recognizing credit losses at an earlier date than would otherwise be recognized under current accounting guidance. The Company is evaluating the impact of the adoption of ASU 2016-13 on January 1, 2020 to its consolidated financial position and results of operations.
The following ASUs have been issued, but not yet adopted, and the Company does not expect a material impact to its consolidated financial position, results of operations, cash flows, or disclosures upon adoption:
•
ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities (“ASU 2017-12”). ASU 2017-12 is effective for fiscal years, including interim periods within, beginning after December 15, 2018 and early adoption is permitted. For cash flow and net investment hedges existing at the date of adoption, a reporting entity must apply the amendments in ASU 2017-12 using the modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The presentation and disclosure amendments in ASU 2017-12 must be applied using a prospective approach.
•
ASU No. 2016-16, Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”). ASU 2016-16 is effective for fiscal years, and interim periods within, beginning after December 15, 2017. Early adoption is permitted as of the first interim period presented in any year following issuance. A reporting entity must apply the amendments in ASU 2016-16 using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. 
•
ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 is effective for fiscal years, and interim periods within, beginning after December 15, 2017. Early adoption is permitted only for updates to certain disclosure requirements. A reporting entity is required to apply the amendments in ASU 2016-01 using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The core principle of the amendments in ASU 2016-01 involves the measurement of equity investments (except those accounted for under the equity method of accounting or those that result in consolidation) at fair value and the recognition of changes in fair value of those investments during each reporting period in net income (loss). As a result, ASU 2016-01 eliminates the cost method of accounting for equity securities that do not have readily determinable fair values. Pursuant to the new guidance in ASU 2016-01, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

NOTE 3.
Master Transactions and Cooperation Agreement with Brookdale (“Brookdale Transactions”)
Master Transactions and Cooperation Agreement with Brookdale
On November 1, 2017, the Company and Brookdale Senior Living Inc. (“Brookdale”) entered into a Master Transactions and Cooperation Agreement (the “MTCA”) to provide the Company with the ability to significantly reduce its concentration of assets leased to and/or managed by Brookdale (the "Brookdale Transaction"). Through a series of dispositions and transitions of assets currently leased to and/or managed by Brookdale, as contemplated by the MTCA and further described below, the Company’s exposure to Brookdale is expected to be significantly reduced.
In connection with the overall transaction pursuant to the MTCA, the Company (through certain of its subsidiaries), and Brookdale (through certain of its subsidiaries) (the “Lessee”) entered into an Amended and Restated Master Lease and Security Agreement (the “Amended Master Lease”), which amended and restated the then-existing triple-net leases between the parties for 78 assets (before giving effect to the contemplated sale or transition of 34 assets discussed below), which account for primarily all of the assets subject to triple-net leases between the Company and the Lessee. Under the Amended Master Lease, the Company has the benefit of a guaranty from Brookdale of the Lessee’s obligations and, upon a change in control, will have various additional protections under the MTCA and the Amended Master Lease including:
•
A security deposit (which increases if specified leverage thresholds are exceeded);
•
A termination right if certain financial covenants and net worth test are not satisfied;
•
Enhanced reporting requirements and related remedies; and
•
The right to market for sale the CCRC portfolio.
Future changes in control of Brookdale are permitted pursuant to the Amended Master Lease, subject to certain conditions, including the purchaser either meeting experience requirements or retaining a majority of Brookdale’s principal officers.

82

The Amended Master Lease preserves the renewal terms and, with certain exceptions, the rents under the previously existing triple-net leases. In addition, the Company and Brookdale agreed to the following:
•
The Company has the right to sell, or transition to other operators, 32 triple-net assets. If such sale or transition does not occur within one year, the triple-net lease with respect to such assets will convert to a cash flow lease (under which the Company will bear the risks and rewards of operating the assets) with a term of two years, provided that the Company has the right to terminate the cash flow lease at any time during the term without penalty;
•
The Company has provided an aggregate $5 million annual reduction in rent on three assets, effective January 1, 2018; and
•
The Company will sell two triple-net assets to Brookdale or its affiliates for $35 million, which it anticipates completing during the first half of 2018.
Also pursuant to the MTCA, the Company and Brookdale agreed to the following:
•
The Company, which owned 90% of the interests in its RIDEA I and RIDEA III joint ventures with Brookdale at the time the MTCA was executed, agreed to purchase Brookdale’s 10% noncontrolling interest in each joint venture for an aggregate purchase price of $95 million. These joint ventures collectively own and operate 58 independent living, assisted living, memory care and/or skilled nursing facilities (the “RIDEA Facilities”). The Company completed its acquisition of the RIDEA III noncontrolling interest in December 2017 and anticipates completing its acquisition of the RIDEA I noncontrolling interest during the first half of 2018;
•
The Company has the right to sell, or transition to other managers, 36 of the RIDEA Facilities and terminate related management agreements with an affiliate of Brookdale without penalty. If the related management agreements are not terminated within one year, the base management fee (5% of gross revenues) increases by 1% of gross revenues per year over the following two years to a maximum of 7% of gross revenues;
•
The Company will sell four of the RIDEA Facilities to Brookdale or its affiliates for $239 million, one of which was sold in January 2018 for $27 million. The Company anticipates completing the sale of the remaining three RIDEA Facilities during the first half of 2018;
•
A Brookdale affiliate continues to manage the remaining 18 RIDEA Facilities pursuant to amended and restated management agreements, which provide for extended terms on select assets, modified performance hurdles for extensions and incentive fees, and modified termination rights (including stricter performance-based termination rights, a staggered right to terminate seven agreements over a 10 year period beginning in 2021, and a right to terminate at will upon payment of a termination fee, in lieu of sale-related termination rights), and two other existing facilities managed in separate RIDEA structures; and
•
The Company has the right to sell, to certain permitted transferees, its 49% ownership interest in joint ventures that own and operate a portfolio of continuing care retirement communities and in which Brookdale owns the other 51% interest (the “CCRC JV”), subject to certain conditions and a right of first offer in favor of Brookdale. Brookdale will have a corresponding right to sell its 51% interest in the CCRC JV to certain permitted transferees, subject to certain conditions, a right of first offer and a right to terminate management agreements following such sale of Brookdale’s interest, each in favor of HCP. Following a change in control of Brookdale, the Company will have the right to initiate a sale of the CCRC portfolio, subject to certain rights of first offer and first refusal in favor of Brookdale.
Fair Value Measurement Techniques and Quantitative Information
The Company performed a fair value assessment of each of the MTCA components that provided measurable economic benefit or detriment to the Company. Each fair value calculation is based on an income or market approach and relies on historical and forecasted EBITDAR (defined as earnings before interest, taxes, depreciation, amortization and rent) and revenue, as well as market data, including, but not limited to, a discount rate of 12%, a management fee rate of 5% of revenue, EBITDAR growth rates ranging from zero to 3%, and real estate capitalization rates ranging from 6% to 7%. All assumptions are supported by independent market data and considered to be Level 2 measurements within the fair value hierarchy.
As a result of the assessment, the Company recognized a $20 million net reduction of rental and related revenues related to the right to terminate leases for 32 triple-net assets and the write-off of unamortized lease intangible assets related to those same 32 triple-net assets. Additionally, the Company recognized $35 million of operating expense related to the right to terminate management agreements for 36 SHOP assets.

83

NOTE 4.
Other Real Estate Property Investments
2017 Real Estate Acquisitions
The following table summarizes real estate acquisitions for the year ended December 31, 2017 (in thousands):
 
 
Consideration
 
Assets Acquired
Segment
 
Cash Paid
 
Net Liabilities
Assumed
 
Real Estate
 
Net
Intangibles
SHOP
 
$
44,258

 
$
797

 
$
37,940

 
$
7,115

Life science
 
315,255

 
3,524

 
305,760

 
13,019

Medical office
 
201,240

 
1,104

 
184,115

 
18,229

 
 
$
560,753

 
$
5,425

 
$
527,815

 
$
38,363

2016 Real Estate Acquisitions 
The following table summarizes real estate acquisitions for the year ended December 31, 2016 (in thousands):
 
 
Consideration
 
Assets Acquired(1)
Segment
 
Cash Paid/
Debt Settled
 
Net Liabilities
Assumed
 
Real Estate
 
Net
Intangibles
Senior housing triple-net
 
$
76,362

 
$
1,200

 
$
71,875

 
$
5,687

SHOP
 
113,971

 
76,931

 
177,551

 
13,351

Life science
 
49,000

 
—

 
47,400

 
1,600

Medical office
 
209,920

 
4,854

 
209,178

 
5,596

Other non-reportable segments
 
17,909

 
—

 
16,596

 
1,313

 
 
$
467,162

 
$
82,985

 
$
522,600

 
$
27,547

_______________________________________
(1)
Revenues and earnings since the acquisition dates, as well as the supplementary pro forma information, assuming these acquisitions occurred as of the beginning of the prior periods, were not material.
Construction, Tenant and Other Capital Improvements
The following table summarizes the Company’s expenditures for construction, tenant and other capital improvements (in thousands):
 
 
Year Ended December 31,
Segment
 
2017
 
2016
 
2015
Senior housing triple-net
 
$
32,343

 
$
49,109

 
$
53,980

SHOP
 
49,473

 
74,158

 
77,425

Life science
 
240,901

 
200,122

 
122,319

Medical office
 
148,926

 
128,308

 
131,021

Other
 
135

 
7,203

 
37

 
 
$
471,778

 
$
458,900

 
$
384,782



84

NOTE 5.
Discontinued Operations and Dispositions of Real Estate
Discontinued Operations - Quality Care Properties, Inc.
Quality Care Properties, Inc.
On October 31, 2016, the Company completed the spin-off (the “Spin-Off”) of its subsidiary, Quality Care Properties, Inc. (“QCP”) (NYSE: QCP). The Spin-Off assets included 338 properties, primarily comprised of the HCR ManorCare, Inc. (“HCRMC”) DFL investments and an equity investment in HCRMC. QCP is an independent, publicly-traded, self-managed and self-administrated REIT. As a result of the Spin-Off, the operations of QCP are now classified as discontinued operations for the years ended December 31, 2016 and 2015.
On October 17, 2016, subsidiaries of QCP issued $750 million in aggregate principal amount of senior secured notes due 2023 (the “QCP Notes”), the gross proceeds of which were deposited in escrow until they were released in connection with the consummation of the Spin-Off on October 31, 2016. The QCP Notes bear interest at a rate of 8.125% per annum, payable semiannually. From October 17, 2016 until the completion of the Spin-Off, QCP (a then wholly-owned subsidiary of HCP) incurred $2 million in interest expense. In addition, immediately prior to the effectiveness of the Spin-Off, subsidiaries of QCP received $1.0 billion of proceeds from their borrowings under a senior secured term loan, bearing interest at a rate at QCP’s option of either: (i) LIBOR plus 5.25%, subject to a 1% floor or (ii) a base rate specified in the first lien credit and guaranty agreement plus 4.25%, bringing the total gross proceeds raised by QCP and its subsidiaries under those financings to $1.75 billion. In connection with the consummation of the Spin-Off, QCP and its subsidiaries transferred $1.69 billion in cash and 94 million shares of QCP common stock to HCP and certain of its other subsidiaries, and HCP and its applicable subsidiaries transferred the assets comprising the QCP portfolio to QCP and its subsidiaries. HCP then distributed substantially all of the outstanding shares of QCP common stock to its stockholders, based on the distribution ratio of one share of QCP common stock for every five shares of HCP common stock held by HCP stockholders as of the October 24, 2016 record date for the distribution. The Company recorded the distribution of the assets and liabilities of QCP from its consolidated balance sheet on a historical cost basis as a dividend from stockholders’ equity of $3.5 billion, and zero gain or loss was recognized. The Company primarily used the $1.69 billion proceeds of the cash distribution it received from QCP upon consummation of the Spin-Off to pay down certain of the Company’s existing debt obligations.
The Company entered into a Separation and Distribution Agreement (the “Separation and Distribution Agreement”) with QCP in connection with the Spin-Off. The Separation and Distribution Agreement divides and allocates the assets and liabilities of the Company prior to the Spin-Off between QCP and HCP, governs the rights and obligations of the parties regarding the Spin-Off, and contains other key provisions relating to the separation of QCP’s business from HCP.
In connection with the Spin-Off, the Company entered into a Transition Services Agreement ("TSA") with QCP. Per the terms of the TSA, the Company agreed to provide certain administrative and support services to QCP on a transitional basis for established fees. The TSA terminated on October 31, 2017.
From October 31, 2016 through June 2017, HCP was the sole lender to QCP of an unsecured revolving credit facility (the “Unsecured Revolving Credit Facility”) which had a total commitment of $100 million at inception. No amounts were drawn on the Unsecured Revolving Credit Facility and the total commitment was reduced to zero at June 30, 2017.

85

The results of discontinued operations through October 31, 2016, the Spin-Off date, are included in the consolidated results for the years ended December 31, 2016 and 2015. Summarized financial information for discontinued operations for the years ended December 31, 2016 and 2015 is as follows (in thousands):
 
Year Ended December 31,
 
2016
 
2015
Revenues:
 
 
 
Rental and related revenues
$
22,971

 
$
27,651

Tenant recoveries
1,233

 
1,464

Income from direct financing leases
384,752

 
572,835

Total revenues
408,956

 
601,950

Costs and expenses:
 
 
 
Depreciation and amortization
(4,892
)
 
(5,880
)
Operating
(3,367
)
 
(3,697
)
General and administrative
(67
)
 
(57
)
Transaction costs
(86,765
)
 
—

Impairments
—

 
(1,295,504
)
Other income (expense), net
71

 
70

Income (loss) before income taxes and income from impairments of equity method investments
313,936

 
(703,118
)
Income tax benefit (expense)
(48,181
)
 
(796
)
Income from equity method investment
—

 
50,723

Impairments of equity method investment
—

 
(45,895
)
Total discontinued operations
$
265,755

 
$
(699,086
)
During the fourth quarter of 2016, using proceeds from the Spin-Off, the Company repaid $500 million of 6.0% senior unsecured notes that were due to mature in January 2017, $600 million of 6.7% senior unsecured notes that were due to mature in January 2018 and $108 million of mortgage debt; incurring aggregate loss on debt extinguishments of $46 million.
HCR ManorCare, Inc. 
Discontinued operations is primarily comprised of QCP’s HCRMC DFL investments and equity investment in HCRMC. During the years ended December 31, 2016 and 2015, the Company recognized DFL income of $385 million and $573 million, respectively, and received cash payments of $385 million and $483 million, respectively, from the HCRMC DFL investments. The carrying value of the HCRMC DFL investments was $5.2 billion at December 31, 2015.
The following summarizes the significant transactions and impairments related to HCRMC:
2015
During the three months ended March 31, 2015, the Company and HCRMC agreed to market for sale the real estate and operations associated with 50 non-strategic facilities that were under a master lease. During the year ended December 31, 2015, the Company completed sales of 22 non-strategic HCRMC facilities for $219 million. During the year ended December 31, 2016, the Company sold an additional 11 facilities for $62 million, bringing the total facilities sold to 33 at the time of the Spin-Off.
On March 29, 2015, certain subsidiaries of the Company entered into an amendment to the master lease (the “HCRMC Lease Amendment”) effective April 1, 2015 (the "HCRMC Amended Master Lease"). The HCRMC Lease Amendment reduced initial annual rent by a net $68 million and reset the minimum rent escalation to 3.0% for each lease year through the expiration of the initial term. The initial term was extended five years to an average of 16 years. As consideration for the rent reduction, the Company received a Deferred Rent Obligation (“DRO”) from the Lessee equal to an aggregate amount of $525 million. As a result of the HCRMC Lease Amendment, the Company recorded an impairment charge of $478 million related to its HCRMC DFL investments. The impairment charge reduced the carrying value of the HCRMC DFL investments from $6.6 billion to $6.1 billion, based on the present value of the future lease payments effective April 1, 2015 under the HCRMC Amended Master Lease discounted at the original DFL investments’ effective lease rate. Additionally, HCRMC agreed to sell, and HCP agreed to purchase, nine post-acute facilities for an aggregate purchase price of $275 million. Through December 31, 2015, HCRMC and HCP completed seven of the nine facility purchases for $184 million. Through Spin-Off, HCRMC and HCP completed the remaining two facility purchases

86

for $91 million, bringing the nine facility purchases to an aggregate $275 million, the proceeds of which were used to settle a portion of the DRO discussed above.
As of September 30, 2015, the Company concluded that its equity investment in HCRMC was other-than-temporarily impaired and recorded an impairment charge of $27 million. The impairment charge reduced the carrying amount of the Company’s equity investment in HCRMC from $48 million to its fair value of $21 million.
The fair value of the Company’s equity investment in HCRMC was based on a discounted cash flow valuation model and inputs were considered to be Level 3 measurements within the fair value hierarchy. The following is a summary of the quantitative information about fair value measurements for the impairment related to the Company’s equity ownership interest in HCRMC using a discounted cash flow valuation model:
Description of Input(s) to the Valuation
 
Valuation Inputs
Range of revenue growth rates(1)
 
(1.8%)-3.0%
Range of occupancy growth rates(1)
 
(0.8%)-0.2%
Range of operating expense growth rates(1)
 
(1.1%)-3.1%
Discount rate
 
15.20%
Range of earnings multiples
 
6.0x-7.0x
_______________________________________
(1)
For growth rates, the value ranges provided represent the highest and lowest input utilized in the valuation model for any forecasted period.
As part of the Company’s fourth quarter 2015 review process, including its internal rating evaluation, it assessed the collectibility of all contractual rent payments under the HCRMC Amended Master Lease, as discussed below and assigned an internal rating of “Watch List” as of December 31, 2015. Further, the Company placed the HCRMC DFL investments on nonaccrual status and began utilizing a cash basis method of accounting in accordance with its policies (see Note 2).
As a result of assigning an internal rating of “Watch List” to its HCRMC DFL investments during the quarterly review process, the Company further evaluated the carrying amount of its HCRMC DFL investments and determined that it was probable that its HCRMC DFL investments were impaired. As a result of the significant decline in HCRMC’s fixed charge coverage ratio in the fourth quarter of 2015, combined with a lower growth outlook for the post-acute/skilled nursing business, the Company determined that it was probable that its HCRMC DFL investments were impaired. In the fourth quarter of 2015, the Company recorded an allowance for DFL losses (impairment charge) of $817 million, reducing the carrying amount of its HCRMC DFL investments from $6.0 billion to $5.2 billion. The allowance for credit losses was determined as the present value of expected future (i) in-place lease payments under the HCRMC Amended Master Lease and (ii) estimated market rate lease payments, each discounted at the original HCRMC DFL investments’ effective lease rate. Impairments related to an allowance for credit losses are included in impairments, net.
The market rate lease payments were based on an income approach utilizing a discounted cash flow valuation model. The significant inputs to this valuation model included forecasted EBITDAR, rent coverage ratios and real estate capitalization rates and are summarized as follows (dollars in thousands):
Description of Input(s) to the Valuation
 
Senior Housing
DFL Valuation Inputs
 
Post-acute/
Skilled nursing
DFL Valuation Inputs
Range of EBITDAR
 
$75,000-$85,000
 
$385,000-$435,000
Range of rent coverage ratio
 
1.05x-1.15x
 
1.25x-1.35x
Range of real estate capitalization rate
 
6.25%-7.25%
 
7.50%-8.50%
In December 2015, the Company concluded that its equity investment in HCRMC was other-than-temporarily impaired and recorded an impairment charge of $19 million, reducing its carrying value to zero. Beginning in January 2016, income was recognized only if cash distributions were received from HCRMC.
2016
The Company’s acquisition of the HCRMC DFL investments in 2011 was subject to federal and state built-in gain tax of up to $2 billion if all the assets were sold within 10 years. At the time of acquisition, the Company intended to hold the assets for at least 10 years, at which time the assets would no longer be subject to the built-in gain tax. In December 2015, the U.S. Federal Government passed legislation which permanently reduced the holding period, for federal tax purposes, to five years. The Company satisfied

87

the five year holding period requirement in April 2016. This legislation was not extended to certain states, which maintain a 10 year requirement.
During the year ended December 31, 2016, the Company determined that it may sell assets during the next five years and, therefore, recorded a deferred tax liability of $47 million, representing its estimated exposure to state built-in gain tax.
Dispositions of Real Estate
Held for Sale
At December 31, 2017, four life science facilities, two senior housing triple-net facilities and six SHOP facilities were classified as held for sale, with an aggregate carrying value of $417 million, primarily comprised of real estate assets of $393 million, net of accumulated depreciation of $93 million. At December 31, 2016, 64 senior housing triple-net facilities, four life science facilities and a SHOP facility were classified as held for sale, with an aggregate carrying value of $928 million, primarily comprised of real estate assets of $809 million, net of accumulated depreciation of $193 million. Liabilities of assets held for sale is primarily comprised of intangible and other liabilities at both December 31, 2017 and 2016.
RIDEA II Sale Transaction
In January 2017, the Company completed the contribution of its ownership interest in RIDEA II to an unconsolidated JV owned by HCP and an investor group led by Columbia Pacific Advisors, LLC (“CPA”) (“HCP/CPA PropCo” and “HCP/CPA OpCo,” together, the “HCP/CPA JV”). In addition, RIDEA II was recapitalized with $602 million of debt, of which $360 million was provided by a third-party and $242 million was provided by HCP. In return for both transaction elements, the Company received combined proceeds of $480 million from the HCP/CPA JV and $242 million in loan receivables and retained an approximately 40% ownership interest in RIDEA II (the note receivable and 40% ownership interest are herein referred to as the “RIDEA II Investments”). This transaction resulted in the Company deconsolidating the net assets of RIDEA II and recognizing a net gain on sale of $99 million. The RIDEA II Investments are currently recognized and accounted for as equity method investments.
On November 1, 2017, the Company entered into a definitive agreement with an investor group led by CPA to sell its remaining 40% ownership interest in RIDEA II for $91 million. The Company expects the transaction to close in the first half of 2018. CPA has also agreed to cause refinancing of the Company’s $242 million loan receivables from RIDEA II within one year following the close of the transaction.
2017 Dispositions
In January 2017, the Company sold four life science facilities in Salt Lake City, Utah for $76 million, resulting in a net gain on sale of $45 million.
In March 2017, the Company sold 64 senior housing triple-net assets, previously under triple-net leases with Brookdale, for $1.125 billion to affiliates of Blackstone Real Estate Partners VIII, L.P., resulting in a net gain on sale of $170 million.
Additionally, during the year ended December 31, 2017, the Company sold the following: (i) a life science land parcel in San Diego, California for $27 million, (ii) a life science building in San Diego, California for $5 million, (iii) four senior housing triple-net facilities for $27 million, (iv) five SHOP facilities for $43 million and (v) four medical office buildings (“MOBs”) for $15 million, and recorded a net gain on sale of $41 million.
2016 Dispositions
During the year ended December 31, 2016, the Company sold the following: (i) a portfolio of five post-acute/skilled nursing facilities and two senior housing triple-net facilities for $130 million, (ii) five life science facilities for $386 million, (iii) seven senior housing triple-net facilities for $88 million, (iv) three MOBs for $20 million and (v) three SHOP facilities for $41 million.
2015 Dispositions
During the year ended December 31, 2015, the Company sold the following: (i) nine senior housing triple-net facilities for $60 million resulting from Brookdale’s exercise of its purchase option received as part of a transaction with Brookdale in 2014, (ii) two parcels of land in its life science segment for $51 million and (iii) a MOB for $400,000.


88

NOTE 6.
Net Investment in Direct Financing Leases
The components of net investment in DFLs consisted of the following (dollars in thousands):
 
December 31,
 
2017
 
2016
Minimum lease payments receivable
$
1,062,452

 
$
1,108,237

Estimated residual value
504,457

 
539,656

Less unearned income
(852,557
)
 
(895,304
)
Net investment in direct financing leases
$
714,352

 
$
752,589

Properties subject to direct financing leases
29

 
30

Certain DFLs contain provisions that allow the tenants to elect to purchase the properties during or at the end of the lease terms for the aggregate initial investment amount plus adjustments, if any, as defined in the lease agreements. Certain leases also permit the Company to require the tenants to purchase the properties at the end of the lease terms.
The following table summarizes future minimum lease payments contractually due under DFLs at December 31, 2017 (in thousands):
Year
 
Amount
2018
 
$
102,983

2019
 
68,204

2020
 
62,781

2021
 
63,175

2022
 
57,762

Thereafter
 
707,547

 
 
$
1,062,452

Direct Financing Lease Internal Ratings
The following table summarizes the Company’s internal ratings for net investment in DFLs at December 31, 2017 (dollars in thousands):
 
 
 
 
 
 
Internal Ratings
Segment
 
Carrying
Amount
 
Percentage of
DFL Portfolio
 
Performing DFLs
 
Watch List DFLs
 
Workout DFLs
Senior housing triple-net
 
$
629,748

 
88
 
$
273,886

 
$
355,862

 
$
—

Other non-reportable segments
 
84,604

 
12
 
84,604

 
—

 
—

 
 
$
714,352

 
100
 
$
358,490

 
$
355,862

 
$
—

Beginning September 30, 2013, the Company placed a 14 property senior housing DFL (the “DFL Portfolio”) on nonaccrual status and classified the DFL Portfolio on “Watch List” status. The Company determined that the collection of all rental payments was and continues to be no longer reasonably assured; therefore, rental revenue for the DFL Portfolio has been recognized on a cash basis. The Company re-assessed the DFL Portfolio for impairment on December 31, 2017 and determined that the DFL Portfolio was not impaired based on its belief that: (i) it was not probable that it will not collect all of the rental payments under the terms of the lease; and (ii) the fair value of the underlying collateral exceeded the DFL Portfolio’s carrying amount. The fair value of the DFL Portfolio was estimated based on an income approach and utilizes inputs which are considered to be a Level 3 measurement within the fair value hierarchy. Inputs to this valuation model include real estate capitalization rates, industry growth rates, and operating margins, some of which influence the Company’s expectation of future cash flows from the DFL Portfolio and, accordingly, the fair value of its investment. During the years ended December 31, 2017, 2016 and 2015, the Company recognized DFL income of $13 million, $13 million and $15 million, respectively, and received cash payments of $18 million, $18 million and $20 million, respectively, from the DFL Portfolio. The carrying value of the DFL Portfolio was $356 million and $361 million at December 31, 2017 and 2016, respectively.

89


NOTE 7.
Loans Receivable
The following table summarizes the Company’s loans receivable (in thousands):
 
December 31,
 
2017
 
2016
 
Real Estate
Secured
 
Other
Secured
 
Total
 
Real Estate
Secured
 
Other
Secured
 
Total
Mezzanine(1)(2)
$
—

 
$
269,299

 
$
269,299

 
$
—

 
$
615,188

 
$
615,188

Other(3)
188,418

 
—

 
188,418

 
195,946

 
—

 
195,946

Unamortized discounts, fees and costs(1)
—

 
(596
)
 
(596
)
 
413

 
(3,593
)
 
(3,180
)
Allowance for loan losses
—

 
(143,795
)
 
(143,795
)
 
—

 
—

 
—

 
$
188,418

 
$
124,908

 
$
313,326

 
$
196,359

 
$
611,595

 
$
807,954

_______________________________________
(1)
At December 31, 2016, included £282 million ($348 million) outstanding and £2 million ($3 million) of associated unamortized discounts, fees and costs both related to the HC-One Facility, which paid off in June 2017.
(2)
At December 31, 2017, the Company had £2 million ($3 million) remaining under its commitments to fund development projects and capital expenditures under its development projects in the United Kingdom ("U.K."). In December 2017, the Company entered into a participating debt financing arrangement to fund a $115 million senior living development project, which remained unfunded at December 31, 2017.
(3)
At December 31, 2017 and 2016, included £123 million ($167 million) and £113 million ($140 million), respectively, outstanding primarily related to Maria Mallaband loans.
The following table summarizes the Company’s internal ratings for loans receivable at December 31, 2017 (dollars in thousands):
 
 
Carrying
Amount
 
Percentage
of Loan
Portfolio
 
Internal Ratings
Investment Type
 
 
 
Performing
Loans
 
Watch List
Loans
 
Workout
Loans(1)
Real estate secured
 
$
188,418

 
60
 
$
188,418

 
$
—

 
$
—

Other secured
 
124,908

 
40
 
19,908

 
—

 
105,000

 
 
$
313,326

 
100
 
$
208,326

 
$
—

 
$
105,000

_______________________________________
(1)
See Tandem Health Care Loan discussion below for additional information.
Real Estate Secured Loans
The following table summarizes the Company’s loans receivable secured by real estate at December 31, 2017 (dollars in thousands):
Final
Maturity
Date
 
Number
of
Loans
 
Payment Terms
 
Principal
Amount(1)
 
Carrying
Amount
2018
 
1
 
monthly interest-only payments, accrues interest at 8.0% and secured by a senior housing facility in Pennsylvania
 
$
21,458

 
$
21,597

2021
 
2
 
aggregate monthly interest-only payments, accrues interest at 8.0% and 9.75% and secured by two senior housing facility in the U.K.
 
22,706

 
24,001

2023
 
1
 
monthly interest-only payments, accrues interest at 7.22% and secured by seven senior housing facilities in the U.K.
 
142,820

 
142,820

 
 
4
 
 
 
$
186,984

 
$
188,418

_______________________________________
(1)
Represents future contractual principal payments to be received on loans receivable secured by real estate.
During the year ended December 31, 2017, the Company recognized $13 million in interest income related to loans secured by real estate.

90

In March 2017, the Company sold its investment in Four Seasons Health Care’s (“Four Seasons”) senior secured term loan at par plus accrued interest for £29 million ($35 million).
Other Secured Loans
HC-One Facility
In November 2014, the Company was the lead investor in the financing for Formation Capital and Safanad’s acquisition of NHP, a company that owned nursing and residential care homes in the U.K. principally operated by HC-One and provided a loan facility (the “HC-One Facility”). In April 2015, the Company converted £174 million of the HC-One Facility into a sale-leaseback transaction for 36 nursing and residential care homes located throughout the U.K. Through the year ended December 31, 2015, the Company received paydowns of £34 million ($52 million). On June 30, 2017, the Company received £283 million ($367 million) from the repayment of its HC-One mezzanine loan.
Tandem Health Care Loan
From July 2012 through May 2015, the Company funded, in aggregate, $257 million under a collateralized mezzanine loan facility (the “Mezzanine Loan”) to certain affiliates of Tandem Health Care (together with its affiliates, “Tandem”). The Mezzanine Loan matures in October 2018 and carries a weighted average interest rate of 11.5%. The fair value of the collateral supporting the Mezzanine Loan had included the value of an in-the-money purchase option (the “Purchase Option”) that is a term of a lease between Tandem and a lessor, which provided Tandem the right to buy the nine Leasehold Properties (as defined below) for a total of $82 million by January 4, 2018 (the “Purchase Option Expiration Date”).
In addition to the Mezzanine Loan outstanding to the Company, Tandem has outstanding to other lenders a $257 million syndicated senior loan (the “Senior Loan”) that matures in July 2018. Tandem owns and operates 32 post-acute/skilled nursing facilities, in addition to operating nine leasehold interests (the “Leasehold Properties”), which, in total, represents 4,766 beds (collectively, the “Tandem Portfolio”) located primarily throughout Florida, Pennsylvania and Virginia. Tandem leases the entire Tandem Portfolio to certain affiliates of Consulate Health Care (together with its affiliates, “Consulate”) under a master lease.
During the quarter ended June 30, 2017, as a result of multiple events of default under Tandem’s master lease with Consulate and operational struggles of Consulate, the Company concluded that it was probable that it would be unable to collect all interest and principal payments, including default interest payments, according to the contractual terms of the Mezzanine Loan. As such, as part of its quarterly review process, the Company recorded an impairment charge and related allowance of $57 million during the three months ended June 30, 2017, reducing the carrying value to $200 million. The decline in fair value was driven by a variety of factors, including recent operating results of the underlying real estate assets, as well as market and industry data, that reflect a declining trend in admissions and a continuing shift away from higher-rate Medicare plans in the post-acute/skilled nursing sector. The calculation of the fair value was primarily based on an income approach and relies on forecasted EBITDAR and market data, including, but not limited to, sales price per unit/bed, rent coverage ratios, and real estate capitalization rates. All valuation inputs are considered to be Level 2 measurements within the fair value hierarchy.
Additionally, on July 31, 2017, subsequent to its second quarter 2017 quarterly review process and the aforementioned impairment, the Company entered into a binding agreement (the “Repurchase Agreement”) with the borrowers to provide an option to repay the Mezzanine Loan at a discounted value of $197 million (the “Repayment Value”) by October 25, 2017, which date was subsequently extended to December 31, 2017 (the “Agreement Maturity Date”). As a result of entering into the Repurchase Agreement, the Company recorded an additional impairment charge and related allowance of $3 million during the quarter ended September 30, 2017 to write down the carrying value of the Mezzanine Loan to the Repayment Value and assigned the loan an internal rating of Workout. As part of the Repurchase Agreement, Tandem posted, in aggregate, $8 million of non-refundable deposits (the “Deposits”), which the Company would be entitled to retain (without any credit against the Mezzanine Loan) if Tandem failed to make interest payments on the $257 million par value of the Mezzanine Loan through the repayment date or the Agreement Maturity Date, as applicable, adjusted for any principal payments received.
Consulate is facing operational and financial challenges and has failed to fully pay its contractual rent to Tandem since April 1, 2017. Tandem, which relies on contractual rent payments in order to service its interest payments to the Company under the Mezzanine Loan, failed to make its monthly interest payment thereunder on November 10, 2017. On November 17, 2017, the Company declared an event of default under the Mezzanine Loan and, as a result, the Repurchase Agreement became null and void and the Deposits were forfeited to the Company. Tandem also failed to make its December 2017, January 2018 and February 2018 interest payments to the Company. Tandem remains current on its interest payments under the Senior Loan.
Despite the Repurchase Agreement having terminated as a result of the event of default, Tandem nonetheless informed the Company that it was continuing to attempt to recapitalize so that it would be in a position to repay the Repayment Value (less the forfeited

91

Deposits) on or prior to the Agreement Maturity Date, should the Company be willing to do so at that time. For example, during the second half of 2017, Tandem sold assets and used proceeds to pay down the Senior Loan. Despite ongoing efforts to recapitalize, Tandem was unable to: (i) repay the Mezzanine Loan at the Repayment Value prior to the Agreement Maturity Date and (ii) close on the Purchase Option by the Purchase Option Expiration Date. The Deposits were applied to reduce the Company’s recorded carrying value of the Mezzanine Loan to $189 million.
As a result of the aforementioned events that occurred during the fourth quarter of 2017 and first quarter of 2018 (during the Company's fourth quarter 2017 financial statement close process), the Company concluded that the Mezzanine Loan was impaired and recorded an impairment charge and related allowance of $84 million, reducing the carrying value of the loan to $105 million as of December 31, 2017. Aggregate impairments on the Mezzanine Loan for the year ended December 31, 2017 were $144 million.
The decline in expected recoverable value of the Mezzanine Loan was primarily driven by the Company’s conclusion that the collateral supporting the Mezzanine Loan may no longer be the sole source in recovering the Company’s investment. The Company is actively evaluating and pursuing multiple alternatives, including, but not limited to: (i) selling all or a portion of the Mezzanine Loan to a third party or (ii) foreclosing on the underlying collateral. As a result, the Company utilized a discounted cash flow model to determine expected recoverability of the Mezzanine Loan. Additionally, a variety of factors further impacted the impairment analysis completed during the Company’s fourth quarter 2017 financial statement close process including recent operating results of the underlying real estate assets, as well as market and industry data, that reflect a declining trend in admissions and a continuing shift away from higher-rate Medicare plans in the post-acute/skilled nursing sector. The calculation relies on: (i) forecasted EBITDAR and market data, including, but not limited to, sales price per unit/bed, rent coverage ratios, and real estate capitalization rates and (ii) recent bids for a sale of the Mezzanine Loan received on February 8, 2018, which incorporate market participant required rates of return and expected hold periods.
Beginning in the first quarter of 2017, the Company elected to recognize interest income on a cash basis. During the years ended December 31, 2017, 2016 and 2015, the Company recognized interest income of $23 million, $31 million and $29 million, respectively, and received cash payments of $25 million, $30 million and $29 million, respectively, from Tandem. The carrying value of the Mezzanine Loan was $105 million and $256 million at December 31, 2017 and 2016, respectively.
NOTE 8.
Investments in and Advances to Unconsolidated Joint Ventures
The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):
 
 
 
 
Carrying Amount
 
 
 
 
December 31,
Entity(1)
 
Ownership %
 
2017
 
2016
CCRC JV
 
49
 
$
400,241

 
$
439,449

RIDEA II
 
40
 
259,651

 
—

Life Science JVs(2)
 
50 - 63
 
65,581

 
67,879

MBK JV
 
50
 
38,005

 
38,909

Development JVs(3)
 
50 - 90
 
23,365

 
10,459

Medical Office JVs(4)
 
20 - 67
 
12,488

 
13,438

K&Y JVs(5)
 
80
 
1,283

 
1,342

Advances to unconsolidated joint ventures, net
 

 
226

 
15

 
 
 
 
$
800,840

 
$
571,491

_______________________________________
(1)
These entities are not consolidated because the Company does not control, through voting rights or other means, the JV.
(2)
Includes the following unconsolidated partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50% ); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).
(3)
Includes four unconsolidated development partnerships (and the Company’s ownership percentage): (i) Vintage Park Development JV (85%); (ii) Waldwick JV (85%); (iii) Otay Ranch JV (90%); and (iv) MBK Development JV (50%).
(4)
Includes three unconsolidated medical office partnerships (and the Company’s ownership percentage): HCP Ventures IV, LLC (20%); HCP Ventures III, LLC (30%); and Suburban Properties, LLC (67%).
(5)
Includes three unconsolidated joint ventures.

92

HCP Ventures III, LLC and HCP Ventures IV, LLC
On December 30, 2015, HCP Ventures III, LLC (“HCP Ventures III”) and HCP Ventures IV, LLC sold 61 MOBs, three hospitals and a redevelopment property for total proceeds of $634 million, recognizing gain on sales of real estate of $59 million, of which the Company’s share was $15 million. As part of these sales, the Company received aggregate distributions of $45 million, including repayment of its loan receivable. During the quarter ended December 31, 2016, HCP Ventures III sold the remaining three assets in its portfolio for $31 million, recognizing gain on sales of real estate of $5 million, of which the Company’s share was $1 million. As part of this sale, the Company received aggregate distributions of $8 million.
See Note 5 for further information on the deconsolidation and pending sale of RIDEA II.
NOTE 9.
Intangibles
The following table summarizes the Company’s intangible lease assets (in thousands):
 
 
December 31,
Intangible lease assets
 
2017
 
2016
Lease-up intangibles
 
$
645,143

    
$
719,788

Above market tenant lease intangibles
 
105,663

 
147,409

Below market ground lease intangibles
 
44,499

 
44,500

Gross intangible lease assets
 
795,305

 
911,697

Accumulated depreciation and amortization
 
(385,223
)
 
(431,892
)
Net intangible lease assets
 
$
410,082

 
$
479,805

The following table summarizes the Company’s intangible lease liabilities (in thousands):
 
 
December 31,
Intangible lease liabilities
 
2017
 
2016
Below market lease intangibles
 
$
123,883

 
$
161,595

Above market ground lease intangibles
 
2,329

 
2,329

Gross intangible lease liabilities
 
126,212

 
163,924

Accumulated depreciation and amortization
 
(73,633
)
 
(105,779
)
Net intangible lease liabilities
 
$
52,579

 
$
58,145

The following table sets forth amortization related to deferred leasing costs and acquisition-related intangibles for the years ended December 31, 2017, 2016 and 2015 (in thousands):
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Depreciation and amortization expense related to amortization of lease-up intangibles
 
$
76,732

 
$
84,487

 
$
74,978

Rental and related revenues related to amortization of net below market lease liabilities
 
2,030

 
3,877

 
3,781

Operating expense related to amortization of net below market ground lease intangibles
 
740

 
664

 
664




93

The following table summarizes the estimated annual amortization for each of the five succeeding fiscal years and thereafter (in thousands):
 
Rental and Related Revenues(1)
 
Operating Expense(2)
 
Depreciation and Amortization(3)
2018
$
4,099

 
$
763

 
$
66,651

2019
4,102

 
763

 
49,868

2020
3,418

 
759

 
40,151

2021
3,401

 
756

 
35,963

2022
4,199

 
756

 
30,490

Thereafter
17,133

 
31,782

 
135,153

 
$
36,352

 
$
35,579

 
$
358,276

_______________________________________
(1)
The amortization of net below market lease intangibles is recorded as an increase to rental and related income.
(2)
The amortization of net below market ground lease intangibles is recorded as an increase to operating expense.
(3)
The amortization of lease-up intangibles is recorded to depreciation and amortization expense.

NOTE 10.
Debt
Bank Line of Credit and Term Loans
On October 19, 2017, the Company executed a $2.0 billion unsecured revolving line of credit facility (the “Facility”), which matures on October 19, 2021 and contains two, six-month extension options. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends upon the Company’s credit ratings. The Company pays a facility fee on the entire revolving commitment that depends on its credit ratings. Based on the Company’s credit ratings at December 31, 2017, the margin on the Facility was 1.00%, and the facility fee was 0.20%. The Facility also includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $750 million, subject to securing additional commitments. At December 31, 2017, the Company had $1.0 billion, including £105 million ($142 million), outstanding under the Facility with a weighted average effective interest rate of 2.74%.
In March 2017, the Company repaid a £137 million unsecured term loan. 
On June 30, 2017, the Company repaid £51 million of its four-year unsecured term loan entered into in January 2015 (the "2015 Term Loan"). Concurrently, the Company terminated its three-year interest rate swap which fixed the interest of the 2015 Term Loan and therefore, beginning June 30, 2017, the 2015 Term Loan accrued interest at a rate of GBP LIBOR plus 1.15%, subject to adjustments based on the Company's credit ratings. At December 31, 2017 the Company had £169 million ($229 million) outstanding on the 2015 Term Loan. The 2015 Term Loan contains a one-year committed extension option. The Company has a one–time right to repay the outstanding GBP balance and re-borrow in USD with all other key terms unchanged.
The Facility and 2015 Term Loan contain certain financial restrictions and other customary requirements, including cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreements: (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60%; (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times; and (v) require a Minimum Consolidated Tangible Net Worth of $6.5 billion at December 31, 2017. At December 31, 2017, the Company was in compliance with each of these restrictions and requirements of the Facility and 2015 Term Loan.
Senior Unsecured Notes
At December 31, 2017, the Company had senior unsecured notes outstanding with an aggregate principal balance of $6.45 billion. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. The Company believes it was in compliance with these covenants at December 31, 2017.

94

The following table summarizes the Company’s senior unsecured notes payoffs for the periods presented (dollars in thousands):
Period
 
Amount
 
Coupon Rate
Year ended December 31, 2017
 
 
 
 
May 1, 2017
 
$
250,000

 
5.625
%
July 27, 2017
 
$
500,000

 
5.375
%
Year ended December 31, 2016:
 
 
 
 

February 1, 2016
 
$
500,000

    
3.750
%
September 15, 2016
 
$
400,000

 
6.300
%
November 30, 2016
 
$
500,000

 
6.000
%
November 30, 2016
 
$
600,000

 
6.700
%

During the years ended December 31, 2017 and 2016, the Company recorded losses on debt extinguishment related to the repurchase of senior notes of $54 million and $46 million, respectively.
There were no senior unsecured notes issuances for either of the years ended December 31, 2017 and 2016.
Mortgage Debt
At December 31, 2017, the Company had $139 million in aggregate principal of mortgage debt outstanding, which is secured by 16 healthcare facilities (including redevelopment properties) with a carrying value of $299 million. In March 2017, the Company paid off $472 million of mortgage debt.
Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

95

Debt Maturities
The following table summarizes the Company’s stated debt maturities and scheduled principal repayments at December 31, 2017 (dollars in thousands):
 
 
Bank Line of Credit(1)
 
Term Loan(2)
 
Senior Unsecured Notes(3)
 
Mortgage Debt(4)
 
Total(5)
Year
 
 
 
Amount
 
Interest Rate
 
Amount
 
Interest Rate
 
2018
 
$
—

 
$
—

 
$
—

 
—
%
 
$
3,512

 
—
%
 
$
3,512

2019
 
—

 
228,674

 
450,000

 
3.95
%
 
3,700

 
—
%
 
682,374

2020
 
—

 
—

 
800,000

 
2.79
%
 
3,758

 
5.08
%
 
803,758

2021
 
1,017,076

 
—

 
700,000

 
5.49
%
 
11,117

 
5.26
%
 
1,728,193

2022
 
—

 
—

 
900,000

 
3.93
%
 
2,861

 
—
%
 
902,861

Thereafter
 
—

 
—

 
3,600,000

 
4.36
%
 
113,619

 
4.09
%
 
3,713,619

 
 
1,017,076

 
228,674

 
6,450,000

 


 
138,567

 


 
7,834,317

Discounts, premium and debt costs, net
 
—

 
(386
)
 
(53,549
)
 
 
 
5,919

 
 
 
(48,016
)
 
 
$
1,017,076

 
$
228,288

 
$
6,396,451

 
 

 
$
144,486

 
 

 
$
7,786,301

_______________________________________
(1)
Includes £105 million translated into USD. 
(2)
Represents £169 million translated into USD.
(3)
Interest rates on the notes ranged from 2.79% to 6.88% with a weighted average effective rate of 4.19% and a weighted average maturity of six years.
(4)
Interest rates on the mortgage debt ranged from 2.08% to 5.91% with a weighted average effective interest rate of 4.19% and a weighted average maturity of 20 years.
(5)
Excludes $94 million of other debt that have no scheduled maturities. Other debt represents (i) $61 million of non-interest bearing life care bonds and occupancy fee deposits at certain of the Company's senior housing facilities and (ii) $33 million of on-demand notes from the CCRC JV which bear interest at a rate of 3.6%.
NOTE 11.
Commitments and Contingencies
Legal Proceedings
From time to time, the Company is a party to, or has a significant relationship to, legal proceedings, lawsuits and other claims. Except as described below, the Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company’s financial condition, results of operations or cash flows. The Company’s policy is to expense legal costs as they are incurred.
Class Action. On May 9, 2016, a purported stockholder of the Company filed a putative class action complaint, Boynton Beach Firefighters’ Pension Fund v. HCP, Inc., et al., Case No. 3:16-cv-01106-JJH, in the U.S. District Court for the Northern District of Ohio against the Company, certain of its officers, HCRMC, and certain of its officers, asserting violations of the federal securities laws. The suit asserts claims under sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and alleges that the Company made certain false or misleading statements relating to the value of and risks concerning its investment in HCRMC by allegedly failing to disclose that HCRMC had engaged in billing fraud, as alleged by the U.S. Department of Justice in a pending suit against HCRMC arising from the False Claims Act. The plaintiff in the suit demands compensatory damages (in an unspecified amount), costs and expenses (including attorneys’ fees and expert fees), and equitable, injunctive, or other relief as the Court deems just and proper. On November 28, 2017, the Court appointed Societe Generale Securities GmbH (SGSS Germany) and the City of Birmingham Retirement and Relief Systems (Birmingham) as Co-Lead Plaintiffs in the class action. Co-Lead Plaintiffs must file a consolidated Amended Complaint by February 28, 2018. Defendants will then have until March 30, 2018 to respond to the Amended Complaint and file a motion to dismiss. The Company believes the suit to be without merit and intends to vigorously defend against it.
Derivative Actions. On June 16, 2016 and July 5, 2016, purported stockholders of the Company filed two derivative actions, respectively Subodh v. HCR ManorCare Inc., et al., Case No. 30-2016-00858497-CU-PT-CXC and Stearns v. HCR ManorCare, Inc., et al., Case No. 30-2016-00861646-CU-MC-CJC, in the Superior Court of California, County of Orange, against certain of the Company’s current and former directors and officers and HCRMC. The Company is named as a nominal defendant. As both derivative actions contained substantially the same allegations, they have been consolidated into a single action. The consolidated action alleges that the defendants engaged in various acts of wrongdoing, including, among other things, breaching fiduciary duties by publicly making false or misleading statements of fact regarding HCRMC’s finances and prospects, and failing to maintain

96

adequate internal controls. As the Subodh/Stearns action is in the early stages, defendants have not yet responded to the complaint. On April 18, 2017, the Court approved the parties’ stipulation staying the action pending further developments, including in the related securities class action litigation. The Court recently adjourned the status conference scheduled for January 10, 2018 to June 11, 2018.
On April 10, 2017, a purported stockholder of the Company filed a derivative action, Weldon v. Martin et al., Case No. 3:17-cv-755, in federal court in the Northern District of Ohio, Western Division, against certain of the Company’s current and former directors and officers and HCRMC. The Company is named as a nominal defendant. The Weldon complaint asserts similar claims to those asserted in the California derivative actions. In addition, the complaint asserts a claim under Section 14(a) of the Exchange Act, alleging that the Company made false statements in its 2016 proxy statement by not disclosing that the Company’s performance issues in 2015 were the direct result of billing fraud at HCRMC. On April 18, 2017, the Court re-assigned and transferred this action to the judge presiding over the related federal securities class action. Defendants have not yet been served or responded to the complaint. On July 11, 2017, the Court approved a stipulation by the parties to stay the case pending disposition of the motion to dismiss the class action.
On July 21, 2017, a purported stockholder of the Company filed another derivative action, Kelley v. HCR ManorCare, Inc., et al., Case No. 8:17-cv-01259, in federal court in the Central District of California, against certain of the Company’s current and former directors and officers and HCRMC. The Company is named as a nominal defendant. The Kelley complaint asserts similar claims to those asserted in Weldon and in the California derivative actions. Like Weldon, the Kelley complaint also additionally alleges that the Company made false statements in its 2016 proxy statement, and asserts a claim for a violation of Section 14(a) of the Exchange Act. On September 25, 2017, Defendants moved to transfer the action to the Northern District of Ohio (i.e., the court where the class action and other federal derivative action are pending) or, in the alternative, to stay the action. The Court granted Defendants’ motion to transfer on November 28, 2017, and Kelley is now before Judge Helmick in the Northern District of Ohio.
In a status conference on January 19, 2018 in the Kelley action, Judge Helmick requested briefing by the parties in both Weldon and Kelley concerning the potential consolidation of the two actions, the appointment of lead plaintiffs and counsel, and whether the stay should continue. Plaintiffs’ briefs will be due on February 23, 2018, defendants’ opposition will be due on March 9, 2018, and plaintiffs’ reply will be due on March 23, 2018. Judge Helmick indicated that he would issue an order explaining and memorializing these deadlines.

The Company’s Board of Directors received letters dated August 17, 2016, April 19, 2017, and April 20, 2017 from private law firms acting on behalf of clients who are purported stockholders of the Company, each asserting allegations similar to those made in the Subodh and Stearns matters discussed above. Each letter demands that the Board of Directors take action to assert the Company’s rights. The Board of Directors completed its evaluation and determined to reject the demand letters. Rejection notices were sent in December of 2017.
The Company believes that the lawsuits and demands are without merit and is unable to estimate the amount of loss or range of reasonably possible losses with respect to the matters discussed above as of December 31, 2017.
Welltower v. Scott M. Brinker. On May 15, 2017, Welltower, Inc. filed a complaint in the Court of Common Pleas in Lucas County, Ohio, against Scott M. Brinker, alleging that he violated his non-competition obligations to Welltower prior to and upon acceptance of an offer of employment with the Company. Mr. Brinker counterclaimed that the non-competition restrictions were unenforceable, and also asserted breach of contract and defamation counterclaims against Welltower, among others. In connection with Mr. Brinker’s hiring, the Company agreed to indemnify him for legal fees and any losses that result from the action. On November 5, 2017, Welltower, Mr. Brinker and the Company agreed to settle the lawsuit for an amount, recognized during the fourth quarter of 2017, that is not material to the Company's financial condition, results of operations or cash flows and file a joint dismissal of all claims and counterclaims.
DownREIT LLCs
In connection with the formation of certain DownREIT LLCs, members may contribute appreciated real estate to a DownREIT LLC in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the member. However, if a contributed property is later sold by the DownREIT LLC, the unamortized pre-contribution gain that exists at the date of sale is specifically allocated and taxed to the contributing members. In many of the DownREITs, the Company has entered into indemnification agreements with those members who contributed appreciated property into the DownREIT LLC. Under these indemnification agreements, if any of the appreciated real estate contributed by the members is sold by the DownREIT LLC in a taxable transaction within a specified number of years, the Company will reimburse the affected members for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected member under the Code (“make-whole payments”). These make-whole payments include a tax gross-up provision. These indemnification agreements have expiration terms that range through 2033 on a total of 35 properties.

97

Commitments
The following table summarizes the Company’s material commitments, excluding debt servicing obligations (see Note 10) and operating leases (see disclosure below), at December 31, 2017 (in thousands):
 
Total
 
2018
 
2019-2020
 
2021-2022
 
More than Five Years
U.K. loan commitments(1)
$
3,236

 
$
3,236

 
$
—

 
$
—

 
$
—

Construction loan commitments(2)
114,691

 
45,863

 
68,828

 
—

 
—

Development commitments(3)
133,371

 
128,101

 
2,228

 
3,042

 
—

Total
$
251,298

 
$
177,200

 
$
71,056

 
$
3,042

 
$
—

_______________________________________
(1)
Represents £2 million translated into USD for commitments to fund the Company’s U.K. loan facilities.
(2)
Represents commitments to finance development projects.
(3)
Represents construction and other commitments for developments in progress.
Credit Enhancement Guarantee
At December 31, 2017, certain of the Company’s senior housing facilities serve as collateral for $83 million of debt (maturing May 1, 2025) that is owed by a previous owner of the facilities. This indebtedness is guaranteed by the previous owner who has an investment grade credit rating. These senior housing facilities, which are classified as DFLs, had a carrying value of $356 million as of December 31, 2017.
Environmental Costs
The Company monitors its properties for the presence of hazardous or toxic substances. The Company is not aware of any environmental liability with respect to the properties that would have a material adverse effect on the Company’s business, financial condition or results of operations. The Company carries environmental insurance and believes that the policy terms, conditions, limitations and deductibles are adequate and appropriate under the circumstances, given the relative risk of loss, the cost of such coverage and current industry practice.
General Uninsured Losses
The Company obtains various types of insurance to mitigate the impact of property, business interruption, liability, flood, windstorm, earthquake, environmental, cyber and terrorism related losses. The Company attempts to obtain appropriate policy terms, conditions, limits and deductibles considering the relative risk of loss, the cost of such coverage and current industry practice. There are, however, certain types of extraordinary losses, such as those due to acts of war or other events that may be either uninsurable or not economically insurable. In addition, the Company has a large number of properties that are exposed to earthquake, flood and windstorm occurrences for which the related insurances carry high deductibles.
Tenant Purchase Options
Certain leases, including DFLs contain purchase options whereby the tenant may elect to acquire the underlying real estate. Annualized base rent from leases subject to purchase options, summarized by the year the purchase options are exercisable, are as follows (dollars in thousands):
Year
 
Annualized
Base Rent(1)
 
Number of
Properties
2018
 
$
8,534

 
8

2019
 
14,702

 
2

2020
 
14,201

 
4

2021
 
12,402

 
6

2022
 
10,459

 
3

Thereafter
 
33,964

 
22

 
 
$
94,262

 
45

_______________________________________
(1)
Represents the most recent month’s base rent including additional rent floors and cash income from DFLs annualized for 12 months. Base rent does not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e., straight- line rents, amortization of market lease intangibles, DFL non-cash and deferred revenues).

98

Rental Expense
The Company’s rental expense attributable to continuing operations was $10 million for each of the years ended December 31, 2017, 2016 and 2015. These rental expense amounts include ground rent and other leases. Ground leases generally require fixed annual rent payments and may also include escalation clauses and renewal options. These leases have terms that are up to 99 years, excluding extension options.
Future minimum lease obligations under non-cancelable ground and other operating leases as of December 31, 2017 were as follows (in thousands):
Year
 
Amount
2018
 
$
6,619

2019
 
6,766

2020
 
6,668

2021
 
6,704

2022
 
6,820

Thereafter
 
362,219

 
 
$
395,796

NOTE 12.
Equity
Common Stock
On February 1, 2018, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.37 per share. The common stock cash dividend will be paid on March 2, 2018 to stockholders of record as of the close of business on February 15, 2018.
During the years ended December 31, 2017, 2016 and 2015, the Company declared and paid common stock cash dividends of $1.480, $2.095 and $2.260 per share, respectively. 
In June 2015, the Company established an at-the-market equity offering program (“ATM Program”). Under this program, the Company may sell shares of its common stock from time to time having an aggregate gross sales price of up to $750 million through a consortium of banks acting as sales agents or directly to the banks acting as principals. During the year ended December 31, 2015, the Company issued 1.8 million shares of common stock at a weighted average price of $40.14 for proceeds of $73 million, net of fees and commissions of $1 million. There was no activity during the years ended December 31, 2017 and 2016.
The following table summarizes the Company’s other common stock activities (shares in thousands):
 
Year Ended
December 31,
 
2017
 
2016
 
2015
Dividend Reinvestment and Stock Purchase Plan
983

    
2,021

    
2,762

Conversion of DownREIT units
78

 
145

 
104

Exercise of stock options
32

 
133

 
823

Vesting of restricted stock units
419

 
529

 
409

Repurchase of common stock
157

 
237

 
198


99

Accumulated Other Comprehensive Loss
The following table summarizes the Company’s accumulated other comprehensive loss (in thousands):
 
December 31,
 
2017
 
2016
Cumulative foreign currency translation adjustment
$
(6,955
)
    
$
(22,817
)
Unrealized gains (losses) on cash flow hedges, net
(13,950
)
 
(3,642
)
Supplemental Executive Retirement plan minimum liability and other
(3,119
)
 
(3,183
)
Total accumulated other comprehensive loss
$
(24,024
)
 
$
(29,642
)
Noncontrolling Interests
On October 7, 2015, the Company issued a 49% noncontrolling interest in HCP Ventures V to an institutional capital investor for $110 million. HCP Ventures V owns a portfolio of 11 on-campus MOBs located in Texas and acquired through a sale-leaseback transaction with Memorial Hermann in June 2015.
At December 31, 2017, there were four million DownREIT units (seven million shares of HCP common stock are issuable upon conversion) outstanding in five DownREIT LLCs, all of which the Company is the managing member. At December 31, 2017, the carrying and market values of the four million DownREIT units were $177 million and $173 million, respectively.
See Note 5 for the deconsolidation of RIDEA II and Note 19 for the supplemental schedule of non-cash financing activities.
NOTE 13.
Segment Disclosures
The Company evaluates its business and allocates resources based on its reportable business segments: (i) senior housing triple-net, (ii) SHOP, (iii) life science and (iv) medical office. The Company has non-reportable segments that are comprised primarily of the Company’s debt investments, hospital properties, unconsolidated joint ventures (see below), and care homes in the U.K. The accounting policies of the segments are the same as those described under Summary of Significant Accounting Policies (see Note 2).
During the fourth quarter of 2017, as a result of a change in how operating results are reported to the chief operating decision makers, for the purpose of evaluating performance and allocating resources, the Company began excluding unconsolidated joint ventures from its evaluation of its segments' operating results. Unconsolidated joint ventures are now reflected in other non-reportable segments, and as a result, excluded from NOI and Adjusted NOI. Prior period NOI and Adjusted NOI have also been recast to conform to current period presentation, which excludes unconsolidated joint ventures.
During the year ended December 31, 2017, 42 senior housing triple-net facilities were transferred to the Company’s SHOP segment. During the year ended December 31, 2016, 17 senior housing triple-net facilities were transitioned to a RIDEA structure (reported in the Company’s SHOP segment). There were no intersegment sales or transfers during the year ended December 31, 2015.
The Company evaluates performance based upon: (i) property net operating income from continuing operations (“NOI”) and (ii) Adjusted NOI. NOI is defined as rental and related revenues, including tenant recoveries, resident fees and services, and income from DFLs, less property level operating expenses. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, lease termination fees and the impact of deferred community fee income and expense. The adjustments to NOI and resulting Adjusted NOI for SHOP have been recast for prior periods presented to conform to the current period presentation which excludes (i) the impact of deferred community fee income and expense, resulting in recognition as cash is received and expenses are paid and (ii) adjustments related to unconsolidated joint ventures (see above).
Non-segment assets consist of assets in the Company's other non-reportable segments (see above) and corporate non-segment assets. Corporate non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, marketable equity securities and, if any, real estate held for sale. See Note 22 for other information regarding concentrations of credit risk.

100

The following tables summarize information for the reportable segments (in thousands):
For the year ended December 31, 2017:
Segments
 
Senior Housing Triple-Net
 
SHOP
 
Life Science
 
Medical Office
 
Other Non-reportable
 
Corporate Non-segment
 
Total
Rental revenues(1)
 
$
313,547

 
$
525,473

 
$
358,816

 
$
477,459

 
$
116,846

 
$
—

 
$
1,792,141

Operating expenses
 
(3,819
)
 
(396,491
)
 
(78,001
)
 
(183,197
)
 
(4,743
)
 
—

 
(666,251
)
NOI
 
309,728

 
128,982

 
280,815

 
294,262

 
112,103

 
—

 
1,125,890

Adjustments to NOI(2)
 
17,098

 
33,227

 
(4,517
)
 
(2,952
)
 
(4,446
)
 
—

 
38,410

Adjusted NOI
 
326,826

 
162,209

 
276,298

 
291,310

 
107,657

 
—

 
1,164,300

Addback adjustments
 
(17,098
)
 
(33,227
)
 
4,517

 
2,952

 
4,446

 
—

 
(38,410
)
Interest income
 
—

 
—

 
—

 
—

 
56,237

 
—

 
56,237

Interest expense
 
(2,518
)
 
(7,920
)
 
(373
)
 
(506
)
 
(4,230
)
 
(292,169
)
 
(307,716
)
Depreciation and amortization
 
(103,820
)
 
(103,162
)
 
(128,864
)
 
(169,795
)
 
(29,085
)
 
—

 
(534,726
)
General and administrative
 
—

 
—

 
—

 
—

 
—

 
(88,772
)
 
(88,772
)
Transaction costs
 
—

 
—

 
—

 
—

 
—

 
(7,963
)
 
(7,963
)
Recoveries (impairments), net
 
(22,590
)
 
—

 
—

 
—

 
(143,794
)
 
—

 
(166,384
)
Gain (loss) on sales of real estate, net
 
280,349

 
17,485

 
45,916

 
9,095

 
3,796

 
—

 
356,641

Loss on debt extinguishment
 
—

 
—

 
—

 
—

 
—

 
(54,227
)
 
(54,227
)
Other income (expense), net
 
—

 
—

 
—

 
—

 
50,895

 
(19,475
)
 
31,420

Income tax benefit (expense)
 
—

 
—

 
—

 
—

 
—

 
1,333

 
1,333

Equity income (loss) from unconsolidated JVs
 
—

 
—

 
—

 
—

 
10,901

 
—

 
10,901

Net income (loss)
 
$
461,149

 
$
35,385

 
$
197,494

 
$
133,056

 
$
56,823

 
$
(461,273
)
 
$
422,634

_______________________________________
(1)
Represents rental and related revenues, tenant recoveries, resident fees and services, and income from DFLs.
(2)
Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, deferral of community fees, net and termination fees.

101

For the year ended December 31, 2016:
Segments
 
Senior Housing Triple-Net
 
SHOP
 
Life Science
 
Medical Office
 
Other Non-reportable
 
Corporate Non-segment
 
Total
Rental revenues(1)
 
$
423,118

 
$
686,822

 
$
358,537

 
$
446,280

 
$
125,729

 
$
—

 
$
2,040,486

Operating expenses
 
(6,710
)
 
(480,870
)
 
(72,478
)
 
(173,687
)
 
(4,654
)
 
—

 
(738,399
)
NOI
 
416,408

 
205,952

 
286,059

 
272,593

 
121,075

 
—

 
1,302,087

Adjustments to NOI(2)
 
(7,566
)
 
(2,686
)
 
(2,954
)
 
(3,536
)
 
(3,022
)
 
—

 
(19,764
)
Adjusted NOI
 
408,842

 
203,266

 
283,105

 
269,057

 
118,053

 
—

 
1,282,323

Addback adjustments
 
7,566

 
2,686

 
2,954

 
3,536

 
3,022

 
—

 
19,764

Interest income
 
—

 
—

 
—

 
—

 
88,808

 
—

 
88,808

Interest expense
 
(9,499
)
 
(29,745
)
 
(2,357
)
 
(5,895
)
 
(9,153
)
 
(407,754
)
 
(464,403
)
Depreciation and amortization
 
(136,146
)
 
(108,806
)
 
(130,829
)
 
(161,790
)
 
(30,537
)
 
—

 
(568,108
)
General and administrative
 
—

 
—

 
—

 
—

 
—

 
(103,611
)
 
(103,611
)
Transaction costs
 
—

 
—

 
—

 
—

 
—

 
(9,821
)
 
(9,821
)
Gain (loss) on sales of real estate, net
 
48,744

 
675

 
49,042

 
8,333

 
57,904

 
—

 
164,698

Loss on debt extinguishment
 


 


 


 


 


 
(46,020
)
 
(46,020
)
Other income (expense), net
 
—

 
—

 
—

 
—

 
—

 
3,654

 
3,654

Income tax benefit (expense)
 
—

 
—

 
—

 
—

 
—

 
(4,473
)
 
(4,473
)
Equity income (loss) from unconsolidated JVs
 
—

 
—

 
—

 
—

 
11,360

 
—

 
11,360

Discontinued operations
 
—

 
—

 
—

 
—

 
—

 
265,755

 
265,755

Net income (loss)
 
$
319,507

 
$
68,076

 
$
201,915

 
$
113,241

 
$
239,457

 
$
(302,270
)
 
$
639,926

_______________________________________
(1)
Represents rental and related revenues, tenant recoveries, resident fees and services, and income from DFLs.
(2)
Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, deferral of community fees, net and termination fees.

102

For the year ended December 31, 2015:
Segments
 
Senior Housing Triple-Net
 
SHOP
 
Life Science
 
Medical Office
 
Other Non-reportable
 
Corporate Non-segment
 
Total
Rental revenues(1)
 
$
428,269

 
$
518,264

 
$
342,984

 
$
415,351

 
$
123,437

 
$
—

 
$
1,828,305

Operating expenses
 
(3,427
)
 
(371,016
)
 
(70,217
)
 
(162,054
)
 
(3,965
)
 
—

 
(610,679
)
NOI
 
424,842

 
147,248

 
272,767

 
253,297

 
119,472

 
—

 
1,217,626

Adjustments to NOI(2)
 
(9,716
)
 
8,145

 
(10,128
)
 
(4,933
)
 
(2,356
)
 
—

 
(18,988
)
Adjusted NOI
 
415,126

 
155,393

 
262,639

 
248,364

 
117,116

 
—

 
1,198,638

Addback adjustments
 
9,716

 
(8,145
)
 
10,128

 
4,933

 
2,356

 
—

 
18,988

Interest income
 
—

 
—

 
—

 
—

 
112,184

 
—

 
112,184

Interest expense
 
(16,899
)
 
(31,869
)
 
(2,878
)
 
(9,603
)
 
(9,745
)
 
(408,602
)
 
(479,596
)
Depreciation and amortization
 
(125,538
)
 
(80,981
)
 
(126,241
)
 
(143,682
)
 
(28,463
)
 
—

 
(504,905
)
General and administrative
 
—

 
—

 
—

 
—

 
—

 
(95,965
)
 
(95,965
)
Transaction costs
 
—

 
—

 
—

 
—

 
—

 
(27,309
)
 
(27,309
)
Recoveries (impairments), net
 
—

 
—

 
—

 
—

 
(108,349
)
 
—

 
(108,349
)
Gain (loss) on sales of real estate, net
 
6,325

 
—

 
—

 
52

 
—

 
—

 
6,377

Other income (expense), net
 
—

 
—

 
—

 
—

 
—

 
16,208

 
16,208

Income tax benefit (expense)
 
—

 
—

 
—

 
—

 
—

 
9,807

 
9,807

Equity income (loss) from unconsolidated JVs
 
—

 
—

 
—

 
—

 
6,590

 
—

 
6,590

Discontinued operations
 
—

 
—

 
—

 
—

 
—

 
(699,086
)
 
(699,086
)
Net income (loss)
 
$
288,730

 
$
34,398

 
$
143,648

 
$
100,064

 
$
91,689

 
$
(1,204,947
)
 
$
(546,418
)
_______________________________________
(1)
Represents rental and related revenues, tenant recoveries, resident fees and services, and income from DFLs.
(2)
Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, deferral of community fees, net and termination fees.
The following table summarizes the Company’s revenues by segment (in thousands):
 
 
Year Ended
 
 
December 31,
Segments
 
2017
 
2016
 
2015
Senior housing triple-net
 
$
313,547

    
$
423,118

 
$
428,269

SHOP
 
525,473

 
686,822

 
518,264

Life science
 
358,816

 
358,537

 
342,984

Medical office
 
477,459

 
446,280

 
415,351

Other non-reportable segments
 
173,083

 
214,537

 
235,621

Total revenues
 
$
1,848,378

 
$
2,129,294

 
$
1,940,489


103

The following table summarizes the Company’s total assets by segment (in thousands):
 
 
December 31,
Segments
 
2017
 
2016
 
2015
Senior housing triple-net
 
$
3,515,400

 
$
3,871,720

 
$
5,092,443

SHOP
 
2,392,130

 
3,135,115

 
2,684,675

Life science
 
4,154,372

 
3,961,623

 
3,613,726

Medical office
 
3,989,168

 
3,724,483

 
3,410,931

Gross reportable segment assets
 
14,051,070

 
14,692,941

 
14,801,775

Accumulated depreciation and amortization
 
(2,919,278
)
 
(2,900,060
)
 
(2,704,425
)
Net reportable segment assets
 
11,131,792

 
11,792,881

 
12,097,350

Other non-reportable segment assets
 
1,904,433

 
2,255,712

 
2,392,823

Assets held for sale and discontinued operations, net
 
417,014

 
927,866

 
5,654,326

Other non-segment assets
 
635,222

 
782,806

 
1,305,350

Total assets
 
$
14,088,461

 
$
15,759,265

 
$
21,449,849

As a result of the change in the composition of reportable segments during the fourth quarter of 2017, as further described above, the Company allocated goodwill to its revised reporting units using a relative fair value approach. The Company completed a goodwill impairment assessment for all reporting units immediately prior to the reallocation and determined that no impairment existed at September 30, 2017. Additionally, the Company completed the required annual goodwill impairment test during the fourth quarter of 2017 and no impairment was recognized. At December 31, 2017, goodwill of $47 million was allocated to segment assets as follows: (i) senior housing triple-net—$21 million, (ii) SHOP—$9 million, (iii) medical office—$11 million and (iv) other—$6 million. At December 31, 2016, goodwill of $42 million was allocated to segment assets as follows: (i) senior housing triple-net—$16 million, (ii) SHOP—$9 million, (iii) medical office—$11 million and (iv) other—$6 million.
NOTE 14.
Future Minimum Rents
The following table summarizes future minimum lease payments to be received, excluding operating expense reimbursements, from tenants under non-cancelable operating leases as of December 31, 2017 (in thousands):
Year
 
Amount
2018
 
$
1,021,212

2019
 
956,092

2020
 
874,617

2021
 
793,058

2022
 
691,352

Thereafter
 
2,807,315

 
 
$
7,143,646

NOTE 15.
Compensation Plans
Stock Based Compensation
On May 11, 2006, the Company’s stockholders approved the 2006 Performance Incentive Plan, which was amended and restated in 2009 (“the 2006 Plan”). On May 1, 2014, the Company’s stockholders approved the 2014 Performance Incentive Plan (“the 2014 Plan”) (collectively, “the Plans”). Following the adoption of the 2014 Plan, no new awards will be issued under the 2006 Plan. The Plans provide for the granting of stock-based compensation, including stock options, restricted stock and restricted stock units to officers, employees and directors in connection with their employment with or services provided to the Company. The maximum number of shares reserved for awards under the 2014 Plan is 33 million shares, and as of December 31, 2017, 30 million of the reserved shares under the 2014 Plan are available for future awards of which 20 million shares may be issued as restricted stock and restricted stock units.

104

Total share-based compensation expense recognized during the years ended December 31, 2017, 2016 and 2015 was $14 million, $23 million and $26 million, respectively. The year ended December 31, 2016 includes a $7 million charge recognized in general and administrative expenses primarily resulting from the termination of the Company’s former chief executive officer (“CEO”) that was comprised of the accelerated vesting of restricted stock units in accordance with the terms of the former CEO’s employment agreement. As of December 31, 2017 and 2016, there was $20 million and $14 million, respectively, related to unvested share-based compensation arrangements granted under the Company’s incentive plans, which is expected to be recognized over a weighted average period of three years associated with future employee service.
Conversion of Equity Awards at the Spin-Off Date
The Plans were established with anti-dilution provisions, such that in the event of an equity restructuring of the Company (including spin-off transactions), equity awards would preserve their value post-transaction. In order to achieve an equitable modification of the existing awards following the Spin-Off, the Company converted pre-spin awards to their post-spin value, resulting in grants to remaining employees denominated solely in the Company’s common stock. The modification assumed a conversion ratio on all awards calculated as the final pre-spin closing price of the Company’s common stock divided by the five trading day average post-spin closing price (“Five Day Average Price”) of the Company’s common stock. The conversion impacted 133 participants, resulted in additional awards being granted and incremental fair value of unvested awards due to the difference between the Five Day Average Price and the pre-spin closing price on the Spin-Off date. The vesting periods were unchanged for unvested grants at the Spin-Off date. The incremental fair value of unvested awards was immaterial.
Stock Options
Stock options are granted with an exercise price per share equal to the closing market price of the Company’s common stock on the grant date. Stock options generally vest ratably over a three- to five-year period and have a 10-year contractual term. Vesting of certain stock options may accelerate, as provided in the Plans or in the applicable award agreement, upon retirement, a change in control or other specified events.
There have been no grants of stock options since 2014. Stock options outstanding and exercisable were 1.1 million at December 31, 2017, and 1.3 million and 1.2 million at December 31, 2016, respectively. Proceeds received from stock options exercised under the Plans for the years ended December 31, 2017, 2016 and 2015 were $1 million, $4 million and $28 million, respectively. Compensation expense related to stock options was immaterial for all periods presented.
Restricted Stock Awards
Under the Plans, restricted stock awards, including restricted stock units and performance stock units are granted subject to certain restrictions. Conditions of vesting are determined at the time of grant. Restrictions on certain awards generally lapse, as provided in the Plans or in the applicable award agreement, upon retirement, a change in control or other specified events. The fair market value of restricted stock awards, both time vesting and those subject to specific performance criteria, are expensed over the period of vesting. Restricted stock units, which vest based solely upon passage of time generally vest over a period of three to six years. The fair value of restricted stock units is determined based on the closing market price of the Company's shares on the grant date. Performance stock units, which are restricted stock awards that vest dependent upon attainment of various levels of performance that equal or exceed targeted levels, generally vest in their entirety at the end of a three year performance period. The number of shares that ultimately vest can vary from 0% to 200% of target depending on the level of achievement of the performance criteria. The fair value of performance stock units is determined based on the Monte Carlo valuation model. The compensation expense recognized for all restricted stock awards is net of actual forfeitures.
Upon vesting of restricted stock awards, the participant is required to pay the related tax withholding obligation. Participants can generally elect to have the Company reduce the number of common stock shares delivered to pay the employee tax withholding obligation. The value of the shares withheld is dependent on the closing market price of the Company’s common stock on the trading date prior to the relevant transaction occurring. During the years ended December 31, 2017, 2016 and 2015, the Company withheld 157,000, 237,000 and 200,000 shares, respectively, to offset tax withholding obligations with respect to the vesting of the restricted stock and performance restricted stock unit awards.
Holders of restricted stock awards, including restricted stock units and performance stock units, are generally entitled to receive dividends equal to the amount that would be paid on an equivalent number of shares of common stock.

105

The following table summarizes restricted stock award activity, including performance stock units, for the year ended December 31, 2017 (units and shares in thousands):
 
Restricted
Stock
Units
 
Weighted
Average
Grant Date
Fair Value
Unvested at January 1, 2017
962

 
$
37.39

Granted
844

 
33.57

Vested
(419
)
 
35.10

Forfeited
(248
)
 
35.04

Unvested at December 31, 2017
1,139

 
33.41

At December 31, 2017, the weighted average remaining vesting period of restricted stock and performance based units was two years. The total fair value (at vesting) of restricted stock and performance based units which vested for the years ended December 31, 2017, 2016 and 2015 was $15 million, $24 million and $21 million, respectively.
Subsequent events. The Company expects to record severance and related charges of approximately $9 million in the first quarter of 2018 related to the departure of our Executive Chairman, effective March 1, 2018.
NOTE 16.
Impairments
Casualty-Related
As a result of Hurricane Harvey and Hurricane Irma during the year ended December 31, 2017, the Company recorded an estimated $13 million of casualty-related losses, net of a small insurance recovery. The losses are comprised of $8 million of property damage and $5 million of other associated costs, including storm preparation, clean up, relocation and other costs. Of the total $13 million casualty losses incurred, $12 million was recorded in Other income (expense), net, and $1 million was recorded in equity income (loss) from unconsolidated joint ventures as it relates to casualty losses for properties owned by certain of our unconsolidated joint ventures. In addition, the Company recorded a $1 million deferred tax benefit associated with the casualty-related losses.
Real Estate
During the third quarter 2017, the Company determined that 11 underperforming senior housing triple-net assets that are candidates for potential future sale were impaired. Accordingly, the Company wrote-down the carrying amount of these 11 assets to their fair value, which resulted in an aggregate impairment charge of $23 million. The fair value of the assets was based on forecasted sales prices which are considered to be Level 2 measurements within the fair value hierarchy.
Other
See Note 7 for further information on the impairment charges related to the mezzanine loan facility to Tandem (the "Tandem Mezzanine Loan").
In June 2015 and September 2015, the Company determined that its Four Seasons senior notes (the “Four Seasons Notes”) were other-than-temporarily impaired resulting from a continued decrease in the fair value of its investment. Although the Company did not intend to sell and did not believe it would be required to sell the Four Seasons Notes before their maturity, the Company determined that a credit loss existed resulting from several factors including: (i) deterioration in Four Seasons’ operating performance since the fourth quarter of 2014 and (ii) credit downgrades to Four Seasons received during the first half of 2015. Accordingly, the Company recorded impairment charges during the three months ended June 30, 2015 and September 30, 2015 of $42 million and $70 million, respectively, reducing the carrying value of the Four Seasons Notes at September 30, 2015 to $100 million (£66 million).
The fair value of the Four Seasons Notes used to calculate the impairment charge was based on quoted market prices. However, because the Four Seasons Notes were not actively traded, these prices were considered to be Level 2 measurements within the fair value hierarchy. When calculating the fair value and determining whether a credit loss existed, the Company also evaluated Four Season’s ability to repay the Four Seasons Notes according to their contractual terms based on its estimate of future cash flows. The estimated future cash flow inputs included forecasted revenues, capital expenditures, operating expenses, care home occupancy and continued implementation of Four Seasons’ business plan which included executing on its business line segmentation and continuing to invest in its core real estate portfolio. This information was consistent with the results of the valuation technique

106

used by the Company to determine if a credit loss existed and to calculate the fair value of the Four Seasons Notes during its impairment review.
In March 2017, pursuant to a shift in the Company’s investment strategy, the Company sold its £138.5 million par value Four Seasons Notes for £83 million ($101 million). The disposition of the Four Seasons Notes generated a £42 million ($51 million) gain on sale, recognized in other income, net, as the sales price was above the previously-impaired carrying value of £41 million ($50 million).
Through October 2015, the Company held a secured term loan made to Delphis Operations, L.P. (“Delphis”). In October 2015, the Company received $23 million in cash proceeds from the sale of Delphis’ collateral and recognized an impairment recovery of $6 million for the amount received in excess of the loan’s carrying value.

NOTE 17.    Income Taxes
The Company has elected to be taxed as a REIT under the applicable provisions of the Code for every year beginning with the year ended December 31, 1985. The Company has also elected for certain of its subsidiaries to be treated as taxable REIT subsidiaries (“TRS” or “TRS entities”) which are subject to federal and state income taxes. All entities other than the TRS entities are collectively referred to as the “REIT” within this Note 17. Certain REIT entities are also subject to state, local and foreign income taxes. 
Distributions with respect to our common stock can be characterized for federal income tax purposes as taxable ordinary dividends, capital gain dividends, nondividend distributions or a combination thereof. Following is the characterization of our annual common stock distributions per share:
 
Year Ended December 31,
 
2017
 
2016
 
2015
Ordinary dividends
$
1.4800

 
$
1.5561

 
$
2.1184

Capital gain dividends
—

 
—

 
0.0316

Nondividend distributions
—

 
6.7089

 
0.1100

 
$
1.4800

 
$
8.2650

(1) 
$
2.2600

_______________________________________
(1)
Consists of $2.095 per common share of quarterly cash dividends and $6.17 per common share of stock dividends related to the Spin-Off (see Note 5).
HCP common stockholders on October 24, 2016, the record date for the Spin-Off (the “Record Date”), received upon the Spin-Off on October 31, 2016 one share of QCP common stock for every five shares of HCP common stock they held (the “Distributed Shares”) and cash in lieu of fractional shares of QCP. For U.S. federal income tax purposes, HCP reported the fair market value of the QCP common stock distributed per each share of HCP common stock outstanding on the Record Date was $6.17, or $30.85 for each share of QCP common stock.
The TRS entities subject to tax reported losses before income taxes from continuing operations of $58 million, $9 million and $22 million for the years ended December 31, 2017, 2016 and 2015, respectively. The REIT’s losses from continuing operations before income taxes from the U.K. were $4 million, $4 million and $15 million for the years ended December 31, 2017, 2016 and 2015, respectively.

107

The total income tax expense (benefit) from continuing operations consists of the following components (in thousands):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Current
 
 
 
 
 
Federal
$
949

 
$
8,525

 
$
4,948

State
1,504

 
8,307

 
1,988

Foreign
1,737

 
1,332

 
828

Total current
$
4,190

 
$
18,164

 
$
7,764

 
 
 
 
 
 
Deferred
 
 
 
 
 
Federal
$
2,730

 
$
(10,241
)
 
$
(11,317
)
State
(5,889
)
 
(1,401
)
 
(1,382
)
Foreign
(2,364
)
 
(2,049
)
 
(4,872
)
Total deferred
$
(5,523
)
 
$
(13,691
)
 
$
(17,571
)
 
 
 
 
 
 
Total income tax expense (benefit)
$
(1,333
)
 
$
4,473

 
$
(9,807
)
On December 22, 2017, the Tax Cuts and Jobs Act was signed into law. As a result of the reduced U.S. federal corporate tax rate, the Company recorded a tax expense of $17 million, due to a remeasurement of deferred tax assets and liabilities, which is included in total deferred tax expense in the table above.
The Company’s income tax expense from discontinued operations was $0, $48 million and $1 million for the years ended December 31, 2017, 2016 and 2015, respectively (see Note 5).

108

The following table reconciles the income tax expense (benefit) from continuing operations at statutory rates to the actual income tax expense recorded (in thousands):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Tax benefit at U.S. federal statutory income tax rate on income or loss subject to tax
$
(21,085
)
 
$
(4,581
)
 
$
(12,630
)
State income tax expense, net of federal tax
(1,222
)
 
6,081

 
(606
)
Gross receipts and margin taxes
1,716

 
1,847

 
1,383

Foreign rate differential
632

 
647

 
2,269

Effect of permanent differences
6

 
(280
)
 
(298
)
Return to provision adjustments
1,597

 
287

 
(368
)
Re-measurement of deferred tax assets and liabilities
17,080

 
—

 
—

Increase (decrease) in valuation allowance
(57
)
 
472

 
443

Total income tax expense (benefit)
$
(1,333
)
 
$
4,473

 
$
(9,807
)
Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table summarizes the significant components of the Company’s deferred tax assets and liabilities from continuing operations (in thousands):
 
December 31,
 
2017
 
2016
 
2015
Property, primarily differences in depreciation and amortization, the basis of land, and the treatment of interest and certain costs
$
31,691

 
$
28,940

 
$
19,862

Net operating loss carryforward
10,720

 
8,784

 
3,703

Expense accruals and other
229

 
(847
)
 
(753
)
Valuation allowance
(548
)
 
(606
)
 
(531
)
Net deferred tax assets
$
42,092

 
$
36,271

 
$
22,281

Deferred tax assets and liabilities are included in other assets, net and accounts payable and accrued liabilities.
At December 31, 2017 the Company had a net operating loss (“NOL”) carryforward of $42 million related to the TRS entities. These amounts can be used to offset future taxable income, if any. The NOL carryforwards begin to expire in 2033 with respect to the TRS entities.
The Company records a valuation allowance against deferred tax assets in certain jurisdictions when it cannot sustain a conclusion that it is more likely than not that it can realize the deferred tax assets during the periods in which these temporary differences become deductible. The deferred tax asset valuation allowance is adequate to reduce the total deferred tax assets to an amount that the Company estimates will “more-likely-than-not” be realized.
The Company files numerous U.S. federal, state and local income and franchise tax returns. With a few exceptions, the Company is no longer subject to U.S. federal, state or local tax examinations by taxing authorities for years prior to 2014.
For the years ended December 31, 2017 and 2016, the tax basis of the Company’s net assets was less than the reported amounts by $1.7 billion and $2.0 billion, respectively. The difference between the reported amounts and the tax basis was primarily related to the Slough Estates USA, Inc. (“SEUSA”) acquisition, which occurred in 2007. For the year ended December 31, 2015, the tax basis of the Company’s net assets was less than the reported amounts by $6.5 billion. The difference between the reported amounts and the tax basis was primarily related to the SEUSA and HCRMC acquisitions which occurred in 2007 and 2011, respectively. Both SEUSA and HCRMC were corporations subject to federal and state income taxes. As a result of these acquisitions, the Company succeeded to the tax attributes of SEUSA and HCRMC, including the tax basis in the acquired company’s assets and liabilities.
The Company is no longer subject to federal corporate-level tax on the taxable disposition of SEUSA pre-acquisition assets.

109

NOTE 18.
Earnings Per Common Share
The following table illustrates the computation of basic and diluted earnings per share (dollars in thousands, except per share data):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Numerator
 
 
 
 
 
Net income (loss) from continuing operations
$
422,634

    
$
374,171

 
$
152,668

Noncontrolling interests' share in earnings
(8,465
)
 
(12,179
)
 
(12,817
)
Net income (loss) attributable to HCP, Inc.
414,169

 
361,992

 
139,851

Less: Participating securities' share in earnings
(1,156
)
 
(1,198
)
 
(1,317
)
Income (loss) from continuing operations applicable to common shares
413,013

 
360,794

 
138,534

Discontinued operations
—

 
265,755

 
(699,086
)
Net income (loss) applicable to common shares
$
413,013

 
$
626,549

 
$
(560,552
)
 
 
 
 
 
 
Denominator
 
 
 
 
 
Basic weighted average shares outstanding
468,759

 
467,195

 
462,795

Dilutive potential common shares - equity awards
176

 
208

 
—

Diluted weighted average common shares
468,935

 
467,403

 
462,795

Basic earnings per common share


 


 


Continuing operations
$
0.88

 
$
0.77

 
$
0.30

Discontinued operations
—

 
0.57

 
(1.51
)
Net income (loss) applicable to common shares
$
0.88

 
$
1.34

 
$
(1.21
)
Diluted earnings per common share


 


 


Continuing operations
$
0.88

 
$
0.77

 
$
0.30

Discontinued operations
—

 
0.57

 
(1.51
)
Net income (loss) applicable to common shares
$
0.88

 
$
1.34

 
$
(1.21
)
Restricted stock and certain performance restricted stock units are considered participating securities because dividend payments are not forfeited even if the underlying award does not vest and require use of the two-class method when computing basic and diluted earnings per share.
For the year ended December 31, 2015, diluted loss per share from continuing operations is calculated using the weighted-average common shares outstanding during the period, as the effect of shares issuable under employee compensation plans and upon DownREIT unit conversions would have been anti-dilutive. All DownREIT units and approximately 1 million stock options were anti-dilutive for all periods presented.

110

NOTE 19.
Supplemental Cash Flow Information
The following table summarizes supplemental cash flow information (in thousands):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Supplemental cash flow information:
 
 
 
 
 
Interest paid, net of capitalized interest
$
309,111

    
$
489,453

 
$
451,615

Income taxes paid
10,045

 
13,727

 
6,959

Capitalized interest
16,937

 
11,108

 
8,798

Supplemental schedule of non-cash investing and financing activities:
 
 
 
 
 
Accrued construction costs
67,425

 
49,999

 
52,511

Non-cash impact of QCP Spin-Off, net
—

 
3,539,584

 
—

Securities transferred for debt defeasance
—

 
73,278

 
—

Settlement of loans receivable as consideration for real estate acquisition
—

 
—

 
299,297

Vesting of restricted stock units and conversion of non-managing member units into common stock
2,908

 
6,622

 
3,388

Noncontrolling interest and other liabilities, net assumed in connection with the RIDEA III acquisition
—

 
—

 
61,219

Deconsolidation of noncontrolling interest in connection with RIDEA II transaction
58,061

 
—

 
—

Noncontrolling interest issued in connection with real estate and other acquisitions
—

 
—

 
10,971

Mortgages and other liabilities assumed with real estate acquisitions
5,425

 
82,985

 
23,218

Foreign currency translation adjustment
15,862

 
(3,332
)
 
(8,738
)
Unrealized gains (losses) on available-for-sale securities and derivatives designated as cash flow hedges, net
(10,315
)
 
3,171

 
1,889

See discussions related to the Brookdale Transaction in Note 3 and the Spin-Off in Note 5.
The following table summarizes cash, cash equivalents and restricted cash (in thousands):
 
 
December 31,
 
 
2017
 
2016
Cash and cash equivalents
    
$
55,306

    
$
94,730

Restricted cash
 
26,897

    
42,260

Cash, cash equivalents and restricted cash
 
$
82,203

 
$
136,990

NOTE 20.
Variable Interest Entities
On January 1, 2016, the Company adopted ASU 2015-2 using the modified retrospective method as permitted by the ASU. As a result of the adoption, the Company identified additional assets and liabilities of certain VIEs in its consolidated total assets and total liabilities at December 31, 2015 of $543 million and $651 million, respectively. Refer to the specific VIE descriptions below for detail on which entities were classified as consolidated VIEs subsequent to the adoption of ASU 2015-2. Additionally, the Company deconsolidated three JVs and recognized $0.5 million as a cumulative-effect adjustment to cumulative dividends in excess of earnings.
Unconsolidated Variable Interest Entities
At December 31, 2017, the Company had investments in: (i) five unconsolidated VIE joint ventures; (ii) 48 properties leased to VIE tenants; (iii) marketable debt securities of one VIE and (iv) three loans to VIE borrowers. The Company has determined that it is not the primary beneficiary of and therefore does not consolidate these VIEs because it does not have the ability to control

111

the activities that most significantly impact their economic performance. Except for the Company’s equity interest in the unconsolidated JVs (CCRC OpCo, RIDEA II PropCo, Vintage Park Development JV, Waldwick JV and the LLC investment discussed below), it has no formal involvement in these VIEs beyond its investments.
The Company holds a 49% ownership interest in CCRC OpCo, a joint venture entity formed in August 2014 that operates senior housing properties in a RIDEA structure and has been identified as a VIE. The equity members of CCRC OpCo “lack power” because they share certain operating rights with Brookdale, as manager of the CCRCs. The assets of CCRC OpCo primarily consist of the CCRCs that it owns and leases, resident fees receivable, notes receivable, and cash and cash equivalents; its obligations primarily consist of operating lease obligations to CCRC PropCo, debt service payments and capital expenditures for the properties, and accounts payable and expense accruals associated with the cost of its CCRCs’ operations. Assets generated by the CCRC operations (primarily rents from CCRC residents) of CCRC OpCo may only be used to settle its contractual obligations (primarily from debt service payments, capital expenditures, and rental costs and operating expenses incurred to manage such facilities).
In January 2017, as a result of the partial sale of its interest in RIDEA II, the Company concluded that it should deconsolidate RIDEA II as it is no longer the primary beneficiary of the joint venture. The HCP/CPA JV is the primary beneficiary of both RIDEA II PropCo and RIDEA II OpCo as it controls the significant activities of RIDEA II PropCo and, of the group that controls the significant activities of RIDEA II OpCo, is most closely associated to the entity. Furthermore, control over the HCP/CPA JV is shared between HCP and CPA, and as such, the Company does not consolidate the HCP/CPA JV. Subsequent to the partial sale of its interest in RIDEA II, the Company continues to hold a direct investment in RIDEA II PropCo, which has been identified as a VIE as Brookdale, the non-managing member, does not have any substantive participating rights or kick-out rights over the managing member, HCP/CPA PropCo. The assets of RIDEA II PropCo primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of a combination of third-party and HCP debt (see Note 5). Assets generated by RIDEA II PropCo (primarily from RIDEA II OpCo lease payments) may only be used to settle its contractual obligations (primarily debt service payments on the third-party and HCP debt).
The Company holds an 85% ownership interest in two development joint ventures (Vintage Park Development JV and Waldwick JV) (see Note 8), which have been identified as VIEs as power is shared with a member that does not have a substantive equity investment at risk. The assets of each joint venture primarily consist of an in-progress senior housing facility development project that it owns and cash and cash equivalents; its obligations primarily consist of accounts payable and expense accruals associated with the cost of its development obligations. Any assets generated by each joint venture may only be used to settle its respective contractual obligations (primarily development expenses and debt service payments).
The Company holds a limited partner ownership interest in an unconsolidated LLC that has been identified as a VIE. The Company’s involvement in the entity is limited to its equity investment as a limited partner, and it does not have any substantive participating rights or kick-out rights over the general partner. The assets and liabilities of the entity primarily consist of those associated with its senior housing real estate and development activities. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development expenses and debt service payments).
The Company leases 48 properties to a total of seven tenants that have also been identified as VIEs (“VIE tenants”). These VIE tenants are “thinly capitalized” entities that rely on the operating cash flows generated from the senior housing facilities to pay operating expenses, including the rent obligations under their leases.
The Company holds commercial mortgage-backed securities (“CMBS”) issued by Federal Home Loan Mortgage Corporation (commonly referred to as Freddie MAC) through a special purpose entity that has been identified as a VIE because it is “thinly capitalized.” The CMBS issued by the VIE are backed by mortgage debt obligations on real estate assets.
The Company provided a £105 million ($131 million) bridge loan to Maria Mallaband Care Group Ltd. (“MMCG”) to fund the acquisition of a portfolio of care homes in the U.K. MMCG created a special purpose entity to acquire the portfolio and funded it entirely using the Company’s bridge loan. As such, the special purpose entity has been identified as a VIE because it is “thinly capitalized.” The Company retains a three-year call option to acquire all the shares of the special purpose entity, which it can only exercise upon the occurrence of certain events.
The Company provided seller financing of $10 million related to its sale of seven senior housing triple-net facilities. The financing was provided in the form of a secured five-year mezzanine loan to a “thinly capitalized” borrower created to acquire the facilities.
Between 2012 and 2015, the Company funded a $257 million mezzanine loan facility to Tandem as part of a recapitalization of the Tandem Portfolio (see Note 7). Due to a decline in the fair value of the Tandem Portfolio over time, there is no longer sufficient equity at risk in Tandem and it has become a “thinly capitalized” borrower.

112

The classification of the related assets and liabilities and their maximum loss exposure as a result of the Company’s involvement with these VIEs at December 31, 2017 are presented below (in thousands):
VIE Type
 
Asset/Liability Type
 
Maximum Loss Exposure and Carrying Amount(1)
VIE tenants - DFLs (2)
 
Net investment in DFLs
 
$
601,723

VIE tenants - operating leases (2)
 
Lease intangibles, net and straight-line rent receivables
 
5,519

CCRC OpCo
 
Investments in unconsolidated joint ventures
 
190,454

RIDEA II PropCo
 
Investments in unconsolidated joint ventures
 
252,743

Development JVs
 
Investments in unconsolidated joint ventures
 
12,563

Tandem Health Care
 
Loans Receivable, net
 
105,000

MMCG Loan
 
Loans Receivable, net
 
142,820

Loan - Seller Financing
 
Loans Receivable, net
 
10,000

CMBS and LLC investment
 
Marketable debt and cost method investment
 
33,750

_______________________________________
(1)
The Company’s maximum loss exposure represents the aggregate carrying amount of such investments (including accrued interest).
(2)
The Company’s maximum loss exposure may be mitigated by re-leasing the underlying properties to new tenants upon an event of default.
As of December 31, 2017, the Company had not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash shortfalls). See Notes 3, 6, 7 and 8 for additional descriptions of the nature, purpose and operating activities of the Company’s unconsolidated VIEs and interests therein.

113

Consolidated Variable Interest Entities
HCP, Inc.'s consolidated total assets and total liabilities at December 31, 2017 and December 31, 2016 include certain assets of VIEs that can only be used to settle the liabilities of the related VIE. The VIE creditors do not have recourse to HCP, Inc. Total assets at December 31, 2017 and December 31, 2016 include VIE assets as follows (in thousands):
 
 
December 31,
 
 
2017
 
2016
Assets
 
 
 
 
Building and Improvements
 
$
2,436,414

 
$
3,522,310

Developments in Process
 
32,285

 
31,953

Land
 
227,162

 
327,241

Accumulated Depreciation
 
(542,091
)
 
(676,276
)
Net Real Estate
 
2,153,770

 
3,205,228

Investments in and advances to unconsolidated joint ventures
 
2,231

 
3,641

Accounts Receivable, Net
 
10,242

 
19,996

Cash and Cash Equivalents
 
15,861

 
35,844

Restricted Cash
 
2,619

 
22,624

Intangible Assets, Net
 
125,475

 
169,027

Other Assets, Net
 
33,749

 
69,562

Total Assets
 
$
2,343,947

 
$
3,525,922

Liabilities
 
 
 
 
Mortgage Debt
 
45,016

 
520,870

Intangible Liabilities, Net
 
10,672

 
8,994

Accounts Payable and Accrued Expenses
 
87,759

 
120,719

Other Liabilities
 
29,034

 
—

Intercompany Accounts
 
331

 
—

Fixed Asset Push Down
 
152,156

 
—

Deferred Revenue
 
14,432

 
23,456

Total Liabilities
 
$
339,400

 
$
674,039

RIDEA I.  The Company holds a 90% ownership interest in JV entities formed in September 2011 that own and operate senior housing properties in a RIDEA structure (“RIDEA I”). The Company has historically classified RIDEA I OpCo as a VIE and, as a result of the adoption of ASU No. 2015-02, Amendments to the Consolidation Analysis (“ASU 2015-02”), also classifies RIDEA I PropCo as a VIE due to the non-managing member lacking substantive participation rights in the management of RIDEA I PropCo or kick-out rights over the managing member. The Company consolidates RIDEA I PropCo and RIDEA I OpCo as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of RIDEA I PropCo primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of notes payable to a non-VIE consolidated subsidiary of the Company. The assets of RIDEA I OpCo primarily consist of leasehold interests in senior housing facilities (operating leases), resident fees receivable, and cash and cash equivalents; its obligations primarily consist of lease payments to RIDEA I PropCo and operating expenses of its senior housing facilities (accounts payable and accrued expenses). Assets generated by the senior housing operations (primarily from senior housing resident rents) of the RIDEA I structure may only be used to settle its contractual obligations (primarily from the rental costs, operating expenses incurred to manage such facilities and debt costs).
HCP Ventures V, LLC.  The Company holds a 51% ownership interest in and is the managing member of a JV entity formed in October 2015 that owns and leases MOBs (“HCP Ventures V”). Upon adoption of ASU 2015-02, the Company classified HCP Ventures V as a VIE due to the non-managing member lacking substantive participation rights in the management of HCP Ventures V or kick-out rights over the managing member. The Company consolidates HCP Ventures V as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE’s economic performance. The assets of HCP Ventures V primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by HCP Ventures V may only be used to settle its contractual obligations (primarily from capital expenditures).

114

Vintage Park JV.  The Company holds a 90% ownership interest in a JV entity formed in January 2015 (“Vintage Park JV”) that owns an 85% interest in an unconsolidated development VIE. Upon adoption of ASU 2015-02, the Company classified Vintage Park JV as a VIE due to the non-managing member lacking substantive participation rights in the management of the Vintage Park JV or kick-out rights over the managing member. The Company consolidates Vintage Park JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE’s economic performance. The assets of Vintage Park JV primarily consist of an investment in the Vintage Park Development JV and cash and cash equivalents; its obligations primarily consist of funding the ongoing development of the Vintage Park Development JV. Assets generated by the Vintage Park JV may only be used to settle its contractual obligations (primarily from the funding of the Vintage Park Development JV).
Watertown JV.  The Company holds a 95% ownership interest in JV entities formed in November 2017 that own and operate a senior housing property in a RIDEA structure (“Watertown JV”). Watertown PropCo is a VIE as the Company and the non-managing member share in control of the entity, but substantially all of the entity's activities are performed on behalf of the Company. Watertown OpCo is a VIE as the non-managing member, through its equity interest, lacks substantive participation rights in the management of Watertown OpCo or kick-out rights over the managing member. The Company consolidates Watertown PropCo and Watertown OpCo as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of Watertown PropCo primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of notes payable to a non-VIE consolidated subsidiary of the Company. The assets of Watertown OpCo primarily consist of leasehold interests in senior housing facilities (operating leases), resident fees receivable, and cash and cash equivalents; its obligations primarily consist of lease payments to Watertown PropCo and operating expenses of its senior housing facilities (accounts payable and accrued expenses). Assets generated by the senior housing operations (primarily from senior housing resident rents) of the Watertown structure may only be used to settle its contractual obligations (primarily from the rental costs, operating expenses incurred to manage such facilities and debt costs).
Hayden JV.  The Company holds a 99% ownership interest in a JV entity formed in December 2017 that owns and leases a life science complex (“Hayden JV”). The Hayden JV is a VIE as the members share in control of the entity, but substantially all of the entity's activities are performed on behalf of the Company. The Company consolidates the Hayden JV as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of the Hayden JV primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by Hayden JV may only be used to settle its contractual obligations (primarily from capital expenditures).
Consolidated Lessees. The Company leases 21 senior housing properties to lessee entities under cash flow leases through which the Company receives monthly rent equal to the residual cash flows of the properties. The lessee entities are classified as VIEs as they are "thinly capitalized" entities. The Company consolidates the lessee entities as it has the ability to control the activities that most significantly impact the economic performance of the lessee entities. The lessee entities' assets primarily consist of leasehold interests in senior housing facilities (operating leases), resident fees receivable, and cash and cash equivalents; its obligations primarily consist of lease payments to the Company and operating expenses of the senior housing facilities (accounts payable and accrued expenses). Assets generated by the senior housing operations (primarily from senior housing resident rents) of the may only be used to settle its contractual obligations (primarily from the rental costs, operating expenses incurred to manage such facilities and debt costs).
DownREITs.  The Company holds a controlling ownership interest in and is the managing member of five DownREITs. Upon adoption of ASU 2015-02, the Company classified the DownREITs as VIEs due to the non-managing members lacking substantive participation rights in the management of the DownREITs or kick-out rights over the managing member. The Company consolidates the DownREITs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of the DownREITs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the DownREITs (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).
Other Consolidated Real Estate Partnerships.  The Company holds a controlling ownership interest in and is the general partner (or managing member) of multiple partnerships that own and lease real estate assets (the “Partnerships”). Upon adoption of ASU 2015-02, the Company classified the Partnerships as VIEs due to the limited partners (non-managing members) lacking substantive participation rights in the management of the Partnerships or kick-out rights over the general partner (managing member). The Company consolidates the Partnerships as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of the Partnerships primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital

115

expenditures for the properties. Assets generated by the Partnerships (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).
Other consolidated VIEs.  The Company made a loan to an entity that entered into a tax credit structure (“Tax Credit Subsidiary”) and a loan to an entity that made an investment in a development JV (“Development JV”) both of which are considered VIEs. The Company consolidates the Tax Credit Subsidiary and Development JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIEs’ economic performance. The assets and liabilities of the Tax Credit Subsidiary and Development JV substantially consist of a development in progress, notes receivable, prepaid expenses, notes payable, and accounts payable and accrued liabilities generated from their operating activities. Any assets generated by the operating activities of the Tax Credit Subsidiary and Development JV may only be used to settle their contractual obligations.
Exchange Accommodation Titleholder.  During the year ended December 31, 2017, the Company acquired a portfolio of 11 MOBs (the "acquired properties") using a reverse like-kind exchange structure pursuant to Section 1031 of the Internal Revenue Code (a "reverse 1031 exchange"). As of December 31, 2017, the Company had not completed the reverse 1031 exchange and as such, the acquired properties remained in the possession of an Exchange Accommodation Titleholder ("EAT"). The EAT is classified as a VIE as it is a “thinly capitalized” entity. The Company consolidates the EAT because it is the primary beneficiary as it has the ability to control the activities that most significantly impact the EAT's economic performance. The properties held by the EAT are reflected as real estate with an aggregate carrying value of $153 million as of December 31, 2017. The assets of the EAT primarily consist of a leased property (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by the EAT may only be used to settle its contractual obligations (primarily from capital expenditures).
NOTE 21.
Fair Value Measurements
Financial assets and liabilities measured at fair value on a recurring basis at December 31, 2017 in the consolidated balance sheets are immaterial.
The table below summarizes the carrying amounts and fair values of the Company’s financial instruments (in thousands):
 
December 31,
 
2017(3)
 
2016(3)
 
Carrying Value
  
Fair Value
 
Carrying Value
  
Fair Value
Loans receivable, net(2)  
$
313,326

 
$
313,242

 
$
807,954

 
$
807,505

Marketable debt securities(2)  
18,690

 
18,690

 
68,630

 
68,630

Bank line of credit(2)  
1,017,076

 
1,017,076

 
899,718

 
899,718

Term loans(2)  
228,288

 
228,288

 
440,062

 
440,062

Senior unsecured notes(1)  
6,396,451

 
6,737,825

 
7,133,538

 
7,386,149

Mortgage debt(2)  
144,486

 
125,984

 
623,792

 
609,374

Other debt(2)  
94,165

 
94,165

 
92,385

 
92,385

Interest-rate swap liabilities(2)  
2,483

 
2,483

 
4,857

 
4,857

Currency swap asset(2)  
—

 
—

 
2,920

 
2,920

Cross currency swap liability(2)  
10,968

 
10,968

 
—

 
—

_______________________________________
(1)
Level 1: Fair value calculated based on quoted prices in active markets.
(2)
Level 2: Fair value based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) or for loans receivable, net, mortgage debt, and swaps, calculated utilizing standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit, term loans and other debt, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company’s credit rating.
(3)
During the years ended December 31, 2017 and 2016, there were no transfers of financial assets or liabilities within the fair value hierarchy.


116

NOTE 22.
Concentration of Credit Risk
Concentrations of credit risk arise when one or more tenants, operators or obligors related to the Company’s investments are engaged in similar business activities or activities in the same geographic region, or have similar economic features that would cause their ability to meet contractual obligations, including those to the Company, to be similarly affected by changes in economic conditions. The Company regularly monitors various segments of its portfolio to assess potential concentrations of credit risks.
The following tables provide information regarding the Company’s concentrations with respect to Brookdale as a tenant as of and for the periods presented:
 
 
Percentage of Gross Assets
 
 
Total Company
 
Senior Housing Triple-Net
 
 
December 31,
 
December 31,
Tenant
 
2017
 
2016
 
2017
 
2016
Brookdale(1)
 
10
 
17
 
39
 
69
 
 
Percentage of Revenues
 
 
Total Company Revenues
 
Senior Housing Triple-Net Revenues
 
 
Year Ended December 31,
 
Year Ended December 31,
Tenant
 
2017
 
2016
 
2015
 
2017
 
2016
 
2015
Brookdale(1)
 
8
 
12
 
13
 
47
 
59
 
58
_______________________________________
(1)
The Company's concentration with respect to Brookdale as a tenant is expected to decrease with the completion of the Brookdale Transaction (see Note 3). Includes revenues from 64 senior housing triple-net facilities that were classified as held for sale at December 31, 2016. Excludes senior housing facilities operated by Brookdale in the Company’s SHOP segment, as discussed below.
As of December 31, 2017 and 2016, Brookdale managed or operated, in the Company’s SHOP segment, approximately 13% and 18%, respectively, of the Company’s real estate investments based on total assets. Because an operator manages the Company’s facilities in exchange for the receipt of a management fee, the Company is not directly exposed to the credit risk of its operators in the same manner or to the same extent as its triple-net tenants. As of December 31, 2017, Brookdale provided comprehensive facility management and accounting services with respect to 78 of the Company’s senior housing facilities and 62 SHOP facilities owned by its unconsolidated joint ventures, for which the Company or joint venture pay annual management fees pursuant to long-term management agreements. The Company's concentration with respect to Brookdale as an operator in its SHOP segment is expected to decrease with the completion of the Brookdale Transaction (see Note 3) and the sale of its remaining 40% ownership interest in RIDEA II (see Note 5). Most of the management agreements have terms ranging from 10 to 15 years, with three to four 5-year renewals. The base management fees are 4.5% to 5.0% of gross revenues (as defined) generated by the RIDEA facilities. In addition, there are incentive management fees payable to Brookdale if operating results of the RIDEA properties exceed pre-established EBITDAR (as defined) thresholds.
Brookdale is subject to the registration and reporting requirements of the U.S. Securities and Exchange Commission (“SEC”) and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. The information related to Brookdale contained or referred to in this report has been derived from SEC filings made by Brookdale or other publicly available information, or was provided to the Company by Brookdale, and the Company has not verified this information through an independent investigation or otherwise. The Company has no reason to believe that this information is inaccurate in any material respect, but the Company cannot assure the reader of its accuracy. The Company is providing this data for informational purposes only, and encourages the reader to obtain Brookdale’s publicly available filings, which can be found on the SEC’s website at www.sec.gov.
See Note 3 for further information on the reduction of concentration related to Brookdale.
To mitigate the credit risk of leasing properties to certain senior housing and post-acute/skilled nursing operators, leases with operators are often combined into portfolios that contain cross-default terms, so that if a tenant of any of the properties in a portfolio defaults on its obligations under its lease, the Company may pursue its remedies under the lease with respect to any of the properties in the portfolio. Certain portfolios also contain terms whereby the net operating profits of the properties are combined for the purpose of securing the funding of rental payments due under each lease.

117

The following table provides information regarding the Company’s concentrations with respect to certain states; the information provided is presented for the gross assets and revenues that are associated with certain real estate assets as percentages of total Company’s total assets and revenues:
 
 
Percentage of Total Company Assets
 
Percentage of Total Company Revenues
 
 
December 31,
 
Year Ended December 31,
State
 
2017
 
2016
 
2017
 
2016
 
2015
California
 
31
 
29
 
26
 
26
 
27
Texas
 
14
 
14
 
17
 
17
 
16
NOTE 23.
Derivative Financial Instruments
The following table summarizes the Company’s outstanding interest-rate and foreign currency swap contracts as of December 31, 2017 (dollars and GBP in thousands):
Date Entered
 
Maturity Date
 
Hedge Designation
 
Notional
 
Pay Rate
 
Receive Rate
 
Fair Value(1)
Interest rate:
 
 
 
 
 
 
 
 
 
 
 
 
July 2005(2) 
 
July 2020
 
Cash Flow
 
44,000

 
3.820%
 
BMA Swap Index

 
(2,483
)
Cross currency swap:
 
 
 
 
 
 
 
 
 
 
 
 
April 2017(3) 
 
February 2019
 
Net Investment
 
£105,000 / $131,000

 
2.584%
 
3.750
%
 
(10,968
)
_____________________________
(1)
Derivative assets are recorded in other assets, net and derivative liabilities are recorded in accounts payable and accrued liabilities on the consolidated balance sheets.
(2)
Represents three interest-rate swap contracts, which hedge fluctuations in interest payments on variable-rate secured debt due to overall changes in hedged cash flows.
(3)
Represents a cross currency swap to pay 2.584% on £105 million and receive 3.75% on $131 million through February 1, 2019, with an initial and final exchange of principals at origination and maturity at a rate of 1.251 USD/GBP. Hedges the risk of changes in the USD equivalent value of a portion of the Company’s net investment in its consolidated GBP subsidiaries’ attributable to changes in the USD/GBP exchange rate.
The Company uses derivative instruments to mitigate the effects of interest rate and foreign currency fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest and foreign currency rates related to the potential impact these changes could have on future earnings and forecasted cash flows. The Company does not use derivative instruments for speculative or trading purposes. Assuming a one percentage point shift in the underlying interest rate curve, the estimated change in fair value of each of the underlying derivative instruments would not exceed $2 million. Assuming a one percentage point shift in the underlying foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $2 million.
As of December 31, 2017, £150 million of the Company’s GBP-denominated borrowings under the 2015 Term Loan and a £105 million cross currency swap are designated as a hedge of a portion of the Company’s net investments in GBP-functional subsidiaries to mitigate its exposure to fluctuations in the GBP to USD exchange rate. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to USD exchange rate of the instrument is recorded as part of the cumulative translation adjustment component of accumulated other comprehensive income (loss). Accordingly, (i) the remeasurement value of the designated £150 million GBP-denominated borrowings and (ii) the change in fair value of the £105 million cross currency swap due primarily to fluctuations in the GBP to USD exchange rate are reported in accumulated other comprehensive income (loss) as the hedging relationship is considered to be effective. The balance in accumulated other comprehensive income (loss) will be reclassified to earnings when the hedged investment is sold or substantially liquidated.

118

NOTE 24.
Selected Quarterly Financial Data (Unaudited)
The following table summarizes selected quarterly information for the years ended December 31, 2017 and 2016 (in thousands, except per share amounts):
 
Three Months Ended 2017
 
March 31
 
June 30
 
September 30
 
December 31
Total revenues
$
492,168

    
$
458,928

    
$
454,023

    
$
443,259

Income (loss) before income taxes and equity income from investments in unconsolidated joint ventures
454,746

 
18,874

 
(12,263
)
 
(50,957
)
Net income (loss)
464,177

 
22,101

 
(5,720
)
 
(57,924
)
Net income (loss) applicable to HCP, Inc.
461,145

 
19,383

 
(7,657
)
 
(58,702
)
Dividends paid per common share
0.37

 
0.37

 
0.37

 
0.37

Basic earnings per common share
0.98

 
0.04

 
(0.02
)
 
(0.13
)
Diluted earnings per common share
0.97

 
0.04

 
(0.02
)
 
(0.13
)
 
Three Months Ended 2016
 
March 31
 
June 30
 
September 30
 
December 31
Total revenues
$
520,457

    
$
538,332

    
$
530,555

    
$
539,950

Total discontinued operations
68,408

 
107,378

 
108,215

 
(18,246
)
Income (loss) before income taxes and equity income from investments in unconsolidated joint ventures
55,949

 
196,352

 
47,453

 
67,530

Net (loss) income
119,745

 
304,842

 
154,039

 
61,300

Net (loss) income applicable to HCP, Inc.
116,119

 
301,717

 
151,250

 
58,661

Dividends paid per common share
0.58

 
0.58

 
0.58

 
0.37

Basic earnings per common share
0.25

 
0.65

 
0.32

 
0.12

Diluted earnings per common share
0.25

 
0.64

 
0.32

 
0.12

The above selected quarterly financial data includes the following significant transactions:
2017
•
During the quarter ended December 31, 2017, the Company recognized $20 million net reduction of rental and related revenues and $35 million of operating expense related to the Brookdale Transaction.
•
During the quarter ended December 31, 2017, the Company recorded an impairment charge of $84 million related to the Tandem Mezzanine Loan.
•
During the quarter ended December 31, 2017, the Company recognized a tax expense of $17 million due to a re-measurement of deferred tax assets and liabilities.
•
During the quarter ended September 30, 2017, the Company repurchased $500 million of our 5.375% senior notes due 2021 and recorded a $54 million loss on debt extinguishment.
•
During the quarter ended June 30, 2017, the Company recorded an impairment charge of $57 million related to the Tandem Mezzanine Loan.
•
The quarter ended March 31, 2017, the Company deconsolidated the net assets of RIDEA II and recognized a net gain on sale of $99 million.
•
The quarter ended March 31, 2017, the Company sold 64 senior housing triple-net assets, resulting in a net gain on sale of $170 million.
•
The quarter ended March 31, 2017, the Company sold its Four Seasons Notes, which generated a £42 million ($51 million) gain on sale.

119

2016
•
The quarter ended December 31, 2016 includes the following related to the Spin-Off: (i) $46 million of loss on debt extinguishment and (ii) $58 million of transaction costs.
•
The quarter ended June 30, 2016 includes $120 million of gain on sales from real estate dispositions.
•
The quarter ended March 31, 2016 includes $53 million of income tax expense associated with state built-in gain tax payable upon the disposition of specific real estate assets, of which $49 million relates to the HCRMC real estate portfolio.

120

Schedule II: Valuation and Qualifying Accounts
Allowance Accounts(1)
 
 
 
Additions
 
Deductions
 
 
Year Ended
December 31,
 
Balance at
Beginning of
Year
 
Amounts
Charged
Against
Operations, net
 
Acquired
Properties
 
Uncollectible
Accounts
Written-off
 
Disposed
Properties
 
Balance at
End of Year
2017
 
$
29,518

 
$
144,135

 
$
—

 
$
(2,732
)
 
$
(1,547
)
 
$
169,374

2016
 
36,180

 
1,177

 
—

 
(2,843
)
 
(4,996
)
 
29,518

2015
 
50,531

 
3,174

 
—

 
(17,209
)
 
(316
)
 
36,180

_______________________________________
(1)
Includes allowance for doubtful accounts, straight-line rent reserves, and allowances for loan and direct financing lease losses and excludes discontinued operations of $818 million for the year ended December 31, 2015.

121

Schedule III: Real Estate and Accumulated Depreciation
 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
Senior housing triple-net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1107
 
Huntsville
 
AL
 
$
—

 
$
307

 
$
5,813

 
$
—

 
$
307

 
$
5,453

 
$
5,760

 
$
(1,534
)
 
2006
 
0786
 
Douglas
 
AZ
 
—

 
110

 
703

 
—

 
110

 
703

 
813

 
(365
)
 
2005
 
0518
 
Tucson
 
AZ
 
—

 
2,350

 
24,037

 
—

 
2,350

 
24,037

 
26,387

 
(11,418
)
 
2002
 
1238
 
Beverly Hills
 
CA
 
—

 
9,872

 
32,590

 
9,188

 
9,872

 
41,030

 
50,902

 
(12,043
)
 
2006
 
0883
 
Carmichael
 
CA
 
—

 
4,270

 
13,846

 
—

 
4,270

 
13,236

 
17,506

 
(3,668
)
 
2006
 
2204
 
Chino Hills
 
CA
 
—

 
3,720

 
41,183

 
24

 
3,720

 
41,205

 
44,925

 
(4,931
)
 
2014
 
0851
 
Citrus Heights
 
CA
 
—

 
1,180

 
8,367

 
—

 
1,180

 
8,037

 
9,217

 
(3,102
)
 
2006
 
0790
 
Concord
 
CA
 
25,000

 
6,010

 
39,601

 
—

 
6,010

 
38,301

 
44,311

 
(11,877
)
 
2005
 
0787
 
Dana Point
 
CA
 
—

 
1,960

 
15,946

 
—

 
1,960

 
15,466

 
17,426

 
(4,801
)
 
2005
 
0798
 
Escondido
 
CA
 
14,340

 
5,090

 
24,253

 
—

 
5,090

 
23,353

 
28,443

 
(7,250
)
 
2005
 
0791
 
Fremont
 
CA
 
—

 
2,360

 
11,672

 
—

 
2,360

 
11,192

 
13,552

 
(3,475
)
 
2005
 
0788
 
Granada Hills
 
CA
 
—

 
2,200

 
18,257

 
—

 
2,200

 
17,637

 
19,837

 
(5,475
)
 
2005
 
0227
 
Lodi
 
CA
 
—

 
732

 
5,453

 
—

 
732

 
5,453

 
6,185

 
(3,008
)
 
1997
 
0226
 
Murietta
 
CA
 
—

 
435

 
5,729

 
—

 
435

 
5,729

 
6,164

 
(3,093
)
 
1997
 
1165
 
Northridge
 
CA
 
—

 
6,718

 
26,309

 
2,710

 
6,752

 
27,780

 
34,532

 
(7,981
)
 
2006
 
0789
 
Pleasant Hill
 
CA
 
6,270

 
2,480

 
21,333

 
—

 
2,480

 
20,633

 
23,113

 
(6,405
)
 
2005
 
2205
 
Roseville
 
CA
 
—

 
3,844

 
33,527

 
—

 
3,844

 
33,527

 
37,371

 
(3,938
)
 
2014
 
1167
 
Santa Rosa
 
CA
 
—

 
3,582

 
21,113

 
2,230

 
3,627

 
22,003

 
25,630

 
(6,189
)
 
2006
 
0793
 
South San Francisco
 
CA
 
—

 
3,000

 
16,586

 
—

 
3,000

 
16,056

 
19,056

 
(4,978
)
 
2005
 
0792
 
Ventura
 
CA
 
—

 
2,030

 
17,379

 
—

 
2,030

 
16,749

 
18,779

 
(5,200
)
 
2005
 
0512
 
Denver
 
CO
 
—

 
2,810

 
36,021

 
1,885

 
2,810

 
37,686

 
40,496

 
(17,547
)
 
2002
 
1000
 
Greenwood Village
 
CO
 
—

 
3,367

 
43,610

 
2,894

 
3,367

 
45,708

 
49,075

 
(12,039
)
 
2006
 
2144
 
Glastonbury
 
CT
 
—

 
1,658

 
16,046

 
378

 
1,658

 
16,423

 
18,081

 
(2,600
)
 
2012
 
0730
 
Torrington
 
CT
 
—

 
166

 
11,001

 
3,686

 
166

 
14,277

 
14,443

 
(3,947
)
 
2005
 
0861
 
Apopka
 
FL
 
—

 
920

 
4,816

 
854

 
920

 
5,570

 
6,490

 
(1,770
)
 
2006
 
0852
 
Boca Raton
 
FL
 

 
4,730

 
17,532

 
5,471

 
4,730

 
22,390

 
27,120

 
(7,570
)
 
2006
 
2467
 
Ft Myers
 
FL
 
—

 
2,782

 
21,827

 
—

 
2,782

 
21,827

 
24,609

 
(1,577
)
 
2016
 
1095
 
Gainesville
 
FL
 
—

 
1,221

 
12,226

 
—

 
1,221

 
12,001

 
13,222

 
(3,375
)
 
2006
 
0490
 
Jacksonville
 
FL
 
—

 
3,250

 
25,936

 
6,170

 
3,250

 
32,106

 
35,356

 
(12,779
)
 
2002
 
1096
 
Jacksonville
 
FL
 
—

 
1,587

 
15,616

 
—

 
1,587

 
15,298

 
16,885

 
(4,303
)
 
2006
 
1017
 
Palm Harbor
 
FL
 
—

 
1,462

 
16,774

 
500

 
1,462

 
16,888

 
18,350

 
(4,842
)
 
2006
 
0732
 
Port Orange
 
FL
 
—

 
2,340

 
9,898

 
1,177

 
2,340

 
10,555

 
12,895

 
(3,299
)
 
2005
 
2194
 
Springtree
 
FL
 
—

 
1,066

 
15,874

 
1,447

 
1,066

 
17,321

 
18,387

 
(3,186
)
 
2013
 
0802
 
St. Augustine
 
FL
 
—

 
830

 
11,627

 
1,288

 
830

 
12,515

 
13,345

 
(4,322
)
 
2005
 
1097
 
Tallahassee
 
FL
 
—

 
1,331

 
19,039

 
—

 
1,331

 
18,695

 
20,026

 
(5,258
)
 
2006
 
1605
 
Vero Beach
 
FL
 
—

 
700

 
16,234

 
—

 
700

 
15,484

 
16,184

 
(3,097
)
 
2010
 
1257
 
Vero Beach
 
FL
 
—

 
2,035

 
34,993

 
201

 
2,035

 
33,634

 
35,669

 
(9,457
)
 
2006
 
2108
 
Buford
 
GA
 
—

 
562

 
3,604

 
499

 
562

 
4,103

 
4,665

 
(788
)
 
2012
 
2109
 
Buford
 
GA
 
—

 
536

 
3,142

 
343

 
536

 
3,486

 
4,022

 
(638
)
 
2012
 
2053
 
Canton
 
GA
 
—

 
401

 
17,888

 
473

 
401

 
18,361

 
18,762

 
(2,366
)
 
2012
 
2165
 
Hartwell
 
GA
 
—

 
368

 
6,337

 
300

 
368

 
6,637

 
7,005

 
(1,009
)
 
2012
 
2066
 
Lawrenceville
 
GA
 
—

 
581

 
2,669

 
417

 
581

 
3,085

 
3,666

 
(654
)
 
2012
 
1241
 
Lilburn
 
GA
 
—

 
907

 
17,340

 
325

 
907

 
17,102

 
18,009

 
(4,841
)
 
2006
 
2086
 
Newnan
 
GA
 
—

 
1,227

 
4,202

 
503

 
1,227

 
4,705

 
5,932

 
(933
)
 
2012
 
1005
 
Oak Park
 
IL
 
—

 
3,476

 
35,259

 
1,862

 
3,476

 
36,575

 
40,051

 
(9,556
)
 
2006
 
1162
 
Orland Park
 
IL
 
—

 
2,623

 
23,154

 
1,614

 
2,623

 
23,992

 
26,615

 
(6,697
)
 
2006
 
1237
 
Wilmette
 
IL
 
—

 
1,100

 
9,373

 
774

 
1,100

 
9,922

 
11,022

 
(2,711
)
 
2006
 
1105
 
Louisville
 
KY
 
—

 
1,499

 
26,252

 
240

 
1,513

 
25,813

 
27,326

 
(7,379
)
 
2006
 
2115
 
Murray
 
KY
 
—

 
288

 
7,400

 
299

 
288

 
7,698

 
7,986

 
(1,286
)
 
2012
 
1158
 
Plymouth
 
MA
 
—

 
2,434

 
9,027

 
879

 
2,438

 
9,105

 
11,543

 
(2,554
)
 
2006
 
1249
 
Frederick
 
MD
 
—

 
609

 
9,158

 
840

 
609

 
9,665

 
10,274

 
(2,830
)
 
2006
 
0281
 
Westminster
 
MD
 
—

 
768

 
5,251

 
1,451

 
768

 
6,758

 
7,526

 
(2,544
)
 
1998
 
0546
 
Cape Elizabeth
 
ME
 
—

 
630

 
3,524

 
93

 
630

 
3,617

 
4,247

 
(1,337
)
 
2003
 
0545
 
Saco
 
ME
 
—

 
80

 
2,363

 
155

 
80

 
2,518

 
2,598

 
(928
)
 
2003
 
1258
 
Auburn Hills
 
MI
 
—

 
2,281

 
10,692

 
—

 
2,281

 
10,692

 
12,973

 
(3,007
)
 
2006
 
1248
 
Farmington Hills
 
MI
 
—

 
1,013

 
12,119

 
939

 
1,013

 
12,418

 
13,431

 
(3,530
)
 
2006
 
1259
 
Sterling Heights
 
MI
 
—

 
1,593

 
11,500

 
—

 
1,593

 
11,181

 
12,774

 
(3,145
)
 
2006
 
1235
 
Des Peres
 
MO
 
—

 
4,361

 
20,664

 
1,225

 
4,361

 
21,271

 
25,632

 
(5,760
)
 
2006
 
1236
 
Richmond Heights
 
MO
 
—

 
1,744

 
24,232

 
368

 
1,744

 
23,915

 
25,659

 
(6,701
)
 
2006
 
0853
 
St. Louis
 
MO
 
—

 
2,500

 
20,343

 
—

 
2,500

 
19,853

 
22,353

 
(7,665
)
 
2006
 
2074
 
Oxford
 
MS
 
—

 
2,003

 
14,140

 
231

 
2,003

 
14,371

 
16,374

 
(2,089
)
 
2012
 
0878
 
Charlotte
 
NC
 
—

 
710

 
9,559

 
—

 
710

 
9,159

 
9,869

 
(2,538
)
 
2006
 
2465
 
Charlotte
 
NC
 
—

 
1,373

 
10,774

 
—

 
1,373

 
10,774

 
12,147

 
(778
)
 
2016
 
2468
 
Franklin
 
NC
 
—

 
1,082

 
8,489

 
—

 
1,082

 
8,489

 
9,571

 
(613
)
 
2016
 
2126
 
Mooresville
 
NC
 
—

 
2,538

 
37,617

 
1,684

 
2,538

 
39,302

 
41,840

 
(5,390
)
 
2012
 
2466
 
Raeford
 
NC
 
—

 
1,304

 
10,230

 
—

 
1,304

 
10,230

 
11,534

 
(739
)
 
2016
 
1254
 
Raleigh
 
NC
 
—

 
1,191

 
11,532

 
489

 
1,191

 
11,681

 
12,872

 
(3,429
)
 
2006
 
2127
 
Minot
 
ND
 
—

 
685

 
16,047

 
676

 
685

 
16,723

 
17,408

 
(2,486
)
 
2012
 
1599
 
Cherry Hill
 
NJ
 
—

 
2,420

 
11,042

 
2,294

 
2,420

 
12,785

 
15,205

 
(3,685
)
 
2010
 
1239
 
Cresskill
 
NJ
 
—

 
4,684

 
53,927

 
501

 
4,684

 
53,406

 
58,090

 
(15,063
)
 
2006
 
0734
 
Hillsborough
 
NJ
 
—

 
1,042

 
10,042

 
491

 
1,042

 
10,066

 
11,108

 
(3,125
)
 
2005
 
1242
 
Madison
 
NJ
 
—

 
3,157

 
19,909

 
179

 
3,157

 
19,468

 
22,625

 
(5,475
)
 
2006
 
0733
 
Manahawkin
 
NJ
 
—

 
921

 
9,927

 
691

 
921

 
10,152

 
11,073

 
(3,191
)
 
2005
 
1231
 
Saddle River
 
NJ
 
—

 
1,784

 
15,625

 
612

 
1,784

 
15,640

 
17,424

 
(4,452
)
 
2006
 
0245
 
Voorhees Township
 
NJ
 
—

 
900

 
7,629

 
520

 
900

 
8,149

 
9,049

 
(3,287
)
 
1998
 
0796
 
Las Vegas
 
NV
 
—

 
1,960

 
5,816

 
—

 
1,960

 
5,426

 
7,386

 
(1,685
)
 
2005
 
1252
 
Brooklyn
 
NY
 
—

 
8,117

 
23,627

 
1,057

 
8,117

 
23,577

 
31,694

 
(6,701
)
 
2006
 
1256
 
Brooklyn
 
NY
 
—

 
5,215

 
39,052

 
1,079

 
5,215

 
39,197

 
44,412

 
(11,181
)
 
2006
 
2174
 
Orchard Park
 
NY
 
—

 
726

 
17,735

 
—

 
726

 
17,735

 
18,461

 
(2,957
)
 
2012
 
1386
 
Marietta
 
OH
 
—

 
1,069

 
11,435

 
668

 
1,069

 
11,898

 
12,967

 
(4,322
)
 
2007
 

122

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
1253
 
Youngstown
 
OH
 
—

 
695

 
10,444

 
744

 
695

 
10,842

 
11,537

 
(3,113
)
 
2006
 
2083
 
Oklahoma City
 
OK
 
—

 
2,116

 
28,007

 
1,939

 
2,116

 
29,946

 
32,062

 
(4,569
)
 
2012
 
2131
 
Keizer
 
OR
 
2,431

 
551

 
6,454

 
—

 
551

 
6,454

 
7,005

 
(938
)
 
2013
 
2152
 
McMinnville
 
OR
 
—

 
3,203

 
24,909

 
5,381

 
3,203

 
28,796

 
31,999

 
(5,040
)
 
2012
 
2089
 
Newberg
 
OR
 
—

 
1,889

 
16,855

 
837

 
1,889

 
17,692

 
19,581

 
(2,428
)
 
2012
 
2133
 
Portland
 
OR
 
—

 
1,615

 
12,030

 
169

 
1,615

 
12,199

 
13,814

 
(1,592
)
 
2012
 
2171
 
Portland
 
OR
 
—

 
—

 
16,087

 
311

 
—

 
16,398

 
16,398

 
(2,069
)
 
2012
 
2050
 
Redmond
 
OR
 
—

 
1,229

 
21,921

 
809

 
1,229

 
22,731

 
23,960

 
(2,932
)
 
2012
 
2084
 
Roseburg
 
OR
 
—

 
1,042

 
12,090

 
134

 
1,042

 
12,223

 
13,265

 
(1,918
)
 
2012
 
2134
 
Scappoose
 
OR
 
—

 
353

 
1,258

 
17

 
353

 
1,275

 
1,628

 
(264
)
 
2012
 
2153
 
Scappoose
 
OR
 
—

 
971

 
7,116

 
142

 
971

 
7,258

 
8,229

 
(1,311
)
 
2012
 
2056
 
Stayton
 
OR
 
—

 
48

 
569

 
19

 
48

 
588

 
636

 
(160
)
 
2012
 
2058
 
Stayton
 
OR
 
—

 
253

 
8,621

 
140

 
253

 
8,762

 
9,015

 
(1,370
)
 
2012
 
2088
 
Tualatin
 
OR
 
—

 
—

 
6,326

 
375

 
—

 
6,701

 
6,701

 
(1,376
)
 
2012
 
2180
 
Windfield Village
 
OR
 
2,722

 
580

 
9,817

 
—

 
580

 
9,817

 
10,397

 
(1,424
)
 
2013
 
1163
 
Haverford
 
PA
 
—

 
16,461

 
108,816

 
12,128

 
16,461

 
116,731

 
133,192

 
(33,431
)
 
2006
 
2063
 
Selinsgrove
 
PA
 
—

 
529

 
9,111

 
237

 
529

 
9,349

 
9,878

 
(1,625
)
 
2012
 
1973
 
South Kingstown
 
RI
 
—

 
1,390

 
12,551

 
630

 
1,390

 
12,918

 
14,308

 
(3,187
)
 
2011
 
1975
 
Tiverton
 
RI
 
—

 
3,240

 
25,735

 
651

 
3,240

 
25,938

 
29,178

 
(6,242
)
 
2011
 
1104
 
Aiken
 
SC
 
—

 
357

 
14,832

 
151

 
363

 
14,395

 
14,758

 
(4,081
)
 
2006
 
1109
 
Columbia
 
SC
 
—

 
408

 
7,527

 
131

 
412

 
7,414

 
7,826

 
(2,123
)
 
2006
 
0306
 
Georgetown
 
SC
 
—

 
239

 
3,008

 
—

 
239

 
3,008

 
3,247

 
(1,236
)
 
1998
 
0879
 
Greenville
 
SC
 
—

 
1,090

 
12,558

 
—

 
1,090

 
12,058

 
13,148

 
(3,341
)
 
2006
 
0305
 
Lancaster
 
SC
 
—

 
84

 
2,982

 
—

 
84

 
2,982

 
3,066

 
(1,142
)
 
1998
 
0880
 
Myrtle Beach
 
SC
 
—

 
900

 
10,913

 
—

 
900

 
10,513

 
11,413

 
(2,913
)
 
2006
 
0312
 
Rock Hill
 
SC
 
—

 
203

 
2,671

 
—

 
203

 
2,671

 
2,874

 
(1,077
)
 
1998
 
1113
 
Rock Hill
 
SC
 
—

 
695

 
4,119

 
322

 
795

 
4,074

 
4,869

 
(1,313
)
 
2006
 
0313
 
Sumter
 
SC
 
—

 
196

 
2,623

 
—

 
196

 
2,623

 
2,819

 
(1,078
)
 
1998
 
2073
 
Kingsport
 
TN
 
—

 
1,113

 
8,625

 
322

 
1,113

 
8,947

 
10,060

 
(1,418
)
 
2012
 
1003
 
Nashville
 
TN
 
—

 
812

 
16,983

 
2,524

 
812

 
18,759

 
19,571

 
(4,691
)
 
2006
 
0843
 
Abilene
 
TX
 
—

 
300

 
2,830

 
—

 
300

 
2,710

 
3,010

 
(785
)
 
2006
 
2107
 
Amarillo
 
TX
 
—

 
1,315

 
26,838

 
582

 
1,315

 
27,417

 
28,732

 
(3,790
)
 
2012
 
1116
 
Arlington
 
TX
 
—

 
2,494

 
12,192

 
249

 
2,540

 
11,847

 
14,387

 
(3,472
)
 
2006
 
0511
 
Austin
 
TX
 
—

 
2,960

 
41,645

 
—

 
2,960

 
41,645

 
44,605

 
(19,781
)
 
2002
 
2075
 
Bedford
 
TX
 
—

 
1,204

 
26,845

 
1,599

 
1,204

 
28,444

 
29,648

 
(4,134
)
 
2012
 
0844
 
Burleson
 
TX
 
—

 
1,050

 
5,242

 
—

 
1,050

 
4,902

 
5,952

 
(1,420
)
 
2006
 
0848
 
Cedar Hill
 
TX
 
—

 
1,070

 
11,554

 
—

 
1,070

 
11,104

 
12,174

 
(3,215
)
 
2006
 
1325
 
Cedar Hill
 
TX
 
—

 
440

 
7,494

 
—

 
440

 
6,974

 
7,414

 
(1,874
)
 
2007
 
0506
 
Friendswood
 
TX
 
—

 
400

 
7,354

 
174

 
400

 
7,528

 
7,928

 
(2,582
)
 
2002
 
0217
 
Houston
 
TX
 
—

 
835

 
7,195

 
454

 
835

 
7,649

 
8,484

 
(3,306
)
 
1997
 
1106
 
Houston
 
TX
 
—

 
1,008

 
15,333

 
183

 
1,020

 
15,052

 
16,072

 
(4,314
)
 
2006
 
0845
 
North Richland Hills
 
TX
 
—

 
520

 
5,117

 
—

 
520

 
4,807

 
5,327

 
(1,392
)
 
2006
 
0846
 
North Richland Hills
 
TX
 
—

 
870

 
9,259

 
—

 
870

 
8,819

 
9,689

 
(2,919
)
 
2006
 
2162
 
Portland
 
TX
 
—

 
1,233

 
14,001

 
1,353

 
1,233

 
15,354

 
16,587

 
(2,520
)
 
2012
 
2116
 
Sherman
 
TX
 
—

 
209

 
3,492

 
377

 
209

 
3,870

 
4,079

 
(647
)
 
2012
 
0847
 
Waxahachie
 
TX
 
—

 
390

 
3,879

 
—

 
390

 
3,659

 
4,049

 
(1,059
)
 
2006
 
2470
 
Abingdon
 
VA
 
—

 
1,584

 
12,431

 
—

 
1,584

 
12,431

 
14,015

 
(898
)
 
2016
 
1244
 
Arlington
 
VA
 
—

 
3,833

 
7,076

 
882

 
3,833

 
7,630

 
11,463

 
(2,248
)
 
2006
 
1245
 
Arlington
 
VA
 
—

 
7,278

 
37,407

 
3,185

 
7,278

 
39,481

 
46,759

 
(10,900
)
 
2006
 
0881
 
Chesapeake
 
VA
 
—

 
1,090

 
12,444

 
—

 
1,090

 
11,944

 
13,034

 
(3,310
)
 
2006
 
1247
 
Falls Church
 
VA
 
—

 
2,228

 
8,887

 
677

 
2,228

 
9,240

 
11,468

 
(2,734
)
 
2006
 
1164
 
Fort Belvoir
 
VA
 
—

 
11,594

 
99,528

 
11,862

 
11,594

 
108,676

 
120,270

 
(31,972
)
 
2006
 
1250
 
Leesburg
 
VA
 
—

 
607

 
3,236

 
206

 
607

 
3,230

 
3,837

 
(3,196
)
 
2006
 
1246
 
Sterling
 
VA
 
—

 
2,360

 
22,932

 
1,059

 
2,360

 
23,228

 
25,588

 
(6,672
)
 
2006
 
2077
 
Sterling
 
VA
 
—

 
1,046

 
15,788

 
385

 
1,046

 
16,173

 
17,219

 
(2,214
)
 
2012
 
0225
 
Woodbridge
 
VA
 
—

 
950

 
6,983

 
1,459

 
950

 
8,442

 
9,392

 
(3,516
)
 
1997
 
1173
 
Bellevue
 
WA
 
—

 
3,734

 
16,171

 
645

 
3,737

 
16,094

 
19,831

 
(4,541
)
 
2006
 
2095
 
College Place
 
WA
 
—

 
758

 
8,051

 
701

 
758

 
8,752

 
9,510

 
(1,437
)
 
2012
 
1240
 
Edmonds
 
WA
 
—

 
1,418

 
16,502

 
105

 
1,418

 
16,102

 
17,520

 
(4,552
)
 
2006
 
2160
 
Kenmore
 
WA
 
—

 
3,284

 
16,641

 
638

 
3,284

 
17,278

 
20,562

 
(2,406
)
 
2012
 
0797
 
Kirkland
 
WA
 
—

 
1,000

 
13,403

 
—

 
1,000

 
13,043

 
14,043

 
(4,049
)
 
2005
 
1251
 
Mercer Island
 
WA
 
—

 
4,209

 
8,123

 
581

 
4,209

 
8,202

 
12,411

 
(2,334
)
 
2006
 
2096
 
Poulsbo
 
WA
 
—

 
1,801

 
18,068

 
224

 
1,801

 
18,292

 
20,093

 
(2,734
)
 
2012
 
2102
 
Richland
 
WA
 
—

 
249

 
5,067

 
135

 
249

 
5,202

 
5,451

 
(764
)
 
2012
 
0794
 
Shoreline
 
WA
 
—

 
1,590

 
10,671

 
—

 
1,590

 
10,261

 
11,851

 
(3,185
)
 
2005
 
0795
 
Shoreline
 
WA
 
—

 
4,030

 
26,421

 
42

 
4,030

 
25,691

 
29,721

 
(7,898
)
 
2005
 
2061
 
Vancouver
 
WA
 
—

 
513

 
4,556

 
246

 
513

 
4,802

 
5,315

 
(888
)
 
2012
 
2062
 
Vancouver
 
WA
 
—

 
1,498

 
9,997

 
192

 
1,498

 
10,189

 
11,687

 
(1,477
)
 
2012
 
2052
 
Yakima
 
WA
 
—

 
557

 
5,897

 
176

 
557

 
6,074

 
6,631

 
(931
)
 
2012
 
2078
 
Yakima
 
WA
 
—

 
353

 
5,668

 
27

 
353

 
5,695

 
6,048

 
(781
)
 
2012
 
2117
 
Bridgeport
 
WV
 
—

 
3,174

 
15,437

 
493

 
3,174

 
15,930

 
19,104

 
(3,028
)
 
2012
 
2148
 
Sheridan
 
WY
 
—

 
915

 
12,047

 
1,242

 
915

 
13,289

 
14,204

 
(2,149
)
 
2012
 
 
 
 
 
 
 
$
50,763

 
$
289,180

 
$
2,387,674

 
$
123,120

 
$
289,448

 
$
2,457,872

 
$
2,747,320

 
$
(641,170
)
 
 
 

123

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
Senior housing operating portfolio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1974
 
Sun City
 
AZ
 
—

 
2,640

 
33,223

 
2,685

 
2,640

 
35,378

 
38,018

 
(9,041
)
 
2011
 
2729
 
Clearlake
 
CA
 
—

 
354

 
4,799

 
306

 
354

 
4,635

 
4,989

 
(898
)
 
2012
 
1965
 
Fresno
 
CA
 
—

 
1,730

 
31,918

 
2,117

 
1,730

 
33,605

 
35,335

 
(8,408
)
 
2011
 
2726
 
Fortuna
 
CA
 
—

 
818

 
3,295

 
63

 
818

 
3,358

 
4,176

 
(1,582
)
 
2012
 
2728
 
Fortuna
 
CA
 
—

 
1,346

 
11,856

 
176

 
1,346

 
10,618

 
11,964

 
(3,568
)
 
2012
 
2593
 
Irvine
 
CA
 
—

 
8,220

 
14,104

 
539

 
8,220

 
14,103

 
22,323

 
(3,465
)
 
2006
 
2725
 
Palm Springs
 
CA
 
—

 
1,005

 
5,183

 
619

 
1,005

 
5,263

 
6,268

 
(2,097
)
 
2006
 
1966
 
Sun City
 
CA
 
—

 
2,650

 
22,709

 
3,863

 
2,650

 
26,118

 
28,768

 
(7,323
)
 
2011
 
2727
 
Yreka
 
CA
 
—

 
565

 
9,184

 
419

 
565

 
6,633

 
7,198

 
(1,675
)
 
2012
 
2505
 
Arvada
 
CO
 
—

 
1,788

 
29,896

 
1,016

 
1,788

 
30,912

 
32,700

 
(2,694
)
 
2015
 
2506
 
Boulder
 
CO
 
—

 
2,424

 
36,746

 
674

 
2,424

 
37,421

 
39,845

 
(2,492
)
 
2015
 
2515
 
Denver
 
CO
 
—

 
2,311

 
18,645

 
1,995

 
2,311

 
20,639

 
22,950

 
(2,519
)
 
2015
 
2508
 
Lakewood
 
CO
 
—

 
4,384

 
60,795

 
1,988

 
4,384

 
62,782

 
67,166

 
(4,928
)
 
2015
 
2509
 
Lakewood
 
CO
 
—

 
2,296

 
37,236

 
1,523

 
2,296

 
38,760

 
41,056

 
(2,538
)
 
2015
 
2603
 
Boca Raton
 
FL
 
—

 
2,415

 
17,923

 
858

 
2,415

 
17,726

 
20,141

 
(4,534
)
 
2006
 
1963
 
Boynton Beach
 
FL
 
—

 
2,550

 
31,521

 
3,665

 
2,550

 
34,521

 
37,071

 
(9,003
)
 
2011
 
1964
 
Boynton Beach
 
FL
 
—

 
570

 
5,649

 
2,826

 
570

 
8,282

 
8,852

 
(2,799
)
 
2011
 
2602
 
Boynton Beach
 
FL
 
—

 
1,270

 
4,773

 
1,918

 
1,270

 
4,775

 
6,045

 
(1,278
)
 
2003
 
2520
 
Clearwater
 
FL
 
—

 
2,250

 
2,627

 
1,588

 
2,250

 
3,635

 
5,885

 
(1,095
)
 
2015
 
2604
 
Coconut Creek
 
FL
 
—

 
2,461

 
16,006

 
2,461

 
2,461

 
15,712

 
18,173

 
(3,933
)
 
2006
 
2601
 
Delray Beach
 
FL
 
—

 
850

 
6,637

 
1,598

 
850

 
6,907

 
7,757

 
(1,891
)
 
2002
 
2517
 
Ft Lauderdale
 
FL
 
—

 
2,867

 
43,126

 
2,927

 
2,867

 
45,896

 
48,763

 
(4,652
)
 
2015
 
2518
 
Lake Worth
 
FL
 
—

 
1,669

 
13,267

 
1,180

 
1,669

 
14,447

 
16,116

 
(1,916
)
 
2015
 
2592
 
Lantana
 
FL
 
—

 
3,520

 
26,452

 
377

 
3,520

 
26,029

 
29,549

 
(9,790
)
 
2006
 
1968
 
Largo
 
FL
 
—

 
2,920

 
64,988

 
12,399

 
2,920

 
76,167

 
79,087

 
(20,269
)
 
2011
 
2522
 
Lutz
 
FL
 
—

 
902

 
15,169

 
55

 
902

 
16,152

 
17,054

 
(1,213
)
 
2015
 
2523
 
Orange City
 
FL
 
—

 
912

 
9,724

 
894

 
912

 
10,618

 
11,530

 
(1,092
)
 
2015
 
2524
 
Port St Lucie
 
FL
 
—

 
893

 
10,333

 
827

 
893

 
11,161

 
12,054

 
(1,252
)
 
2015
 
1971
 
Sarasota
 
FL
 
—

 
3,050

 
29,516

 
6,239

 
3,050

 
35,325

 
38,375

 
(9,497
)
 
2011
 
2525
 
Sarasota
 
FL
 
—

 
1,426

 
16,079

 
1,304

 
1,426

 
17,383

 
18,809

 
(1,854
)
 
2015
 
2526
 
Tamarac
 
FL
 
—

 
970

 
16,037

 
924

 
970

 
16,968

 
17,938

 
(1,324
)
 
2015
 
2513
 
Venice
 
FL
 
—

 
1,140

 
20,662

 
1,647

 
1,140

 
22,309

 
23,449

 
(1,838
)
 
2015
 
2527
 
Vero Beach
 
FL
 
—

 
1,048

 
17,392

 
1,342

 
1,048

 
18,733

 
19,781

 
(1,440
)
 
2015
 
2200
 
Deer Park
 
IL
 
—

 
4,172

 
2,417

 
44,534

 
4,229

 
44,478

 
48,707

 
(2,244
)
 
2014
 
2594
 
Mount Vernon
 
IL
 
—

 
296

 
15,935

 
4,340

 
512

 
19,728

 
20,240

 
(5,122
)
 
2006
 
1969
 
Niles
 
IL
 
—

 
3,790

 
32,912

 
5,884

 
3,790

 
38,024

 
41,814

 
(10,772
)
 
2011
 
1961
 
Olympia Fields
 
IL
 
—

 
4,120

 
29,400

 
3,832

 
4,120

 
32,706

 
36,826

 
(8,523
)
 
2011
 
1952
 
Vernon Hills
 
IL
 
—

 
4,900

 
45,854

 
5,999

 
4,900

 
51,157

 
56,057

 
(13,321
)
 
2011
 
2595
 
Indianapolis
 
IN
 
—

 
1,197

 
7,718

 
1,084

 
1,197

 
8,570

 
9,767

 
(2,137
)
 
2006
 
2596
 
W Lafayette
 
IN
 
—

 
813

 
10,876

 
1,324

 
813

 
11,949

 
12,762

 
(3,023
)
 
2006
 
2746
 
Watertown
 
MA
 
—

 
8,828

 
29,112

 
53

 
8,828

 
29,165

 
37,993

 
(129
)
 
2017
 
2583
 
Ellicott City
 
MD
 
19,469

 
3,607

 
31,720

 
1,239

 
3,607

 
32,959

 
36,566

 
(1,280
)
 
2016
 
2584
 
Hanover
 
MD
 
9,065

 
4,513

 
25,625

 
867

 
4,513

 
26,492

 
31,005

 
(1,009
)
 
2016
 
2585
 
Laurel
 
MD
 
5,879

 
3,895

 
13,331

 
993

 
3,895

 
14,323

 
18,218

 
(709
)
 
2016
 
2541
 
Olney
 
MD
 
—

 
1,580

 
33,802

 
158

 
1,580

 
33,960

 
35,540

 
(2,247
)
 
2015
 
2586
 
Parkville
 
MD
 
21,008

 
3,854

 
29,061

 
902

 
3,854

 
29,963

 
33,817

 
(1,356
)
 
2016
 
2587
 
Waldorf
 
MD
 
8,501

 
392

 
20,514

 
650

 
392

 
21,164

 
21,556

 
(799
)
 
2016
 
2741
 
Lexington
 
NE
 
—

 
474

 
8,405

 
474

 
474

 
6,362

 
6,836

 
(1,657
)
 
2012
 
2589
 
Albuquerque
 
NM
 
—

 
767

 
9,324

 
253

 
767

 
9,079

 
9,846

 
(4,059
)
 
1996
 
2740
 
Rio Rancho
 
NM
 
—

 
1,154

 
13,726

 
495

 
1,154

 
14,221

 
15,375

 
(2,259
)
 
2012
 
2735
 
Roswell
 
NM
 
—

 
618

 
7,038

 
1,010

 
618

 
7,741

 
8,359

 
(1,578
)
 
2012
 
2738
 
Roswell
 
NM
 
—

 
837

 
8,614

 
997

 
837

 
9,288

 
10,125

 
(1,979
)
 
2012
 
2733
 
Las Vegas
 
NV
 
—

 
667

 
14,469

 
509

 
667

 
10,347

 
11,014

 
(2,592
)
 
2012
 
2743
 
Clifton Park
 
NY
 
—

 
2,257

 
11,470

 
4

 
2,257

 
11,484

 
13,741

 
(1,926
)
 
2012
 
2742
 
Orchard Park
 
NY
 
—

 
478

 
11,961

 
—

 
478

 
11,961

 
12,439

 
(1,984
)
 
2012
 
2516
 
Centerville
 
OH
 
—

 
1,065

 
10,901

 
1,520

 
1,065

 
12,421

 
13,486

 
(1,643
)
 
2015
 
2512
 
Cincinnati
 
OH
 
—

 
1,180

 
6,157

 
1,393

 
1,180

 
7,549

 
8,729

 
(1,442
)
 
2015
 
2597
 
Fairborn
 
OH
 
—

 
298

 
10,704

 
3,895

 
298

 
14,368

 
14,666

 
(3,732
)
 
2006
 
2736
 
Gresham
 
OR
 
—

 
465

 
6,403

 
265

 
465

 
6,668

 
7,133

 
(1,563
)
 
2012
 
2744
 
Hermiston
 
OR
 
2,327

 
582

 
8,087

 
—

 
582

 
8,087

 
8,669

 
(1,400
)
 
2013
 
2739
 
Portland
 
OR
 
—

 
1,677

 
9,469

 
374

 
1,677

 
6,940

 
8,617

 
(2,306
)
 
2012
 
2730
 
Cumberland
 
RI
 
—

 
2,630

 
19,050

 
803

 
2,630

 
13,145

 
15,775

 
(4,644
)
 
2011
 
1959
 
East Providence
 
RI
 
—

 
1,890

 
13,989

 
1,447

 
1,890

 
15,183

 
17,073

 
(4,117
)
 
2011
 
1960
 
Greenwich
 
RI
 
—

 
450

 
11,845

 
1,846

 
450

 
13,414

 
13,864

 
(3,796
)
 
2011
 
2511
 
Johnston
 
RI
 
—

 
2,037

 
12,724

 
3,724

 
2,037

 
16,448

 
18,485

 
(2,468
)
 
2015
 
2731
 
Smithfield
 
RI
 
—

 
1,250

 
17,816

 
656

 
1,250

 
17,192

 
18,442

 
(4,724
)
 
2011
 
1962
 
Warwick
 
RI
 
—

 
1,050

 
17,389

 
6,772

 
1,050

 
23,804

 
24,854

 
(5,580
)
 
2011
 
2401
 
Germantown
 
TN
 
—

 
3,640

 
64,588

 
264

 
3,640

 
64,852

 
68,492

 
(5,393
)
 
2015
 
2608
 
Arlington
 
TX
 
—

 
2,002

 
19,110

 
128

 
2,002

 
18,857

 
20,859

 
(5,035
)
 
2006
 
2531
 
Austin
 
TX
 
—

 
607

 
15,972

 
424

 
607

 
16,396

 
17,003

 
(1,126
)
 
2015
 
2588
 
Beaumont
 
TX
 
—

 
145

 
10,404

 
324

 
145

 
10,282

 
10,427

 
(4,679
)
 
1995
 
2438
 
Dallas
 
TX
 
—

 
2,091

 
11,698

 
2,091

 
2,091

 
12,307

 
14,398

 
(2,074
)
 
2015
 
2528
 
Graham
 
TX
 
—

 
754

 
8,803

 
782

 
754

 
9,586

 
10,340

 
(1,088
)
 
2015
 
2529
 
Grand Prairie
 
TX
 
—

 
865

 
10,650

 
1,118

 
865

 
11,768

 
12,633

 
(1,196
)
 
2015
 
1955
 
Houston
 
TX
 
—

 
9,820

 
50,079

 
10,526

 
9,820

 
59,293

 
69,113

 
(16,391
)
 
2011
 
1957
 
Houston
 
TX
 
—

 
8,170

 
37,285

 
5,658

 
8,170

 
42,112

 
50,282

 
(11,285
)
 
2011
 
1958
 
Houston
 
TX
 
—

 
2,910

 
37,443

 
7,685

 
2,910

 
44,233

 
47,143

 
(11,666
)
 
2011
 
2402
 
Houston
 
TX
 
—

 
1,740

 
32,057

 
95

 
1,740

 
32,153

 
33,893

 
(2,801
)
 
2015
 
2606
 
Houston
 
TX
 
—

 
2,470

 
21,710

 
2,176

 
2,470

 
23,036

 
25,506

 
(10,451
)
 
2002
 
2530
 
N Richland Hills
 
TX
 
—

 
1,190

 
17,756

 
1,104

 
1,190

 
18,859

 
20,049

 
(1,659
)
 
2015
 
2532
 
San Antonio
 
TX
 
—

 
613

 
5,874

 
990

 
613

 
6,863

 
7,476

 
(931
)
 
2015
 
2607
 
San Antonio
 
TX
 
—

 
730

 
3,961

 
375

 
730

 
4,022

 
4,752

 
(1,391
)
 
2002
 
2533
 
San Marcos
 
TX
 
—

 
765

 
18,175

 
898

 
765

 
19,073

 
19,838

 
(1,380
)
 
2015
 

124

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
1954
 
Sugar Land
 
TX
 
—

 
3,420

 
36,846

 
5,097

 
3,420

 
41,242

 
44,662

 
(11,131
)
 
2011
 
2510
 
Temple
 
TX
 
—

 
2,354

 
52,859

 
1,144

 
2,354

 
54,004

 
56,358

 
(3,819
)
 
2015
 
2400
 
Victoria
 
TX
 
—

 
1,032

 
7,743

 
339

 
1,032

 
7,186

 
8,218

 
(906
)
 
2015
 
2605
 
Victoria
 
TX
 
—

 
175

 
4,290

 
3,642

 
175

 
6,477

 
6,652

 
(2,661
)
 
1995
 
1953
 
Webster
 
TX
 
—

 
4,780

 
30,854

 
4,628

 
4,780

 
29,464

 
34,244

 
(8,264
)
 
2011
 
2534
 
Wichita Falls
 
TX
 
—

 
430

 
2,856

 
804

 
430

 
3,745

 
4,175

 
(642
)
 
2015
 
2582
 
Fredericksburg
 
VA
 
—

 
2,370

 
19,725

 
87

 
2,370

 
19,811

 
22,181

 
(689
)
 
2016
 
2581
 
Leesburg
 
VA
 
12,345

 
1,340

 
17,605

 
907

 
1,340

 
18,512

 
19,852

 
(664
)
 
2016
 
2514
 
Richmond
 
VA
 
—

 
2,981

 
54,203

 
1,894

 
2,981

 
56,097

 
59,078

 
(3,675
)
 
2015
 
2737
 
Moses Lake
 
WA
 
—

 
429

 
4,417

 
189

 
429

 
4,606

 
5,035

 
(1,328
)
 
2012
 
2732
 
Spokane
 
WA
 
—

 
903

 
5,363

 
171

 
903

 
5,228

 
6,131

 
(1,073
)
 
2012
 
2734
 
Yakima
 
WA
 
—

 
721

 
8,872

 
1,518

 
721

 
10,390

 
11,111

 
(2,168
)
 
2012
 
2745
 
Madison
 
WI
 
—

 
834

 
10,050

 
445

 
834

 
10,495

 
11,329

 
(1,732
)
 
2012
 
 
 
 
 
 
 
$
78,594

 
$
194,278

 
$
1,866,536

 
$
216,811

 
$
194,551

 
$
2,024,260

 
$
2,218,811

 
$
(359,316
)
 
 
 

125

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
Life science
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1482
 
Brisbane
 
CA
 
—

 
31,160

 
1,789

 
20,319

 
31,160

 
22,103

 
53,263

 
—

 
2007
 
1486
 
Brisbane
 
CA
 
—

 
11,331

 
—

 
20,529

 
11,331

 
20,529

 
31,860

 
—

 
2007
 
1487
 
Brisbane
 
CA
 
—

 
8,498

 
—

 
6,812

 
8,498

 
6,812

 
15,310

 
—

 
2007
 
1401
 
Hayward
 
CA
 
—

 
900

 
7,100

 
1,045

 
900

 
8,145

 
9,045

 
(2,705
)
 
2007
 
1402
 
Hayward
 
CA
 
—

 
1,500

 
6,400

 
3,682

 
1,719

 
9,863

 
11,582

 
(4,280
)
 
2007
 
1403
 
Hayward
 
CA
 
—

 
1,900

 
7,100

 
4,666

 
1,900

 
11,512

 
13,412

 
(2,709
)
 
2007
 
1404
 
Hayward
 
CA
 
—

 
2,200

 
17,200

 
1,434

 
2,200

 
18,634

 
20,834

 
(4,485
)
 
2007
 
1405
 
Hayward
 
CA
 
—

 
1,000

 
3,200

 
7,478

 
1,000

 
10,678

 
11,678

 
(6,391
)
 
2007
 
1549
 
Hayward
 
CA
 
—

 
1,006

 
4,259

 
3,463

 
1,055

 
6,409

 
7,464

 
(2,493
)
 
2007
 
1550
 
Hayward
 
CA
 
—

 
677

 
2,761

 
5,583

 
710

 
4,954

 
5,664

 
(3,401
)
 
2007
 
1551
 
Hayward
 
CA
 
—

 
661

 
1,995

 
4,264

 
693

 
6,227

 
6,920

 
(4,220
)
 
2007
 
1552
 
Hayward
 
CA
 
—

 
1,187

 
7,139

 
1,346

 
1,222

 
8,094

 
9,316

 
(3,385
)
 
2007
 
1553
 
Hayward
 
CA
 
—

 
1,189

 
9,465

 
7,361

 
1,225

 
16,791

 
18,016

 
(5,675
)
 
2007
 
1554
 
Hayward
 
CA
 
—

 
1,246

 
5,179

 
1,867

 
1,283

 
6,133

 
7,416

 
(2,739
)
 
2007
 
1555
 
Hayward
 
CA
 
—

 
1,521

 
13,546

 
6,401

 
1,566

 
19,889

 
21,455

 
(7,177
)
 
2007
 
1556
 
Hayward
 
CA
 
—

 
1,212

 
5,120

 
3,049

 
1,249

 
5,216

 
6,465

 
(2,098
)
 
2007
 
1424
 
La Jolla
 
CA
 
—

 
9,600

 
25,283

 
8,220

 
9,719

 
31,414

 
41,133

 
(9,072
)
 
2007
 
1425
 
La Jolla
 
CA
 
—

 
6,200

 
19,883

 
152

 
6,276

 
19,958

 
26,234

 
(5,264
)
 
2007
 
1426
 
La Jolla
 
CA
 
—

 
7,200

 
12,412

 
5,493

 
7,291

 
15,961

 
23,252

 
(6,509
)
 
2007
 
1427
 
La Jolla
 
CA
 
—

 
8,700

 
16,983

 
6,177

 
8,767

 
21,859

 
30,626

 
(7,302
)
 
2007
 
1949
 
La Jolla
 
CA
 
—

 
2,686

 
11,045

 
743

 
2,686

 
11,458

 
14,144

 
(2,690
)
 
2011
 
2229
 
La Jolla
 
CA
 
—

 
8,753

 
32,528

 
6,228

 
8,777

 
38,732

 
47,509

 
(3,923
)
 
2014
 
1488
 
Mountain View
 
CA
 
—

 
7,300

 
25,410

 
1,901

 
7,567

 
27,044

 
34,611

 
(7,597
)
 
2007
 
1489
 
Mountain View
 
CA
 
—

 
6,500

 
22,800

 
1,866

 
6,500

 
24,666

 
31,166

 
(7,030
)
 
2007
 
1490
 
Mountain View
 
CA
 
—

 
4,800

 
9,500

 
442

 
4,800

 
9,942

 
14,742

 
(2,746
)
 
2007
 
1491
 
Mountain View
 
CA
 
—

 
4,200

 
8,400

 
1,249

 
4,209

 
8,998

 
13,207

 
(2,458
)
 
2007
 
1492
 
Mountain View
 
CA
 
—

 
3,600

 
9,700

 
862

 
3,600

 
9,835

 
13,435

 
(2,527
)
 
2007
 
1493
 
Mountain View
 
CA
 
—

 
7,500

 
16,300

 
2,142

 
7,500

 
17,842

 
25,342

 
(4,942
)
 
2007
 
1494
 
Mountain View
 
CA
 
—

 
9,800

 
24,000

 
203

 
9,800

 
24,203

 
34,003

 
(6,362
)
 
2007
 
1495
 
Mountain View
 
CA
 
—

 
6,900

 
17,800

 
3,245

 
6,900

 
21,045

 
27,945

 
(6,313
)
 
2007
 
1496
 
Mountain View
 
CA
 
—

 
7,000

 
17,000

 
6,364

 
7,000

 
17,332

 
24,332

 
(4,595
)
 
2007
 
1497
 
Mountain View
 
CA
 
—

 
14,100

 
31,002

 
10,111

 
14,100

 
31,487

 
45,587

 
(8,280
)
 
2007
 
1498
 
Mountain View
 
CA
 
—

 
7,100

 
25,800

 
8,101

 
7,100

 
33,901

 
41,001

 
(14,611
)
 
2007
 
2017
 
Mountain View
 
CA
 
—

 
—

 
20,240

 
1,117

 
—

 
21,255

 
21,255

 
(4,000
)
 
2013
 
1470
 
Poway
 
CA
 
—

 
5,826

 
12,200

 
6,048

 
5,826

 
12,542

 
18,368

 
(3,199
)
 
2007
 
1471
 
Poway
 
CA
 
—

 
5,978

 
14,200

 
4,253

 
5,978

 
18,453

 
24,431

 
(7,951
)
 
2007
 
1472
 
Poway
 
CA
 
—

 
8,654

 
—

 
11,906

 
8,654

 
11,906

 
20,560

 
(1,286
)
 
2007
 
1473
 
Poway
 
CA
 
—

 
11,024

 
2,405

 
9,148

 
11,024

 
11,553

 
22,577

 
—

 
2007
 
1474
 
Poway
 
CA
 
—

 
5,051

 
—

 
5,522

 
5,051

 
5,522

 
10,573

 
—

 
2007
 
1475
 
Poway
 
CA
 
—

 
5,655

 
—

 
5,697

 
5,655

 
5,697

 
11,352

 
—

 
2007
 
1477
 
Poway
 
CA
 
—

 
25,359

 
2,475

 
14,835

 
25,359

 
17,310

 
42,669

 
—

 
2007
 
1478
 
Poway
 
CA
 
—

 
6,700

 
14,400

 
6,145

 
6,700

 
14,400

 
21,100

 
(3,750
)
 
2007
 
1499
 
Redwood City
 
CA
 
—

 
3,400

 
5,500

 
2,564

 
3,407

 
7,177

 
10,584

 
(2,476
)
 
2007
 
1500
 
Redwood City
 
CA
 
—

 
2,500

 
4,100

 
1,220

 
2,506

 
4,563

 
7,069

 
(1,508
)
 
2007
 
1501
 
Redwood City
 
CA
 
—

 
3,600

 
4,600

 
860

 
3,607

 
5,024

 
8,631

 
(1,722
)
 
2007
 
1502
 
Redwood City
 
CA
 
—

 
3,100

 
5,100

 
954

 
3,107

 
5,801

 
8,908

 
(1,937
)
 
2007
 
1503
 
Redwood City
 
CA
 
—

 
4,800

 
17,300

 
3,300

 
4,818

 
20,582

 
25,400

 
(6,253
)
 
2007
 
1504
 
Redwood City
 
CA
 
—

 
5,400

 
15,500

 
949

 
5,418

 
16,431

 
21,849

 
(4,246
)
 
2007
 
1505
 
Redwood City
 
CA
 
—

 
3,000

 
3,500

 
826

 
3,006

 
4,115

 
7,121

 
(1,646
)
 
2007
 
1506
 
Redwood City
 
CA
 
—

 
6,000

 
14,300

 
7,503

 
6,018

 
21,178

 
27,196

 
(4,637
)
 
2007
 
1507
 
Redwood City
 
CA
 
—

 
1,900

 
12,800

 
13,559

 
1,912

 
26,347

 
28,259

 
(7,202
)
 
2007
 
1508
 
Redwood City
 
CA
 
—

 
2,700

 
11,300

 
12,120

 
2,712

 
23,409

 
26,121

 
(5,871
)
 
2007
 
1509
 
Redwood City
 
CA
 
—

 
2,700

 
10,900

 
10,476

 
2,712

 
20,840

 
23,552

 
(7,349
)
 
2007
 
1510
 
Redwood City
 
CA
 
—

 
2,200

 
12,000

 
5,395

 
2,212

 
13,501

 
15,713

 
(3,543
)
 
2007
 
1511
 
Redwood City
 
CA
 
—

 
2,600

 
9,300

 
1,828

 
2,612

 
10,561

 
13,173

 
(2,708
)
 
2007
 
1512
 
Redwood City
 
CA
 
—

 
3,300

 
18,000

 
12,361

 
3,300

 
30,361

 
33,661

 
(8,155
)
 
2007
 
1513
 
Redwood City
 
CA
 
—

 
3,300

 
17,900

 
14,839

 
3,326

 
32,713

 
36,039

 
(9,544
)
 
2007
 
0678
 
San Diego
 
CA
 
—

 
2,603

 
11,051

 
3,143

 
2,603

 
14,194

 
16,797

 
(4,623
)
 
2002
 
0679
 
San Diego
 
CA
 
—

 
5,269

 
23,566

 
16,072

 
5,669

 
35,937

 
41,606

 
(12,274
)
 
2002
 
0837
 
San Diego
 
CA
 
—

 
4,630

 
2,028

 
8,982

 
4,630

 
11,010

 
15,640

 
(6,567
)
 
2006
 
0838
 
San Diego
 
CA
 
—

 
2,040

 
903

 
5,111

 
2,040

 
6,014

 
8,054

 
(2,208
)
 
2006
 
0839
 
San Diego
 
CA
 
—

 
3,940

 
3,184

 
5,733

 
4,047

 
5,591

 
9,638

 
(1,769
)
 
2006
 
0840
 
San Diego
 
CA
 
—

 
5,690

 
4,579

 
720

 
5,830

 
4,734

 
10,564

 
(1,566
)
 
2006
 
1418
 
San Diego
 
CA
 
—

 
11,700

 
31,243

 
6,403

 
11,700

 
37,646

 
49,346

 
(12,927
)
 
2007
 
1420
 
San Diego
 
CA
 
—

 
6,524

 
—

 
4,986

 
6,524

 
4,986

 
11,510

 
—

 
2007
 
1421
 
San Diego
 
CA
 
—

 
7,000

 
33,779

 
1,209

 
7,000

 
34,988

 
41,988

 
(9,021
)
 
2007
 
1422
 
San Diego
 
CA
 
—

 
7,179

 
3,687

 
4,521

 
7,184

 
8,202

 
15,386

 
(2,287
)
 
2007
 
1423
 
San Diego
 
CA
 
—

 
8,400

 
33,144

 
18

 
8,400

 
33,162

 
41,562

 
(8,637
)
 
2007
 
1514
 
San Diego
 
CA
 
—

 
5,200

 
—

 
—

 
5,200

 
—

 
5,200

 
—

 
2007
 
1558
 
San Diego
 
CA
 
—

 
7,740

 
22,654

 
2,371

 
7,888

 
23,645

 
31,533

 
(6,279
)
 
2007
 
1947
 
San Diego
 
CA
 
—

 
2,581

 
10,534

 
3,952

 
2,581

 
14,486

 
17,067

 
(3,154
)
 
2011
 
1948
 
San Diego
 
CA
 
—

 
5,879

 
25,305

 
2,559

 
5,879

 
27,861

 
33,740

 
(7,790
)
 
2011
 
2197
 
San Diego
 
CA
 
—

 
7,621

 
3,913

 
6,549

 
7,626

 
9,167

 
16,793

 
(2,459
)
 
2007
 
2476
 
San Diego
 
CA
 
—

 
7,661

 
9,918

 
3,359

 
7,661

 
13,277

 
20,938

 
(189
)
 
2016
 
2477
 
San Diego
 
CA
 
—

 
9,207

 
14,613

 
6,484

 
9,207

 
21,097

 
30,304

 
(649
)
 
2016
 
2478
 
San Diego
 
CA
 
—

 
6,000

 
—

 
—

 
6,000

 
—

 
6,000

 
—

 
2016
 
2617
 
San Diego
 
CA
 
—

 
2,734

 
5,195

 
777

 
2,734

 
5,971

 
8,705

 
—

 
2017
 
2618
 
San Diego
 
CA
 
—

 
4,100

 
12,395

 
—

 
4,100

 
12,395

 
16,495

 
(317
)
 
2017
 
2622
 
San Diego
 
CA
 
—

 
—

 
—

 
1,070

 
—

 
1,070

 
1,070

 
—

 
2004
 
1407
 
South San Francisco
 
CA
 
—

 
7,182

 
12,140

 
9,612

 
7,182

 
17,860

 
25,042

 
(8,032
)
 
2007
 
1408
 
South San Francisco
 
CA
 
—

 
9,000

 
17,800

 
1,260

 
9,000

 
19,060

 
28,060

 
(5,588
)
 
2007
 
1409
 
South San Francisco
 
CA
 
—

 
18,000

 
38,043

 
4,692

 
18,000

 
42,735

 
60,735

 
(10,828
)
 
2007
 
1410
 
South San Francisco
 
CA
 
—

 
4,900

 
18,100

 
157

 
4,900

 
18,257

 
23,157

 
(4,793
)
 
2007
 

126

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
1411
 
South San Francisco
 
CA
 
—

 
8,000

 
27,700

 
313

 
8,000

 
28,013

 
36,013

 
(7,288
)
 
2007
 
1412
 
South San Francisco
 
CA
 
—

 
10,100

 
22,521

 
2,156

 
10,100

 
24,437

 
34,537

 
(6,066
)
 
2007
 
1413
 
South San Francisco
 
CA
 
—

 
8,000

 
28,299

 
3,743

 
8,000

 
32,042

 
40,042

 
(7,468
)
 
2007
 
1414
 
South San Francisco
 
CA
 
—

 
3,700

 
20,800

 
2,248

 
3,700

 
22,845

 
26,545

 
(5,965
)
 
2007
 
1430
 
South San Francisco
 
CA
 
—

 
10,700

 
23,621

 
3,519

 
10,700

 
27,140

 
37,840

 
(7,606
)
 
2007
 
1431
 
South San Francisco
 
CA
 
—

 
7,000

 
15,500

 
876

 
7,000

 
16,375

 
23,375

 
(4,109
)
 
2007
 
1435
 
South San Francisco
 
CA
 
—

 
13,800

 
42,500

 
37,029

 
13,800

 
79,529

 
93,329

 
(19,435
)
 
2008
 
1436
 
South San Francisco
 
CA
 
—

 
14,500

 
45,300

 
36,865

 
14,500

 
82,165

 
96,665

 
(19,964
)
 
2008
 
1437
 
South San Francisco
 
CA
 
—

 
9,400

 
24,800

 
46,308

 
9,400

 
69,539

 
78,939

 
(14,428
)
 
2008
 
1439
 
South San Francisco
 
CA
 
—

 
11,900

 
68,848

 
48

 
11,900

 
68,896

 
80,796

 
(17,948
)
 
2007
 
1440
 
South San Francisco
 
CA
 
—

 
10,000

 
57,954

 
10

 
10,000

 
57,964

 
67,964

 
(15,094
)
 
2007
 
1441
 
South San Francisco
 
CA
 
—

 
9,300

 
43,549

 
8

 
9,300

 
43,557

 
52,857

 
(11,342
)
 
2007
 
1442
 
South San Francisco
 
CA
 
—

 
11,000

 
47,289

 
91

 
11,000

 
47,380

 
58,380

 
(12,371
)
 
2007
 
1443
 
South San Francisco
 
CA
 
—

 
13,200

 
60,932

 
2,645

 
13,200

 
63,576

 
76,776

 
(15,600
)
 
2007
 
1444
 
South San Francisco
 
CA
 
—

 
10,500

 
33,776

 
360

 
10,500

 
34,135

 
44,635

 
(8,995
)
 
2007
 
1445
 
South San Francisco
 
CA
 
—

 
10,600

 
34,083

 
9

 
10,600

 
34,092

 
44,692

 
(8,877
)
 
2007
 
1458
 
South San Francisco
 
CA
 
—

 
10,900

 
20,900

 
8,294

 
10,909

 
23,962

 
34,871

 
(7,082
)
 
2007
 
1459
 
South San Francisco
 
CA
 
—

 
3,600

 
100

 
223

 
3,600

 
323

 
3,923

 
(94
)
 
2007
 
1460
 
South San Francisco
 
CA
 
—

 
2,300

 
100

 
118

 
2,300

 
218

 
2,518

 
(100
)
 
2007
 
1461
 
South San Francisco
 
CA
 
—

 
3,900

 
200

 
221

 
3,900

 
421

 
4,321

 
(200
)
 
2007
 
1462
 
South San Francisco
 
CA
 
—

 
7,117

 
600

 
4,927

 
7,117

 
5,179

 
12,296

 
(2,140
)
 
2007
 
1463
 
South San Francisco
 
CA
 
—

 
10,381

 
2,300

 
20,527

 
10,381

 
22,827

 
33,208

 
(5,749
)
 
2007
 
1464
 
South San Francisco
 
CA
 
—

 
7,403

 
700

 
11,638

 
7,403

 
7,987

 
15,390

 
(1,479
)
 
2007
 
1468
 
South San Francisco
 
CA
 
—

 
10,100

 
24,013

 
4,774

 
10,100

 
26,642

 
36,742

 
(7,801
)
 
2007
 
1480
 
South San Francisco
 
CA
 
—

 
32,210

 
3,110

 
11,217

 
32,210

 
14,327

 
46,537

 
—

 
2007
 
1559
 
South San Francisco
 
CA
 
—

 
5,666

 
5,773

 
12,966

 
5,695

 
18,641

 
24,336

 
(10,250
)
 
2007
 
1560
 
South San Francisco
 
CA
 
—

 
1,204

 
1,293

 
517

 
1,210

 
1,789

 
2,999

 
(1,456
)
 
2007
 
1983
 
South San Francisco
 
CA
 
—

 
8,648

 
—

 
95,860

 
8,648

 
95,860

 
104,508

 
(6,072
)
 
2016
 
1984
 
South San Francisco
 
CA
 
—

 
7,845

 
—

 
84,569

 
7,844

 
84,569

 
92,413

 
(1,692
)
 
2017
 
1985
 
South San Francisco
 
CA
 
—

 
6,708

 
—

 
98,300

 
6,708

 
98,301

 
105,009

 
(1,212
)
 
2017
 
1986
 
South San Francisco
 
CA
 
—

 
6,708

 
—

 
107,084

 
6,708

 
107,084

 
113,792

 
—

 
2011
 
1987
 
South San Francisco
 
CA
 
—

 
8,544

 
—

 
47,227

 
8,544

 
47,228

 
55,772

 
—

 
2011
 
1988
 
South San Francisco
 
CA
 
—

 
10,120

 
—

 
414

 
10,120

 
414

 
10,534

 
—

 
2011
 
1989
 
South San Francisco
 
CA
 
—

 
9,169

 
—

 
3,649

 
9,169

 
3,649

 
12,818

 
—

 
2011
 
2553
 
South San Francisco
 
CA
 
—

 
2,897

 
8,691

 
1,160

 
2,897

 
9,852

 
12,749

 
(735
)
 
2015
 
2554
 
South San Francisco
 
CA
 
—

 
995

 
2,754

 
50

 
995

 
2,804

 
3,799

 
(166
)
 
2015
 
2555
 
South San Francisco
 
CA
 
—

 
2,202

 
10,776

 
589

 
2,202

 
11,365

 
13,567

 
(675
)
 
2015
 
2556
 
South San Francisco
 
CA
 
—

 
2,962

 
15,108

 
168

 
2,962

 
15,276

 
18,238

 
(908
)
 
2015
 
2557
 
South San Francisco
 
CA
 
—

 
2,453

 
13,063

 
128

 
2,453

 
13,191

 
15,644

 
(783
)
 
2015
 
2558
 
South San Francisco
 
CA
 
—

 
1,163

 
5,925

 
58

 
1,163

 
5,983

 
7,146

 
(356
)
 
2015
 
2614
 
South San Francisco
 
CA
 
—

 
5,079

 
8,584

 
1,330

 
5,079

 
9,914

 
14,993

 
(3,383
)
 
2007
 
2615
 
South San Francisco
 
CA
 
—

 
7,984

 
13,495

 
3,243

 
7,984

 
16,739

 
24,723

 
(5,481
)
 
2007
 
2616
 
South San Francisco
 
CA
 
—

 
8,355

 
14,121

 
1,876

 
8,355

 
15,998

 
24,353

 
(5,598
)
 
2007
 
2624
 
South San Francisco
 
CA
 
—

 
25,502

 
41,293

 
181

 
25,502

 
41,474

 
66,976

 
(382
)
 
2017
 
9999
 
Denton
 
TX
 
—

 
100

 
—

 
—

 
100

 
—

 
100

 
—

 
2016
 
2630
 
Lexington
 
MA
 
—

 
15,966

 
48,444

 
—

 
15,966

 
48,444

 
64,410

 
(187
)
 
2017
 
2631
 
Lexington
 
MA
 
—

 
10,940

 
139,201

 
28

 
10,940

 
139,229

 
150,169

 
(367
)
 
2017
 
2011
 
Durham
 
NC
 
6,118

 
448

 
6,152

 
21,379

 
448

 
27,494

 
27,942

 
(5,000
)
 
2011
 
2030
 
Durham
 
NC
 
—

 
1,920

 
5,661

 
34,120

 
1,920

 
39,781

 
41,701

 
(7,054
)
 
2012
 
0464
 
Salt Lake City
 
UT
 
—

 
630

 
6,921

 
2,562

 
630

 
9,483

 
10,113

 
(3,123
)
 
2001
 
0465
 
Salt Lake City
 
UT
 
—

 
125

 
6,368

 
68

 
125

 
6,436

 
6,561

 
(2,379
)
 
2001
 
0466
 
Salt Lake City
 
UT
 
—

 
—

 
14,614

 
7

 
—

 
14,621

 
14,621

 
(4,872
)
 
2001
 
0507
 
Salt Lake City
 
UT
 
—

 
280

 
4,345

 
226

 
280

 
4,572

 
4,852

 
(1,694
)
 
2002
 
0799
 
Salt Lake City
 
UT
 
—

 
—

 
14,600

 
90

 
—

 
14,690

 
14,690

 
(3,976
)
 
2005
 
1593
 
Salt Lake City
 
UT
 
—

 
—

 
23,998

 
—

 
—

 
23,998

 
23,998

 
(5,393
)
 
2010
 
 
 
 
 
 
 
$
6,118

 
$
880,878

 
$
2,044,568

 
$
1,131,979

 
$
883,075

 
$
3,094,702

 
$
3,977,777

 
$
(635,314
)
 
 
 


127

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
Medical office
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0638
 
Anchorage
 
AK
 
—

 
1,456

 
10,650

 
12,309

 
1,456

 
22,907

 
24,363

 
(6,114
)
 
2006
 
2572
 
Springdale
 
AR
 
—

 
—

 
27,714

 
—

 
—

 
27,714

 
27,714

 
(916
)
 
2016
 
0520
 
Chandler
 
AZ
 
—

 
3,669

 
13,503

 
2,538

 
3,669

 
15,751

 
19,420

 
(5,883
)
 
2002
 
2040
 
Mesa
 
AZ
 
—

 
—

 
17,314

 
896

 
—

 
18,181

 
18,181

 
(2,567
)
 
2012
 
0468
 
Oro Valley
 
AZ
 
—

 
1,050

 
6,774

 
925

 
1,050

 
7,124

 
8,174

 
(2,857
)
 
2001
 
0356
 
Phoenix
 
AZ
 
—

 
780

 
3,199

 
2,271

 
780

 
4,550

 
5,330

 
(1,884
)
 
1999
 
0470
 
Phoenix
 
AZ
 
—

 
280

 
877

 
120

 
280

 
961

 
1,241

 
(351
)
 
2001
 
1066
 
Scottsdale
 
AZ
 
—

 
5,115

 
14,064

 
3,553

 
4,839

 
17,035

 
21,874

 
(5,539
)
 
2006
 
2021
 
Scottsdale
 
AZ
 
—

 
—

 
12,312

 
1,818

 
—

 
14,046

 
14,046

 
(3,839
)
 
2012
 
2022
 
Scottsdale
 
AZ
 
—

 
—

 
9,179

 
1,222

 
—

 
10,270

 
10,270

 
(2,942
)
 
2012
 
2023
 
Scottsdale
 
AZ
 
—

 
—

 
6,398

 
1,570

 
—

 
7,848

 
7,848

 
(1,871
)
 
2012
 
2024
 
Scottsdale
 
AZ
 
—

 
—

 
9,522

 
663

 
—

 
10,184

 
10,184

 
(2,438
)
 
2012
 
2025
 
Scottsdale
 
AZ
 
—

 
—

 
4,102

 
1,482

 
—

 
5,492

 
5,492

 
(1,650
)
 
2012
 
2026
 
Scottsdale
 
AZ
 
—

 
—

 
3,655

 
1,211

 
—

 
4,826

 
4,826

 
(1,118
)
 
2012
 
2027
 
Scottsdale
 
AZ
 
—

 
—

 
7,168

 
1,455

 
—

 
8,605

 
8,605

 
(2,140
)
 
2012
 
2028
 
Scottsdale
 
AZ
 
—

 
—

 
6,659

 
1,285

 
—

 
7,944

 
7,944

 
(1,937
)
 
2012
 
0453
 
Tucson
 
AZ
 
—

 
215

 
6,318

 
1,390

 
326

 
7,073

 
7,399

 
(3,414
)
 
2000
 
0556
 
Tucson
 
AZ
 
—

 
215

 
3,940

 
1,285

 
267

 
4,745

 
5,012

 
(1,541
)
 
2003
 
1041
 
Brentwood
 
CA
 
—

 
—

 
30,864

 
3,002

 
187

 
33,138

 
33,325

 
(9,716
)
 
2006
 
1200
 
Encino
 
CA
 
—

 
6,151

 
10,438

 
4,583

 
6,646

 
13,736

 
20,382

 
(5,095
)
 
2006
 
0436
 
Murietta
 
CA
 
—

 
400

 
9,266

 
4,140

 
638

 
11,876

 
12,514

 
(5,682
)
 
1999
 
0239
 
Poway
 
CA
 
—

 
2,700

 
10,839

 
3,710

 
2,887

 
12,438

 
15,325

 
(6,698
)
 
1997
 
2654
 
Riverside
 
CA
 
—

 
2,758

 
9,908

 
—

 
2,758

 
9,908

 
12,666

 
—

 
2017
 
0318
 
Sacramento
 
CA
 
—

 
2,860

 
37,566

 
27,137

 
2,911

 
63,801

 
66,712

 
(10,335
)
 
1998
 
2404
 
Sacramento
 
CA
 
—

 
1,268

 
5,109

 
374

 
1,299

 
5,453

 
6,752

 
(649
)
 
2015
 
0234
 
San Diego
 
CA
 
—

 
2,848

 
5,879

 
1,450

 
3,009

 
5,053

 
8,062

 
(3,231
)
 
1997
 
0235
 
San Diego
 
CA
 
—

 
2,863

 
8,913

 
2,913

 
3,068

 
8,297

 
11,365

 
(5,276
)
 
1997
 
0236
 
San Diego
 
CA
 
—

 
4,619

 
19,370

 
4,023

 
4,711

 
16,760

 
21,471

 
(10,173
)
 
1997
 
0421
 
San Diego
 
CA
 
—

 
2,910

 
19,984

 
16,343

 
2,964

 
34,954

 
37,918

 
(8,524
)
 
1999
 
0564
 
San Jose
 
CA
 
—

 
1,935

 
1,728

 
2,616

 
1,935

 
3,302

 
5,237

 
(1,348
)
 
2003
 
0565
 
San Jose
 
CA
 
—

 
1,460

 
7,672

 
527

 
1,460

 
7,721

 
9,181

 
(3,004
)
 
2003
 
0659
 
Los Gatos
 
CA
 
—

 
1,718

 
3,124

 
622

 
1,758

 
3,592

 
5,350

 
(1,336
)
 
2000
 
1209
 
Sherman Oaks
 
CA
 
—

 
7,472

 
10,075

 
5,915

 
7,943

 
14,851

 
22,794

 
(7,274
)
 
2006
 
0439
 
Valencia
 
CA
 
—

 
2,300

 
6,967

 
3,761

 
2,404

 
8,727

 
11,131

 
(3,716
)
 
1999
 
1211
 
Valencia
 
CA
 
—

 
1,344

 
7,507

 
733

 
1,383

 
7,969

 
9,352

 
(2,377
)
 
2006
 
0440
 
West Hills
 
CA
 
—

 
2,100

 
11,595

 
4,182

 
2,259

 
12,225

 
14,484

 
(5,826
)
 
1999
 
0728
 
Aurora
 
CO
 
—

 
—

 
8,764

 
2,807

 
—

 
8,997

 
8,997

 
(3,157
)
 
2005
 
1196
 
Aurora
 
CO
 
—

 
210

 
12,362

 
6,074

 
210

 
17,720

 
17,930

 
(4,037
)
 
2006
 
1197
 
Aurora
 
CO
 
—

 
200

 
8,414

 
5,398

 
200

 
13,482

 
13,682

 
(3,541
)
 
2006
 
0882
 
Colorado Springs
 
CO
 
—

 
—

 
12,933

 
10,716

 
—

 
22,506

 
22,506

 
(7,988
)
 
2006
 
1199
 
Denver
 
CO
 
—

 
493

 
7,897

 
1,865

 
622

 
9,401

 
10,023

 
(3,494
)
 
2006
 
0808
 
Englewood
 
CO
 
—

 
—

 
8,616

 
9,322

 
11

 
16,830

 
16,841

 
(6,146
)
 
2005
 
0809
 
Englewood
 
CO
 
—

 
—

 
8,449

 
3,767

 
—

 
10,997

 
10,997

 
(4,304
)
 
2005
 
0810
 
Englewood
 
CO
 
—

 
—

 
8,040

 
7,711

 
—

 
14,746

 
14,746

 
(5,510
)
 
2005
 
0811
 
Englewood
 
CO
 
—

 
—

 
8,472

 
4,743

 
—

 
11,614

 
11,614

 
(3,760
)
 
2005
 
2658
 
Highlands Ranch
 
CO
 
—

 
1,637

 
10,063

 
—

 
1,637

 
10,063

 
11,700

 
—

 
2017
 
0812
 
Littleton
 
CO
 
—

 
—

 
4,562

 
2,405

 
257

 
5,803

 
6,060

 
(2,317
)
 
2005
 
0813
 
Littleton
 
CO
 
—

 
—

 
4,926

 
1,910

 
106

 
6,089

 
6,195

 
(2,126
)
 
2005
 
0570
 
Lone Tree
 
CO
 
—

 
—

 
—

 
20,096

 
—

 
19,400

 
19,400

 
(6,614
)
 
2003
 
0666
 
Lone Tree
 
CO
 
—

 
—

 
23,274

 
2,663

 
—

 
25,414

 
25,414

 
(8,551
)
 
2000
 
2233
 
Lone Tree
 
CO
 
—

 
—

 
6,734

 
27,690

 
—

 
34,424

 
34,424

 
(1,641
)
 
2014
 
1076
 
Parker
 
CO
 
—

 
—

 
13,388

 
1,048

 
8

 
14,215

 
14,223

 
(4,262
)
 
2006
 
0510
 
Thornton
 
CO
 
—

 
236

 
10,206

 
3,648

 
454

 
13,289

 
13,743

 
(5,213
)
 
2002
 
0434
 
Atlantis
 
FL
 
—

 
—

 
2,027

 
352

 
5

 
2,219

 
2,224

 
(1,141
)
 
1999
 
0435
 
Atlantis
 
FL
 
—

 
—

 
2,000

 
931

 
—

 
2,566

 
2,566

 
(1,346
)
 
1999
 
0602
 
Atlantis
 
FL
 
—

 
455

 
2,231

 
991

 
455

 
2,958

 
3,413

 
(984
)
 
2000
 
0604
 
Englewood
 
FL
 
—

 
170

 
1,134

 
486

 
198

 
1,398

 
1,596

 
(522
)
 
2000
 
0609
 
Kissimmee
 
FL
 
—

 
788

 
174

 
649

 
788

 
721

 
1,509

 
(217
)
 
2000
 
0610
 
Kissimmee
 
FL
 
—

 
481

 
347

 
793

 
494

 
975

 
1,469

 
(452
)
 
2000
 
0671
 
Kissimmee
 
FL
 
—

 
—

 
7,574

 
2,521

 
—

 
8,525

 
8,525

 
(2,817
)
 
2000
 
0603
 
Lake Worth
 
FL
 
—

 
1,507

 
2,894

 
1,807

 
1,507

 
4,569

 
6,076

 
(1,962
)
 
2000
 
0612
 
Margate
 
FL
 
—

 
1,553

 
6,898

 
1,499

 
1,553

 
8,204

 
9,757

 
(2,827
)
 
2000
 
0613
 
Miami
 
FL
 
—

 
4,392

 
11,841

 
4,300

 
4,392

 
14,622

 
19,014

 
(5,453
)
 
2000
 
2202
 
Miami
 
FL
 
—

 
—

 
13,123

 
4,193

 
—

 
17,207

 
17,207

 
(2,767
)
 
2014
 
2203
 
Miami
 
FL
 
—

 
—

 
8,877

 
2,793

 
—

 
11,671

 
11,671

 
(1,607
)
 
2014
 
1067
 
Milton
 
FL
 
—

 
—

 
8,566

 
269

 
—

 
8,816

 
8,816

 
(2,544
)
 
2006
 
2577
 
Naples
 
FL
 
—

 
—

 
29,186

 
—

 
—

 
29,186

 
29,186

 
(903
)
 
2016
 
2578
 
Naples
 
FL
 
—

 
—

 
18,819

 
—

 
—

 
18,819

 
18,819

 
(494
)
 
2016
 
0563
 
Orlando
 
FL
 
—

 
2,144

 
5,136

 
6,662

 
2,343

 
10,110

 
12,453

 
(3,982
)
 
2003
 
0833
 
Pace
 
FL
 
—

 
—

 
10,309

 
3,217

 
26

 
11,206

 
11,232

 
(2,918
)
 
2006
 
0834
 
Pensacola
 
FL
 
—

 
—

 
11,166

 
478

 
—

 
11,644

 
11,644

 
(3,316
)
 
2006
 
0614
 
Plantation
 
FL
 
—

 
969

 
3,241

 
1,595

 
1,017

 
4,151

 
5,168

 
(1,475
)
 
2000
 
0673
 
Plantation
 
FL
 
—

 
1,091

 
7,176

 
1,979

 
1,091

 
8,714

 
9,805

 
(2,579
)
 
2002
 
2579
 
Punta Gorda
 
FL
 
—

 
—

 
9,379

 
—

 
—

 
9,379

 
9,379

 
(280
)
 
2016
 
0701
 
St. Petersburg
 
FL
 
—

 
—

 
13,754

 
8,866

 
—

 
21,181

 
21,181

 
(5,713
)
 
2006
 
1210
 
Tampa
 
FL
 
—

 
1,967

 
6,602

 
6,482

 
2,194

 
10,646

 
12,840

 
(4,722
)
 
2006
 
1058
 
Blue Ridge
 
GA
 
—

 
—

 
3,231

 
228

 
—

 
3,459

 
3,459

 
(934
)
 
2006
 
2576
 
Statesboro
 
GA
 
—

 
—

 
10,234

 
—

 
—

 
10,234

 
10,234

 
(412
)
 
2016
 
1065
 
Marion
 
IL
 
—

 
99

 
11,484

 
775

 
100

 
12,090

 
12,190

 
(3,723
)
 
2006
 
1057
 
Newburgh
 
IN
 
—

 
—

 
14,019

 
4,265

 
—

 
18,278

 
18,278

 
(5,266
)
 
2006
 
2039
 
Kansas City
 
KS
 
—

 
440

 
2,173

 
17

 
448

 
2,181

 
2,629

 
(369
)
 
2012
 
2043
 
Overland Park
 
KS
 
—

 
—

 
7,668

 
366

 
—

 
8,034

 
8,034

 
(1,283
)
 
2012
 
0483
 
Wichita
 
KS
 
—

 
530

 
3,341

 
716

 
530

 
3,620

 
4,150

 
(1,214
)
 
2001
 

128

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
1064
 
Lexington
 
KY
 
—

 
—

 
12,726

 
1,323

 
—

 
13,835

 
13,835

 
(4,443
)
 
2006
 
0735
 
Louisville
 
KY
 
—

 
936

 
8,426

 
5,714

 
936

 
11,622

 
12,558

 
(9,574
)
 
2005
 
0737
 
Louisville
 
KY
 
—

 
835

 
27,627

 
6,376

 
878

 
32,459

 
33,337

 
(11,571
)
 
2005
 
0738
 
Louisville
 
KY
 
—

 
780

 
8,582

 
5,857

 
851

 
12,321

 
13,172

 
(7,304
)
 
2005
 
0739
 
Louisville
 
KY
 
—

 
826

 
13,814

 
1,842

 
832

 
14,195

 
15,027

 
(4,774
)
 
2005
 
0740
 
Louisville
 
KY
 
—

 
2,983

 
13,171

 
4,853

 
2,991

 
16,849

 
19,840

 
(7,188
)
 
2005
 
1944
 
Louisville
 
KY
 
—

 
788

 
2,414

 
—

 
788

 
2,414

 
3,202

 
(676
)
 
2010
 
1945
 
Louisville
 
KY
 
—

 
3,255

 
28,644

 
971

 
3,291

 
29,278

 
32,569

 
(7,073
)
 
2010
 
1946
 
Louisville
 
KY
 
—

 
430

 
6,125

 
152

 
430

 
6,277

 
6,707

 
(1,461
)
 
2010
 
2237
 
Louisville
 
KY
 
—

 
1,519

 
15,386

 
2,941

 
1,542

 
18,304

 
19,846

 
(2,233
)
 
2014
 
2238
 
Louisville
 
KY
 
—

 
1,334

 
12,172

 
1,660

 
1,511

 
13,654

 
15,165

 
(1,896
)
 
2014
 
2239
 
Louisville
 
KY
 
—

 
1,644

 
10,832

 
4,947

 
1,718

 
15,704

 
17,422

 
(1,762
)
 
2014
 
1324
 
Haverhill
 
MA
 
—

 
800

 
8,537

 
2,191

 
869

 
9,373

 
10,242

 
(2,817
)
 
2007
 
1213
 
Ellicott City
 
MD
 
—

 
1,115

 
3,206

 
2,692

 
1,222

 
4,979

 
6,201

 
(2,094
)
 
2006
 
0361
 
GlenBurnie
 
MD
 
—

 
670

 
5,085

 
—

 
670

 
5,085

 
5,755

 
(2,712
)
 
1999
 
1052
 
Towson
 
MD
 
—

 
—

 
14,233

 
3,611

 
—

 
15,132

 
15,132

 
(6,086
)
 
2006
 
2650
 
Biddeford
 
ME
 
—

 
1,949

 
12,244

 
—

 
1,949

 
12,244

 
14,193

 
—

 
2017
 
0240
 
Minneapolis
 
MN
 
—

 
117

 
13,213

 
3,095

 
117

 
15,773

 
15,890

 
(8,465
)
 
1997
 
0300
 
Minneapolis
 
MN
 
—

 
160

 
10,131

 
4,653

 
160

 
13,649

 
13,809

 
(6,940
)
 
1997
 
2032
 
Independence
 
MO
 
—

 
—

 
48,025

 
1,220

 
—

 
49,245

 
49,245

 
(6,371
)
 
2012
 
1078
 
Flowood
 
MS
 
—

 
—

 
8,413

 
762

 
—

 
9,148

 
9,148

 
(3,005
)
 
2006
 
1059
 
Jackson
 
MS
 
—

 
—

 
8,868

 
122

 
—

 
8,990

 
8,990

 
(2,534
)
 
2006
 
1060
 
Jackson
 
MS
 
—

 
—

 
7,187

 
2,189

 
—

 
9,376

 
9,376

 
(3,271
)
 
2006
 
1068
 
Omaha
 
NE
 
—

 
—

 
16,243

 
1,309

 
17

 
17,465

 
17,482

 
(5,270
)
 
2006
 
2651
 
Charlotte
 
NC
 
—

 
2,001

 
11,217

 
—

 
2,001

 
11,217

 
13,218

 
—

 
2017
 
2655
 
Wilmington
 
NC
 
—

 
1,341

 
17,376

 
—

 
1,341

 
17,376

 
18,717

 
—

 
2017
 
2656
 
Wilmington
 
NC
 
—

 
2,071

 
11,592

 
—

 
2,071

 
11,592

 
13,663

 
—

 
2017
 
2657
 
Shallotte
 
NC
 
—

 
918

 
3,609

 
—

 
918

 
3,609

 
4,527

 
—

 
2017
 
2647
 
Concord
 
NH
 
—

 
1,961

 
23,018

 
—

 
1,961

 
23,018

 
24,979

 
—

 
2017
 
2648
 
Concord
 
NH
 
—

 
815

 
8,749

 
—

 
815

 
8,749

 
9,564

 
—

 
2017
 
2649
 
Epsom
 
NH
 
—

 
919

 
5,758

 
—

 
919

 
5,758

 
6,677

 
—

 
2017
 
0729
 
Albuquerque
 
NM
 
—

 
—

 
5,380

 
700

 
—

 
5,758

 
5,758

 
(1,750
)
 
2005
 
0348
 
Elko
 
NV
 
—

 
55

 
2,637

 
12

 
55

 
2,649

 
2,704

 
(1,432
)
 
1999
 
0571
 
Las Vegas
 
NV
 
—

 
—

 
—

 
19,276

 
—

 
17,895

 
17,895

 
(6,235
)
 
2003
 
0660
 
Las Vegas
 
NV
 
—

 
1,121

 
4,363

 
5,809

 
1,328

 
7,991

 
9,319

 
(3,289
)
 
2000
 
0661
 
Las Vegas
 
NV
 
—

 
2,305

 
4,829

 
5,304

 
2,447

 
8,897

 
11,344

 
(3,992
)
 
2000
 
0662
 
Las Vegas
 
NV
 
—

 
3,480

 
12,305

 
5,502

 
3,480

 
15,360

 
18,840

 
(5,449
)
 
2000
 
0663
 
Las Vegas
 
NV
 
—

 
1,717

 
3,597

 
10,833

 
1,724

 
12,732

 
14,456

 
(2,176
)
 
2000
 
0664
 
Las Vegas
 
NV
 
—

 
1,172

 
—

 
631

 
1,803

 
—

 
1,803

 
(53
)
 
2000
 
0691
 
Las Vegas
 
NV
 
—

 
3,244

 
18,339

 
7,583

 
3,273

 
24,434

 
27,707

 
(9,610
)
 
2004
 
2037
 
Mesquite
 
NV
 
—

 
—

 
5,559

 
470

 
34

 
5,983

 
6,017

 
(875
)
 
2012
 
1285
 
Cleveland
 
OH
 
—

 
823

 
2,726

 
925

 
853

 
2,713

 
3,566

 
(1,105
)
 
2006
 
0400
 
Harrison
 
OH
 
—

 
—

 
4,561

 
300

 
—

 
4,861

 
4,861

 
(2,577
)
 
1999
 
1054
 
Durant
 
OK
 
—

 
619

 
9,256

 
1,925

 
659

 
11,120

 
11,779

 
(3,115
)
 
2006
 
0817
 
Owasso
 
OK
 
—

 
—

 
6,582

 
1,521

 
—

 
5,592

 
5,592

 
(1,450
)
 
2005
 
0404
 
Roseburg
 
OR
 
—

 
—

 
5,707

 
700

 
—

 
6,407

 
6,407

 
(3,180
)
 
1999
 
2570
 
Limerick
 
PA
 
—

 
925

 
20,072

 
51

 
925

 
20,123

 
21,048

 
(779
)
 
2016
 
2234
 
Philadelphia
 
PA
 
—

 
24,264

 
99,904

 
20,524

 
24,288

 
120,324

 
144,612

 
(9,466
)
 
2014
 
2403
 
Philadelphia
 
PA
 
—

 
26,063

 
97,646

 
10,578

 
26,110

 
108,177

 
134,287

 
(11,345
)
 
2015
 
2571
 
Wilkes-Barre
 
PA
 
—

 
—

 
9,138

 
—

 
—

 
9,138

 
9,138

 
(364
)
 
2016
 
2573
 
Florence
 
SC
 
—

 
—

 
12,090

 
91

 
—

 
12,181

 
12,181

 
(380
)
 
2016
 
2574
 
Florence
 
SC
 
—

 
—

 
12,190

 
88

 
—

 
12,278

 
12,278

 
(383
)
 
2016
 
2575
 
Florence
 
SC
 
—

 
—

 
11,243

 
56

 
—

 
11,299

 
11,299

 
(435
)
 
2016
 
0252
 
Clarksville
 
TN
 
—

 
203

 
841

 
60

 
210

 
893

 
1,103

 
(495
)
 
1998
 
2634
 
Clarksville
 
TN
 
—

 
259

 
1,555

 
—

 
259

 
1,555

 
1,814

 
(877
)
 
2017
 
0624
 
Hendersonville
 
TN
 
—

 
256

 
1,530

 
1,827

 
256

 
2,864

 
3,120

 
(1,093
)
 
2000
 
0559
 
Hermitage
 
TN
 
—

 
830

 
5,036

 
6,314

 
851

 
10,014

 
10,865

 
(4,011
)
 
2003
 
0561
 
Hermitage
 
TN
 
—

 
596

 
9,698

 
5,893

 
596

 
14,332

 
14,928

 
(5,958
)
 
2003
 
0562
 
Hermitage
 
TN
 
—

 
317

 
6,528

 
2,925

 
317

 
8,579

 
8,896

 
(3,891
)
 
2003
 
0154
 
Knoxville
 
TN
 
—

 
700

 
4,559

 
4,984

 
700

 
9,087

 
9,787

 
(4,349
)
 
1994
 
0625
 
Nashville
 
TN
 
—

 
955

 
14,289

 
3,901

 
955

 
16,560

 
17,515

 
(5,510
)
 
2000
 
0626
 
Nashville
 
TN
 
—

 
2,050

 
5,211

 
4,334

 
2,055

 
8,695

 
10,750

 
(3,334
)
 
2000
 
0627
 
Nashville
 
TN
 
—

 
1,007

 
181

 
724

 
1,060

 
791

 
1,851

 
(427
)
 
2000
 
0628
 
Nashville
 
TN
 
—

 
2,980

 
7,164

 
2,756

 
2,980

 
9,506

 
12,486

 
(4,166
)
 
2000
 
0630
 
Nashville
 
TN
 
—

 
515

 
848

 
400

 
528

 
1,048

 
1,576

 
(334
)
 
2000
 
0631
 
Nashville
 
TN
 
—

 
266

 
1,305

 
1,552

 
266

 
2,441

 
2,707

 
(922
)
 
2000
 
0632
 
Nashville
 
TN
 
—

 
827

 
7,642

 
4,072

 
827

 
10,270

 
11,097

 
(3,912
)
 
2000
 
0633
 
Nashville
 
TN
 
—

 
5,425

 
12,577

 
6,113

 
5,425

 
18,199

 
23,624

 
(7,312
)
 
2000
 
0634
 
Nashville
 
TN
 
—

 
3,818

 
15,185

 
9,661

 
3,818

 
23,722

 
27,540

 
(9,437
)
 
2000
 
0636
 
Nashville
 
TN
 
—

 
583

 
450

 
309

 
583

 
759

 
1,342

 
(296
)
 
2000
 
2611
 
Allen
 
TX
 
—

 
1,330

 
5,960

 
76

 
1,330

 
6,036

 
7,366

 
(231
)
 
2016
 
2612
 
Allen
 
TX
 
—

 
1,310

 
4,165

 
84

 
1,310

 
4,249

 
5,559

 
(173
)
 
2016
 
0573
 
Arlington
 
TX
 
—

 
769

 
12,355

 
4,310

 
769

 
15,677

 
16,446

 
(5,592
)
 
2003
 
2621
 
Cedar Park
 
TX
 
—

 
1,617

 
11,640

 
—

 
1,617

 
11,640

 
13,257

 
(142
)
 
2017
 
0576
 
Conroe
 
TX
 
—

 
324

 
4,842

 
2,528

 
324

 
6,139

 
6,463

 
(2,117
)
 
2000
 
0577
 
Conroe
 
TX
 
—

 
397

 
7,966

 
2,461

 
397

 
9,924

 
10,321

 
(3,702
)
 
2000
 
0578
 
Conroe
 
TX
 
—

 
388

 
7,975

 
4,103

 
388

 
10,549

 
10,937

 
(3,375
)
 
2006
 
0579
 
Conroe
 
TX
 
—

 
188

 
3,618

 
1,337

 
188

 
4,807

 
4,995

 
(1,721
)
 
2000
 
0581
 
Corpus Christi
 
TX
 
—

 
717

 
8,181

 
5,663

 
717

 
11,673

 
12,390

 
(4,090
)
 
2000
 
0600
 
Corpus Christi
 
TX
 
—

 
328

 
3,210

 
3,945

 
328

 
6,632

 
6,960

 
(3,044
)
 
2000
 
0601
 
Corpus Christi
 
TX
 
—

 
313

 
1,771

 
1,923

 
325

 
3,193

 
3,518

 
(1,173
)
 
2000
 
2244
 
Cypress
 
TX
 
—

 
—

 
7,705

 
25,335

 
—

 
33,039

 
33,039

 
(2,054
)
 
2015
 
0582
 
Dallas
 
TX
 
—

 
1,664

 
6,785

 
4,053

 
1,746

 
9,839

 
11,585

 
(3,861
)
 
2000
 
1314
 
Dallas
 
TX
 
—

 
15,230

 
162,971

 
33,595

 
23,882

 
185,238

 
209,120

 
(54,567
)
 
2006
 

129

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
0583
 
Fort Worth
 
TX
 
—

 
898

 
4,866

 
2,334

 
898

 
6,607

 
7,505

 
(2,403
)
 
2000
 
0805
 
Fort Worth
 
TX
 
—

 
—

 
2,481

 
1,211

 
2

 
3,290

 
3,292

 
(1,625
)
 
2005
 
0806
 
Fort Worth
 
TX
 
—

 
—

 
6,070

 
690

 
5

 
6,566

 
6,571

 
(2,065
)
 
2005
 
2231
 
Fort Worth
 
TX
 
—

 
902

 
—

 
44

 
946

 
—

 
946

 
(12
)
 
2014
 
2619
 
Fort Worth
 
TX
 
—

 
1,180

 
13,432

 
6

 
1,180

 
13,437

 
14,617

 
(153
)
 
2017
 
2620
 
Fort Worth
 
TX
 
—

 
1,961

 
14,139

 
72

 
1,961

 
14,211

 
16,172

 
(166
)
 
2017
 
1061
 
Granbury
 
TX
 
—

 
—

 
6,863

 
1,090

 
—

 
7,882

 
7,882

 
(2,083
)
 
2006
 
0430
 
Houston
 
TX
 
—

 
1,927

 
33,140

 
13,211

 
2,151

 
44,381

 
46,532

 
(18,994
)
 
1999
 
0446
 
Houston
 
TX
 
—

 
2,200

 
19,585

 
18,770

 
2,209

 
32,783

 
34,992

 
(18,259
)
 
1999
 
0589
 
Houston
 
TX
 
—

 
1,676

 
12,602

 
5,972

 
1,706

 
15,878

 
17,584

 
(5,555
)
 
2000
 
0670
 
Houston
 
TX
 
—

 
257

 
2,884

 
1,378

 
318

 
3,659

 
3,977

 
(1,406
)
 
2000
 
0702
 
Houston
 
TX
 
—

 
—

 
7,414

 
2,005

 
7

 
8,410

 
8,417

 
(2,880
)
 
2004
 
1044
 
Houston
 
TX
 
—

 
—

 
4,838

 
3,339

 
—

 
6,481

 
6,481

 
(1,929
)
 
2006
 
2542
 
Houston
 
TX
 
—

 
304

 
17,764

 
—

 
304

 
17,764

 
18,068

 
(1,364
)
 
2015
 
2543
 
Houston
 
TX
 
—

 
116

 
6,555

 
—

 
116

 
6,555

 
6,671

 
(595
)
 
2015
 
2544
 
Houston
 
TX
 
—

 
312

 
12,094

 
—

 
312

 
12,094

 
12,406

 
(1,105
)
 
2015
 
2545
 
Houston
 
TX
 
—

 
316

 
13,931

 
—

 
316

 
13,931

 
14,247

 
(970
)
 
2015
 
2546
 
Houston
 
TX
 
—

 
408

 
18,332

 
—

 
408

 
18,332

 
18,740

 
(2,003
)
 
2015
 
2547
 
Houston
 
TX
 
—

 
470

 
18,197

 
—

 
470

 
18,197

 
18,667

 
(1,684
)
 
2015
 
2548
 
Houston
 
TX
 
—

 
313

 
7,036

 
—

 
313

 
7,036

 
7,349

 
(834
)
 
2015
 
2549
 
Houston
 
TX
 
—

 
530

 
22,711

 
—

 
530

 
22,711

 
23,241

 
(1,394
)
 
2015
 
0590
 
Irving
 
TX
 
—

 
828

 
6,160

 
2,834

 
828

 
8,600

 
9,428

 
(3,351
)
 
2000
 
0700
 
Irving
 
TX
 
—

 
—

 
8,550

 
3,620

 
8

 
11,154

 
11,162

 
(4,592
)
 
2006
 
1202
 
Irving
 
TX
 
—

 
1,604

 
16,107

 
1,030

 
1,633

 
17,007

 
18,640

 
(5,268
)
 
2006
 
1207
 
Irving
 
TX
 
—

 
1,955

 
12,793

 
1,904

 
1,986

 
14,617

 
16,603

 
(4,520
)
 
2006
 
2613
 
Kingwood
 
TX
 
—

 
3,035

 
28,373

 
212

 
3,035

 
28,584

 
31,619

 
(1,161
)
 
2016
 
1062
 
Lancaster
 
TX
 
—

 
172

 
2,692

 
1,119

 
185

 
3,733

 
3,918

 
(1,550
)
 
2006
 
2195
 
Lancaster
 
TX
 
—

 
—

 
1,138

 
679

 
131

 
1,686

 
1,817

 
(387
)
 
2006
 
0591
 
Lewisville
 
TX
 
—

 
561

 
8,043

 
2,120

 
561

 
9,727

 
10,288

 
(3,315
)
 
2000
 
0144
 
Longview
 
TX
 
—

 
102

 
7,998

 
715

 
102

 
8,270

 
8,372

 
(4,258
)
 
1992
 
0143
 
Lufkin
 
TX
 
—

 
338

 
2,383

 
80

 
338

 
2,423

 
2,761

 
(1,239
)
 
1992
 
0568
 
Mckinney
 
TX
 
—

 
541

 
6,217

 
2,364

 
541

 
7,876

 
8,417

 
(2,842
)
 
2003
 
0569
 
Mckinney
 
TX
 
—

 
—

 
636

 
8,418

 
—

 
8,174

 
8,174

 
(2,665
)
 
2003
 
1079
 
Nassau Bay
 
TX
 
—

 
—

 
8,942

 
1,384

 
—

 
10,116

 
10,116

 
(3,279
)
 
2006
 
0596
 
N Richland Hills
 
TX
 
—

 
812

 
8,883

 
3,050

 
812

 
11,487

 
12,299

 
(3,998
)
 
2000
 
2048
 
North Richland Hills
 
TX
 
—

 
1,385

 
10,213

 
2,135

 
1,400

 
12,150

 
13,550

 
(2,613
)
 
2012
 
1048
 
Pearland
 
TX
 
—

 
—

 
4,014

 
4,306

 
—

 
7,326

 
7,326

 
(2,395
)
 
2006
 
2232
 
Pearland
 
TX
 
—

 
—

 
3,374

 
13,919

 
—

 
17,293

 
17,293

 
(713
)
 
2014
 
0447
 
Plano
 
TX
 
—

 
1,700

 
7,810

 
6,394

 
1,792

 
13,329

 
15,121

 
(6,390
)
 
1999
 
0597
 
Plano
 
TX
 
—

 
1,210

 
9,588

 
4,693

 
1,224

 
13,176

 
14,400

 
(4,565
)
 
2000
 
0672
 
Plano
 
TX
 
—

 
1,389

 
12,768

 
2,545

 
1,389

 
13,984

 
15,373

 
(4,617
)
 
2002
 
1284
 
Plano
 
TX
 
—

 
2,049

 
18,793

 
2,377

 
2,101

 
18,958

 
21,059

 
(7,525
)
 
2006
 
1286
 
Plano
 
TX
 
—

 
3,300

 
—

 
—

 
3,300

 
—

 
3,300

 
—

 
2006
 
2653
 
Rockwall
 
TX
 
—

 
788

 
9,020

 
—

 
788

 
9,020

 
9,808

 
—

 
2017
 
0815
 
San Antonio
 
TX
 
—

 
—

 
9,193

 
2,654

 
12

 
11,039

 
11,051

 
(3,584
)
 
2006
 
0816
 
San Antonio
 
TX
 
3,376

 
—

 
8,699

 
2,872

 
175

 
10,675

 
10,850

 
(3,770
)
 
2006
 
1591
 
San Antonio
 
TX
 
—

 
—

 
7,309

 
641

 
12

 
7,906

 
7,918

 
(2,086
)
 
2010
 
1977
 
San Antonio
 
TX
 
—

 
—

 
26,191

 
1,536

 
—

 
27,482

 
27,482

 
(6,622
)
 
2011
 
2559
 
Shenandoah
 
TX
 
—

 
—

 
—

 
27,194

 
—

 
27,194

 
27,194

 
(401
)
 
2016
 
0598
 
Sugarland
 
TX
 
—

 
1,078

 
5,158

 
2,774

 
1,170

 
7,077

 
8,247

 
(2,729
)
 
2000
 
0599
 
Texas City
 
TX
 
—

 
—

 
9,519

 
169

 
—

 
9,532

 
9,532

 
(2,864
)
 
2000
 
0152
 
Victoria
 
TX
 
—

 
125

 
8,977

 
394

 
125

 
9,370

 
9,495

 
(4,846
)
 
1994
 
2550
 
The Woodlands
 
TX
 
—

 
115

 
5,141

 
—

 
115

 
5,141

 
5,256

 
(403
)
 
2015
 
2551
 
The Woodlands
 
TX
 
—

 
296

 
18,282

 
—

 
296

 
18,282

 
18,578

 
(1,235
)
 
2015
 
2552
 
The Woodlands
 
TX
 
—

 
374

 
25,125

 
—

 
374

 
25,125

 
25,499

 
(1,513
)
 
2015
 
1592
 
Bountiful
 
UT
 
—

 
999

 
7,426

 
674

 
999

 
8,101

 
9,100

 
(1,991
)
 
2010
 
0169
 
Bountiful
 
UT
 
—

 
276

 
5,237

 
1,447

 
363

 
6,159

 
6,522

 
(2,940
)
 
1995
 
0346
 
Castle Dale
 
UT
 
—

 
50

 
1,818

 
73

 
50

 
1,828

 
1,878

 
(983
)
 
1998
 
0347
 
Centerville
 
UT
 
—

 
300

 
1,288

 
276

 
300

 
1,394

 
1,694

 
(704
)
 
1999
 
2035
 
Draper
 
UT
 
5,088

 
—

 
10,803

 
183

 
—

 
10,879

 
10,879

 
(1,455
)
 
2012
 
0469
 
Kaysville
 
UT
 
—

 
530

 
4,493

 
226

 
530

 
4,719

 
5,249

 
(1,786
)
 
2001
 
0456
 
Layton
 
UT
 
—

 
371

 
7,073

 
1,265

 
389

 
8,034

 
8,423

 
(3,704
)
 
2001
 
2042
 
Layton
 
UT
 
—

 
—

 
10,975

 
412

 
—

 
11,388

 
11,388

 
(1,503
)
 
2012
 
0359
 
Ogden
 
UT
 
—

 
180

 
1,695

 
240

 
180

 
1,814

 
1,994

 
(993
)
 
1999
 
0357
 
Orem
 
UT
 
—

 
337

 
8,744

 
2,041

 
306

 
8,268

 
8,574

 
(4,302
)
 
1999
 
0371
 
Providence
 
UT
 
—

 
240

 
3,876

 
618

 
282

 
4,163

 
4,445

 
(2,057
)
 
1999
 
0353
 
Salt Lake City
 
UT
 
—

 
190

 
779

 
164

 
201

 
885

 
1,086

 
(477
)
 
1999
 
0354
 
Salt Lake City
 
UT
 
—

 
220

 
10,732

 
2,204

 
220

 
12,421

 
12,641

 
(6,638
)
 
1999
 
0355
 
Salt Lake City
 
UT
 
—

 
180

 
14,792

 
2,647

 
180

 
16,688

 
16,868

 
(8,675
)
 
1999
 
0467
 
Salt Lake City
 
UT
 
—

 
3,000

 
7,541

 
2,274

 
3,145

 
9,323

 
12,468

 
(3,784
)
 
2001
 
0566
 
Salt Lake City
 
UT
 
—

 
509

 
4,044

 
2,510

 
509

 
6,121

 
6,630

 
(2,320
)
 
2003
 
2041
 
Salt Lake City
 
UT
 
—

 
—

 
12,326

 
335

 
—

 
12,661

 
12,661

 
(1,682
)
 
2012
 
2033
 
Sandy
 
UT
 
—

 
867

 
3,513

 
842

 
1,153

 
4,069

 
5,222

 
(1,245
)
 
2012
 
0482
 
Stansbury
 
UT
 
—

 
450

 
3,201

 
1,147

 
529

 
3,944

 
4,473

 
(1,245
)
 
2001
 
0351
 
Washington Terrace
 
UT
 
—

 
—

 
4,573

 
2,493

 
17

 
6,279

 
6,296

 
(3,509
)
 
1999
 
0352
 
Washington Terrace
 
UT
 
—

 
—

 
2,692

 
1,309

 
15

 
3,306

 
3,321

 
(1,657
)
 
1999
 
2034
 
West Jordan
 
UT
 
—

 
—

 
12,021

 
264

 
—

 
12,285

 
12,285

 
(1,604
)
 
2012
 
2036
 
West Jordan
 
UT
 
547

 
—

 
1,383

 
1,522

 
—

 
2,905

 
2,905

 
(610
)
 
2012
 
0495
 
West Valley City
 
UT
 
—

 
410

 
8,266

 
1,002

 
410

 
9,268

 
9,678

 
(4,567
)
 
2002
 
0349
 
West Valley City
 
UT
 
—

 
1,070

 
17,463

 
128

 
1,036

 
17,581

 
18,617

 
(9,488
)
 
1999
 
1208
 
Fairfax
 
VA
 
—

 
8,396

 
16,710

 
10,434

 
8,494

 
26,168

 
34,662

 
(8,694
)
 
2006
 
2230
 
Fredericksburg
 
VA
 
—

 
1,101

 
8,570

 
—

 
1,101

 
8,570

 
9,671

 
(837
)
 
2014
 
0572
 
Reston
 
VA
 
—

 
—

 
11,902

 
967

 
—

 
12,026

 
12,026

 
(4,458
)
 
2003
 
0448
 
Renton
 
WA
 
—

 
—

 
18,724

 
3,092

 
—

 
20,685

 
20,685

 
(10,299
)
 
1999
 

130

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
0781
 
Seattle
 
WA
 
—

 
—

 
52,703

 
15,806

 
—

 
64,279

 
64,279

 
(22,985
)
 
2004
 
0782
 
Seattle
 
WA
 
—

 
—

 
24,382

 
12,686

 
126

 
34,881

 
35,007

 
(13,765
)
 
2004
 
0783
 
Seattle
 
WA
 
—

 
—

 
5,625

 
1,375

 
183

 
6,690

 
6,873

 
(6,322
)
 
2004
 
0785
 
Seattle
 
WA
 
—

 
—

 
7,293

 
6,215

 
—

 
12,213

 
12,213

 
(4,804
)
 
2004
 
1385
 
Seattle
 
WA
 
—

 
—

 
45,027

 
3,619

 
—

 
48,471

 
48,471

 
(15,524
)
 
2007
 
2038
 
Evanston
 
WY
 
—

 
—

 
4,601

 
222

 
—

 
4,823

 
4,823

 
(681
)
 
2012
 
 
 
 
 
 
 
$
9,011

 
$
279,168

 
$
2,785,660

 
$
822,680

 
$
295,620

 
$
3,434,989

 
$
3,730,609

 
$
(924,333
)
 
 
 


131

 
    
    
    
 
    
Encumbrances at December 31, 2017
 
Initial Cost to Company
    
Costs Capitalized Subsequent to Acquisition
    
Gross Amount at Which Carried
As of December 31, 2017
    
Accumulated Depreciation
    
Year Acquired/ Constructed
    
City
 
 
 
State
 
    
Land
    
Buildings and Improvements
 
 
Land
    
Buildings and Improvements
    
Total(1)
 
 
 
Other non-reportable segments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other-Hospitals
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0126
 
Sherwood
 
AR
 
—

 
709

 
9,604

 
—

 
709

 
9,587

 
10,296

 
(5,723
)
 
1989
 
0113
 
Glendale
 
AZ
 
—

 
1,565

 
7,050

 
20

 
1,565

 
7,050

 
8,615

 
(4,277
)
 
1988
 
1038
 
Fresno
 
CA
 
—

 
3,652

 
29,113

 
21,935

 
3,652

 
51,048

 
54,700

 
(16,338
)
 
2006
 
0423
 
Irvine
 
CA
 
—

 
18,000

 
70,800

 
—

 
18,000

 
70,800

 
88,800

 
(36,755
)
 
1999
 
0127
 
Colorado Springs
 
CO
 
—

 
690

 
8,338

 
—

 
690

 
8,338

 
9,028

 
(4,960
)
 
1989
 
0887
 
Atlanta
 
GA
 
—

 
4,300

 
13,690

 
—

 
4,300

 
11,890

 
16,190

 
(6,440
)
 
2007
 
0112
 
Overland Park
 
KS
 
—

 
2,316

 
10,681

 
24

 
2,316

 
10,680

 
12,996

 
(6,712
)
 
1988
 
1383
 
Baton Rouge
 
LA
 
—

 
690

 
8,545

 
87

 
690

 
8,496

 
9,186

 
(4,139
)
 
2007
 
2031
 
Slidell
 
LA
 
—

 
3,000

 
—

 
643

 
3,643

 
—

 
3,643

 
—

 
2012
 
0886
 
Dallas
 
TX
 
—

 
1,820

 
8,508

 
26

 
1,820

 
7,454

 
9,274

 
(2,019
)
 
2007
 
1319
 
Dallas
 
TX
 
—

 
18,840

 
155,659

 
1,557

 
18,840

 
157,216

 
176,056

 
(48,404
)
 
2007
 
1384
 
Plano
 
TX
 
—

 
6,290

 
22,686

 
5,706

 
6,290

 
28,203

 
34,493

 
(13,334
)
 
2007
 
2198
 
Webster
 
TX
 
—

 
2,220

 
9,602

 
—

 
2,220

 
9,602

 
11,822

 
(1,850
)
 
2013
 
Other-Post-acute/skilled nursing
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2469
 
Rural Retreat
 
VA
 
—

 
1,876

 
14,720

 
—

 
1,876

 
14,720

 
16,596

 
(1,064
)
 
2013
 
Other-United Kingdom
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2210
 
Adlington
 
EG
 
—

 
548

 
7,108

 
1,951

 
650

 
8,961

 
9,611

 
(757
)
 
2014
 
2211
 
Adlington
 
EG
 
—

 
568

 
4,318

 
—

 
568

 
4,318

 
4,886

 
(359
)
 
2014
 
2216
 
Alderley Edge
 
EG
 
—

 
1,252

 
8,719

 
—

 
1,252

 
8,719

 
9,971

 
(656
)
 
2014
 
2217
 
Alderley Edge
 
EG
 
—

 
1,218

 
6,827

 
—

 
1,218

 
6,828

 
8,046

 
(539
)
 
2014
 
2340
 
Altrincham
 
EG
 
—

 
1,745

 
18,693

 
—

 
1,745

 
18,694

 
20,439

 
(1,218
)
 
2015
 
2312
 
Armley
 
EG
 
—

 
447

 
2,670

 
—

 
447

 
2,670

 
3,117

 
(278
)
 
2015
 
2313
 
Armley
 
EG
 
—

 
1,001

 
3,114

 
—

 
1,001

 
3,114

 
4,115

 
(335
)
 
2015
 
2309
 
Ashton under Lyne
 
EG
 
—

 
649

 
4,507

 
—

 
649

 
4,507

 
5,156

 
(472
)
 
2015
 
2206
 
Bangor
 
EG
 
—

 
386

 
2,064

 
—

 
385

 
2,064

 
2,449

 
(213
)
 
2014
 
2207
 
Batley
 
EG
 
—

 
649

 
3,203

 
—

 
649

 
3,203

 
3,852

 
(454
)
 
2014
 
2336
 
Birmingham
 
EG
 
—

 
677

 
2,451

 
601

 
677

 
3,052

 
3,729

 
(522
)
 
2015
 
2320
 
Bishopbriggs
 
EG
 
—

 
907

 
4,166

 
—

 
907

 
4,166

 
5,073

 
(452
)
 
2015
 
2323
 
Bonnyrigg
 
EG
 
—

 
947

 
6,239

 
—

 
947

 
6,239

 
7,186

 
(644
)
 
2015
 
2335
 
Cardiff
 
EG
 
—

 
1,434

 
4,838

 
744

 
1,434

 
5,581

 
7,015

 
(771
)
 
2015
 
2223
 
Catterick Garrison
 
EG
 
—

 
798

 
1,467

 
—

 
798

 
1,467

 
2,265

 
(294
)
 
2014
 
2226
 
Christleton
 
EG
 
—

 
528

 
5,103

 
—

 
528

 
5,103

 
5,631

 
(401
)
 
2014
 
2327
 
Croydon
 
EG
 
—

 
1,597

 
2,494

 
17

 
1,596

 
2,511

 
4,107

 
(296
)
 
2015
 
2221
 
Disley
 
EG
 
—

 
345

 
1,621

 
—

 
345

 
1,620

 
1,965

 
(175
)
 
2014
 
2227
 
Disley
 
EG
 
—

 
690

 
3,964

 
—

 
690

 
3,964

 
4,654

 
(319
)
 
2014
 
2306
 
Dukinfield
 
EG
 
—

 
758

 
4,054

 
—

 
758

 
4,053

 
4,811

 
(412
)
 
2015
 
2316
 
Dukinfield
 
EG
 
—

 
392

 
2,491

 
—

 
392

 
2,491

 
2,883

 
(236
)
 
2015
 
2317
 
Dukinfield
 
EG
 
—

 
528

 
2,811

 
—

 
528

 
2,811

 
3,339

 
(309
)
 
2015
 
2318
 
Dumbarton
 
EG
 
—

 
920

 
3,825

 
—

 
920

 
3,825

 
4,745

 
(429
)
 
2015
 
2303
 
Eckington
 
EG
 
—

 
501

 
1,638

 
—

 
500

 
1,638

 
2,138

 
(213
)
 
2015
 
2333
 
Edinburgh
 
EG
 
—

 
4,533

 
24,135

 
558

 
4,533

 
24,693

 
29,226

 
(2,431
)
 
2015
 
2208
 
Elstead
 
EG
 
—

 
893

 
3,061

 
—

 
893

 
3,060

 
3,953

 
(346
)
 
2014
 
2328
 
Forfar
 
EG
 
—

 
852

 
6,200

 
427

 
853

 
6,626

 
7,479

 
(746
)
 
2015
 
2214
 
Gilroyd
 
EG
 
—

 
998

 
1,691

 
—

 
998

 
1,691

 
2,689

 
(322
)
 
2014
 
2330
 
Glasgow
 
EG
 
—

 
1,854

 
6,645

 
1,207

 
1,854

 
7,853

 
9,707

 
(1,136
)
 
2015
 
2307
 
Hyde
 
EG
 
—

 
1,394

 
5,144

 
—

 
1,394

 
5,144

 
6,538

 
(581
)
 
2015
 
2324
 
Lewisham
 
EG
 
—

 
1,921

 
7,113

 
604

 
1,922

 
7,717

 
9,639

 
(933
)
 
2015
 
2332
 
Linlithgow
 
EG
 
—

 
1,448

 
7,434

 
599

 
1,448

 
8,033

 
9,481

 
(933
)
 
2015
 
2213
 
Ilkley
 
EG
 
—

 
954

 
2,518

 
—

 
954

 
2,518

 
3,472

 
(403
)
 
2014
 
2209
 
Kingswood
 
EG
 
—

 
1,042

 
3,884

 
—

 
1,042

 
3,884

 
4,926

 
(405
)
 
2014
 
2212
 
Kirk Hammerton
 
EG
 
—

 
438

 
561

 
—

 
438

 
561

 
999

 
(131
)
 
2014
 
2310
 
Kirkby
 
EG
 
—

 
568

 
2,712

 
—

 
568

 
2,712

 
3,280

 
(302
)
 
2015
 
2304
 
Knotty Ash
 
EG
 
—

 
649

 
2,275

 
—

 
649

 
2,274

 
2,923

 
(270
)
 
2015
 
2322
 
Laindon
 
EG
 
—

 
1,191

 
2,771

 
—

 
1,191

 
2,771

 
3,962

 
(329
)
 
2015
 
2215
 
Leeds
 
EG
 
—

 
503

 
795

 
—

 
504

 
795

 
1,299

 
(196
)
 
2014
 
2326
 
Limehouse
 
EG
 
—

 
2,219

 
3,168

 
23

 
2,219

 
3,191

 
5,410

 
(409
)
 
2015
 
2321
 
Luton
 
EG
 
—

 
1,069

 
3,169

 
—

 
1,069

 
3,169

 
4,238

 
(336
)
 
2015
 
2339
 
Manchester
 
EG
 
—

 
1,685

 
15,136

 
—

 
1,685

 
15,136

 
16,821

 
(1,004
)
 
2015
 
2225
 
N Wadebridge
 
EG
 
—

 
298

 
6,158

 
—

 
298

 
6,159

 
6,457

 
(518
)
 
2014
 
2331
 
Paisley
 
EG
 
—

 
1,231

 
3,995

 
13

 
1,232

 
4,007

 
5,239

 
(444
)
 
2015
 
2308
 
Prescot
 
EG
 
—

 
541

 
1,934

 
—

 
541

 
1,934

 
2,475

 
(248
)
 
2015
 
2305
 
Prescot
 
EG
 
—

 
636

 
2,382

 
—

 
636

 
2,382

 
3,018

 
(284
)
 
2015
 
2219
 
Ripon
 
EG
 
—

 
189

 
906

 
—

 
189

 
906

 
1,095

 
(130
)
 
2014
 
2319
 
Sheffield
 
EG
 
—

 
744

 
2,705

 
—

 
745

 
2,704

 
3,449

 
(303
)
 
2015
 
2314
 
Stalybridge
 
EG
 
—

 
704

 
3,608

 
—

 
704

 
3,608

 
4,312

 
(380
)
 
2015
 
2315
 
Stalybridge
 
EG
 
—

 
555

 
1,887

 
—

 
555

 
1,887

 
2,442

 
(212
)
 
2015
 
2218
 
Stapeley
 
EG
 
—

 
995

 
6,491

 
—

 
994

 
6,491

 
7,485

 
(567
)
 
2014
 
2325
 
Stirling
 
EG
 
—

 
907

 
4,929

 
451

 
907

 
5,380

 
6,287

 
(640
)
 
2015
 
2329
 
Stirling
 
EG
 
—

 
1,110

 
4,041

 
646

 
1,109

 
4,687

 
5,796

 
(673
)
 
2015
 
2224
 
Stockton-on-Tees
 
EG
 
—

 
292

 
2,086

 
—

 
292

 
2,086

 
2,378

 
(240
)
 
2014
 
2220
 
Thornton-Cleveleys
 
EG
 
—

 
913

 
4,566

 
—

 
913

 
4,566

 
5,479

 
(482
)
 
2014
 
2228
 
Upper Wortley
 
EG
 
—

 
455

 
3,366

 
—

 
454

 
3,366

 
3,820

 
(334
)
 
2014
 
2311
 
Wigan
 
EG
 
—

 
717

 
2,660

 
—

 
717

 
2,661

 
3,378

 
(366
)
 
2015
 
2337
 
Wigan
 
EG
 
—

 
541

 
1,820

 
16

 
534

 
1,843

 
2,377

 
(247
)
 
2015
 
2338
 
Wigan
 
EG
 
—

 
474

 
3,788

 
23

 
474

 
3,811

 
4,285

 
(399
)
 
2015
 
2222
 
Woolmer Green
 
EG
 
—

 
832

 
6,062

 
—

 
832

 
6,061

 
6,893

 
(577
)
 
2014
 
2334
 
Wotton under Edge
 
EG
 
—

 
636

 
2,490

 
164

 
636

 
2,654

 
3,290

 
(378
)
 
2015
 
 
 
 
 
 
 
$
—

 
$
122,434

 
$
641,667

 
$
38,042

 
$
123,171

 
$
675,704

 
$
798,875

 
$
(181,404
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total operations properties
 
 
 
 
 
$
144,486

 
$
1,765,938

 
$
9,726,105

 
$
2,332,632

 
$
1,785,865

 
$
11,687,527

 
$
13,473,392

 
$
(2,741,537
)
 
 
 
Corporate and other assets
 
 
 
—

 
—

 
—

 
—

 
—

 
181

 
181

 
(158
)
 
 
 
Total
 
 
 
 
 
$
144,486

 
$
1,765,938

 
$
9,726,105

 
$
2,332,632

 
$
1,785,865

 
$
11,687,708

 
$
13,473,573

 
$
(2,741,695
)
 
 
 

132

_______________________________________
1.
Buildings and improvements are depreciated over useful lives ranging up to 60 years.
2.
At December 31, 2017, the tax basis of the Company’s net real estate assets is less than the reported amounts by $900 million (unaudited).
(b)
A summary of activity for real estate and accumulated depreciation follows (in thousands):
 
Year ended December 31,
 
2017
 
2016
 
2015
Real estate:
 
 
 
 
 
Balances at beginning of year
$
13,974,760

 
$
14,330,257

 
$
12,931,832

Acquisition of real estate and development and improvements
995,443

 
987,135

 
1,930,931

Sales and/or transfers to assets held for sale and discontinued operations
(589,391
)
 
(1,227,614
)
 
(473,057
)
Deconsolidation of real estate
(825,074
)
 
(10,306
)
 
—

Impairments
(37,274
)
 
—

 
(3,118
)
Other(1)
(44,891
)
 
(104,712
)
 
(56,331
)
Balances at end of year
$
13,473,573

 
$
13,974,760

 
$
14,330,257

Accumulated depreciation:
 
 
 
 
 
Balances at beginning of year
$
2,648,930

 
$
2,476,015

 
$
2,190,486

Depreciation expense
436,085

 
465,945

 
418,591

Sales and/or transfers to assets held for sale and discontinued operations
(115,195
)
 
(239,112
)
 
(86,001
)
Deconsolidation of real estate
(152,572
)
 
(5,868
)
 
—

Other(1)
(75,553
)
 
(48,050
)
 
(47,061
)
Balances at end of year
$
2,741,695

 
$
2,648,930

 
$
2,476,015

_______________________________________
(1)
Represents real estate and accumulated depreciation related to fully depreciated assets written off, foreign exchange translation or where the lease classification has changed to direct financing leases.


ITEM 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
ITEM 9A.
Controls and Procedures
Disclosure Controls and Procedures.  We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As required by Rules 13a-15(b) and 15d-15(b) of the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2017. Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective, as of December 31, 2017, at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting.  There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fourth quarter of 2017 to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

133

Management’s Annual Report on Internal Control over Financial Reporting.  Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control—Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective as of December 31, 2017.
The effectiveness of our internal control over financial reporting as of December 31, 2017 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report, which is included herein.

134

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of HCP, Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of HCP, Inc. and subsidiaries (the “Company”) as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2017, of the Company and our report dated February 13, 2018, expressed an unqualified opinion on those financial statements and included an explanatory paragraph regarding the Company’s adoption of Accounting Standards Update 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 
/s/ Deloitte & Touche LLP
Los Angeles, California
February 13, 2018

135

ITEM 9B.
Other Information
None.

136

PART III
ITEM 10.
Directors, Executive Officers and Corporate Governance
We have adopted a Code of Business Conduct and Ethics that applies to all of our directors and employees, including our Chief Executive Officer and all senior financial officers, including our principal financial officer, principal accounting officer and controller. We have also adopted a Vendor Code of Business Conduct and Ethics applicable to our vendors and business partners. Current copies of our Code of Business Conduct and Ethics and Vendor Code of Business Conduct and Ethics are posted on our website at www.hcpi.com/codeofconduct. In addition, waivers from, and amendments to, our Code of Business Conduct and Ethics that apply to our directors and executive officers, including our principal executive officer, principal financial officer, principal accounting officer or persons performing similar functions, will be timely posted in the Investor Relations section of our website at www.hcpi.com.
We hereby incorporate by reference the information appearing under the captions “Proposal No. 1 Election of Directors,” “Our Executive Officers,” “Board of Directors and Corporate Governance” and “Section 16(a) Beneficial Ownership Reporting Compliance” in the Registrant’s definitive proxy statement relating to its 2018 Annual Meeting of Stockholders to be held on April 26, 2018.
ITEM 11.
Executive Compensation
We hereby incorporate by reference the information under the caption “Executive Compensation” in the Registrant’s definitive proxy statement relating to its 2018 Annual Meeting of Stockholders to be held on April 26, 2018.
ITEM 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
We hereby incorporate by reference the information under the captions “Security Ownership of Principal Stockholders, Directors and Management” and “Equity Compensation Plan Information” in the Registrant’s definitive proxy statement relating to its 2018 Annual Meeting of Stockholders to be held on April 26, 2018.
ITEM 13.
Certain Relationships and Related Transactions, and Director Independence
We hereby incorporate by reference the information under the caption “Board of Directors and Corporate Governance” in the Registrant’s definitive proxy statement relating to its 2018 Annual Meeting of Stockholders to be held on April 26, 2018.
ITEM 14.
Principal Accounting Fees and Services
We hereby incorporate by reference under the caption “Audit and Non-Audit Fees” in the Registrant’s definitive proxy statement relating to its 2018 Annual Meeting of Stockholders to be held on April 26, 2018.

137

PART IV
ITEM 15.
Exhibits, Financial Statement Schedules
(a) 1.  Financial Statement Schedules
The following Consolidated Financial Statements are included in Part II, Item 8-Financial Statements and Supplementary Data of this Annual Report on Form 10-K.
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets-December 31, 2017 and 2016
Consolidated Statements of Operations-for the years ended December 31, 2017, 2016 and 2015
Consolidated Statements of Comprehensive Income (Loss)-for the years ended December 31, 2017, 2016 and 2015
Consolidated Statements of Equity-for the years ended December 31, 2017, 2016 and 2015
Consolidated Statements of Cash Flows-for the years ended December 31, 2017, 2016 and 2015
Notes to Consolidated Financial Statements
(a) 2.  Financial Statement Schedules
The following Consolidated Financial Statements are included in Part II, Item 8-Financial Statements and Supplementary Data of this Annual Report on Form 10-K.
Schedule II: Valuation and Qualifying Accounts
Schedule III: Real Estate and Accumulated Depreciation


(a) 3.
Exhibits
Exhibit
 
 
 
Incorporated by reference herein
Number
 
Description
 
Form
 
Date Filed
2.1
 
 
Current Report on Form 8-K
(File No. 001-08895)
 
October 31, 2016
3.1
 

 
Quarterly Report on Form 10-Q (File No. 001-08895)
 
November 2, 2017
3.2
 

 
Quarterly Report on Form 10-Q (File No. 001-08895)
 
November 2, 2017
4.1
 
 
Registration Statement on Form S‑3/A
(Registration No. 333‑86654)
 
May 21, 2002
4.1.1
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
January 24, 2011
4.2
 
 
Current Report on Form 8‑K
(File No. 001‑ 08895)
 
November 19, 2012
4.2.1
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
November 19, 2012

138

4.2.2
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
November 13, 2013
4.2.3
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
February 24, 2014
4.2.4
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
August 14, 2014
4.2.5
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
January 21, 2015
4.2.6
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
May 20, 2015
4.2.7
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
December 1, 2015
4.3
 

 
Current Report on Form 8‑K
(File No. 001‑08895)
 
January 24, 2011
4.4
 

 
Current Report on Form 8‑K
(File No. 001‑08895)
 
January 24, 2011

4.5
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
January 23, 2012
4.6
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
July 23, 2012
4.7
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
November 19, 2012
4.8
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
November 13, 2013
4.9
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
February 24, 2014
4.10
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
August 14, 2014
4.11
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
January 21, 2015
4.12
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
May 20, 2015
4.13
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
December 1, 2015
10.1
 
 
Quarterly Report on Form 10‑Q
(File No. 001‑08895)
 
November 3, 2009
10.2
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
August 5, 2014
10.3
 
 
Quarterly Report on Form 10-Q
(File No. 001-08895)
 
November 1, 2016
10.4
 
 
Quarterly Report on Form 10-Q (File No. 001 08895)
 
November 1, 2016
10.5
 
 
Annex 2 to HCP’s Proxy Statement
(File No. 001‑08895)
 
March 10, 2009
10.5.1
 
 
Quarterly Report on Form 10‑Q
(File No. 001‑08895)
 
May 1, 2012
10.6
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
May 6, 2014

139

10.6.1
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
August 5, 2014
10.6.2
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
August 5, 2014
10.6.3
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
May 5, 2015
10.6.4
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
May 5, 2015
10.6.5
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
May 5, 2015
10.6.6
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
May 5, 2015
10.6.7
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
May 5, 2015
10.6.8
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
May 5, 2015
10.6.9
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
May 5, 2015
10.7
 
 
Annual Report on Form 10‑K, as amended (File No. 001‑08895)
 
February 12, 2008
10.8
 
 
Registration Statement on Form S‑3
(Registration No. 333‑49746)
 
November 13, 2000
10.9
 
 
Annual Report on Form 10‑K
(File No. 001‑ 08895)
 
March 29, 1999
10.9.1
 
 
 
 
 
10.10
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
November 9, 2012
10.11
 
 
Quarterly Report on Form 10‑Q
(File No. 001‑ 08895)
 
November 12, 2003
10.11.1
 
 
Quarterly Report on Form 10‑Q
(File No. 001‑08895)
 
November 8, 2004
10.11.2
 
 
Annual Report on Form 10‑K
(File No. 001‑08895)
 
March 15, 2005
10.11.3
 
 
Quarterly Report on Form 10‑Q
(File No. 001‑08895)
 
November 1, 2005
10.11.4
 
 
Annual Report on Form 10‑K, as amended (File No. 001‑08895)
 
February 12, 2008
10.12
 
 
Current Report on Form 8-K
(File No. 001‑08895)
 
April 20, 2012
10.13
 
 
Quarterly Report on Form 10-Q
(File No. 001‑08895)
 
August 5, 2014

140

10.14
 
 
Current Report on Form 8‑K
(File No. 001‑08895)
 
October 20, 2017
10.15
 
 
Current Report on Form 8-K (File No. 1-08895)
 
June 26, 2015
10.16
 
 
 
 
 
10.16.1
 
 
 
 
 
21.1
 
 
 
 
 
23.1
 
 
 
 
 
31.1
 
 
 
 
 
31.2
 
 
 
 
 
32.1
 
 
 
 
 
32.2
 
 
 
 
 
101.INS
 
XBRL Instance Document.†
 
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document.†
 
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document.†
 
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document.†
 
 
 
 
101.LAB
 
XBRL Taxonomy Extension Labels Linkbase Document.†
 
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document.†
 
 
 
 
_______________________________________
*
Management Contract or Compensatory Plan or Arrangement.
**
Portions of this exhibit have been omitted pursuant to a request for confidential treatment with the SEC.
***
Certain schedules or similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplemental copies of any of the omitted schedules or attachments upon request by the SEC.
†
Filed herewith.

ITEM 16.
Form 10-K Summary
None.

141

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: February 13, 2018
 
HCP, Inc. (Registrant)
 
 
 
/s/ THOMAS M. HERZOG
 
Thomas M. Herzog,
President and Chief Executive Officer
(Principal Executive Officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature
 
Title
 
Date
 
 
 
 
 
/s/ THOMAS M. HERZOG
 
President and Chief Executive Officer
 
February 13, 2018
Thomas M. Herzog
 
(Principal Executive Officer), Director
 
 
 
 
 
 
 
/s/ PETER A. SCOTT
 
Executive Vice President and Chief Financial Officer
 
February 13, 2018
Peter A. Scott

 
(Principal Financial Officer)
 
 
 
 
 
 
 
/s/ SHAWN G. JOHNSTON
 
Senior Vice President and Chief Accounting Officer
 
February 13, 2018
Shawn G. Johnston
 
(Principal Accounting Officer)
 
 
 
 
 
 
 
/s/ DAVID B. HENRY
 
Chairman of the Board
 
February 13, 2018
David B. Henry
 
 
 
 
 
 
 
 
 
/s/ BRIAN G. CARTWRIGHT
 
Director
 
February 13, 2018
Brian G. Cartwright
 
 
 
 
 
 
 
 
 
/s/ CHRISTINE N. GARVEY
 
Director
 
February 13, 2018
Christine N. Garvey
 
 
 
 
 
 
 
 
 
/s/ JAMES P. HOFFMANN
 
Director
 
February 13, 2018
James P. Hoffmann
 
 
 
 
 
 
 
 
 
/s/ MICHAEL D. MCKEE
 
Director
 
February 13, 2018
Michael D. McKee
 
 
 
 
 
 
 
 
 
/s/ PETER L. RHEIN
 
Director
 
February 13, 2018
Peter L. Rhein
 
 
 
 
 
 
 
 
 
/s/ JOSEPH P. SULLIVAN
 
Director
 
February 13, 2018
Joseph P. Sullivan
 
 
 
 

142